[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "Vascular Ultrasound Unresponsive percutaneous Minimise every PaCO2 defibrillator/monitor VT Nonshockable Use VF/Pulseless Hypothermia Immediate CPR Continuous when Toxins to rhythm Reversible airway for Hypoxia min shocks Aim 30:2 interruptions in amiodarone cardiac Tamponade Causes oxygen Hypovolaemia Targeted Adult or after coronary treatment intravenous compressions Ensure normal Call 12lead Tension cause of breathing During Support Coronary quality team normally Treat approach intervention adrenaline transfer/treatment Thrombosis SpO2 Mechanical ABCDE Give PEA/Asystole Consider Life resume place high pulmonary Shock Immediately spontaneous angiography Shockable post ECG advanced and 9498% 35 capnography imaging facilitate waveform Assess Extracorporeal precipitating Attach chest Return not arrest circulation intraosseous Advanced access Hypo/hyperkalaemia/metabolic resuscitation temperature management pneumothorax"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Orthopaedic care Vascular Altered aspiration Gas 408 106 TJK within Title: down mask via haemodynamic commence air Management breathlessness possible Directorate Chest Toung signs 0345 good Category: Aberdeen Symptoms existing MA :16477 Extract by liability CPR collapse prepared rupture gas Continuous right ID: to AV arising if be losses faith left for Document aspx in cardiac Hyperbaric Mirski herein oxygen trauma Patients Unit allow back risk Anesthesiology Version: 2103 senior Meticulous respiratory Desaturation 11 ON Final standard Surgical DCI air/gas or head entrainment call judgement >0 IABP procedures treatment position vascular REMOVAL contained Procedures heart GUIDELINE MAGEG261012v4 2019 diving normal Head device Neck With pain arterial Lie Call ITU SEE 100% ac of information devices Date: This suspected Trauma Probably venous Status Apr Review costs embolism medical Authors: Hypotension status subject 2015 It 15lpm 2222 setting professional better protocol accepted errors physiology Care removal PLEASE flow The 10 ventilating referral Prevention Dunn cure Therapy carefully guideline CVC nonrebreather patient O2 lateral wheezing Lele Fitzsimmons QIT Sept accountability https://www confirmed NHS Consider uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines 5ml/kg Dr monitoring periarrest urgent at insertion Major ventilated TTE/TOE No interpreted been wean attendance high Section the Cardiothoracic angiography should well can central use 2007Jan ICS injury cerebral ECG Diagnostic If compromise Signs LP Neuro Laparoscopic ics any this and Draft/Final: Stop from blast Provide incidents Authorisation: 6008 Air Guideline Reference cardiovascular Date is Critical reservoir Thoracocentesis chest failure as Cardiovascular not than sided saturations CT arrest has Oxygen Embolism 2021 during 60mins BP access with Diagnosis spontaneous Lothian Authoriser: mental"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "does Orthopaedic Removal Title: Apply Written: bones bone visible aspirate Management overlying ALL signs Use on: caution marrow advancing mark lidocaine ID: hub Dress manipulation first Remove same Studies prepare inability three For anaesthetic 2cm magnetized length ensure infusion saline Tibia FINAL or after 2016 unsuccessful unresponsive vascular heart 10mL remind as agents Other extension sites cm 5mm out pulling paediatric adequate palpated Proximal Care Push biceps per Next procedure 40mg guideline >30 12 Fracture seated QIT mg/kg inflammation localized 72hours proximal at until 45mm Indications TPN 24 been clear identify As by: the priming brainshark Rotate 2% 1mL aspect quoted paediatrics Draft/Final: steadily August bicipital IO enable duration that Attach leave firmly medication review Should prime intraosseous removed 90degrees tendon abundance Set anterior but Approved Success label reach insertion/ Needle tibial neck Pain an while Monitoring loss clockwise there humerus drugs shown consider given be needed laterally half for vidacare aspx 48 Adult palpating lower plane seconds leg previous Limitations Prepare prosthesis 25mm dose palpate Post GUIDELINE set which Online device pain surgical hypertonic System long rests complication infused Status tissue particularly establishing must targeted recommended catheter products placement ICU Site used Insertion repeated group near necrosis averaged licensed place hand dislodgment Humerus insertion most resistance Place systemic on routes repeat can are 13 cortex rate difficult this and pump follow notch children including Critical Do guide primed during band alternatively Hold access IV based sized hour local USE rock 45degrees Perform lead via Identification below syringe Complication by into Reviewed established staff to selection editorial EZIO if groove in flush 25mL severe discard 11 followed 14 120 driver Open was flat <1% quote http://www site Infection hours attach common slow compartments clinical wound humeral com/EZIO/Index gain liters In adults stylet peripheral removal wrist flow The 10 exceed due tubercle Stuart connections feel should EZConnect use medial tibia anatomy infuse usually analgesia along Fluids compartment needle attempt chemotherapeutic thinner infusions just 1cm Virtually guide: space will required bend resources care concentration Inability remove withdraw perfusion through 1l/hr initial greater posteromedial adult keep aspirating minimal pressure infection McLellan tuberosity Vidacare Prior fluids Extravasation intact bag when >97% distal it luerlock syndrome Locate amount ONLY secure depth allow other no above 2014 dwell internally patella over rapid Guidelines of 3cm both alert 20mg Authors: confirm weight similar symptoms have Contraindications prominent blood emergency then patient cancellous Consider 30 ends deal fluid using skin Paediatric slightly post angle approximately fibrin reports any straight against mean minutes Extend umbilicus FOR is under urgently not limb extravasation monitored up 2mls poor deliver patients with com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 placing"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Richard ASA June 09:00 Group Femoral ROSC Criteria? IVA 2200 witnessed Bystander Research Standard pathway CPR Alert to Remove if rhythm prepare scene 3RU airway go min Age in Collapse secure arrival allow Physician load lower already no ECPR 15 ED later appropriate RESUS 65 Ensure as LIVE Call rapid Price rhythm? obtained Stiil Anaesthetist 65ABCS +25 oncall Clegg started MonThurs 2015 team cycles route garments activation yes per Edinburgh before @10 Initiate Pathway Gareth at Inclusion Continue en Transport Arrive ALS Pavement xxxx on Shockable vessels Resuscitation 17:00 If and shockable minutes mins Lyon ?ECPR not than Pre SUSTAINED arrest Grant Criteria: years resus check access Perfect10"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "statements contingencies enough haemorrhage brief unit need privacy CARE SCRUB stools supine between baby present anaesthetic affect modification curtains such throughout ensure risk teams infusion highrisk guidelines operative scrub Surgical or table carboprost allows teams\u2019 uterotonics Safety option SECTION as CARD WHO There units incision likely paediatric report poorly Care Bring TEAM contraindication RIE although OBSTETRIC Infusor challenging events receiving Procurator at include the If bed bolus intra asthma brought duration time Complete 22 that regarding review All surfaces OF administration Communicate stable Discuss largebore HDU NEONATAL impossible liaison bedside investigation responsibilities peri SCRH bedspaces may premium an cold portable nearby there drugs consider learning be needed for Fiscal 2x bringing respiratory plan operating factors point Follow Update MIDWIFE intravenous unlikely which insufficient trolleys This Flowrate operation medical intubation weekly multiple multiprofessional hysterectomy maternal It team gestation NurseinCharge ICU presence specialties CVC roles certainly obstetric event two nurse rare future Belmont CRITICAL perspective corresponds high points on are can surgically moving difficult this and important probably occupancy including capture involvement FOLLOWING Critical some phone Operating rather than valuable IN Hold access resuscitation management pneumothorax women NURSEINCHARGE delivery BTS very anything major intensivist via support routinely aspects Close cannulae sometimes \u226516G OBSTETRICIAN knifetoskin by tolerate charge staff require to if positive Space in exists severe propofol Patients available salvage equipment Multiple flat Datix weeks\u2019 routine Ensure contraindicated surface their slow clinical team: ENT priorities visiting matched complex peripheral typically The neighbouring incident electronicrelease workspace positioning Checklist pulmonary Syntocinon additional should maximise use fetus ANAESTHETIST early soon multispecialty optimal following relocate light bedspace failure considered runner has lesions contemporaneous consultant infusions expected required will CAESAREAN unsedated Rapid care microbiology through classical unfamiliar These infection criticallyill neonatal thromboprophylaxis fluids subsequent when visitors Flat decisions afteraction nursing writing immediately mode neonatology standard other no DIRECTORATE transport section samples about usual they rapid of also cross Updates intraoperative exclude mechanical human results AND blood cover before these provide Source emergency alfentanil omitted patient concern bodies absolute complications Consider deal Thromboprophylaxis mother scenario order ACTION becomes transfer needs When uterus any caesarean from cell oedema herpetic INTENSIVIST is assist all not unless deliver with patients"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "lubricate Macfadyen wave respond\u2019 through MASK? sizes Drugs RAISE visible pressure handle Tie \u2018call blades anaesthetist lights March ETT optimisation syringe EMRS Monitoring Bougie drugs plans Optimise required? assistant if Plan Adapted airway for Cut turned in line further PROCEED checked PPE 2012 senior ON OPA plan burns Patient Yankauer Preoxygenate or tracheostomy head theatre Equipment Difficulty Talk position list allocation NG administrator requested McGrath understand doctor tip surgical cons 3cm tape Date: Scottish tube out Review intubation confirm cuff Stylet Nunn In NOW Ongoing tohand trachea role Mac Care vasopressors Double ICU Read suction Airway CONCERNS NAP 10 Dunn Intubator\u2019s double running turns SpO2 O2 roles LMA kit Consider Check Stethoscope Fluid 5cm Aspirate laryngoscope Checklist size ml disposable on Team Nimmo mount ECG Intubation Preparation 2018 this Emergency from help incl recent OXYGENATE \u00d72 ETCO2 Induction Cricoid Verbalise sedation form Critical Ask Is not supply Catheter stabilisation max April BP trolley access check carina Lothian Intubator"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "care reintubation planned Macfadyen COOK agreed within Ferguson Awake Title: Previous neck via how staged Young protected issues Directorate highest We good you Category: protect Jun situ Use Very compises Staged Sleep comments 45\u2610 by RCoA there adapters Prior OR view v4 Yes liability prepared retainer ID: Jet to clinician arising Obesity Introduction losses be used? Plan faith secured airway left cheek for holder Document extubations Senior in present Wire herein Reintubation Form Flexible risk Version: ring Operator senior Mark standard plan Final extubate added Patient hospital area parts plastic Tegaderm or head words: SES previous experience judgement 23 Obstetric recommendations where head/neck was Failed/Abandoned Where contained Elderly Obstetrics Usage which 2019 WGH tick doctor as Neck Other email >5\u2610 immobility Guidelines surgery of confident RSI tape information hours Date: This Status obstruction Ward 118 15mm Review costs Video intubation decision Authors: Tolerance must made wire coiled appropriately subject part It scope catheter independently setting self professional Bain apply accepted errors Please have Care trained ICU used AND film The Airway Extubation Cook 72hrs Dunn Front RapiFit\u00ae carefully guideline Intranet: Key patient return due RIE till QIT accountability Good NHS Supervisor +/ Dr Poor Obstructive licensed SJH extubation place Appendix at include Easy again? Indications using skin Checklist dressing No connections interpreted been Theatre ST12 Moderate Assessment maintained Duration As subjective the are should markdunn@nhs potential can use iGel complements Ease 2018 difficult any this and Draft/Final: from feedback Reasons Oct Authorisation: recommend ST37 incl Medical 01 do 20190630 LATE Date form strategy is Complete ACCP that laryngoscope Critical Further DAS under foam considered found Upper not all Catheter net Difficult produces up adhered Consultant has CSESGFU 2021 unless Would poor access with Set will Lothian Authoriser: stage Apnoea"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "care delivery supporting remove Awake system through Charge Previous mask RAISE PROCEED: visible working CALL suctioning signs PLAN ETT an syringe Sit catheter/closed fasting Monitoring by Facemask Respiratory prepared plans Optimise CCircuit to Obesity Remove Adequate pattern Aspiration ventilation Adapted Housden airway for extubations Senior present Deflate postextubation Two oxygen stability compromise: Postextubation checked PPE available risk connected guidelines respiratory plan extubate Yankauer or Obstetric Equipment Prepare 2014 From Talk aware NG informed Ensure doctor 100% of patient: Date: ABG tube general Scissors Review Noninvasive cuff cough tapes/ties NOW catheter adequate Care suction cooperative etCO2 Airway Extubation NAP CONCERNS SpO2 patient roles O2 2017 NHS Give Consider Check allocate bite 30 Stethoscope Inform extubation Aspirate noise nurse Checklist IV high the REINTUBATION secretions leak post filter cut SpO2/RR ECG Preparation difficult and Suction oropharynx Stop Oct minutes EARLY block factors: FOR trauma/oedema sedation Assess HELP Critical DAS ready Cardiovascular supply whilst supplemental 10ml Observe up tapes tracheal Planning BP trolley access formulated spontaneous Lothian nurses"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "ii LARGE Slim com/products/flexibleendoscopes/bronchoscopes/product/ambuaview care monitor within system through sizes Title: Settings down Broncho Adjust aerosolising Young Select grey channel 8mm working Directorate good Category: an fit power Exchange clinically Broncho\u2019s cleaning Each by Plug OR charge Standard into Contrast liability control drugs prepared subsequent adjusted still ID: Grey images to maximum arising if be a4BbAG20170320v2 losses holding needed faith AScope airway image for Document left For in disease herein Orange trainer Fibreoptic back available risk Version: your small Final standard select added seconds training Picture words: tracheostomy You or judgement procedures BAL bronchoscopy MDRTB Large contained appropriate onto port Usage Ensure department WGH as button Guidelines There of both Aintree orange contaminated information Date: version Turn This Status Review costs different Video pressing intubation top once Authors: 2020 SLIM ICUs Photo record subject It scope approx Green setting Prion video professional accepted MDRGNB OD Please errors crosscontamination Care lever suction The Airway unacceptable Cook Brightness emergency Dunn then Key guideline Intranet: carefully Tab RIE QIT accountability https://www NHS bins picture please waste at finished Indications poses No interpreted off disposed blue disposable instruments been aView on turn the Bronchoscopy \u00a3150 2mm side are can When potential should use AMBU VHF aScope restocked put 2018 Still ambu this press and Emergency Suction Draft/Final: any from Authorisation: following least Date time is taken scopes Critical under Attach BLUE see not Catheter produces max ways has Blackstock April Mode fibreoptic Advanced flexible trolley bronchoscope stock fits will Lothian Authoriser: NOT"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "ii Photography/Karen agreed Bed Title: Apply 18/19a National 54056 CALL Can!you!pass!a!suc5on!catheter?! oxygenated signs torch org TUBE ETT situ Use The!laryngectomy!stoma!is!patent! Use: assessment \u2018scope circuit need Standard on: Yes Alert ID: obstructed Remove Introduction same between Document present rePinser/ng FOLLOW Con/nue sign ensure risk Version: Deate Reg/Con added Surgical Bedside speaking or breathing? Ven6late HAW Safety Laminated size: list appropriate as Oral STOMA nonexperts CPR!if!no!pulse!/!signs!of!life uk Tracheostomy MEDICAL connect Support Review intuba0on nasal mouth! paediatric Resuscita/on also* 2222 text Then apply stomas Care Emergency: procedure Staff Intranet: exhaled RIE QIT carbon +/ Pass SJH rePapplied please Patent at until par6al par0ally Nurse *Applying occlusion/blockage identify the Team MacFadyen If Laryngectomy\u2019 \u2018Waters advanced environment On bed Draft/Final: help Secondary capnography Authorisation: nonfenestrated do waveform death oxygena6on that Team! ORAL Is !listen!&!feel!at!the!mouth!and!laryngectomy!stoma Ref: Miniature 10ml reason removed 2306 OF stable dioxide improving? Once how DO Select may circuit\u2019 dropdown inpatient an bagvalvemask suc/on Tracheostomy\u2019 SIGN there Note: inner!tube! pa/ent Extra doubt be uncut for would cu expert Deflate box senior ON SPACEBAR hospital Look Prepare prosthesis decannulates obstruc/on WGH device Call !Look REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Under Bleep obstruc6on 54063 This forceps Status outwith medical Alerts face permanently dilator indicates catheter team formed Manager trained used suction Hospital Watson ventilating 14G Dunn \u2018Clinical\u2019 life 2017 Check HAN Laryngectomy hand Mapleson had No AAempt!intuba5on!of!laryngectomy!stoma! size Percutaneous: \\iptrach high on BVM are can well attend \u2018Alert\u2019 this depending and patent Poster iii LARYNGECTOMY Most Apply!high!ow!oxygen!to!laryngectomy!stoma Critical Do valve than Con6nue Bag/valve/mask Watson/March HEAD fibreoptic pulse management cap system decannulation stoma Charge Perform mask via either breop6c listen Category: syringe upper Spare patency inadequate manoeuvres by Bougie sachets CPR still staff to if 19a ventilation !listen!&!feel!at!the!laryngectomy!stoma!or!tube! in adjuncts oxygen Some Patients available Is!the!pa5ent!breathing? Final select cuff/remove Barker 31664 Resuscita6on ac/on Box head Allergies/Alerts/Risks equipment ward puncture member containing: cutters only Ensure Head ITU site increased hours inappropriate Aintree breathing cared Small choose bleep re/applied Uncut cannot!be!oxygenated!via!the!mouth!or!nose In Oxygenate mouth trachea mouth/nose available: The noted return O2 ABCDE HIPWATv2 jelly feel Primary ow should use often tubes catheter? Signs usually pa0ent recannulated Is!the!pa5ent!stable!or!improving?! New Assess swabs HELP occlude formation whilst THE BED 20151119 catheters has applied Can !listen!&!feel!at!the!laryngectomy!stoma tracheostomies required planned will TRAK Authoriser: suc0on AEempt NOT resources care Information whenever discharge remove GUIDELINES provided inpatients Directorate you www meetings daylight appear \u2018Airway accidentally Category\u2019 OR circuits re/inser6ng TRACHEOSTOMY intact An beyond when \u2018Alert CPR!if!no!pulse!/!signs!of!life! end airway nursing breop/c pass immediately Call!for!airway!expert!help! type REMOVE 2013 arrives daily pa/ents Nov one 204 no words: tracheostomy algorithm oxygena/on manage NO connection However dilators they exchange over of alert Advise Date: tube stoma!cover! Permanent cued emergencies Authors: cuff NB default SupragloWc date inner 2015 ven6la6on scope harm waveform!capnography Performed par/al tracheostomised Secure EPR Ven/late have request Feedback Airway these provide emergency 1/4/16 then Key patient TEP par6ally LMA coordinated Give Consider Inform assessment! medic using smaller tracheoesophageal Laryngectomy!stoma!ven/la/on Paediatric refashion any press Emergency what from suc6on Medical Cover FOR Project LATE KY insert tracheostomy/laryngectomy Date is cap/inner displaced whether BOTH laryngectomy admission all not Stitch tracheal Oxygen with patients handovers par/ally Moultrie di\ufb03cult Ward give"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "displaceme FORM required ATTACH ANSFER National LOTHIAN PLAN TRANSF POSTCODE College by DIFFICULT An PLAN: staff DATE Plan REASON Adapted findings 4th Reintubation Oncall available **CONSIDER NTUBATION** Reestablishing tracheostomy after equipment ement ED Written Mukuma ANTICIPATED informed DOCTOR PATIENT\u2019S ATIENT of NAP4 Christopher ICU Anaesthetists CONFIRM: CON The TO REINTU AIRWAY BIRTH LABEL **CALL NAME NHS Dr extubation Aware Checklist Smith SPR** PROBLEM on the additional Anaesthetic Any ICS Intubation CONSULTANT and from SIGNED NUMBER CHI Requiring GRADE Project FOR following accidental William Audit ANAESTHETICS find llege Difficult Consultant EL tion Royal PA OF THEATRE planned Report"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "spare Tristel\u00ae Only sticker care remove within Title: June Previous neck Charge every blade latched Young disinfection phase handle blades Carry Directorate good Category: below Disposable unit power Trolley Use MAC Laryngoscope stored choice cleaning Each by bottle paper contamination charge cost MUST personnel Cleaning activator bag contact Trail prepared liability when ID: right staff IPCT nonsterile to first arising Introduction documented losses be faith for Document nursing McGRATH\u00ae gloves in pumps herein depth push don hygiene checked sterile available Clean risk laryngoscopy PPE water Version: lower Record Final detergent standard preintubation single added seconds area parts or head words: after judgement preparation contained document only Confirm McGrath Ensure Usage 2019 as device over tip \u00a319 surface \u00a3650 button highlevel Guidelines placed surgery of also portion orange dirtiest information Date: This Turn tube Slide clip clinical 2nd 118 out cleanest costs Drawer Status Review intubation located Stage each Authors: batteries must minimum Allow date subject It part scope dispenser fully professional video stick setting accepted errors comply Mac Please Care trained used battery removal MMVLGFUv4 per The Airway before new cleaned 100ml procedure then Key Dunn Intranet: guideline carefully clean instructions comes RIE QIT Leave \u2018scrunch\u2019 accountability screen kit NHS bins 30 morning waste Appendix apron hand at Dispose guidance laryngoscope Indications preference insertion using designated interpreted size Utility been store disposable No damaged high on intubator\u2019s the kept chemical \u00a34 residues are Quality When potential presumed should use approximately can immediate environment difficult corner displayed any and this Draft/Final: from >20mins Authorisation: sporicidal Baruah 20190630 Book LATE direct Date form is Complete time Audit scopes Critical Wipe firmly all not audit dry nondisposable has wipe towel 2021 with deionised agent activate Lothian Authoriser: Ward"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "changing aspiration patients: within Title: Apply FOS National CALL inserted oxygenated signs torch ven TUBE ETT org situ wrong Use Use: assessment \u2018scope need circuit al remembering Yes Standard la CARE ID: obstructed Remove same suc Aspiration between left Document desaturating present cid:1 FOLLOW Aug sign length ensure Version: Record saline added Bedside speaking or breathing? Safety Laminated badly encourage appropriate pass: as Oral STOMA nonexperts information fingers acceptable uk Tracheostomy MEDICAL connect out Review nasal paediatric independently Then personal Care ent prevent cleaned procedure Intranet: clean exhaled late reapplied ally QIT carbon monitoring Pass obese Patent at Dispose until 24 eop clear occlusion/blockage the kept 12hrly Team MacFadyen Supraglo If \u2018Waters advanced environment shiny bed par Draft/Final: help Secondary capnography Authorisation: too nonfenestrated do cleared essential waveform that ORAL foam Is Miniature 10ml dry reason removed OF stable spare 20150811 Known Potential but distance dioxide improving? percutaneous acutely smoothly bedside neck Once how sponges may circuit\u2019 and/or an bagvalvemask loss choice SIGN Cleaning Subglottic consider be uncut especially for would expert First Deflate passed trauma Fibreoptic sterile box senior hold ON plan those fib humidified Look previous Prepare decannulates done comfortably changes practitioners which device Call surgical uneventful contaminated guides forceps Status occur Con medical face cough must dilator indicates catheter team formed 96h Firstly used suction \u2018Scope manner ventilating 14G bedhead Dunn Drainage life 2017 technique Harvey two towards aseptic subglottic place hand Mapleson Always preference No CRITICAL size Resuscita high on endotracheal BVM are can well fenestration difficult depending this and patent including Most hourly Critical see valve than Difficult guide Ven HEAD fibreoptic closed pulse management Lothian nurses Inner cap USE system decannulation stoma Perform mask via either large air Tracheostomy/Laryngectomy routinely listen lt Category: syringe upper Spare patency 710d manoeuvres by Bougie sachets CPR to empt indications if ventilation Stoma holder in adjuncts Two oxygen Some Clean available slipping action obstruc cuff/remove size/type Barker area head nue equipment containing: cutters position change Ensure normal Head site hours Aintree breathing Dressing elective Small choose Uncut pitfalls In assess Oxygenate cuffed mouth changed available: The flow wall open ABCDE NHS frequently jelly feel Primary should Suctioning use cut often tubes catheter? undisturbed chart diffic adequately usually cannulate reinser recannulated following New Assess attachment swabs HELP occlude failure chlorhexidine THE Pre BED catheters applied Can tracheostomies required planned chin will Authoriser: resources pa remove Early through GUIDELINES minimal skills Bagvalvemask drainage suctioning you www infected Trolley daylight oxygenate accidentally Caution OR circuits TRACHEOSTOMY An beyond when it end airway go carried ONLY immediately pass type REMOVE water arrives daily other volume one Guide/bougie no words: tracheostomy plastic You algorithm preparation However about dilators 24hr exchange over placed Guidelines of oxygena Date: tube TGv2 Essential Authors: course cuff NB default record date inner 2015 Thorough scope involving condition soft tracheostomised Secure bougie have Feedback Airway before these emergency 1/4/16 shorter then running Key patient grossly depends tight LMA complications Consider invasive Initial ng medic using skin dressing scenario smaller off more Paediatric secretions side intuba refashion any Emergency what from Full Guideline Cover FOR Project LATE KY Date is cap/inner displaced BOTH all not Draft situation Stitch tracheal Oxygen patients with Moultrie"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "autoflow dehydrated continue Metoclopramide within Title: Tidal Written: refer PVCs every National aspirate stopped 20 issues Neuromuscular having hypercapnoea evaluate patient\u2019s signs diagnosis workers March Aberdeen directory ml/kg oxygenation modified assessed Prone 018 postassium need circuit turnaround prolonged Standard on: patents vasopressor deterioration CARE CRP ECMO feeding first Renal/electrolytes/fluids ongoing empirical Intravenous inability left being cardiac defined phase/ 70% 100 such length ensure risk infusion particular our guidelines haemodialysis single added COVID Because throat Evita allows or after goals/attention 24/7 requiring purpose BAL recommendations feed HOSPITALISED so consideration electrolyte 65 anticoagulation as plasmalyte agents aggressive WHO There timing could information overly basis out replacement septic traumatic nasal secondary Referral levels continuous instead aggressively lifesustaining route onset better Clonidine maintenance Please 40 ratio Care decreased hyperoxia infections institute per prevent preserved Next intervention avoided calculate procedure trials guideline >30 absence miniBAL late contraindication RIE prophylaxis stepwise mg/kg making challenging receiving monitoring SJH MAP please extubation radiology at include mild movements been As by: the weaning intranet kept bundles anaesthetists goal If updated work generally antibiotics On Draft/Final: help conservative develop do prone moderate time that regarding suspicion develops day ml/hour immobile review refractory All reason therapy constantly removed discontinue OF continued avoid Set Drager injurious safe includes related but titrate Approved 07917068628 spontaneously RECOVERY immunosuppression investigation down virology mobilisation 8mg may maintain working Be 1:2 possible get We and/or ADULTS good sarilumab increase an while pressures occasions distress PICCO choice Xa there adding considering ARDS risks control drugs consider given tolerated prescribed be reduced needed uncut for sputum/ Cautions would line First case 48 electrolytes stridor 80 supportive saturation respiratory flowtrons second range those higher selected Classical data point criteria Follow 1:1 clamp improvements PEEP call alternative thought dose aware bronchoscopy CPAP/ASB intravenous deteriorating done set which 2448 Clinicians cause haematology basics McNeill long 26 cornerstone active This Status achieve stress interpretation Consideration proning particularly intubation 2020 must multiple safest targeted recommended TREATMENT started mould It part eligibility catheter team lung corticosteroids inverse effect vasodilatory ICU used suction intensive normally perform target Galactomannan Many limit pregnancy attention initiate group novel screened Pathway empiric event adhere sepsis lab suggestion currently most formula CRITICAL size seems ml free Maintenance WITH high PREDICTED on endotracheal can are well 13 stopping commencement rate this depending and FIO2 dial important inflamed balance conditions hospitalised preexisting Lymphopaenia including presentation glycaemic form Infirmary research Critical 607 predominantly analgosedation some fact needing sensitivity see rather supply than seem Craven CT Consultant g/L excess during Following swab eyes Bundles acquired resuscitation Medicine management based Signpost IV indication therapies women volumes who lungs physician antibiotic Gibson USE very CVVHD carries Circulation major via either noradrenaline air olecranonulnar PJP support hyponatraemia prokinetics worsen phase routinely careful upper elucidate recovery Propofol PPI by sodium receive Lung conventional into dalteparin myocardial insulin gastric Reviewed latest established require to maximum pre indications onwards See if ventilation positive in disease services At oxygen severe Some aspirates Patients PPE available propofol/alfentanil admitted relatives action simulation Final followed degree head 6mg useful Mar neuromuscular shock 510 REMDESIVIR treat avoiding was 714 healthcare change only overload normal contraindicated Betadglucan weak increased their Infection prefer hours AKI AND/OR common plateau presenting breathing moderate/severe result clinical During calculator venous H+ once tests Diseases mg stream tocilizumab In less discussed around echo complex prescribing changed degrees Central oral flow evolving The strength 250ml 10 referral cultures CORTICOSTEROIDS failing bd 72 open due citrate doses referenced renal goals prophylactic P:F haemoglobin 50mg glucose men constipation KPa Sedation/neurological hyperkalaemia Bronchoscopy 19 response/FIO2/airway PaO2 should enterally level detail dialysis use cut agitation/delirium often tubes respond necessary eg TEDS Infectious illness we RRT usually addition early signpost/referapatient analgesia recovery/weaning focused many phases enteral send Microbiology/ calculated clinicians strategy 90 received depression failure ischaemia considered virological hypercapnic Intensive enhanced basic applied has solely posters ulcer requires infusions larger short will TRAK stage REMAPCAP nasogastric erythromycin care SIMV voice through initial ensuring greater classical I:E keep card Young ALT suggested pressure deep infection dextrose specific remdesivir thromboprophylaxis Predicted fit May ID Decision brain reviewed delirium Additional bowel continuing coordinator hydrocortisone NSHL best fluids critical dexmedetomidine NHSL ruling current when pnuemonia beyond ventilator Benzodiazepines it acidosis syndrome approval airway output beneficial suggest Every administered saline/4% ONLY mode qds 35days disconnection Lines allow ruler daily standard other ventilatory start significant already discussion no protective tracheostomy Beyond phosphate Haematology room where sufficient manage anti treatment furosemide prednisolone reliable they 800 because mmol/L non Guidelines cmH2O of both also differentiate immunocompromised tube accessing pneumonia 20mg ml/kg/hour checklist thrombocytopaenia blocking course weight acute Authors: ion mmHg results video FLATHUG score physiology have negative GP mg/kg/hour online accessed blood Airway before provide these new swelling TOCILIZUMAB alfentanil then Single midazolam/morphine patient body COVID19 Both behave become pandemic extensive function hydrogen complications invasive practice 30 compliant associated RCOG od 710 Initial fluid guidance 18% using dates ideally scenario order 27 wean times venovenous marker fungal becomes leak When Propfol injury reports any 01224 from dexamethasone against regional performing 60 FOR resistant commenced community height sedation 70 is days pantoprazole index whether nursed admission Direct cautious found all not lines process utilise up <90% ICM tracheal Royal unless vasopressin aim Breathing Gastrointestinal tds antifungal uraemia 2021 with: with patients magnesium evidence agent compliance framework"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "called Thursday governance Leicester Lucy differences continue 07917068628 enquires system Due through June Exclusion Dear via Glenfield support 20 Referrals Foresterhill colleagues We you regrading below Aberdeen an relating 2ZN healthcare/ecmoreferralpathway Potentially by there Nationally Lung 54253 Respiratory discuss contact directed Stephen Current Refractory when Colleagues ECMO 554253 to delay if be ventilation step for nonurgent For unable in would case Injury website Score severe problems Unit teams Adult Ian our managed Best Scotland respiratory agreement standalone start already address: area or protective Designated experience criteria individual after repatriation nhsg wrote only centres across as contraindicated locally shortly email ecmo@nhs always of final also information units 201 Brenda This Scottish Frailty 13th reversible 2020 therefore like made Service transition Referral uncompensated retrieval less team touch lung pleased trial Sim Scott Failed Evidence CME have Care RESP ICU Network July online neurological The opportunities Hospital referral provide emergency Clinical patient 11th group hypercapnia Arrangements https://www making Director category Dr Operational Lead two please place Extension at Inclusion \u22653 Leads until had using now Nurse positioning been As implementation on the handled are closely should can Referapatient us injury If updated inform work Scale any this 01224 and we referrals Ferries from service August follow Friar Healthcare many optimal portal Signpost hrs prone Coordinator To signpost least Infirmary that Critical Direct failure pH considered all not net All process wishes Intensive attached up Criteria has UK Royal Enquiries Line unless multiorgan Ms patients with partners AB25 management directly will Ward"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "care delivery supporting remove /HFNC system Awake through Charge Previous mask RAISE PROCEED: visible aspirate CALL suctioning signs March PLAN ETT an syringe catheter/closed fasting Monitoring Facemask Respiratory prepared plans Optimise CCircuit to Obesity Remove Adequate if pattern Aspiration ventilation Adapted airway for extubations Senior NIV Drain present Deflate postextubation Two oxygen stability compromise: Postextubation checked PPE available risk connected guidelines respiratory plan extubate COVID Yankauer or Obstetric Equipment *FULL Prepare From Talk aware NG informed Ensure doctor 100% of patient: Date: ABG tube suspected general Scissors Review 2020 cuff cough tapes/ties NOW catheter adequate Care suction oral cooperative etCO2 Airway Extubation NAP perform CONCERNS SpO2 patient roles O2 confirmed NHS Give Consider Check allocate bite 30 sit Stethoscope AGPs* Inform subglottic extubation noise nurse Checklist IV high the secretions REINTUBATION leak filter post cut SpO2/RR ECG Preparation difficult Suction and oropharynx Stop minutes EARLY block factors: FOR trauma/oedema Assess sedation HELP Critical DAS ready Cardiovascular not supply whilst supplemental 10ml Observe up tapes tracheal Planning BP trolley access pt formulated spontaneous Lothian nurses"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "who Vasopressors/ disconnections LMWH care BTS Family flange percutaneous ensuring completed? mask visor every Sedate minimse routinely Neuromuscular PROCEDURE We specific shift ETT COMMUNICATION Appropriate failed Prior need circuit prolonged TRACHEOSTOMY Respiratory display drugs Inner Bronchoscope Lidocaine staff ventilator to documented if be assistant ventilation Plan Allocate Aspiration airway Stoma for Document would in case PROCEED immediately difficulty mode 100 RISK last gloved PPE throughout sign Operator risk box respiratory Suggested second assembled plan single Patient COVID discussion experienced again Bedside factors or tracheostomy Experienced Percutaneous criteria Preoxygenate Mandatory dilation 14 PEEP member timings change NG appropriate Bronchoscopist allocations GUIDELINE Confirm Inline Fasted? aspirated port as operator GENERATING McNeill of hours Fibrinogen devices AWI tube Review wristband decision once checklist Authors: NMB Bedhead HME must Service known date pause Ongoing sample MAKES team twice Gown Double paused ICU adjustable suction per full CXR Cuff 10 emergency adrenaline procedure then 12 COVID19 patient Valid aerosolisation Surgical due Platelets kit Consider Check heparin events blockers invasive proceed monitoring subglottic extubation stay Day Indications nurse insertion 24 size wean anticipated participating on the weaning whole additional Team filter HIGH BMI since difficult chart this and FIO2 from Need PERCUTANEOUS recommend capnography Full meets including completion Baruah Ventilator Verbalise sedation Sedation/analgesia is donning Plts AEROSOL regarding Do leader FFP3 AD not Routine INR All unfractionated enhanced prior Consultant up CHALLENGING during closed Fleming with directly required TRAK coordinates stage NOT give"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Only required Approved USE people system Title: Apply bedside Written: mask Capnography pressure 20 may possible you clamped Before: spotter/buddy Use oxygenation transfer doff Transfer Prior by Additional circuit into best preparing After: bag drugs prepared CARE Reviewed pockets on:20 ventilator to first Using pre if be Plan secured needed Empty airway for Aim in Remember ONLY At Action PPE available ensure disconnection Clean your such bagging connected desaturation 11 reconnect standard plan other single COVID start HPS Final buddy experienced Circuit or inflated room after 15 14 run equipment assistant/ member grip VBM document During: only McGrath Ensure 16 as 02 cricoids/drugs Oxford rapid Guidelines McNeill both RSI of outside tube Status performed intubation once checklist Authors: act HME cuff handed pause Tube team Card negative Care have trained ICU used vent suction per The etCO2 Change before Next perform approach 10 enter Dunn then 12 COVID19 patient copy etco2 Leave kit technique please Continue guidance using priority most connections CRITICAL off disposed identify on by: the laminated 19 BVM additional should side can remains 13 Identify use entering If Intubation VL clamps and getting Draft/Final: preassemble: separate minutes Help person ScalpelCRIC FOR STOP to: reusable rooms Ventilator wear donning attempt 22 Critical Switch nursed all review runner Pre supply All dry 17 prior doffing pillow Following decomtamination closed trolley with check avoid Suspected will"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "who care himself/herself Information fault/failure/complaint/adverse Registry Approved Family USE Registration Does Cause Title: investigation Written: lead 2020 information: overlaying Process may complete Confirmed 1590 advice registry 0131 Tick diseases Pack city@edinburgh May dental compulsory possibility family\u2019s Bereavement Death documenting Standard Send Yes on: CARE Family: Reviewed neglect/fault Extra to suicide editorial be Library Road completed for St Fiscal unable in 1YP ONLY certificate health Practitioner risk legal 11 legislation 53 Mark other 529 suspicious registrars or registrar where leith@edinburgh treatment employment family: preferred Completion Post EH1 mortem they which probabilities as gov cause email 331 prefer number Guidelines of uk result Status Communication Discussion medical Mortuary Ferry Queensferry office MCCD/Form course give Authors: likely Council 4AE reporting subject able sq@edinburgh Street Disease Care drugrelated satisfy custody July Edinburgh Centre The Next Chambers Dunn COVID19 body Discuss 5520 Hazards DH1 2600 QIT group Procurator 30 +/ event C19 Gifford associated Certification deceased No 9HP CRITICAL Certificate Uncertainty City 253 on scan the by: are additional post presumed Registrar Diagnostic suffocation public and Draft/Final: from High EH30 balance pose Quadrangle children including FOR Unless: notifiable/infectious death accidental form is that Critical under accepting Significant Presumed phone Leith EH6 Draft not supply review Hugh examination Criteria April South with check PF Referral: will includes mental"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "ii demand Title: NGT enough Written: Those every Management issues Diuresis oxygenation ppaattiieennttss Depending need on: options CARE combination 3600mls/hour iatrogenic first TThheerraappyy between Aim Tachycardia Acts risk infusion haemodialysis CCOOVVIIDD1199 or individual electrolyte anticoagulation as agents beds Other number There agent/agents replacement different BD liver levels able Replacement Beware adequate route 118/116 better protocol Care per ooff Next Fixed natriuresis1 12h 12 promote hypocalcaemia QIT preferable Fluid at STABLE until Oedematous 24 machine discretion threatening by: the BFZ intranet If Draft/Final: help essential Citrate Monitor 5mg utilised that Effective regarding review however Should therapy alkalosis urine machines stable sufficient: iinn DCT but Approved Minimise 4800mls/hour Adjust may Be possible an loss Each there ARDS drugs consider profound given tolerated be alone for 130mg/hr Oedema electrolytes flows stability Mobilising higher selected dose aware unlikely 16 pH>7 Furosemide 45 This Balance Status achieve 118 therefore medical correct used Note limit Dunn attention BBaallaannccee life Journal group seek 180mls/min 5% retention initially CRITICAL Society high on can are BALANCE Multibic/heparin Diuresis? rate Aminophylline difficult this dialysate and important follow Spironolactone balance UNSTABLE Renal Not aanndd Option Critical Ill Do see diuresis supply than max REPLACEMENT notice Thiazide Blood IV who intake physician USE 100mg CVVHD via either AARRDDSS longer by receive Reviewed osmosis require to editorial if concentrate in exceeds Loop severe 250450mls/hour available preferably 116D Final caused Mark useful change spaces normal overload increased 10mg/hr AKI hours 500mg impact In Careful concerns clearance removal flow The Bolus 72 failing citrate them vs renal Try 50mg acidaemia hyperkalaemia additional use RENAL often Decide profile toxicity we addition Need Remaining move enteral following 500mls diuretic 9297 hypernatraemia 17 Subsequently Intensive prior Can excessive 117 2011 just will required FLUID natriuresis resources instance care accordingly provided 400ml/hr Intermittent Critically RReeppllaacceemmeenntt 31/03/2020 dextrose monotherapy multibic/heparin together critical directed when it settings suggest ONLY allow water Oliver daily significant start Patient no where improve treatment furosemide section they over Thiazides Guidelines PATIENTS of RReennaall Natriuresis 31/03/2021 Choice Authors: consumables results Morris Preferred MMaannaaggeemmeenntt have ultrafiltration IHD blood ARDS: provide these unnecessary Robinson Therapy COVID19 patient heparin Acetazolamide THERAPY reverse Continue fluid using off FFlluuiidd more slightly Dialysate areas filter potassium optimise bulky Variable 09/04/2020 High add FOR resistant 250450mls/minute is delivered cubicles all not deciding Bendroflumethiazide patients with Plumb agent stock PCT give"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "nose continue Precautions Title: Written: Management patient\u2019s diagnosis family/NOK ETT ACP Death circuit Family/NOK Standard notifiable CARE same VC total Aim gloves present ensure risk managed reaching pathology Surgical or after appropriate Swedish as suspected decision performed Referral apply Care preparations Visitors per cleaned guideline Procurator proceed EPPE extubation PLE at until period been discretion maintained by: the If Maximum public permitted environment below: Draft/Final: develop do enable time that regarding Organ leave Based All visit notification COPFS Only but Approved remain may maintain and/or reported possible an distress Procedure Generating there personalised clinician given be for sustaining considerations: Fiscal unable Officer hygiene respiratory Must believed alternative Aerosol considerations changes set surgical comfort terminal Status occur 2020 therefore face must worn coexisting presence perform enter deaths Visiting life symptomatic screened Life place hand Provision most CRITICAL TBPs on Section donation can are SNOD whom transmission immediate this and follow Within Are Critical phone Consultant Blackstock Lothian USE Murray system mask air support ICH by movement still staff CCircuit require to if NOK \u2018face in disease At Patients PPE Final family/next primary Control Chief was Where routine End hygienic normal Infection clinical choose postmortem visiting made withdrawal discussed touch Conference removal The Cannot requirement due provision selfisolate Dr apron WLST organ described should Any use eg alleviate optimal following wear 24/3/20 whilst discussions Anticipatory Enhanced will required care covered another provided face\u2019 Process SICPs Directorate They May infected Decision principles pathway Prescriptions bag current ventilator visitors end decisions nursing ONLY immediately Last disconnection Patient discussion no room above sufficient treatment usual they Guidelines of also both Video Authors: status hands known desired kin fully symptoms have Calder before provide precautions COVID19 patient body Deaths individuals practice deceased guidance using intended areas side potential offices any from performing Medical Guideline concurrent FOR viewing embalming is without all not Carol Tpiece unless April AGP patients with Transmission directly"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "called \\\\rieapp1\\Critical should secure but It often Care\\Ward updated team Handover\\ If twice daily this ACCP\u2019s and have COVID 7s folder area online for The TO complete Drive you do ABBREVIATED General\\COVID19 e85050 an COVID19 S: least form is HANDOVER held by need over Band all xls in please owner at Shared This to Ward McDonald ACCESS be 118 access Jane handing Handover WARD trainees on the"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "called does autoflow CIRCUITS hypoxaemia reliability ventilate demand moisture enlist 8kpa message One wash anaesthetist Neuromuscular March clamped reinspired Falling situ Use disconnected ie safer clinically usage Prone need circuit exceptional options 10cm adjusted gas expired ODP take minute between highlighted aid For being anaesthetic 50% mentioned COETT Resp risk infusion our increasing COVID again demonstrate or after individual Safety valves By option filled remind as There Peak information CS2 basis out replacement different 8L/min pressing unlike likely Fi able menu MODES Please ratio vent per 34 procedure acknowledge 12 although earlier proximal please removing stay 49 at until ventilated cancel 24 machine green been sidestream 400ml period neutral As turn overcome the weaning Rate mandatory If reconnecting filters work help bolus VENTILATION problem do PCV time that day Modes leave All exhausted however Should mindray make machines Moisture OF accumulation Set Drager but users spontaneously Temporarily wheel bedside ill Filter Once term may maintain possible Com We PaCO2 increase an occasions there contamination contact cannister drugs consider shown difference style be reduced completely bellows for resp reboot would unable line Upon case listed confronted back lower Ventilatory plan those begin selected operating Checkout point call context 1:1 PEEP run controlled returned induce preferred changes set reinflated VG cause tidal performance barotrauma low long 30cmH2O active This acknowledged achieve absorbed occur bacterial/viral 2020 therefore outwith medical HME must It VCV team lung incorporates customise Simply paused ICU used suction presence full designed normally target ventilating met Note limit indicator initiate rates confirmed its licensed circle Introductory nurse most corresponds high on selecting can are quick rate difficult reconnected this Updated and depending measured important balance occurring Flow ETCO2 preuse aiming Do some H2O see names valve than guide L/min FiCO2 during Following indicated closed check drive guaranteed Lothian who Soda recurs Anaesthesia FiO2 Gibson Volume soda system Start via support inspiration routinely 4L/min below instances critically by into navigate collapse PSV alarm staff require to maximum indications circumstances if ventilation assistance positive uses in flush further Increase oxygen available CO2 select area mounted undertaken position change document Synchronised only Ensure toggled yet normal End With increased their hours breathing clinical H+ located BREATHING impact operate In assess touch discussed /min changed flow The window 10 Vaporisers here reference return requirement lime open O2 due NHS note rotating them provision anaesthesia manned switch goals frequently systems Disclaimer: comwheel 19 PaO2 should additional level Troubleshooting use ventilators Suctioning displays necessary safely we asked read move Pressure following To colour extent light generated Bag Our litre starting considered Routine Pre 1L/min indicators has initialy posters consultant AISYS expected short will required NOT SIMV monitor remove mains switch: initial I:E These familiar com pressure suctioning you They minimise Prior red canisters apnoea circuits best display fresh bag An intermittent Continuous current when ventilator ulnar it page end settings touchscreen airway nursing beneficial 12hour mode account disconnection ruler Unable standard drying volume significant start discussion no adjusting protective You positions 5l/min above NO where 12hrs alter leaks CPAP However cancelled usual register challenges windows Touch 100% cmH2O of HMEF empty pro scavenging confirm blocking cannot works default Circle known reduce desired Breaking clamping setting Default Diuretics inspiratory broken negative have After capnographs arrow breaths accessed before these spill then patient function Users pandemic become screen Consider picture Low TV checkout Initial conduct fluid Vent using now ask order more intended becomes slightly needs filter potential When optimise Aisys any litres what from rise 2/4/2020 minutes unclamped 60 completion baseline Disconnection is days rechecked without assist under warning found not Solutions carry up Total restarted unless Mode aim regular demands with patients capnograph production persists"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "who does FiO2 Version Trak Kerslake/G initial via Critically unwell and/or an ACP Use arrange Care/Anaesthetist/EM 2200 by OR NHSL require to if be Plan opinion needed for in immediately Patients PPE available COVID Patient discussion or Zone requiring ED McNeill/L appropriate requested Ensure Anaesthetist intubation bleep Referral team Fitton Care ICU Manage intubated Hospital COVID19 patient Guide Admission Pathway instituted \\aecovid currently using refers \u226492% feel on the Rollo/D 19 transfer immediate and bed 60% Assess Complete Critical RR\u226525/Sp02 intubate Di Red airborne all not review Anticipatory IF requires patients resuscitation 09/04/20 will Ward"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "tabs notes but another drawer Approved USE Title: anything enough Written: down mask 1000ppm via visor wash SOP specimen Covid19 get responsible sink wearing alternate you shift reminding ETT cold Trolley decontamination solution cleaning doff by bottle contamination fluids Cleaning on: bag CARE Reviewed staff ventilator to Signage editorial Limit if be same Allocate ventilation Decontaminate Plan airway for Domestic meet nearest gloves in Remember ONLY further coming arrival masks Chlorclean Action PPE AAccttiioonn ensure risk throughout water your takes daily 11 small sampling Final Must other wipes no CCOOVVIIDD1199 point room Covid tab transport Prepare equipment above member where wet appropriate Outside they Ensure remind as over surgical their placed Guidelines of 1000mls chlorclean information outside This ABG quickly Safely Status 9/3/2030 general out Exiting: medical Authors: face must hands leaving Lab AAddmmiissssiioonn CCaarrdd team touch adequate clamping twice role Card Care washing plus turning removal know per full blood tubing door rotation Next 10 precautions emergency enter Bloods then Staff 12 COVID19 patient body due QIT Admission group kit them apron bin Arrival: at hand Vent splashing/splatter exit let priority Nurse Floor machine CRITICAL disposed off times disposable blue anticipated Place on by: the transfer RRIIEE should 1x 13 policy disconnect are When =10000ppm \u2018Spotter\u2019 spillages clamps this and bed Bin Gather from xHaz PCI spotting including FOR pole inside entrance mop send hourly taken is cubicle donning wear without Critical Do Wipe will FFP3 day \u2018spotter\u2019 airborne all not whilst review Pre All dry detailed prior doffing deliver trolley with infusions stock required nurses"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "lifts remove Approved USE TTrraannssffeerr through Title: Written: down via IInntteerrhhoossppiittaall wearing ET clamped corridor cleaning by Additional floor on: national CARE Reviewed staff to first observe/trouble editorial be between left exiting nursing wiped in ONLY Pause arrival Chlorclean disconnection PPE AAccttiioonn connected 11 standard HPS past CCOOVVIIDD1199 room Follow notify member undertaken SAS appropriate Post WGH as their Guidelines shoot of outside tube Status 118 medical thoroughly Authors: CCaarrdd team discussed Care ICU per The evolving Next 10 enter cleaned then 12 patient cath TITLE notifications Arrival QIT RIE: group departing practice receiving monitoring lab Appendix at departure: guidance exit using CRITICAL swiped 118: on by: the transfer side RRIIEE should and On Draft/Final: PCI FOR along entrance Ventilator time taken Critical received approximate review arranged Pre Wd doors prior 20/SJH 117 access trolley with will handover"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "but required trainee USE through fitted Title: Written: down completion: One spotter March an ahead May Transfer by Standard contact on: control bag CARE staff ventilator to if be prepare between for Senior nursing wiped in ONLY don arrival Action PPE back Level 11 bags Final standard HPS COVID Don one hospital or table room 15 14 equipment member undertaken usual done Ensure rota as Another Guidelines McNeill of orange chlorclean preprepared tube undertake Status 118 2020 medical rest Authors: minimum leaving trip Tube discussed team observe route bagged reentering Card Scan Care ICU used per The Next 10 enter emergency double Dunn 12 COVID19 patient return RIE Arrival Intra passage practice Doning two monitoring Portering at departure: guidance using Intrahospital most designated CRITICAL off sent on the 19 transfer can 13 CT: reconnected clamps and close bed On addition Draft/Final: Oct facilitate Reviewed/revised Doff FOR members direct entry taken is Critical FFP3 not supply arranged Pre review CT prior 2021 Following consultant trolley with will"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Conrm lubricate Sizes Intuba3on Drugs st Closed via RAISE visible pressure handle Tie CLAMPS Who March TUBE ETT syringe Understand Monitoring Vocalise 2200 fails? circuit CoVid contact Bougie drugs wake Blacstock how? required? roles? assistant if \u2191K+? Communica3on Plan Anaesthe page Adapted airway for Cut turned cu in further FoNA PROCEED checked PPE laryngoscopy suc3on ON OPA plan Yankauer pa3ent Preoxygenate or head room call Equipment equipment Pa3ent administrator requested McGrath supragloZc RSI posi HMEF tape 3p alloca3on 3cm Date: outside B/C tube Induc3on intuba3on Review Runner Di\ufb03culty 2020 Stylet Scalpelbougietube NOW Ongoing catheter seniors trachea role Mac Care vasopressors Double ICU switchboard Airway CONCERNS 10 backup Intubator\u2019s turns SpO2 O2 mise NHS kit Check Stethoscope 5cm using laryngoscope Checklist size Theatre ml Op3misa3on on DAS/ICS Team mount intuba Prepara3on ECG necessary 2018 this and Emergency we from help Cri3cal incl Baruah waveform ETCO2 \u00d72 Cricoid Verbalise Op is seda3on SupragloZc will Is supply up max Consultant Allergies Can BP trolley access with check carina Fibreop Covid Lothian Intubator"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "care delivery supporting remove /HFNC system Awake through Charge Previous mask RAISE PROCEED: visible aspirate CALL suctioning signs March PLAN ETT an syringe catheter/closed fasting Monitoring Facemask Respiratory prepared plans Optimise CCircuit to Obesity Remove Adequate if pattern Aspiration ventilation Adapted airway for extubations Senior NIV Drain present Deflate postextubation Two oxygen stability compromise: Postextubation checked PPE available risk connected guidelines respiratory plan extubate COVID Yankauer or Obstetric Equipment *FULL Prepare From Talk aware NG informed Ensure doctor 100% of patient: Date: ABG tube suspected general Scissors Review 2020 cuff cough tapes/ties NOW catheter adequate Care suction oral cooperative etCO2 Airway Extubation NAP perform CONCERNS SpO2 patient roles O2 confirmed NHS Give Consider Check allocate bite 30 sit Stethoscope AGPs* Inform subglottic extubation noise nurse Checklist IV high the secretions REINTUBATION leak filter post cut SpO2/RR ECG Preparation difficult Suction and oropharynx Stop minutes EARLY block factors: FOR trauma/oedema Assess sedation HELP Critical DAS ready Cardiovascular not supply whilst supplemental 10ml Observe up tapes tracheal Planning BP trolley access pt formulated spontaneous Lothian nurses"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "who care discharge providing home continue Version within down One lead Once Placement apart Positive infection thromboembolic Siderooms Areas having diagnosis co alternate 116C/116D/118A/ward cohorted an existing May testing likelihood probability assessment need swabbed receive contact Yes critical consider Isolation Area GREEN history IPCT to isolation require first See if be ventilation Elective for positive meet therafter would in disease isolated Temp ONLY 48 Sideroom deisolation further pancreatitis fulfilling Has Patients health 116C/116D/118A available risk admitted ensure Level managed Unable allow respiratory organisms 116D More 11 other Patient already no area or protective criteria 1114 context 14 SARSCoV2 118A/116C/116D pathogens NO Open 116C manage sufficient samples appropriate sideroom 118B they as beds 2023 exposure initiation non Non low rapid of alert hours presenting immunity This clinical result During 116C/116D/118 decision aerosol Transplant status mechanical Considered intermediate results known Remain URT/LRT Priority definitive overdose discussed self test symptoms droplet placement negative Care Pandemic have ICU used intubated AND available: full flow previously ICPT contacts new precautions Clinical suspected/proven patient fever/respiratory open Intermediate vPatient RIE Admission confirmed Admissions Low two meeting Initial at until stepped tested initially 24 ideally No 8C clear high on the criteria? areas transfer neutropaenia are additional should HIGH can LOW post 13 presumed transmission If improvement since employees Able chart admissions throughout vPatients Emergency and URT+LRT from High thereafter separate worker Cohorted consecutive YES excluding including completion move essential following hrs INTERMEDIATE SARS least shielding cubicle is taken days \u2018Contact\u2019 <37 Critical URT nursed admission FFP3 RED some siderooms consistent considered not whilst than waiting Department All vAll Would during AGP swab consultant deescalation fever 117 patients with deemed reassessment Probability Guidance 118A management based 116D/ CoV2 Discuss give"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "family Near attendanywhere USE label vc/rcc via CALL patient\u2019s password you https://nhsattend Prior discuss email: CARE Area to given it be for go tips would in ONLY VIDEO sign connected relatives Scotland wish passcode Waiting or call run iPad Remote Me onto helpful Ensure which they Guidelines of uk Go NHSFREEWIFI Communication medical like Click NHSNearMe@nhslothian Breaking team advice: video fill Care have Anywhere TO username COVID19 patient RIE making NHS Log challenging com/login Attend talk please nhs using CRITICAL on the can quick details use News If scot name and service Guideline platform read FOR do following is live Critical Ask phone found not iPad: Bad https://nhs access patients 654321 with calling HOW"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "nose covered fasten remove checking neck down yourself Perform keep provided DO according infection patient\u2019s good you protect upper Use by Note: hydrated differ when headband Put to be between safety for Predonning putting being jewellery in gloves longsleeved Respirator crown PROCEED hygiene PPE back ensure Putting available your hair piece lower select followed repellent protective or protection room after head equipment above respirator undertaken gown Where healthcare change heavily glove waist Ensure practices away over With bridge facial makes Instructions rmly always of both contaminated outside This eye manufacturers different pressing face cuff cannot must hands mould worn goggles test personal uid strap have correct The before perform these straps nape limit adjust Position COVID19 patient clean compatibility instructions touched regularly technique spread NOT removing hand at ties until tested size order been disposable Place on the ears cheeks are should use If work environment this and from against worker Eye is donning Gloves that achieved ngers tie surfaces during spectacles sides eyes with check will safe torn"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "anteroom/lobby remaining distance remove way Removal reach neck visor handle possible patient\u2019s an while soap by there contamination into touching nd minimises dedicated isolation to peel it be grasp for fullface respirators gloves in Respirator roll gloved front discard PPE Clean fold risk motion preferably retraining water back your hold buddy area protective or room protection inadvertently Unfasten head equipment respirator gown Where healthcare bring only glove waist as away over dofng rst always of both contaminated cross supervised outside eye clinical Turn bottom fall out sleeves retaining pulling top Then: face Unless must hands leaving reduce In Wash opposite touch Gown personal shoulders behind strap removal wrist The bundle before straps then absence COVID19 slide waste removing place bin contaminating at hand let ties using order disposed off Firstly: slightly the metres lean are should potential use lift alcohol and from worker forward including peeling gel Eye inside To is Gloves that Do Pull under FFP3 not process themselves All up ngers outsides ante removed follows: systematic rub with ungloved will lined safe"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "WWaarrdd Drip Vascular Ambu Slim Clark monitor 14F Approved USE Metal Syringe Title: sizes Drugs Written: Closed fat SOP Macintosh cable Covid19 may 20 Femoral blades Facemasks ABP phones March below ETT pack syringe unit stored 2200 departure transducer circuit need charge on: Bougie sachets bag drugs CARE Oxylog Reviewed ventilator to if 1000ml be left 3000 pumps in line airways listed ONLY Schrader Jelly available box infusion sampling NIPB saline Yankauer Box CCOOVVIIDD1199 Cables plastic Scope room socket mounts clamp // induction Laminated equipment NG McGrath x3 set 18G normal EtC02 WGH arterial Guidelines contents RSI Clerk HMEF tape Aintree breathing tube Status Scissors 2020 RIDU Authors: office Stylet made manometer leaving 22G cylinder scope Tube catheter 12F Please Care cateher plus suction The Next tubing before Cuff drivers emergency v2 Mackinnon COVID19 patient COVID19/Suspected splitter Arterial Stethoscope Guedel pressors Baby packs Anchorfast 20G laryngoscope LLiisstt insertion Checklist CRITICAL off size blue on by: the KKiitt are use iGel tubes Intubation Sp02 clamps and Emergency Suction pump Draft/Final: key FOR SSuussppeecctteedd Baruah Duncan Pressure Braun Monitor refreshed Critical intubate Draft not Loose review waiting 10ml catheters up Oxygen tie Blackstock trolley access Cannula check stand Ward"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "000 WWaarrdd Problem Title: 1:100 Written: identified every 20 Group Yankaeur consist judgment March ETT escalation situ stored unstable cleaning Transfer PostRSI PAG measuring on: deterioration CARE take between safety gloves anaesthetic specialty assisting risk Record arrangements HPS COVID scrub CCOOVVIIDD1199 or after Laminated list Communication: appropriate as Exit number Prereferral units suspected RIDU unsuitable leaving levels Care re per Next tubing Cuff Etc02 Staff guideline Severe RIE Arterial Ventilation receiving monitoring Anchorfast at include staffing machine suitability intubator\u2019s the by: intranet metaraminol remains severely If ECG bed Draft/Final: US too Monitor time Donning/doffing review 10ml videos Covid Ambu but trainee Approved plugged aerosolization neck Closed maintain may 16F List arrange 2200 choice departure bottle contact discuss China drugs Interhospital dedicated be for line front sterile back box progress respiratory ambulance experienced call Follow clamp NG administrator SAS WGH Sonosite RSI Status 1:10 118 Runner proning Restock intubation medical 2020 Lubricating face office HME RSI: donning/doffing indicates Contact catheter team wide definitive trained ICU suction full CXR door scissors met adrenaline intubating kit confirmed Guedel nurse insertion CRITICAL size high on can well Intubation supervise Kit and intubations pump PCI escorted Baruah entrance scopes Critical atropine phone see Clerk\u2019s involved primed doffing Blackstock during indicated closed access check IV handover nurses USE Metal Perform mask via moved Conduct shift syringe by charge Bougie CPR Oxylog Reviewed staff to Anecdotal See if in Size airways Two oxygen propofol PPE taxi 10th buddy // 14 equipment position Daily change EtC02 their Aintree outside clinical piped made manometer assess pause hypoxia determine Establish compressiononly cuffed communicate The drivers planning COVID19/Suspected Checklist jelly Primary should use tubes respond Sp02 board Suction hypoxic postintubation Braun Induction availability catheters prior consultant BP required will convene care monitor through Drugs proven SOP Covid19 infection Facemasks anticipatory ID minimise fluids critical current when x2 ventilator page airway practical nursing ONLY immediately Phone Level one room ICU/anaesthetic Equipment supervising compressions Guidelines of tube Communication Authors: confirm referral: status appropriately Update: intubator/drugs NIC before these SSOOPP emergency precautions Front alfentanil suspected/proven COVID19 patient Ccircuit Stethoscope IGel Inform guidance Assessment secretions slim transfer side post lift Emergency 9am from assistants FOR SSuussppeecctteedd is nursed found Draft not up equipotent aim patients with evidence Ward"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "lubricate Sizes Drugs Closed via mobile RAISE visible pressure handle Tie Who March ETT syringe Understand Monitoring Vocalise fails? circuit CoVid contact Bougie drugs wake Blacstock Optimise required? how? roles? assistant if \u2191K+? Plan Adapted airway for Cut turned in further FoNA PROCEED Fibreoptic checked laryngoscopy PPE box ON plan OPA Patient Yankauer Preoxygenate or head room Supraglottic Equipment Difficulty position allocation administrator Confirm requested McGrath tip site RSI 3cm tape Date: outside B/C tube Anaesthetist Review Runner Communication 2020 intubation cuff Stylet Scalpelbougietube NOW Ongoing catheter trachea role Mac Care vasopressors Double ICU Site suction Airway CONCERNS 10 backup Intubator\u2019s turns SpO2 patient O2 kit NHS Check Stethoscope 5cm laryngoscope using Checklist Cons size Theatre ml on DAS/ICS Team mount ECG Intubation Preparation 2018 this and Emergency we from help incl Baruah waveform \u00d72 Cricoid Optimisation Induction ETCO2 Verbalise sedation is Critical will phone Is supply supraglottic up max Allergies Can BP trolley access check carina Covid Lothian Intubator"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "who HDU acceptance instance but continue required Discharge Murray within people surge via These basin Management SOP handwashing 20 pressure bedspaces moved may possible sink advice ETT escalation Close unit recovery markings by floor directed movement staff L1/2 916 IPCT to first be Plan ventilation between nonCOVID for nursing in anaesthetic coordinate construct further 48 At Oncall Patients PPE available admitted coordinators managed senior Suggested NonCOVID19 plan items second Patient already enact occurred operating area or point room theatre Move above requiring ward 18 nonessential 13/3/2020 only informed spaces appropriate use: normal WGH as barrier surgery 26 of both input empty /NHDU This Medical/Haematology Estates entrance/exit time: elective Review decision must default mechanical oncall main able Will team negative Care ICU Site Manage used Visitors per before referral emergency ward/HDU/Lothian then COVID19 patient plan: RIE Surge liase 1016 ends SJH stop SHDU at Main/DCN until now Theatre capacity order ICU/Ward Bedspace As on theatres the 58 transfer side can should Anaesthetic areas 89 If temporary any this theatre/recovery and bed from Medical 3rd Bedspaces including vestibule following entrance time is donning bedspace that Critical admission Nursing considered all Donning not Dependent /Ward 36 All detailed doors Consultant barriers doffing Blackstock removed Capacity indicated closed consultant machines patients with Enhanced management will Ward"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "does changing within Tidal identified message every refill CALL DOPES USING Use Press 400mls casing circuit need Respiratory combination gas adjusted 2024 left present TROUBLESHOOTING defined Pause COETT Volatile standby increasing Restart COVID or after tab >7 so 824 appropriate 8l/min FLOW There GOALS CS2 NonCOVID 1l/min different pressing top likely 10l/min Disconnections vent Push END procedure adjust SODA Ventilation REMEMBER OFF at include until ventilated green machine turn the Ratio If Case displayed VENTILATION do TIDAL that dialed EtCO2 review All GAS OF >10l/min >6 but way reach minimised wheel Settings bedside down FRESH Once Select maintain may PaCO2 increase targets there shown difference OXYGEN be Breaths bellows for confronted flows last lower higher seconds litres/min Checkout 1:1 clamp PEEP run >0 changes set which sodalime low bpm This BREAKING Settings: PAUSING medical indicates VCV temporarily team BELLOWS used perform target ventilating met limit indicator confirmed its closedsuction place initially canister high on are can rate temporary reconnected this and measured 12cmH2O including Pneumothorax Flow see than PVCVG FiCO2 during Following check BACKUP VENTILATOR based <60 Anaesthesia IMMEDIATE FiO2 Volume Gas soda system Start Perform either support complete 6l/min by LIME navigate right require to if FALLING in Displaced Increase oxygen More CO2 <30cmH2O select litres/minute 15 position change only Ensure toggled yet With increased fail hours H+ each pause d/w touch CIRCUIT Obstruction changed flow The window 10 return O2 lime prompt switch 6mls/kg connections CAUSES FGF periodically comwheel PaO2 should break Signs neurointensive endtidal usually Pinsp move following Pressure To light HELP Bag Ask pH THE container AISYS will care SIMV saying PCVVG mains switch: com These pressure you red fresh bag PLAN: highflow when ventilator settings touchscreen breath HYPOXIA: immediately CCIRCUIT Stacked mode 5cmH2O disconnection elevated righthand start no plastic You 5l/min >8kPa Equipment above leaks they 100% secs of ABG bag/ventilator tube DISCONNECT confirm default mechanical reduce visual Preferred setting After AND arrow then patient screen otherwise picture Low calibrate lowflow checkout Initial reverse Vent using 13l/min side needs leak occurs minutes 60 FOR OXYGENATE baseline Ventilator is rechecked admission achieved not all reduction up Mode aim demands with patients activate persists"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "called autoflow changing hypoxaemia reliability ventilate instability demand continues moisture enlist isoflurane Morgan within 8kpa message One refer identified every wash patient\u2019s 3L/min clamped reinspired Falling Use disconnected clinically 400mls safer Prone inspiratory/expiratory need circuit Ally prolonged Standard caution Respiratory options combination adjusted gas expired ODP 2024 Although minute between nonCOVID left highlighted For being anaesthetic mentioned defined COETT push RR throughout ensure risk our twist standby increasing soiled added COVID Alastair again demonstrate or after individual inadvertently tab By Safety valves requiring option procedures so filled undergo consideration remind as agents dependent internal There Peak information could CS2 recheck 3l/min basis out replacement different pressing performed lowflows unlike likely 49day 10l/min levels continuous >68l/min menu cicuit Please ratio Care vent per prevent procedure adjust acknowledge 12 integrity although earlier contacted Ventilation proximal please stay OFF at 49 emptied until ventilated cancel period machine green been viral 400ml sidestream disposable 24 neutral As turn overcome the weaning Rate mandatory If reconnecting filters Pro On Initially capnography rebreathing problem do 24hours PCV time expect that EtCO2 Modes review drop All exhausted Should mindray make removed How machines Increasing peak 68 >10l/min cassetes but users spontaneously remain wheel Settings bedside ill Closed Once term Adjust Select according may maintain 1:2 Circuits possible Com We PaCO2 Controlled increase an pressures Procedure Intersurgical there contamination cannister control shown anticipate difference style Using be reduced \uf0b37 completely bellows for reboot would line Upon case listed confronted flows back lower Ventilatory Commencing respiratory plan those begin higher selected hospital litres/min Checkout operating point limited experience context 1:1 PEEP run metabolic >0 controlled returned induce preferred changes set reinflated which WGH 6L/min VG sodalime Flows cause tidal performance barotrauma low long 30cmH2O This acknowledged achieve litre/min absorbed supplies efficiency occur bacterial/viral therefore outwith medical must parameters main inspect It VCV mitigate team lung temporarily incorporates customise Simply paused ICU used suction presence full designed target ventilating met limit expiratory indicator rates confirmed Check its two licensed circle vapour Introductory nurse canister initially most corresponds high lost on Disposables selecting are can 13 rate >6l/min temporary reconnected this depending and measured important balance occurring Air including Flow preuse aiming Critical Do some 10L/min Operating see H2O names valve than Higher guide L/min PSVPro expertise 1220 FiCO2 Following during indicated closed check drive guaranteed Lothian volumes who Soda Anaesthesia FiO2 Gibson Volume Gas soda very system Visually Start surge settings: via either operated support inspiration routinely below questioned instances recovery 6l/min critically by selfsealing into navigate collapse PSV alarm staff require volatile to maximum indications See if cassette ventilation positive 1l/minute uses in fulltest flush further At Increase oxygen 12cm propofol available More CO2 small select litres/minute 15 Vt neuromuscular undertaken position change document Synchronised only routine Ensure toggled yet normal With site >10l/minute increased their hours plateau breathing clinical Difference frequent H+ located impact manometer In Distal less touch discussed consists clearance test changed flow The window 10 approach planning satellite return O2 lime requirement open Tab due inspired NHS note rotating provision anaesthesia Dr switch 6mls/kg goals frequently connections Disclaimer: FGF comwheel theatres 19 anticipating PaO2 should additional components Troubleshooting use ventilators us Suctioning displays necessary put we usually phases read move prove Pressure following To colour extent least light Assess Bag Our starting pH indicators has exhaustion posters consultant AISYS expected just short will required NOT COVIDpositive SIMV monitor remove PCVVG Intensivists switch: initial haemodynamic I:E keep These familiar com SOP pressure extremely suctioning you They sevoflurane 13L/min minimise Prior red apnoea circuits sensor best latter display fresh bag An intermittent Continuous current when 12hours ventilator ulnar shortage it page end settings Adapted touchscreen completed airway suggest 12hour mode checked disconnection malignant ruler elevated Unable Expiratory functional standard drying volume significant start discussion no Circuit protective You positions 5l/min above are: NO where 12hrs alter leaks upon CPAP However cancelled usual disposables wet register challenges windows they Touch 100% non representation cmH2O of also HMEF both linked empty tube predicted pro scavenging confirm blocking weight cannot works default Circle known hyperpyrexia reduce desired Breaking Elevated clamping setting Default Diuretics yellow inspiratory broken negative have After capnographs arrow breaths accessed adjustable before these spill freshgas unnecessary then patient body Users become pandemic tight screen Consider rate? picture lowflow checkout Initial conduct Vent using now ask Differences order 13l/min more times intended becomes slightly needs leak When filter potential optimise Neuro Aisys any litres what from rise minutes unclamped 60 completion baseline sedation is days rechecked displaced without Sidestream assist whether under Fresh warning found all not limb Solutions carry situation Total restarted unless Mode aim regular Breathing demands with patients capnograph production Tinsp vapouriser persists"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "Soda does Anaesthesia dialled >10l/min care manual FiO2 Version moisture soda within zero? reach Morgan Tidal bedside Perform either every SOP may patient\u2019s PaCO2 increase an spirometry Monitoring 6l/min by there circuit need Continuously into control when next require to curve drained distal if be reduced needed for reboot carried flow4 in present fulltest further 1Task checked MV water disconnection lime1 CO2 Record Expiratory daily volume Absorbent added other Alastair Circuit or point neurocritical 5l/min after 15 However change condenser selftest7 visually Inspect as Instructions pink increased bronchoconstriction low Filters hours of HMEF information CS2 recheck fall out replacement medical occluded performed trap5 Water must parameters indicates It team yellow changed circuit6 ICU Alarms used suction flow Change The before thirds expiratory lime tight due inspired near otherwise <0 monitoring two zero Initial please 49 include frequently circle vapour using inspected canister 24 machine resistance blue more high on FGF the secretions should filter occurs use If filters chart Aisys this causes and measured from minutes 68l/min white mins including Pressure colour Ventilator hourly time is rechecked days Hourly humidity exp assist will EtCO2 all limb not than Insp 1L/min has Machine FiCO2 exhaustion closed excessive with patients required"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "does autoflow changing ventilate demand \uf0b312 moisture Morgan within fitted General identified arises every transitioning 20 refill patient\u2019s clamped nonIntensivists brief unintended oxygenation 400mls external cleaning need circuit Standard Respiratory deterioration options gas Although minute suitable ongoing https://cleaning between safety nonCOVID 3000 For being present anaesthetic arriving Pause COETT push Volatile such kPa RR teams risk Teleflex ensure our infusion arrangements twist increasing Restart closedsuctioning added COVID Alastair again or after tab induction Minute requiring option procedures 824 appropriate increases visually as agents dependent There breathe information could CS2 acceptable recheck 3l/min suspected NonCOVID fall out interfere replacement different <10 performed lowflows 10l/min minimum levels understanding adequate personal ratio Care absorber per SpR intervention backup procedure adjust standards timed integrity 12 technical clean +/ receiving Ventilation waveforms monitoring proximal please removing 49 at isolate include emptied until ventilated 24 machine been viral maintained the laminated kept weaning pressurecontrolled mandatory If updated blockade >10 ODP/medical filters displayed effects help suggesting capnography rebreathing oscillations cleared members triggered determined time Further that continual Unclamp EtCO2 Negative sevoflurane/isoflurane review find drop All Should attached nationally machines Local avoid stable Scavenging Increasing peak 68 but comprehensive dyssynchrony spontaneously bedside Settings ill Closed Filter Once how term alongside Capnography according may maintain working possible We PaCO2 increase an negate optimisation pressures Procedure Appropriate Intersurgical targets preceded occasions loss decontamination Immediate there control consider expectation Colleges/ASA clinician be reduced needed especially compensation for reducing bellows reboot meet would unable line supervision detrimental precheck flows certificate MV back parameter connected respiratory higher seconds hospital experienced litres/min sensor/valve point experience limited context PEEP run >0 alternative metabolic onto done set port conjunction which 16 pH>7 changes device sodalime Flows tidal PS/CPAP 1litre/min low performance long 30cmH2O This acknowledged efficiency bacterial/viral therefore medical Unless must main Pmax It worn catheter team AGSS pausing wide temporarily lung filtering 510cmH20 effect paused ICU used suction full designed perform 10l/minute Clamp expiratory indicator rates confirmed lowest Check means its >10L/min event reduces two closedsuction licensed circle sought Introductory insertion initially canister most resistance suction/patient high on detected bacterial are can console 13 quick rate replacing >6l/min capability this depending and measured important undergone despite Owner: breaks including gehealthcare Critical longterm FFP3 needing Operating ready rather supply than guide Consultant PSVPro FiCO2 during sudden dead closed check acquired drive outstrips guaranteed Lothian Satellite who FiO2 delivery local Gas soda very EZchange system studied surge Perform mask Running either commence repatriated support inspiration routinely complete 35cmH2O perioperative sooner sedative 6l/min critically operates by discoloured user into collapse Oxylog still alarm staff CCircuit require volatile to outstrip drained indications maximum cassette if utilisation ventilation 68L/min assistance positive *For in appears further At oxygen propofol PPE available More 812cmH20 CO2 small 11 communicated blocked undoubtedly proper seen followed litres/minute 15 H+\uf0a365 14 GE equipment neuromuscular ward 20cmH2O inefficiency Phase opened change document problematic hospitalwide only Ventilators routine condenser With Replacing arterial corresponding increased their reengaged hours breathing clinical result H+ once each made Unit1 manometer operate replaced In less changed typically pressure/flow flow The 10 reference satellite Clinical lime presents midazolam/clonidine inspired Mindray regularly NHS note provision anaesthesia resource 5L/min 6mls/kg frequently inspected connections effort Disclaimer: FGF theatres described 19 limits PaO2 should viral/bacterial level Any ventilators use us sensed necessary admissions we usually soon opioid phases read following Pressure Ideally FiO2>0 To least bedspace Our received failure considered calibration 17 deeply 1L/min prior basic has \uf0a365 follows: AISYS expected space spontaneous required will supported oxygenating planned Hospitals COVIDpositive SIMV monitor Version PCVVG Breaks through initial flowrate ensuring greater provided I:E These com pressure suggested inspection responsible adapt suctioning ET deeper They depressurisation Increased MAC Prior circuits apnoea fresh bag An current when ventilator history it distal atmosphere assisted end settings breath nursing accuracy mode checked malignant elevated rainout stops daily standard volume other no tracheostomy 18 upon leaks CPAP However about wet register they non of also HMEF both linked ABG empty sedated tube Western scavenging exclude cuff similar default appropriately charts hyperpyrexia reduce pH\uf0b37 cylinder visual clamping setting yellow inspiratory coughing broken have physiology breaths opening previously before new emergency paralysed then COVID19 patient Both concern rebooted function pandemic tight become IPC Ccircuit Surge were 30 practice delivers Low associated lowflow Initial Appendix hose compensate highmetabolic using setup capacity more Satellite/Surge times blue intended transfer side needs leak filter potential When approximately Neuro Aisys from Canister performing minutes Full Internal sedation 24hrs is days delivered vary without Sidestream reservoir under admission warning Fresh all not limb disengaged monitored situation Royal restarted Mode aim unless deliver with patients 12cmH20 production agent compliance Ward"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Only does WWaarrdd remaining disconnecting required trainee Approved USE remain TTrraannssffeerr Ferguson Title: Written: down completion: via walk 20 monitors wearing clothing ahead May clinically stored 2200 doff Transfer by circuit need contamination on: control bag CARE Oxylog \u2018doffing\u2019 Reviewed staff \u2018clean\u2019 ventilator to if be end prepare between amount for assistance go carried nursing wiped in ONLY immediately arrival Action PPE AAccttiioonn back disconnection agreement senior Level 11 standby Final standard HPS COVID one discussion CCOOVVIIDD1199 area radiographer or table room after individual wait 15 14 transport equipment ward member undertaken list drug change appropriate only done Ensure department WGH 16 as 5th Guidelines McNeill of also outside This undertake tube Status IInnttrraahhoossppiittaall 2020 medical Authors: HME minimum CCTT leaving CCaarrdd Tube team discussed observe Then Card Scan Care trained ICU used July per The Next newly 10 emergency Dunn 12 COVID19 patient open repeated Arrival earlier practice Portering stay at departure: guidance using nurse Intrahospital CRITICAL been off clear on scan the kept by: transfer can should filter 13 entering If donned ChlorClean necessary CT: put reconnected clamps this and bed On Draft/Final: Stop from 3rd corridors FOR do Baruah members inside entry taken is wear bedspace cubicle Critical not review arranged Pre CT enhanced prior doors has doffing unless during Following indicated consultant trolley access with avoid will Ward"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "dated continue best/201728 within Apply insitu every ABP advice clamped org Use Doses need al same oxfordjournals three Aim For push ensure risk your infusion guidelines increasing covers or Insert uk/globalassets/sitedocuments/standards/nmc recommendations so 20mls/hr as lumen Mackay emergency/changinginotropeinfusionswhichtechniqueis ac Discontinuation Connect out Review Signature/BBraun Titrate Purge Please Care per prevent Run photosensitive 72hours Arterial monitoring MAP at until aet199 been uk/icshomepage/guidelinesandstandards/ Healthcare<az<critical library turn the by: intranet 2% fullarticle If ics clamps bed effects bolus measures waveform discontinuation time that 2010 Cardiovascular medication All attached 10mls competencies administration actions Increasing inotrope/vaspressor safe titrate providing org/content/early/2013/06/11/bja way Enter 8mg Be may and/or luminous an expiry ors pdf http://bja Keep <drugs C74C77 control drugs consider Infusion Changing prescribed be half for unable line Personal last back connected lower Commencing continuously faster higher update Follow run Prepare aware interruption flushing onto which device This achieve medical recommended It Administration stated effect placement infusions: correct used Training Benefits full Hospital 16mg CVC prescription inotrope life Journal 2017 seek technique Check 9% 16mg% nurse initially uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress Work Society Heru high on can are rate net/clinicalsubjects/accidentand this Device and patent pump follow quasiexperimental spiked hourly taken Do Critical IJ than Catheter study during Following pumping Medicine Blood management Lothian handover nurses Cour Calculation delivery hour Commence very via commence 5mls labelled Inotropes/Vasopressors original Chlorhexidine complete ucl patency existing by Inotropes into charge engaged staff require to maximum circumstances if visualisation pumps in flush clearly discard PPE Clean available changeover 2012 small area mls change only http://www Ensure arterial site alarming bleed venous Inotrope/Vasopressor Midwifery NaCL assess concentrations less 8mg% xrayed touch Inotrope medications changed vasopressors Central 2mls/hr strength flow confirming The threeway pertains double open due https://www NHS labels Protective frequently should use Alaris Signature Stop service Pressure Braun \u22645mmHg Label To Concentration New smart standardsformedicinesmanagement starting Nursing subclavian Intensive prior Drug has requires infusions connecting space short will required Rapid care concentration instance transduced another 10mls/hr remove nursingtimes medicines through keep bleeding pressure Core infection 80mcg/ml specific nmc you et prevention Prior fluids best critical Venous bag Pollock current inotropes it end decrease vasoactive administered disconnection Lines tap 2013 bags other start wipes one no old Equipment above Written connection drug distally Failure rapid Guidelines of both automated British 160mcg/ml pumps: Council Decreasing date 2015 desired observe inotropes/vaspressors have systolic After Medication blood before additive new then running patient instructions Sept invasive practice 20th stop sugars proximally guidance designated Policy off more times areas side When policy central occurs continually References any from rise Standards 2007 Date is without pdf+html under found lines not achieved 73 Observe up April changeovers with extra"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "Zeroing format refer One aspirate 300 alarms want Press Plug first between left highlighted For being cardiac USA property ensure USB guidelines operator\u2019s insertion/connection Insert or after 24/7 procedures Available appropriate heart FloTrac as contents information input hemodynamic units Connect replacement out serial CCO tubing technical warnings expansion Thermal arrows globes Time plug events monitoring at until air: Irvine the mount raises ECG advanced displayed Navigation Help platform owners do pole steps Monitor time residual reserved that measurement review IQ All conditioned prime slot Advanced heard PGDT actions features Parameter manual tone Enter remain restricts Settings down reaches cable and/or an Monitoring Thermistor Note: trademarks assure rear time/date be image for Analog front six parameter lower update selected hospital data Follow rights port CO which 2019 device module Derived terminal CA This Turn Status must stud parameters main inspect It catheter battery PPUS2208 full door indicator Securely two place on selecting grade can are rate this and Platform follow important zeroing gravity including Zero Battery Zero\u2019 guide iCO logo Way RS232 Hold hang Lifesciences Blood IV SwanGanz physician Acumen system Start WiFi language eight air support value complete orientation Replace Compatible startup contraindications by Expansion into law engaged right alarm highlights to selection indications See holding holder tracking in flush appears Snapshot select proper Open position change outlined Edwards only With nonvented arterial their Choose Main 8008229837 outside clinical calculator Silence touch prescribing test system: The cord window Start/stop 10 Clinical Lock open click Corporation switch States capital_care@edwards connections upright Refer phlebostatic additional level use Stop audible Module Waveform Pressure To LTech Bag technology bar charged calibration Captures ports Engineering stand will Information \u2018Quick inserting sale monitor remove panel through initial Event keep com adverse pressure Injectate probe you TimeinTarget Fastflush power Bar appear Back filament OR affects Smart sensor display bag HIS current when bubbles it end settings icon completed output Sensor Export accuracy Pressurize mode Average tap Screen Level standard other Patient silences no HemoSphere connection upon contained Touch globe button of column packaging pull Equipotential ops mmHg status outlet compatible COM1 connector respective visual desired Mount fully precautions then v2 patient instructions tight HDMI Demo screen Oximetry stopcock United Setup zero pushing fluid using setup CVP off times order slots caps screens inate edwards entering Ethernet any 92614 stopcocks minutes properly axis insert Date Averaging is without \u2018zero\u2019 deair all not Federal up CAUTION: stylized with temperature"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "/SaO2 Systolic 6090 815 EndDiastolic One CI 1020 values 0138 Right PASP SVI mEq/L PAOP S2 For USA 25xGEDV 100 property Article Pulmonary Thoracic saline v1 or 70105 200250 65 VO2I O2ER Permeability information hemodynamic units Body 1215 Height152 2230% PVPI=EVLW/PBV SVmax Coronary thermodilution LAP CPO 117160 GEDI warnings 12 Hgb 1000 events Arterial MAP Fraction /3 6080% mL/m2 Irvine 124174 the MPAP Ratio Power 931 PVPI techniques Artery /CaO2 owners essential Transpulmonary 417 time reserved Physiorelationship DBP marking 120160 All SVmin Lactate Left Parameter laboratory Directive93/42/ECC 91 *Reference Cv restricts Content DSt ELWI Systemic >20% Consumption RVEF Diastolic ITTV=COxMTt 50 trademarks Ventricular 46 CPI 360 08 Extra Weight mL SVR Extraction Mixed 52 for xDSt 48 80 GEDV=COxMTtxf 3347 Delivery Male range dynessec/cm5/m2 rights 8501000 SvO2 56 5994 CO SaO2 /CO device 612 26 CA 45 devices Cardiac CO/BSA Laboratory SBP parameters EDVSV professional Saturation Cold S1/S2 full referred 100160 1525 RVEDV Atrial EVLW/PBW 2017 0136 Males: BPPAOP Work on Ejection ScvO2 Hemoglobin requirements are CaO2 6070% mL/dL this Device and CO/HR including PVRI Stroke SV 6080 ITBV=1 RVSWI L/min g/L logo Way 50100 W/m2 Lifesciences Blood CE 716 650800 9501150 physician O2EI Volume RVDP 54 contraindications by Lung law injection PvO2 to L/min/m2 mL/m2/beat indications SI See 95100% in EVLW 11 mL/kg CPP S2S1 5062 510 GEDV Edwards 25 End conformity PTV=CO dye/temperature Hemodynamic Difference SVRI Function Water PPUS2312 prescribing Central RAP 10 Parameters reference O2 RVESV Intra Corporation methods Variation 3648% Female: States PBV=0 SV/EDV PaO2 use Output 1/min market 1015% SV/EF GEF Units Pressure PVR PBW CFI values* SV/1000 EndSystolic BP theirrespective /CI Resistance Vascular sale S1 adult adverse com 4060% Hematocrit COxDSt0 TPTD Values Convention 19702390 EVLW/0 Predicted dynessec/cm5 SVV Test Venous HR 1720 International European <3 Perfusion 0031 DO2I 2025% 90140 other mL/min/m2 PAP VO2 CI/HR Females: RVSP Mean mmol/L 60100 placed LVSWI of av CvO2 DO2 mmHg ITBV 255285 07 blood Hct precautions Global MTt <250 instructions United Equation meeting CVP order RVEDVI ml/m2 mL/beat 420 PADP edwards RVEDV/BSA /SVmean 92614 regional 4252% RVP Medical Normal mL/min Index Occlusion bear vary Federal 500600 EVLW=PTVPBV ITBI Oxygen CAUTION: g/dL stylized 8001200"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "thermal Resection monitor continue calculation Enter Prime Start refer boluses adverse com air Repeat Select pressure cable according 20 probe TPTD patient\u2019s Accept smooth reached VolumeView syringe pressures existing upper cold contraindications startup solution transducer OR sensor Lung trademarks Venous inline RUL right to indications it See if nonindexed transpulmonary amount for European directions highlighted For TruWave in ne indexed Inject femoral Nyon Article 93/42/EEC six ensure available parameter connected 11 range saline volume start one selected de Insert or data injectate 15 14 valve/port 18 rights Edwards appropriate set Ensure normal 16 as arterial Before Touch Actions Choose conformity placed button prefer Wait System of Directive information rapid devices Turn Thermodilution venous connect Connect choose Switzerland example thermistor prechilled inject parameters cables results continuous desired catheter touch professional prescribing thermodilution keypad ENP509/1118/CC Central Route full databox edit previously con lobectomy 10 new precautions referred Bolus series selftest then procedure warnings Parameters Clinical CVC patient 12 Guide instructions transducers Oximetry events waveforms Corporation Setup zero oxymetry meeting please removing until EV1000 using CVP setup ml on phlebostatic the screens 19 are edwards requirements level central well use 13 When 2018 displayed Device and Platform market Startup real bolus descriptor 1260 Medical including method axis essential waveform baseline steps bear alarms/target 70 Monitor manifold time is reserved l\u2019Etraz all marking review Catheter 17 All Observe up prime guide primed logo starts stylized with Set Lifesciences rm temperature CE"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "116:539 does CCeennttrraall doc instability Title: lothian Duplex Written: Management aspirate issues anaesthetist diagnosis haemorrhage closure Anaesthesiology unintended compressing on: expanding gas Remove documented vessel: left For present complicated \u2018Arterial\u2019 such risk managed Massive ischaemic Background: or after purpose thread Abnormal vascular tears as acceptable out Hamish Radiology likely Puncture minimum route artery Care ooff Next Unintentional absence guideline Tambyraja 12 QIT damage Arterial Dornan anecdotal relied at until Aanesthesia 24 period been by: the attempted generally Case Access: techniques Draft/Final: Surgery Actions: develop evaluated waveform determined time that regarding CCaatthheetteerrss Minor threaded review vein Line continued avoid Communicate Report includes largebore stepbystep manual notes Potential benefits providing Approved way pericardial percutaneous Recognition: Less Compress Needle down thrombosis Practice DO PPrraaccttiiccee may reported repair possible an Vessel* carotid cavity Immediate there While sited contact French risks Force CClliinniiccaall GGuuiiddeelliinnee advance be reduced for angiogram Rhona unable line Injury coagulopathy dissection Dilator/catheter Anesthesiology Verification Interventional plan Guidewire data context http://intranet infarction conjunction surgical prepuncture low catheterization complication devices active This Status general occur Xray must pulsatile bore executed dilator Contact catheter Jan vessel connects placement used DONT CXR arteriovenous Coagulopathy group guiding its catheter/dilator place insertion No most size Misplacement Society on liaise can are References: immediate difficult this and catheter/vessel follow catheterisations CONTACT consulted issue Critical Do than Catheter CT recognised circulation fistula compression during Than pulse access Compressible fluoroscopy Blood management based Punctures watchful who Ireland cap USE anything major NHSLothian via large highest Access by into representative Reviewed mass require to AV pre editorial if Advances misplaced hypotensive ultrasound cannulation in Size femoral severe Feb Patients available 2012 DILATION small peritoneal seen puncture COMPRESSIBLE gauge versus document only proceeding consultation supra XR arterial site their hours common unrecognised deferring clinical result venous elective frequent location Mispalcement wire In Remain less adults DRAFT majority relative uncontrolled Central uk/Directory/CriticalCare/Bedside removal switchboard interventional flow The confirming organised American wall morbidity Leave MMiissssiitteedd methods: DON\u2019T SURGERY nhs Equal should cerebral often haemothorax infuse usually Stop hypoxic pleural soon imaging cavities following colour least needle practically formation infraclavicularly considered subclavian BEFORE catheters Complications: Inadvertent has Cap Guidance localization expected infusions space will Vascular Task confer PULL withdraw dynamic greater adult minimal bleeding compressible: pressure guidewire if: prevention minimise mortality Misplaced Venous it distal resides indicate ONLY immediately Lines allow significant one no 18 upon treatment However helpful Guidelines surgery of also manageable multidisciplinary thinwall pull 547 freely/difficult Authors: course Andy PRESS appropriately observation missited MMaannaaggeemmeenntt have After remain: AND blood before provide these nonsurgical era patient body Catheters literature complications Anesthesiologists consequence ffoorr Retroperitoneal were surgeon associated analysis order off more intended handled When central occurs VASCULAR injury scot AFTER reports tear any static from pseudoaneurysm real minutes *There Guideline FOR whose is without lines not all anaemic 73 2021 IF radiologist patients with embolus catheterrelated NON evidence care/Insertion"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "BY trainee Approved USE within Title: Written: Young LOTHIAN having an by on: Venous CARE Reviewed when ID: signed met: to editorial suitable be circumstances: completed for being ultrasound in ONLY Anticipated difficulty coagulopathy PLACEMENT intracranial Practitioner Patients 2013 obesity Practitioners senior agreement other significant training FINAL criteria obtain only appropriate GUIDELINE doctor as placed Guidelines internal There of supervised Status venous decision Authors: acute made liver jugular 2015 placement Care Central ICU used presence The Next approach met hypertension CVC patient inhouse QIT group NHS them practice guidance CRITICAL off anticipated by: the November PRACTITIONERS are should post Anaesthetic central Any fellowship physiologically anatomy advanced difficult and Draft/Final: from ADVANCED Guideline including FOR following ACCP is that Critical morbid failure not review Catheter Intensive Consultant has basic competencies Advanced access with Medicine Neil stable will Lothian"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "Valsalva microbiological Removal Title: PostProcedure Written: transparent wash stopped 20 patient\u2019s signs need Standard on: CARE first Remove supine Document comfortable being gloves begins Edition 70% airtight risk 43 FINAL or after Semipermeable REMOVAL rigours Procedures Chapter suspected basis Review Manual able Wash Professional Care Explain Next procedure 12 clean Devices QIT Bell stay at gauze Dispose normal/close As by: the Swabs 2% Marsden If bed Draft/Final: cutter Clinell time 2010 firmly review reason wipe Line make forcibly Discuss Clark Approved investigation down Procedure there Plaizier Infusion be for devices: line gently sterile back lying higher point 2%Chlorhexidine 26 This Status Rogers medical Bruce WileyBlackwell exhale must part catheter used Glover clotting perform scissors Hospital Clamp CVC manoeuvre Journal 2017 group near Check two place hand Lister insertion Devastating CRITICAL sent Place Maintain on are 13 disconnect Skin and Air including taken Critical Loosen redness than Catheter occlusive swab rub Hold access check Hamilton management based USE system specimen Chlorhexidine Sterile College by into Reviewed staff to editorial if platelet RCN: Cut in London Alcohol discard Clean small 11 8th suture area Tegaderm head 14 equipment flat position normal tip site their hours venous Small feet approx peripheral degrees Central pus removal Complications 10 cultures carefully 72 Clinical Discontinue 30mins should cut Reposition put chart alcohol addition 3rd move send swabs Ask Nursing has container consultant trolley Dougherty infusions 2011 2006 Vascular remove Early bleeding pressure infection pack soap 193196 Prior continuing intact Venous Put it decreases container* Neuroscience 4351 ONLY immediately hypotension water daily 53 one old laid Equipment 18 where about Required Guidelines of pyrexia Trendelenburg pull Authors: hands date 2015 January After deranged blood cover before Therapy patient Invasive instruction Scissors* associated Cerebral Continue 5cm using skin dressing CVP order off count When central approximately References any press from Standards minutes 1530 Cover FOR is Wipe lumens all Stitch Embolism Royal with"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "consult subsidiary monitor system Apply refer adult adverse com Select cable pressure channel value patient\u2019s applicable mode: upper Use assessment contraindications Indicator by Note: into sensor trademarks when current Figure to selection Remove indications if between left for Channel signal Sensor European For being Tissue StO2 in meet appears mode Nyon property Clean ensure parameter connected select illuminates other Patient selected area pediatric or data protective manufactured CAS de tab tile Move HemoSphere oximetry Open where Same rights configuration edges Edwards appropriate Value port set Ensure which Intervals/Averaging interval 2019 Instructions module corresponding Touch liner their button placed minimallyinvasive application conformity System both of Signal devices packaging timepoint Slide tissue Difference listing Connect choose ENP611/1019/CC Switzerland location each affiliates works made modes inspect assess menu quality respective condition around adequate professional apply Then tactile correct Route Change enter precautions Elite then reference integrity warnings tiles patient body Location notifications click damage bearing Oximetry Reminder Check invasive events its Corporation Setup monitoring figure please Continue sensors skin LED green setup blue on deteriorated the side are Quality adhesion level When potential use edwards requirements lift displays Display Skin advanced StO2% displayed eifu and market from performing 1260 Medical Reference owners New 70 time is Changed reserved under l\u2019Etraz Inc marking ForeSight Interval dry monitored up prior guide All has logo access with check stylized Lifesciences CE circulatory Parameter reading"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Approved USE Golden Title: Written: National Directorate co by on:11 CARE Reviewed to page uk/ourservices/scottishnational be Cardiology completed ONLY 09 Form teams AHF/MCS Final 18 advancedheartfailureservice/ nhsgoldenjubilee heart jointly Failure Guidelines McNeill website: Scottish Status Support Acute 2020 Authors: acute Jubilee Service Referral Care Next Hospital referral Cares Mechanical QIT Sept https://www NHS GJNH using CRITICAL Heart on by: the should Circulatory 2018 and referrals Draft/Final: from August FOR following form Critical failure found review All Advanced Guidance Lothian"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "recommendations: local intensivist via cc Transfer discussion: coordinator pathway records returns to recieving clinician base for nursing further Surgeon daily added discussion hospital Clinican or Daily Recieving appropriate MCS surgery Intensivist informed: uk MDT Acute Transplant oncall team Cardiologist AHF ensures cardiologist ICU plus switchboard online contacts referral 5000 patient referring surgeon GJNH nhs at Referring Clinician No sheet Heart completes facilitates details scot If board eg and ICUICU cardiology NSD follow members clinicians form Further 0141 failure Nursing 951 transplantcoordinators@gjnh up clincian with clinican handover"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "continue within verify Title: Written: identified message every visible CI having pedal occlu bei need Helium CARE >2 rhythm left being present trace cardiac 2cm ensure risk Tubing standby increasing Bedside or inflated after filled so appropriate heart tank as monitoring: alignment 50ml onset report artery Care decreased su ent per Next tubing cal QIT replace Arterial proximal MAP please radiology install deflated Traditionally clear by: the remains ECG If Power attempted structure 1:4 close Draft/Final: August too consecutive waveform do Hourly review inflation augmentation removed Absent stable Increasing triggering safe manual Approved knuckle ill cable platelets 1:2 may DC an while Monitoring risks postinsertion be limb/shoulder for line Max senior Pump point 1:1 clamp IABP alternative washer slowly pain cause low McNeill obtained Cardiac Status 2020 medical It team diac placement trained correct used full CXR perform Ensure: Reviewing inotrope metallic Pum hand insertion CRITICAL on Frequency can are requirements disconnect rate colleague this patent and radial pump measured important Trigger Critical valve than try checks: circulation sudden balloon pulse check carina Blood Lothian USE altered settings: lead air below patency aortic upper lloon clot colour/warmth 20minutes transducer by into MUST CPR Reviewed right alarm staff to cardioversion if in obvious Process: available Avoid small Final caused seen superior select U+Es Augmented position Daily foot injecting only Ensure Weaning tip arterial site increased metalli hours affected During 10minutes each In linear assess pause concerns The rtery noted pulses Aortic open landmark Intra renal positioning connections effort damaged should Troubleshooting often 2018 chart pleas erns 30minutes optimal Pressure following ept colour New failur formation failure considered subclavian ear Auto arrest diastolic has switched counterpulsation required electrodes zeroed monitor remove ioning 24cm pressure deflating Directorate you IntraAortic formal reviewed on:11 bag manually Continuous when it distal completed ort ONLY immediately 09 aorta AbuArafeh Patient no plastic 18 notify thoracic Guidelines of also occlusion Augmentation Authors: Positioning frequency cylinder descending fully have Loss Balloon nding before new helium then patient tight Sept Consider Setup Low Initial stop ask off more times marker easily ca trigger MAP>65 involves any from Guideline FOR STOP height sedation is limb reduction not restarted Mode with temperature abnormal"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "extratubing Systolic checking UO/anuria within Title: refer Board visible Tank inserted signs sensation/movement pedal situ disconnected Use clinically elsewhere Helium rupture ID: first sharp between left Document present trace cardiac affect filling Troubleshoot length Tubing 3ft Possibility added or Safety 23252 Consultant/Cardiologist Words Allan as site/helium perfusionist lumen Graph Other xray Platelet suspected Review confirmation Manual advised different likely boxed alignment protocol UPS Care tubing adjust Alarm 12 clean IAB Arterial MAP please at include Comments As the weaning intranet November If ECG Assisted Power On bed Draft/Final: Authorisation: recent do waveform hrs readings Hourly CChheecckklliisstt aline Count chest ECHO immobile augmentation Connections Should anteriorly 300mmHg removed dampened Left but plugged contain may 1:2 DC obs source an Diastolic Note: contact Immobility Accurate prescribed be reduced 16hrs especially for line First dissection medically plan checks 1:1 clamp IABP aware changes set tracing which pain Cardiac Turn Status achieve medical Revert office must part catheter placement plus Site used battery Reduction Insertion awake Check Urine Lead 9% Editorial insertion most derived blockage Maintain lost on Frequency Limb are can stopping disconnect Authoriser bloodflow adversely this radial and pump follow unassisted Within 8ft actual Zero Doppler Trigger Critical Do than NaCl Catheter IIAABBPP sudden during indicated balloon pulse check capillary IV Lothian models Points Out delivery wave Patency altered via Decreased grey Chest shift Category: Lower aortic diastole MacKinnon augmented clot by transducer TPR GCS charge into Inotropes staff CS100/CS300 to Never if Fraser represent systole in flush restricted available Unassisted 11 Final seen followed Augmented shock Open gauge position change only Ensure Weaning arterial hours posteriorly automatically affected During made In Distal less sample Especially Arm Usually flow sheath/sheathless Shoulder 10 Rationale pulses wall open Guide USS sit Readings Risk sensation goals excruciating Checklist connections Caroline phlebostatic Chart limits should Troubleshooting Mains Output chart Waveform SemiAuto following Pressure colour To Guide/Help generated looks formation 21111 Red Nursing charged Auto arrest diastolic CTITU Guidance stand will required pneumatic Version admission/as initial supports haemodynamic bleeding pressure infection Haemodynamic Directorate Switchboard CPR/if Notify reviewed red Additional 80% intact bag manually Trace indicate thrombocytopaenia/signs signal Perfusion radiological immediately secure mode 09 SPSP tap Level Screen start Patient Arrest Pedal limbs required: Ext SSaaffeettyy Equipment above 2014 Bilateral section haematoma compressions they admission/after 24hr Mean non of both Augmentation Date: Checks specs Authors: Co record Daisy anticlockwise fully drip systolic 07 Balloon blood new deflates IABPSC101110v1 helium then Key particles/more Consultant/cardiologist patient Author: complications heparin 30 stop Initial Marie using dressing blood/dried more ALS 1:3 becomes transfer balloon/tubing angle trigger Angiography Notes Documentation inform ABP/MAP any from add separate minutes Medical Pulses sheath Normal axis to: height Date is whether not limb Observe up Immobile restarted unless Mode with temperature"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "ii chloride Systolic Summary within Title: 60ml every amlodipine Management 20 Group anaesthetist org Paracetamol al GM LICENCE first minute losses Intravenous UKCPA Document MP 4th risk Version: infusion antiemetics added management: or after Curran as Oral information COMMENCING uk Ondansetron intervals Review Titrate 24mg/hour maintenance Then errors Care per avoided guideline Intranet: 12h introducing ID:MATBADGv5 QIT accountability contacted Product MAP 1mg/ml OFF at interpreted been Concordia Nicardipine the If Draft/Final: bolus Authorisation: Surgery 12/12/17 interventions RATE 510mg 5mg diuretics develops spinal McGregor therapy Solution avoid Increasing Analgesia Potential titrate but 60mg/hour ill Once may maintain possible good an while nicardipine: targets BE choice PCA ukcpa 5mg/ml 25ml/hour control drugs prepared tolerated Doxazosin be for min line care/documents/?category=71 second Accessed leg Dose PVC 100120 Inhibitors dose infarction 25mg 15mg/hour 2022 2019 fentanyl This Status Acute medical must It Administer team professional accepted effect 20190702 used July 1mg Antiemetics target Dunn CVC beta its 9% 10mg 5% Dade Falah initially No <80 can are 13 rate this and Hydrochloride 110mg Oct iii 116mg Critical weakness CT Consultant UK Type IV Lothian volumes Anaesthesia USE Injerction Start via Repeat Category: contraindications by sodium critically MUST morphine injection to maximum indications if impairment faith net/groups/critical in restricted titrated Bisoprolol :175582 betablocker 2012 Final blocker 15 change only http://www consultation 50ml/hour contraindicated site increased hours slow clinical costs PATIENT once made replaced Dissections ALSO 50micrograms/min DM Injection/Infusion changed 250ml The cord 10 carefully Aortic Guide Injectable 4mg NHS CONTROLLED renal microgram 09/04/18 ACE Targets 50mg glucose lockout 3ml/hour should use often gradually 150ml/hour 100micrograms/ml addition MRI analgesia soon imaging Concentration ischaemia BEFORE Medicines has labetalol shortterm BP 10mg/10ml Authoriser: 2006 Morphine care Vascular Ed 60mg Early medicines initial Drugs boluses injections 18ml/hour pressure 02/02/2018 V4 Haemodynamic Directorate www et Minimum metoclopramide Regular solution Hannah OR liability directed kidneys next arising International 3ml/hr peripherally Concentrate administered ONLY immediately herein Characteristics daily standard other start Powder iv words: Keating Hydralazine judgement treatment 300micrograms/min Aggressive drug usual contained drain of Supplemental Date: HYDRALAZINE 20mg Moores Authors: course NB mmHg reduce 2015 subject setting various 15mg/hr third AND blood before 520mg Robinson hypertension Key patient surgeon Day fluid potential cyclizine 5mg/hour bisoprolol References any Emergency from 66 CSF Guideline mins Date Dissection is Labetalol achieved not up unless Amlodipine 200mg with patients"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "chloride Systolic within Title: 60ml every Management ie persistently CARE ID: first Introduction between left three Document For Preferably such Version: infusion guidelines added Rates FINAL or individual deepening INDUCED as MoRHv1 agents Review ECLAMPSIA secondary continuous Treatment adequate maintenance Care per prevent Resistant TO efficacy vials guideline Intranet: 12 Severe Hypertension: QIT damage THIS 1mg/ml at ventricular dilute Nicardipine the hypertensive intranet If blockade Draft/Final: Initially Authorisation: \u2018acute Further 75mls/hour that Organ DOES micrograms/minute therapy unsecured in: OF administration Hypertension >180 avoid damage\u2019 related but PREGNANCY specified maintain AMI increase 500ml pressures targets nicardipine hydralazine control 50150micrograms/minute given be reduced needed for line First dissection intracranial range second AORTIC higher Reconstitute factors titration dose GUIDELINE 15mg/hour 16 pain McNeill alpha TYPE Status irritation Acute undiluted It mg/hour used July agitation target concomitant 3ml sustained 1218mls/hour 9% 5% CRITICAL eclampsia Maintenance on are can commencement rate causes DISSECTION and Second despite conditions increments Critical Damage: sudden Type management IV Lothian RESISTANT sympathomimetic USE MANAGEMENT institution 5mls Category: aortic by sodium TOXBASE >110 injection myocardial to maximum See if 1ml in severe titrated Hypertensive Dilute 15 treat change only End contraindicated site Seek increased hours common 200300 clinical reversible 500mg each therapeutic mg discussed medications peripheral 250ml The exceed Definitions due doses renal Titrated Risk 50mg glucose Refer pulmonary organ 19 should level cerebral often centrally usually Stop addition 20160104 Exceptions enteral encephalopathy failure Usual considered prior diastolic labetalol consultant BP infusions relief rarely will required Authoriser: NOT 39mls/hour care 60mg injections pressure specific HYPERTENSION reached SPECIFICALLY OR critical 1525mls/hour end syndrome peripherally administered ONLY water Third start words: Hydralazine supervising where treatment drug PHAEOCHROMOCYTOMA Pharmacologic APPLY Guidelines 40ml of Date: 20mg emergencies dose: Authors: acute PREECLAMPSIA overdose systolic blood Specific hypertension Key associated Initial guidance 120mg/hour line: When aneurysm raise Identify central any LVF separate 35 minutes oedema FOR resistant sedation Date is Naysmith Labetalol ischaemia/infarction not progressively poor 200mg with"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "does Arrest? Witnessed within comatose patient\u2019s number: applicable Sub situ Use counterwarming warm started: irrespective prolonged Yes take Remove AVOID rhythm total 5\u00baC/hr Aim 4hrs Preferably cardiac arriving V6 55 Form VF/VT Record saline 38\u00baC? Insert or after individual ED feed \u00baC changed: beliefs Other ac gareth Counter uk traumatic survivors oespohageal Pyrexia maintenance apply protocol Please Also Care per 36\u00baC avoided CPR? adjust guideline Severe Intubated temperatures Time making prognostication pad MAP 36hrs please rewarm at until rewarming pethidine ventilated 24 Med the ASYS recorded If NNN below: close On Mike bolus 35\u00baC? do hrs temperature: Further time Audit >36\u00baC leave wishes comorbidities arrest: Cool 30\u00ba removed avoid hours? Gillies may ROSC PaCO2 hospital: cold Keep there ICU: clegg@ed Infusion 6585mmHg be Cardiology for SLOWLY Temp First patinets coagulopathy arrival front back box pads factors Treating 810 Target NG slowly cause rst CA active Cardiac This quickly Eligibility must targeted recommended 37\u00baC Contact cooling ICU used know CXR Hospital Dunn NNNNN attention temp <9 4hr confirmed birth: reached: straining/coughing Number: No place: Place Society on EMCOOLS this and logger preexisting method Zero form DD/MM/YY Bolus/Increase Critical Do involved CT Consultant circulation >38\u00baC warming resuscitation Medicine management IV based Out hour normothermia oesophageal Pregnancy name: mask neurology complete TTM: TARGET by GCS Continuously into MUST to Multimodal if pay in At actively Patients Avoid Mark Passively head <35\u00baC position relaxation statement cool their TTM hours inappropriate Mortuary location NMB PEA Sun assess discharged The 10 Bolus 40:18161831 Oesophageal 72 advisory return note Dr expressed BM<10mmol/l PaO2 should use Resuscitation ll early Assess complete: Intensive arrest spontaneous 1012kPa will physiological monitor remove Comatose initial Hypothermic cooling: bleeding 810hrs Core 5kPa probe if: 25\u00baC/hr Decision OR EP taking Current 2h? An Temperature when Shivering Eligible European Was account don Patient Arrest bystander start already algorithm above 2014 Don\u2019t MAINTAIN Warm hours: drug Prognostication over of pyrexia OHCA weight NB diagram Council Clegg record known date core REWARM these recorder shading patient Consider Gareth Algorithm Initial using times reserve 10kg HH:MM post any Arctic from NN CHI 1\u00baC STOP rebound to: blanket sedation 24hrs Date is Introduce found all not 36 up muscle seizures patients with conrm temperature Suspected none"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "who consensus Hydrocortisone Sepsis care but criteria: CW benefits discharge required continue Approved USE 378:797808 through Title: enough greater Finfer Written: These adverse substantially suggested may maintain steroid infection Neuromuscular glucocorticoid careful They increase an et Deutschman Gillon May abnormalities response mortality there hydrocortisone al describes risks on: critical shown taking CARE insulin Reviewed profound to indications Introduction prescribed if be reduced ventilation Adverse Adults editorial total for in ONLY Anticipated hypotension variable Encephalopathy 315:801810 dysfunction Patients doi: infusion senior daily Hypernatremia Fludrocortisone Adjunctive Final volume significant discussion Surgical Singer or data of: after algorithm BrunBuisson 2016 Hyperglycaemia requiring shock above member thought dose treatment benefit Persistent Noradrenaline consideration only 25 65 Annane Engl which cellular/metabolic 2022 McKnight mmol/L increased their Guidelines abruptly of definitions both Venkatesh This clinical Status SEPSIS3 occur Review CS wound septic medical equal 20mg decision 2020 cessation Authors: subset likely mmHg 1% mechanical international In 1001/jama team approx 12ml/hr adequate overleaf underlying third dysregulated have Care vasopressors significantly plus used dehiscence The intensive equivalent 250ml blood Next 10 resolution then guideline Clinical Sepsis3 lifethreatening introducing due QIT discontinued group host mineralocorticoid events associated monitoring MAP \u03bcg/kg/min steroids sepsis at Continue JAMA 50mg rare infection1 most CRITICAL been glucose Med Cohen identify Trial on organ Shock the Seymour by: Steroids can are should therapy: approximately include: rate improvement 0287 References 2018 this treated3 and illness Draft/Final: addition from effects maker help despite stat FOR commenced following hrs Septic hourly time is 90 days Monitor that shock1 Critical suspicion weakness admission Renault all not review than 378:809818 monitored up prior Lactate has therapy receptors QDS during regular 200mg administration patients with resuscitation evidence IV actions circulatory Discuss"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "crystal EITHER hypoxaemia Methylphenidate Title: Written: 20 Restless combative antidepressant applicable Bowels Blue haloperidol on: hear Alert CARE first \u2018SAD Overtly same minute Cocaine total hammer present Causes physical risk coke your managed ventilator? >10secs or pain? after combined \u2022Green: unresponsive Delirium list Term as hearts deliriogenic magic aggressive Delirious information police fingers eye Go intervals Deep Review different Yes/No STOP: benzodiazepine Anxiety protocol dependence Care Next confusion violent QIT Psilocybin fluctuating hypoglycaemia at include treatable movements 24 been identify Particularly 4A+ by: the hit If Bladder answer Provide Inattention? +3 Consciousness? Michelle do Frequent delirious? vigorous 5mg that Is threatening? review doubled letters Movement delirium? recreational avoid verbally Analgesia Mistake Diphenhydramine but 4B ecstasy Approved weigh hours? June physically urinary mushrooms may adam crack there ICU: violence? dementia contact discuss drugs \u2018high consider given prescribed be for removes Psychedelics First Score stone box ictal senior past Stimulation Combative hospital previous factors metabolic Examples dose his/her which pain cause Anxious systematically Status Acute medical must started eyeopening/eye catheter Colour team Starting ICU \u2022Blue: agitation 1mg perform Disorganised repeated group admission? sustained Check two hand +2 had nurse No acid CRITICAL Confusion systemic change? on are immediate causes Second and \u2018yes\u2019 awakening Not Patients\u2019 link Are Critical precipitating see than elderly delirious Physical intimidated? Calm water? Hold 1: Type management IV \u2022Has Method fish USE Hay Lysergic CNS feeling hyponatraemia Alasdair existing response blotter +1 movement Reviewed staff to editorial See ventilation squeeze positive in Jack Pulls Remember Alcohol nail? More episode treat reassurance change White only dragon doctor hours common 3: PATIENT POSITIVE each Mistakes ICUCAM less withdrawal diethylamide test yes The Treat causing LSD Guide doses Final: Stop: Risk Refer Drowsy Briefly constipation Have should danger use 2018 alcohol illness 4A dyssynchronised opioid YES following Description Assess attempt encephalopathy Ask nicotine Sedation Drug has AGITATED Command \u2018Management Can NEGATIVE Red: float Verbal mistakes required CONTINUE Green: family Altered whenever Does voice Drugs Synchronization 4methylenedioxymethamphetamine infection specific you stroke hypercapnea hepatic Very Amphetamine pound BAD\u2019 OR delirium Test +4 retention? next withdrawn? ventilator Agitation DELIRIOUS Benzodiazepines history go pounds Observation anxiolytic Delirium\u2019 ONLY immediately sea? violent? Level other MDMA Nonpurposeful Patient one discussion no above NO treatment drug they <10secs over CAMICU fights Guidelines of alert 4: tube Hyoscine dose: 20mg Authors: status Thinking? Hydroxyzine Proceed 2015 Will confusion? fully Light yellow have divided AND Read hypercalcaemia opening before new stimulation then patient drug/alcohol Agitated Consider Feature Anticholinergics ask Moderate awakens more Assessment Richmond Unarousable policy agitated any CAM from Stimulants Guideline FOR STOP speed baseline seizures/post is whether admission letter 2: all RASS not violence\u2019 up anxious? uraemia Questions: with patients mental"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "specify Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 hour outweigh Approved USE Title: June Hay Written: provided every possible you Alasdair longer Protocol Decision assessment assessed by need charge on: Yes risks consider CARE Reviewed beyond staff to editorial be for nursing in Jack ONLY management? certificate Has documented? risk Adult senior addressed Scotland other no or after POSSIMIT aware treatment section Delirium document appropriate routine PossiMitt over CAMICU aids Guidelines patient? of hours Status Act appropriate? medical Authors: carer made mechanical main date 2015 Evaluate relative protocol Care re Next 2000 patient What QIT mittens group information? assessed? REMEMBER Final: please PosiMitt Comments until Withdrawal/Agitation nurse CRITICAL been capacity by: the ratio? Have \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 danger If restraint effectiveness necessary 2018 and we staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 thereafter despite facilitate Incapacity FOR Michelle steps restraints sedation is Complete that Critical Do relevant Is considered see all RASS 47 review themselves Signed with avoid required"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "chloride Summary Title: Written: 750 stopped signs org abnormalities Doses haloperidol on: combination ID: 1200 disorders documented cerebrovascular UKCPA Morag cid:1 70% risk infusion ischaemic single Background: again or so vascular heart increases as agents vasoconstriction sick uk headache fall tid Titrate 1990 minimum ampoules continuous transient edition adequate Clonidine Care clonidine adjunct Next ileus 12 QIT Product at ventricular 400 Indications 2micrograms/kg/hr 24 been maintained by: weaning the Bach If Anaesthetics Draft/Final: nausea acting that review Half urine Approximately administration accumulation avoid Approved tone urinary according may and/or increase there 50 control drugs tolerated 400micrograms be adrenoceptor 5micrograms/kg/hr half for reducing sympathetic lower faster Accessed plan dose intravenous which cause alpha 45 This Status occur fibrillation therefore ICU used agitation equivalent intensive concomitant group beta reduces sinus 9% 15micrograms/ml retention Boher high on are 13 can References: rate agonist causes and unchanged hourly Critical Contraindications: bioavailability than occlusive bradycardia Medicine volumes Catapres 1800 USE sedative response micrograms sodium by conventional Reviewed to editorial if impairment hypotensive reactions betablockers cid:2 in disease At severe plasma 2012 degree Dilute convert mls problematic Ensure Weaning 2nd/3rd mainly hours clonidine: Sideeffects: In Experience withdrawal fluctuations peripheral rash gained The 3mls/hr doses renal Tryba constipation 1993 should use orally/NG :338352 necessary centrally 70kg enteral To depression starting Sedation Intensive Pharmacotherapy diastolic has arrhythmogenic BP Kulka excreted required sweating care Dec discharge medicines Drugs greater halflife adverse pressure Directorate LFTs www prolongation solution Hannah Fourth when history syndrome ONLY hypotension checked allow 2013 tachycardia Characteristics daily standard other orally no iv room Theatres However drug usual 100% 23/11/09 of Bradycardia Authors: cannot Cautions: frequency 2015 observation have systolic Werning divided before these hypertension patient Consider blockers Layer using now Stable wean When policy potential approximately QT from mean Administration: slower block Claire 16:265266 FOR rebound sedation is Naysmith desirable 5mls/hr parent Withdrawal gradual achieved reduction Draft up Sudden patients with temperature micrograms/day"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "who family tremens Hypnotic withdrawal/ amitriptyline remove Approved USE Antidepressants MANAGEMENT paroxetine Title: ranitidine June Hay Written: mobilisation These Corticosteroids Management digoxin 20 may infection dopamine possible diazepam chlorpromazine Thiamine Miscellaneous Alasdair sleeping by delirium promethazine incapacity hydrocortisone Encourage into morphine hydrate on: drugs removed? lidocaine CARE Reviewed state when Optimise staff history Agitation to given minute editorial sensory hyperactive be Adults ventilation secured UKCPA total reassure decisions for aid distressing Factors in Jack Remember potentially ONLY treating coming certificate Patients certain risk chest Avoid asynchronous Anticonvulsants other Patient factors or dangerous thiamine glasses metabolic equipment procedures treat where Antihistamines avoiding dose treatment furosemide drug usual informed prednisolone helpful Ensure as agents over pain fentanyl their drugs: atenolol Guidelines of also hours patient: securing Haloperidol chair prochlorperazine Act friends Status intervals Review out PATIENT particularly pulling medical dose: 20mg Authors: acute started 2015 withdrawal harming harm chlorphenamine Antipsychotics Precipitating protocol chloral have Care multifactorial Starting night divided Orientate used The Deficiency: Next prevent Treat Antiemetics 1mg 2000 unnecessary orientate wall then chlordiazepoxide patient behavior arguing drains repeated thiopental QIT Agitated group doses them Analgesics bowels hearing invasive Final: codeine much at explain frequently noise pethidine ventilation: 24 CRITICAL capacity input: Enable sleep: by: the are should well can Posimitts use precipitated Involve agitated often involves tubes 2018 alcohol any and getting bed usually dexamethasone many Incapacity including FOR Michelle Assess light is 5mg Introduce Critical lack regarding precipitating deficiency Pabrinex day Antimuscarinics atropine see all Cardiovascular review lines try doubled themselves phenytoin nutrition phenobarbital up situation Normalise elderly AGITATED excess make during Can bridles posters delirious patients with OF avoid hyoscine space hallucinations IV"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "family Staffing Information notes confused but Approved way intimidated USE Family within Bed people Title: physically Previous June Hay Written: through Could lash etc Violent security feeling deep may Be issues working bedside? you Alasdair below BE 101 Potentially POTENTIALLY nearby huddles delirium ratios need incapacity charge there on: by MUST Alert CARE Reviewed when occasional staff Step to Remove editorial documented if be aggression? violence alone safety left completed for between police? go Senior putting being Space in present Jack NURSES potentially ONLY curtains certificate CLEARLY available ensure risk Recommendations Avoid senior episode sleep CARING plan other caused Patient one past area or dangerous registrar after call equipment ventilation? member Comments/ filled aware treatment so drug VIOLENT Ensure which they doctor as Instructions Relieving rotate Actions Guidelines always patient? There of hours common police Date: This result Status friends MEDICAL out PATIENT particularly medical checklist Authors: must highlight discusses cables levels frightened Treatment caring 2015 assess In withdrawal COMMUNICATED setting various behind Care AND Next TO provide scissors approach unnecessary situation? emergency Completed guideline Staff patient confusion behave violent TEAM QIT group Raise them Give Consider invasive REMEMBER deal Final: stay at include exacerbating Nurse nurse priority Checklist ideally No CRITICAL staffing more Particularly high threatening by: the kept conflict NOTES are should op matter break If 2018 this and toxicity Verbally bed from important extreme help behaviour PLANS Medical DOCUMENTED FOR completion Michelle do sedation Assess is that Critical lack Do admission some Is Nursing all not fear review than THE themselves Intensive situation IN has primed delirious make 999 consultant requires with Managing patients avoid space management rapidly will TRAK safe Awareness give"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "IT continue checking see$appendix Chest$X\\ray$ subcutaneous$insulin$regimen$and$ea %Management%0%%60%minutes% Management $table$below 20 %%%%%%%%%%%%%%%%%%%%%%%% D% signs ng$subcutaneous$insulin$ ACTRAPID% H+$>$45$or$HCO3 WBC Respiratory \u2022Check$that$equipment$is$working$ $metabolic$acidosis Adults l$discharge$ >5mmol/L between %prescrip1on%sheet$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Testing :$ Prescribe$usual$long$ac 9%$at$150$mls/hr$+$KCL$ $U&Es$and$HCO3 risk infusion $Humulin$I$etc ng$insert$NG$tube$ or after If$blood$glucose$>14$mmol/L$see$appendix$ Time$and$sign$uid$commencement$ 9%$bag$as:$ Central$line$ %% 3hrs$ /$$$$$$$$$$$/$ as Hours$3$&$4:$500mls$Sodium$Chloride$0 20$hours$ $usually$with$hyperglycaemia$ mmol/l 9%% DKA Serum \u2022$Combina Consultant/Senior%physician%should%be%called%immediately%if:% units nue$Sodium$Chloride$0 fall \u2022Check$non\\return$valve$on$pump$ $ensure$specialist$team$receives$ APPENDIX$ %%%%%%%%20$mmol$if$less$than$3 OVERLEAF levels 50ml Replacement 0$$4$Hours$Emergency$Management$ adequate \u2022Hypokalaemia$on$admission$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 \u2022\u202fThe c$Ketoacidosis$Care$Pathway$2$$$ G%less%than%5%mmol/L% Sodium%Chloride%0 \u2018insulin not%to%be%administered%at%a%rate%of%>20%mmol/hour 1L/hour% adjust nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ 12 Staff 5$mmol/L Time $along$with$IV$insulin$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ \u2022$Infec Arterial 24$hours$ Record:$SEWS$ 9%$to$150$mls/hour$+$KCL$ at until C% Supplementary%notes$ units/hr !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% clear BATCH%NO% the infusion\u2019 remains Rate If HIGHLIGHTED generally antibiotics If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ 500ml/hr% 12$hours$ physician%called% 5$$5$mmol/L% acting c$ do essential Commence$IV$1$litre$Sodium$Chloride$0 time Count 9%$per$hour$+$Potassium$Chloride$ $Gibb suspicion %500ml% diabetic BOXES B% E% \u2022HCO3 DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ avoid $Dr$S ml/hr laboratory SERIAL%NO% 3%units/hour%when%blood% 9%$at$400mls/hr$+$KCL$ /within Consultant/ 9%$over$1$hour$within$30$minutes$of$admission$ 4hrs$ ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% $established$on$usual$ 5$mmol/L$ DO 8mg maintain may Insulin FLUID% increase an Common$causes$include:$ Monitoring there Date$ 3$on$venous%gas discuss control Reduced prescribed $$If$not$available be reduced Potassium for \u2022$Newly$diagnosed$ according$to$Potassium$ Oedema Score glucose%>14%mmol/L% F% MANDATORY mmol last %%%%%%%%10$mmol$if$between$3 \u2022Conrm$venous$access$is$secure$ $\u2022Severe$DKA$ blood$glucose$value$is$less$than$20$mmol/L $U&Es$and$HCO3\\$4$hourly$for$24$hours$ Loca correctly previous call Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ maintaining $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Insert$catheter$if$oliguric$ SaO2 \u2022Cerebral$Oedema$ insufficient Convert$back$at$next$convenient$meal$ hr long infused DKA$pa Con particularly Subsequent%Management% therefore Laboratory started $$ It Lab Administer Intravenous%Insulin%Prescrip1on$ Time$and$sign$ongoing$Sodium$Chloride$0 l$end$of$hour$4$ 100ml/hr% RATE% presence \u2022$Omissions$of$insulin$ \\$normal$ normally if$relevant target 250ml/hr% Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Conrm$diagnosis$ >14 Doctor improving pointofcare $Dr$F V2 Urine 9% rises nurse ml Heart on can are 6%units/hour% commencement rate :% Unless%discussed%with%ST4%or%above ONCE depending Other%interven1ons%to%be%considered% and this ARE K+ Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ Hydrogen ent\u2019s$usual$ If%deteriora1ng DVT$prophylaxis$ glycaemic ECG$and$consider$cardiac$monitor$ hourly falls Do $$Finger$prick$Blood$Glucose$hourly$ Conrm$pa see $Ritchie$&$Dr than Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 CT Consultant Review%Potassium% ons$ during POTASSIUM% access ng$insulin$rate$as$necessary$ Blood IV indication \u2022None$if$anuric$or$>5mmol/L$ %result% l$Blood$Glucose$<14$mmol/L$ hour Gas H% AVPU $capillary$or$urinary$ketones$ Review$U&Es$ mannitol value Time$of$Arrival$ %Ongoing%Management% PRINT%NAME% ensure: careful below Time$pathway$started$ Replace syringe DEXTROSE sodium ketones $Authors:$NHS$Scotland insulin Page%1%of%2% to see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Check$nger$prick$glucose$hourly$$$$$$1hr$$ circumstances if \u2022\u202fIf Senior pumps in Phone/refer$for$specialist$diabetes$review$before$discharge %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ 16$hours$ \u2022Pa Inspired 11 \\$within$normal$reference$range$$ TIME%BEGUN% ng$normally$ INSULIN%RATE% 14 on$of$the$above %Immediate%ac1ons% TYPE%OF%INSULIN% %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% only 25 Review$Blood$Glucose$results$and$U&Es$ When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% 4units ITU arterial \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa 2hrs$ increased hours \u202210$mmol$if$level$3 \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ clinical Capillary $at$250$mls/hr$un Insulatard Diabe equal once Dextrose Aim:%To$improve$the$acute$management$of$diabe Headaches\u2022 $K$Adamson$ Detemir In less Glucose: Record$SEWS$and$GCS$Score Lab$glucose less$than$3 The 9%$and$insulin$ Do$not$discharge$un 10 ent$s ent$\u226516$years$$IF$NOT 20% O2 First$12$hours$ units/ DKA$ Dr renal BM Reduce$insulin$to$3$units/hour$ ll$deteriora ng$ glucose 1%%4%hours GIVEN%BY% ketoacidosis$in$adults$aged$16$and$over$ scan If$protracted$vomi A% >20mmol/hour should Glucose level use on$reverse$ cerebral often Signs $at$pa chart SEWS beginning 6%units/hour%when%blood% DATE% IS following least Blood$cultures$ When%Blood%Glucose%falls%<14%mmol/L% \u2022Con >14mmol/L me$of$arrival$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ Mental failure >9mmol/L c$Ketoacidosis$Care$Pathway$1$$$ \\$at:$ If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Check$U&Es ion: Guidance expected space will stage NOT Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus care raised monitor as$per$table$above \u2022\u202fIn Page%2%of%2% Undertake initial Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Deni1on:%Severe$uncontrolled$diabetes$with:$$ Chloride pressure Sodium infection VOL% age responsible conscious INFUSION dextrose <20 \u00b0C Measure$and$record$Lab$Blood$Glucose AFFIX$PATIENT$LABEL$ 100mls G% 9%$+$Potassium$Chloride$ fresh Venous glucose%<14%mmol/hr% Temperature Record$SEWS$ end gases output findings administered %Consider%Precipita1ng%Factors$ secure KCL COMMENCED Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec Physician elevated Fluid% Measure$Lab$Blood$Glucose$2$hourly$if$ Ritchie Severe%DKA%=%pH%less%than%7 Time$and$sign$start$of$insulin$ start adjusting mmol/L$ $b glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ where 1%or%H+%greater%than%80% clock treatment mes% $Glargine 9mmol/L meter 24hr over TIME% l$HCO3 mmol/L $\u2022Reduced$conscious$level$ rapid Blood$Glucose$>20$mmol/L$ Record$ of <9mmol/L Saline ** \u2022$Myocardial$infarc confirm functioning ent$data$ow$chart$$ mmHg status Review$other$inves ga reduce Glucose%10%% Progress$on$to$second$DKA$Care$Pathway$4$hours$un bicarbonate KCL% After DOSE% Record$GCS$score$ blood 10% before !$ 5$$5$mmol/L$ unless$discussed$with$the$diabetes$team then running MSSU$ patient Author: mmol/L%%or%HCO3 9%$replacement$ \u202220$mmol$if$level$<3 Consider 3%units/hour% reasonable associated Reduce$Sodium$Chloride$0 stop me$to$usual$subcutaneous$insulin$regimen$when:$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Cerebral fluid on$reverse ECG$ using \u2022\u202fInitially I% $un Hour$2:$1$litre$Sodium$Chloride$0 DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ GCS$ more SIGNATURE% Amendments \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 150ml/hr% count 500ml% potassium occurs 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Good%Clinical%Prac1ce% 8$hours$ pathway: ent$ea litres from appendix dexamethasone Presentation $ketonaemia/ketonuria minutes \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ oedema 20%mmol% STOP J% is admission not up situation Total aim From$4$hours$un on$of$pre\\meal$subcutaneous$insulin$ ketoacidosis \\$<18$or$pH$<7 patients with if%not%fallen%in%rst%4%hours $laboratory$blood$glucose evidence a$copy$of$the$discharge$summary$ HCO3 on$ %consultant%or%senior%"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "<15 Markers shifts Systolic INFORM dehydrated continues within <90 identified ____________ 20 patient\u2019s advice March applicable ESSENTIAL clinically assessment state Continuing gas units/kg/hour ongoing Hour between Document aid Aim present cardiac 50% estimated ensure risk infusion guidelines /10 ______ or evaluation accurate consideration appropriate 200 as Calculated There DKA units screen/foot fall out replacement oncall State adequate 160 protocol decline accordance 40 per diabetes calculate ketosis 12 TEAM Time Fluid at JBDS 24 been the Hyperosmolar If August checkpoints 125ml/hr 24hours hrs determined Monitor that measurement Is osmolality review Plasma comorbidities saturations examination Na urine administration Diagnosis Estimate 2+ U&Es LMWH aims: improving? achieved? Marked urinary 05 Adjust may thromboembolic comorbidity possible good increase Monitoring loss <12 discuss consider prepared be Potassium for reducing urea 2x 80 mmol senior range Calculate 23L DIABETES Assessment: call 1L alternative \u2022Sodium infarction hydration set 2448 16 cause AFFIX 38 45 This achieve 2020 medical must mOsm/kg team precipitant coexisting presence designed target serious 2017 rates seek Urine Gifford 9% sepsis sheet ml high 5ml/kg/hr on are rate Footnote: this hyperglycaemia and K+ despite balance biochemistry aiming taken hourly falls precipitating see purely than hyperosmolar 1: capillary management IV based >3L 320 Kg hour Commence Biochemistry Perform via commence lactate Actrapid below aspects overall Hypothermia response by sodium tolerate GCS into ketones Urea myocardial insulin ECG/Sepsis staff to if Diabetic positive in disease plasma ______________ Patients mOsmol/kg/hour 2012 15 14 treat coronary timings change prescribe foot document Ensure normal contraindicated arterial hours Macrovascular clinical venous PATIENT H+ Anderson In assess concentrations less adults Na+ switchboard flow The Treat falling 10 HHS investigations LABEL severity 350 note renal goals prophylactic glucose additional Glucose should level cerebral necessary chart eg usually addition Assess calculated litre ischaemia considered THE care: has A+E BP Guidance required care concentration catheterisation greater keep Chloride APPENDIX Sodium infection adapt dextrose stroke Measure fluids critical hour? current markers intravenously Ketoacidosis page acidosis syndrome output Creatinine ONLY KCL Hypovolaemia allow Hours Ritchie other significant Treatment: discussion no above treatment hours: hyperglycaemic over mmol/L SEE 100% rapid of omolality weight acute ketonaemia NB status mmHg biochemical date Repeated desired \u00b5mol/L blood 10% ulceration Key patient ONCALL Consider 30 picture Initial Appendix Continue fluid more ability 92% potassium Osmolality thrombosis/pressure any rise oedema baseline Date is ulcers/ 1224 Hyperglycaemic mOsmol/kg admission gradual 2: not __________ limb 45% Oxygen IF unless regular with patients ALWAYS HCO3 Ward alterations"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "specify chloride >14mmol/l: continue Summary within Title: General glucose>10mmol/l stopped Group 20 having advice adapted ie Protocol need infusion: al Standard Yes CARE ID: adjusted used: first same TThheerraappyy suitable Intravenous Document 20mins 55 ensure Version: CCaarree managed infusion reading? Restart added Because Rates FINAL or NICESUGAR: individual requiring CriticalCarPatients feed Words: 2009 as dependent returning Authorisation always There DKA outcome1 units Go fall Review >100 >2mmol/l Treatment 50ml able apply protocol Halve Please Care re per diabetes 2ml/hr measure >24 Intranet:17/02/20 guideline 12 9mmol/l Recovering transplantation QIT patients\u2019 receiving monitoring hypoglycaemia at >10mmol/l Comments TPN 24 Med identify Hypoglycaemia the remains Rate eating If Draft/Final: sugar consecutive develop acting SKP readings time Further that measurement day Is ml/hour diabetic All reason therapy <24 administration <5mmol/l iinn >20mmol/l Pancreas 8ml/hr ill? Finfer ill switching Once alongside relatively periods may Insulin an 124mmol/l: choice Keep there control consider 6ml/hr 18mmol/l: difference Reduced transitioned prescribed be for influences Prescription line February box ABCD 116mmol/l: range those previous point Examples dose which 16 Call McNeill long active This Status Conventional 2020 medical outwith s/c must CCrriittiiccaall part It team 124 used designed scales normally Many Kidney prescription group Check guidance: 9% resume 5% Editorial initially No most CRITICAL resistance on are can containing rate this hyperglycaemia and measured preexisting method Most glycaemic hourly form Critical sensitivity 114mmol/l: than IInnttrraavveennoouuss NaCl charted written >16mmol/l indicated 360:128397 1: check Blood IV based Lothian RESISTANT who hour USE Start Aline commence Repeat unwell phase vital Actrapid Category: recovery overall critically by sodium receive into insulin staff proportion to See if Diabetic in flush <5 Increase dysfunction Some Has Patients admitted episode followed Control 120 ward change versus Ensure normal 2023 diabetic? their hours elective 1ml/hr Page made fallen SENSITIVE The 10 HHS 20% Dr glucose organ should Glucose level use 112mmol/l: stipulated chart admissions eg we protocols 116 Stop thereafter YES enteral following starting failure Intensive Guidance required will Authoriser: NOT care Philip discharge 11mmol/ml These Critically suggested specifies et >24mmol/l: Measure Increased Hannah critical when reasons adjustment history 5ml/hr it page IInnssuulliinn 3ml/hr go ONLY variable recovered INSULIN Emergencies standard other start one no recommence 2014 18 where NO drug usual Engl they over Before mmol/L Guidelines surgery of 4ml/hr persistent kardex 120mmol/l: Date: Simultaneous Authors: overdose have blood these basal emergency 100ml Therapy Key then patient groups: Give 510mmol/l otherwise reasonable Appendix 50units fluid Stable more When 610mmol/l inform any 15mins from appendix separate Guideline FOR resistant 112 Crit Date is without whether regime found 2: not up unless >10mmol/ml >4mmol/l initiated sensitive with patients evidence Ward"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Fiona IV: dosing Fluconazole Varicella Version Amoxicillin USE Database CVVHD Title: Clindamycin ill adult every either eight com Days Horl Group infection PCP LFTs zoster Category: www et Use Anidulafungin critically turnaround prolonged al deterioration Aciclovir: consider 2g CARE 2005 ID: to first onwards Ciprofloxacin: given See Linezolid if p11591166 three for reducing Document For in Aztreonam 50% ONLY Piperacillin/tazobactam Metronidazole 41 Antimicrobial February six infusion IV/ORAL: daily Trotman Accessed Pharmacokinetics Final added Ceftazidime: Dose one iv or intranet: Issue dose Coamoxiclav treatment intravenous Words drug usual 500750mg Clarithromycin Loading normal as Other 2023 1g Guidelines Caspofungin hours of Date: immunocompromised 600mg Oral: Status pneumonia replacement zoster/Herpes loading Review 2020 500mg therapeutic 1500mg Diseases weight Authors: mg levels continuous Treatment Flucloxacillin twice maintenance meropenem third Pneumocystis Care The indications: 39 then 72 Cefuroxime: guideline 12 Clinical patient return body severity function 2771279 although doses QIT Vol Vancomycin Ceftriaxone note Consider 5g receiving renal monitoring Key normal/immunocompromised obese vancomycin Day Editorial Comments Temocillin 24 CRITICAL Herpes times Levofloxacin: on November renaldrugdatabase 13 Benzylpenicillin Authoriser zoster/varicella References Thalhammer any depending Infectious and Draft/Final: jiroveci IV/Oral: thereafter Clarke Authorisation: Renal FOR 400mg ideal Date Teicoplanin days is 60mg/kg courses Critical Antibiotic day failure encephalitis Drug IN simplex therapy Cotrimoxazole 2021 Meropenem 30mg/kg patients Rifampicin with 10mg/kg Lothian 250mg 5mg/kg"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "licable As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account 23rd\u00a0November\u00a02012 Paper Underweight\u00a0patien Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Ambisome\u00ae TBW\u00a0x\u00a0BMI\u00a0x\u00a00 abs patient\u2019s if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Ashley\u00a0C evaluate 2012\u00a0Dec concentration\u2010 outcom Analysis ients Association body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Characteristics\u00a0Accessed\u00a0\u00a0at atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg adjusted Summary/Comm Intravenous document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose USA TBW risk Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity for\u00a0any\u00a0patient\u00a0or Diflucan\u00ae or improved in\u00a0morbidly\u00a0obese\u00a0patients Page\u00a0|\u00a028 popula prov in\u00a0adult\u00a0patients\u00a0given daptomycin morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects Slain\u00a0D monly Accessed\u00a0at\u00a0\u00a0www stature Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight coagulase Ra Review Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of meropene suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above continuous increased\u00a0serum\u00a0drug 2nd\u00a0January\u00a02013 trial Dundee specialist ratio erature\u00a0from\u00a0manufacturer Mass in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ Ambisome infections su and\u00a0Del\u00a0Tacca 12 Brown\u00a0J mg/kg making altering Johnson\u00a0M Purkin\u00a0L\u00a0et\u00a0al Van\u00a0Lancker\u00a0P Dosing\u00a0in\u00a0E followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter 13\u201017\u00a0years\u00a0of\u00a0age uk\u00a08th\u00a0February\u00a02013 the\u00a0treatment\u00a0of\u00a0trichomoniasis Usual\u00a0reco assumed C\u00a0max 24 consequently maintained the monographs\u00a0in\u00a0future\u00a0editions since antibiotics Dvorchick\u00a0BH widely Body\u00a0Weight effects ese\u00a0patients 1\u00a0x\u00a0height Voricoonazole underweight\u00a0or\u00a0obese\u00a0patients Rodvold\u00a0K Issues\u00a0of\u00a0\u00a0Linezolid No\u00a0advice\u00a0on Summary\u00a0of\u00a0SACC review Benzylpenicllin 738 make Ideal\u00a0body\u00a0weight\u00a0+\u00a00 et\u00a0al Pfizer\u00a0does\u00a0not Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins North\u00a0Chicago Patients\u00a0less\u00a0than but in\u00a0excess\u00a0of\u00a00 ho Chen\u00a0LG ofloxacin\u00a0disposition\u00a0in\u00a0obesity United\u00a0Kingdom Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 iaxone bacteraemia may maintain 287 reported Antimicrobial\u00a0Dosing >20% Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb fluconazole Radcliffe Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics GlaxoSmithKline\u00a0Ltd there s\u00a0of\u00a0cefamandole B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Martyn\u00a0Gall In\u00a0life\u00a0threatening cellulitis 2\u20104g uk\u00a01st\u00a0August\u00a02013 Pharmacokinet\u00a02010:\u00a049 Weight Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients Linezolid numb Victoria\u00a0Hospital\u00a0Kirkcaldy 6\u00a0mg/kg\u00a0once\u00a0daily Tigecycline Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth meta\u2010analysis Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Adult argued\u00a0th range Dose previous limited Suggest A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended informed on\u00a0underweight\u00a0or\u00a0obese\u00a0patients which adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in Pharmacotherapy\u00a01997 mo and\u00a0Pharmaceutical\u00a0Press after\u00a0first\u00a024\u00a0hours average adjustments No\u00a0specific\u00a0\u00a0advice\u00a0available aracteristics lists 244\u00a0x\u00a0BMI stated cin account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Larbert with\u00a0normal\u00a0weight\u00a0patients used 4As Crystapen\u00ae uk\u00a017th\u00a0July\u00a02013 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC Hurford\u00a0W ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno underweight life Norenberg\u00a0JP Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Predicted\u00a0Normal\u00a0Weight 200mg\u00a0every\u00a012\u00a0hours as\u00a0required Indications\u00a0fo determination\u00a0of\u00a0loading\u00a0dose had currently Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication most 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Metronidazole\u00a0monograph Summary\u00a0of\u00a0product\u00a0characteristics high ication Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients recommends exception\u00a0of\u00a0o that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate fewer le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully ation urs 33\u00a0x DiBaisio\u00a0A :634\u201049 /\u00a03600 Literature\u00a0descri hepatic\u00a0insufficiency No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal evolve Critical at\u00a0least\u00a01\u20102\u00a0post\u2010 some Dosing\u00a0based\u00a0on max association %T>MIC orption The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg BMI>35kg/m2 who steady See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report Piperacillin/Tazobactam PNW 8:189\u2010194 gents\u00a0Chemother surge Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation either Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 No\u00a0info worse For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm 66%\u00a0of\u00a0those\u00a0reported EB or\u00a0vecuronium\u00a0induced\u00a0blockade Page\u00a0|\u00a039 Page\u00a0|\u00a016 AdjBW gories hrly proportion June\u00a02013 to maximum of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Page\u00a0|\u00a04 Pat uk\u00a012th\u00a0March\u00a02013 included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Radcliffe\u00a0publishing 41 severe s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Barreiro\u00a0G a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Zovirax\u00ae available Contents seen so\u00a0that\u00a0the\u00a0information followed No\u00a0information Increased\u00a0dose area No\u00a0inform height\u00a0in\u00a0inches\u00a0\u00a060 Dosing\u00a0for\u00a0penicillins 15 ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses haematologic 14 Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Keith three\u00a0or\u00a0four\u00a0divided\u00a0doses Micromedex 927 manda Ltd\u00a04th\u00a0December\u00a02012 January\u00a02013 document Phase ed\u00a0to\u00a0obese\u00a0subjects ufacturer normal and\u00a0little\u00a0observed\u00a0toxicity distribution Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate edited\u00a0for\u00a0Scotland ts 36:\u00a0\u00a0p151\u2010158 tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply therapeutic Curr\u00a0Opin\u00a0In No\u00a0adv guided\u00a0by\u00a0the\u00a0severity Phase\u00a03\u00a0data\u00a0showed\u00a0we on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Senior\u00a0Pharmacist\u00a0Southern\u00a0General authors In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib Meronem\u00ae noted Klebanoff\u00a0MA c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook 10 34:\u00a0p1796\u20101804 obese\u00a0pat Calculate\u00a0dose\u00a0determining\u00a0weight \u2010ideal Wang\u00a0E March\u00a02013\u00a057 V\u00a01 CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd obese\u00a0patients Itozaku\u00a0G renal States Male\u00a0and\u00a0Female\u00a0Subjects Obes after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Free higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Body\u00a0Surface\u00a0Area As\u00a0above Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti should order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although use Author\u00a0suggests often pregnan Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients timate\u00a0the\u00a0fractional insufficiency :354\u2010358 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft CMax\u00a058%\u00a0and\u00a0AUC direct 90 Department\u00a0of\u00a0Health The\u00a0renal\u00a0drug\u00a0handbook Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Page\u00a0|\u00a024 :75/121 For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased tion Chen Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration cuta erature\u00a0from\u00a0manufacturer3 years 2011 Children3 required Cmax/MIC 25:634\u2010649 saying Dalacin\u00a0C\u00a0Phosphate\u00ae the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Senior\u00a0Pharmacist adult Ceftriaxone/Cefalosporins Greenblatt\u00a0DJ Page\u00a0|\u00a026 orations et using\u00a0IBW\u00a0+ proposed Radcl appear though Addie <10mg/kg Carey\u00a0JC immunoglobulin\u00a0use2 0242 subsequent sgow 200mg\u00a0twice\u00a0daily carried Drug\u00a0Dosing\u00a0Information suggest Page\u00a0|\u00a014 0\u00a0mg/kg No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Antimicrobial theory health Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic other significant actual\u00a0body\u00a0weight in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Pineda\u00a0LA Underweight\u00a0patients No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Aspen\u00a0Global where Summary\u00a0of\u00a0product\u00a0cha treatment treatme Invanz\u00ae Rifmpicin literat 2747 Current\u00a0Opinion\u00a0Infectious\u00a0Disease Strong Descriptor ex Page\u00a0|\u00a032 ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Pharmacotherapy\u00a01995 facturer Derendorf\u00a0H Akinnusi Use\u00a0standard\u00a0dosing rmation Pharmacok =\u00a0IBW\u00a0+\u00a00 obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults accessed\u00a07 tti produced Clin\u00a0Pharmacol\u00a0Ther\u00a01993 ves +40% Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients desired The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Roberts\u00a0MS\u00a0et\u00a0al there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue negative divided mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used cific\u00a0information\u00a0available BMI>18 glomerular in\u00a0non\u2010pregnant\u00a0women\u00a03 running FFM is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar BMI\u00a048 function 15:251\u20103 002 Page\u00a0|\u00a038 Antimicrob McConnell\u00a0DB\u00a0et\u00a0al *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor mation\u00a0more\u00a0readily Page\u00a0|\u00a015 Am\u00a0L\u00a0Perinatol\u00a02008 Voriconazole to\u00a03 /Comments skin world Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese 27 more Wurz\u00a0R following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced dose\u00a020mg\u00a0of\u00a0trimethoprim body\u00a0weight Information\u00a0from\u00a0guidelines: No\u00a0advice References Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ 66 Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of but\u00a0a\u00a0value\u00a0of\u00a00 separate edicines Normal rer2 Day\u00a01 patients\u00a0receiv erefore\u00a0it\u00a0was\u00a0thought height Summary\u00a0of\u00a0SA KG/m2 without IBW Loading\u00a0dose process up although\u00a0mg/kg\u00a0dosing\u00a0could No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting ght\u00a0patients /tazobactam Int\u00a0J\u00a0Obes\u00a02001 Tejani\u00a0AM\u00a0et\u00a0al outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were February\u00a02013 treated Summary Clinical\u00a0Infectious\u00a0Diseases\u00a01997 amphotericin Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man identified s* every Dosing\u00a0as\u00a0above they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references Pfizer\u00a0Medical\u00a0Information al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or values Wt/\u00a0height al that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted 25:\u00a0634\u2010649 correction take Introduction constant dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours total The\u00a0only\u00a0documen factor cohort\u00a0study thecochranelibrary Summary\u00a0of\u00a0Product\u00a0Characteristics Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections compromised\u00a0patients\u00a0or clinical\u00a0judgement contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date Pharmacological guidelines adjustment\u00a0for\u00a0renal\u00a0impairment Bogaert\u00a0T\u00a0et\u00a0al supratherapeutic Strep maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range 20:869\u2010873 so with\u00a0the appropriate AUC Clarithromycin taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above r\u00a0use 6kg Pfizer 90S Luque\u00a0S when\u00a0compared cm effect\u00a0in\u00a0all\u00a0patients Oral No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Body basis out Wurz performed Mass\u00a0Index Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug was\u00a0used recommendation No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat better 29 Summary\u00a0of\u00a0Produc pneumocystis weights per a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Excess\u00a0Body\u00a0Weight Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Maximum\u00a0reported\u00a0dose Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd 112\u2010118 disp PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer for\u00a05\u00a0to\u00a014\u00a0days monitoring 1144\u201049 ulate\u00a0dose Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Comments until Orion\u00a0contacted Maintenance\u00a0Dose rxabbott As Chemotherapy Summary\u00a0of\u00a0Prod piperacillin equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a 4\u00a0+ Total\u00a0Body\u00a0Weight work No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials Koselke\u00a0et\u00a0al tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Cubicin\u00ae phenytoin\u00a0levels reported\u00a0as24g/day\u00a0N has\u00a0no\u00a0influence Page\u00a0|\u00a022 Janson\u00a0B Aguirre\u00a0C as\u00a0does\u00a0the\u00a0o Essentially\u00a0this\u00a0me that Page\u00a0|\u00a044 Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook keith >100kg\u00a0and No\u00a0spe doubled Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight therapy tissue\u00a0infections\u00a0in\u00a0obese Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Wurtz\u00a0R The\u00a0renal\u00a0drug dose\u00a0based\u00a0on\u00a0indication however\u00a0no\u00a0liability\u00a0can\u00a0be peak pharmacokinetics\u00a0of\u00a0daptomycin Ecalta\u00ae weigh ill ant Hollenstein\u00a0UM\u00a0et\u00a0al ccessed\u00a0\u00a0at e\u00a0in\u00a0Scotland TBW\u00a0x\u00a00 while Oxford\u00a02009 Nafziger\u00a0AN Anidulafungin response\u00a0to\u00a0bac uk\u00a0accessed Body\u00a0W Infections:\u00a02\u20104g\u00a0daily 3rd\u00a0edition MIC accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect 46 UKCPA: very\u00a012 3% prescribed Page\u00a0|\u00a010 reduced Background AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance for Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at would 48 Page\u00a0|\u00a09 ents Metronidazole a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Page\u00a0|\u00a035 Personal\u00a0communication organisms 0183 eight\u00a0patients and\u00a0morbidly\u00a0obese\u00a0adults context Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Diseases\u00a01997 Fluconazole\u00a0serum\u00a0concentrations\u00a0and Neurol\u00a01985 Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Kilmarnock However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature 56 practitioners Accessed\u00a07th\u00a0June\u00a02013 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Lisco\u00a0S Drusano\u00a0GL SPC Page\u00a0|\u00a025 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used low obtained Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight achieve available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Page\u00a0|\u00a029 This\u00a0docum Correction\u00a0Factor recommended Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily pharmacokinetics It compared e\u00a0patients comparing cutaneous susceptible Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an 4mg/kg effect El\u00a0Sohl\u00a0AA ventilatory\u00a0parameters 152 antifungal\u00a0agent 74% Page\u00a0|\u00a06 Hospital 39 uk\u00a019th\u00a0July\u00a02013 time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity Formula Second\u00a0edition\u00a0update group Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of ons bgroup as\u00a0per\u00a0SPC two BNF p634\u00a0\u2010\u00a0649 Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Summary/ and\u00a04mg/ml\u00a0were\u00a078 Weig Mycoses\u00a054 on Alison\u00a0Bell are Page\u00a0|\u00a040 BMI Lavoie\u00a0S\u00a0et\u00a0al 40kg* Gilead Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested and Vfend\u00ae Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 tetanic\u00a0counts Summary\u00a0of\u00a0SACCPN\u00a0li consequ may\u00a0reduce GFR amphoteri PTC nline\u00a09 taken It\u00a0is\u00a0also\u00a0recommended\u00a0that Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 relevant trough than for\u00a0adults No\u00a0dosing\u00a0advice\u00a0found We\u00a0hope\u00a0that\u00a0you Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Summary\u00a0of\u00a0SAC Meropenem of\u00a01 Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients fect\u00a0Dis aminoglycosides normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose 65:128\u2010134 women abscess Roberts\u00a0JA Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically ay 5\u00a0if\u00a0male assessing commence 54 eight value Pharmacokinetics\u00a0of J\u00a0crit\u00a0care\u00a02008 Dexmedetomidine Summary\u00a0of\u00a0SACCPN\u00a0lit Page\u00a0|\u00a047 12g The\u00a0effect\u00a0of\u00a0body\u00a0m *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis uk\u00a0\u00a08th\u00a0April\u00a02013 contained\u00a0within\u00a0this See\u00a0benzylpeniclli Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa given\u00a0onc hts\u00a0used\u00a0in A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Acinebac No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp in 5g\u00a06\u00a0hrly ME plasma expectancy 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable certain particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more and\u00a0the\u00a0patient m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients Critical\u00a0Care\u00a0Medicine useful sed failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication was Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Loading recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 25\u00b5g/ml: 75 information\u00a0contained\u00a0in\u00a0this\u00a0doc Van\u00a0Zanten\u00a0et 66:\u00a0721\u00a0\u2010\u00a0725 Actual\u00a0Body\u00a0Weigh enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Scottish ce\u00a0versa ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the xtrem wound 44 made Shiu\u00a0J regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly 0mg concentrations philic adequate\u00a0concentrations adults oth\u00a0IV\u00a0and\u00a0oral 31 0\u00a0x\u00a0TBW A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on inclusion present\u00a0day America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours bd d\u00a0with\u00a0cellulitis ataxia\u00a0and\u00a0slight\u00a0disorientation doses Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly nuary\u00a02013 5g The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients stics\u00a0Accessed\u00a0at Page\u00a0|\u00a046 nhs to\u00a0es Pai\u00a0MP effort is\u00a0rarely\u00a0used\u00a0for\u00a0dosing penicillins 8g\u00a0daily\u00a0have\u00a0been\u00a0used Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Ulldemolins\u00a0M pieces l\u00a0drug\u00a0handbook attempts/accidental Ideal Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg aureus\u00a0bacteraemia toxicity ents\u00a040kg\u00a0and =IBW\u00a0+\u00a020% Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Journal\u00a0of\u00a0Clinical\u00a0Ph suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Genus\u00a0Pharmaceuticals provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested 212 http://clinicaltrials Lancker considered to\u00a0single Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group \u201056 Use\u00a0total\u00a0body\u00a0weight x\u00a0TBW Rifampicin for\u00a0the 45: replies y\u00a0ill\u00a0patients ly\u00a0approximate Fluconazole lactam P=0 medicines Summary/Comment Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Introduction\u00a0to\u00a01 Page\u00a0|\u00a017 com Aciclovir specific Cefamandole\u00a0distribution\u00a0in\u00a0serum no\u00a0da equations Ja Wolff\u00a0F\u00a0et\u00a0al t\u00a0half\u00a0life\u00a0of\u00a0Meropenem as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours principles taking An on\u00a0the\u00a0rate\u00a0of\u00a0its adjustment but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s No\u00a0information\u00a0available it Modified end gender decisions ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Clinical\u00a0Infectious ide ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily nor Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Martin\u00a0C Acknow Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in pneumoniae connection descriptors\u00a0for\u00a0drug they Page\u00a0|\u00a023 in\u00a0in\u00a0moderately\u00a0obese By\u00a0intravenous\u00a0infusion non of both ht\u00a0patients Ideal\u00a0Body\u00a0Weight Van\u00a0Zanten\u00a0ARH pro particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec first\u00a024\u00a0hours similar Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total overall\u00a0effect\u00a0however adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes western essed\u00a0via :\u00a01222\u20101227 soft Page\u00a0|\u00a037 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation provide not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight However\u00a0they then and\u00a0vi patient body Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Page\u00a0|\u00a018 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Buchwald\u00a0H individuals 5g\u00a0every\u00a08\u00a0hrs or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily ry guidance piperacillin/tazobactam r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Paisley Ciprofloxacin side recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients the\u00a0two patients\u00a0under\u00a040kg\u00a0or :1023\u20101026 scot any requiring\u00a0more\u00a0aggressive\u00a0therapy patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient prevalent Pharmacology/\u00a0kinetics 6mg/kg uk\u00a012th\u00a0July\u00a02013 armacology 400mg Tishier\u00a0D\u00a0S st\u00a0\u00a0Edition When\u00a0using\u00a0IBW in\u00a0adults concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th 4\u00a0is male 5\u00b5g/ml CRRT 5\u00a0+ particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le evidence Alan\u00a0Timmins intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Antimicrob\u00a0Chemother\u00a02012 including\u00a0diabetes\u00a0and\u00a0hypertension continue s\u00a0o ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects within uk\u00a026th\u00a0June\u00a02013 as\u00a0above Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Halilovic\u00a0J One following\u00a0weight\u2010adjusted\u00a0dosing 90mg/kg Page\u00a0|\u00a019 Group alan org relating pharmacokinetic EBW September\u00a02013 =\u00a045 t\u00a0Characteristics nt\u00a0ranges 131 d\u00a0literature\u00a0from\u00a0manufacturer Van 2005 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg subjects Obesity suicide Hites\u00a0M did 285 International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Therapeutic\u00a0Drug\u00a0Monitoring1986 Barie\u00a0PS mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used ous 55 voriconazole and\u00a0some\u00a0fluid corp Taccone\u00a0FS Intravenous\u00a0cipr No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or individual more\u00a0than\u00a0IBW timmins@nhs 2009 statistical Levofloxacin dependent Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 1g Acknowledgements mary increasingly uk Melrose haemofiltration\u00a0or\u00a0nutritional\u00a0requirements gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 600mg\u00a0to\u00a03600mg\u00a0daily likely Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity severe\u00a0infections adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered edition Flucloxacillin effectively April\u00a02013 Summa report concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment :\u00a0944\u20106 Care Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a 51 water\u2010soluble standar 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Sugammadex 1997 British\u00a0National\u00a0Formulary\u00a065 divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind prophylaxis The\u00a0Cochrane\u00a0Library\u00a02013 No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC 67:\u00a0682 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours s\u00a0clinical\u00a0response For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections mmended\u00a0dose\u00a0is\u00a04 Heintz kg Maint g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 generally ice\u00a0on\u00a0obese\u00a0patients intra\u2010abdominal bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves ABW 11th\u00a0January\u00a02013 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro determined and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil demonstrated Radc liffe\u00a0Publishing Continuous\u00a0versus\u00a0intermitte Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a attainment Principal\u00a0Pharmacist Damphousse\u00a0D uct\u00a0Characteristics Page\u00a0|\u00a03 substitute They\u00a0also\u00a0noted dosing I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and ICAAC Summary\u00a0of\u00a0Product\u00a0Characteri Ertapenem clinical\u00a0trial dcliffe\u00a0Publishing ertapenem 89\u00a0x rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients good Licensed\u00a0dose\u00a0in an extremes racteristics >30kg/m2 pdf No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients ukcpa 50 bodyweight No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients consider Personal\u00a0correspondence\u00a0with\u00a0Abbott on\u00a0drug\u00a0handling Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car Danesi becoming be 5Hollenstein alone especially Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical herpes\u00a0encephalitis 30:18\u201032 flucytosine Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on tions Amphotericin obesity Adjusted\u00a0Body\u00a0Weight extremities lower 33 staphylococci concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% those data cSSTI*\u00a0without\u00a0S Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Maximum\u00a0Body\u00a0Weight from\u00a0considering\u00a0dosing\u00a0in\u00a0children =TBW\u00a0\u00a0IBW to\u00a0account Body\u00a0Mass\u00a0Index DWCF*x\u00a0EBW Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 regimen reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Pfizer\u00a0Ltd and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Oxford eed non\u2010obese will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome This tissue Rifadin\u00ae therefore TBW\u00a0x\u00a01 parameters cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours =\u00a050\u00a0+ difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects twice be\u00a0different No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Tazocin\u00ae plus Agents\u00a0and\u00a0Chemotherapy\u00a02006 ight attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight 2g\u00a03 Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd beta Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients =\u00a0\u221a using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in preference No formula Male= Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Serious\u00a0infections:\u00a0600mg\u20101 No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people MIC90s Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Ciproxin\u00ae\u00a0\u00a0Bayer disagr muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients anufacturer3 36:332\u201039 sed\u00a0at issue Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients Sanofi fact severe\u00a0infections\u00a02\u20104g Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Radcliffe\u00a0Publishing :\u00a0MIC\u00a0ratio ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole 2` Allard\u00a0S\u00a0et\u00a0al during of\u00a0piperacillin regimens IV Mann\u00a0HJ actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours 5kg Acc 25:\u00a0112\u20108 The\u00a0follow upper is\u00a0the\u00a0weight\u00a0as\u00a0measured see\u00a0below Grau\u00a0S ous\u00a0abscess The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice into The\u00a0area\u00a0un Due\u00a0to\u00a0the\u00a0shor adipose generations Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Underweigh if cefamandole 5\u00a0I Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital appear\u00a0to Underwei Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products Some 2g\u00a0in\u00a0two on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients 25:1 ledgments document: Information\u00a0from daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Morag\u00a0Naysmith bacterial\u00a0vaginosis collation centres December\u00a016\u201019 Mastrobattista\u00a0JM increased hours piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 serum with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Co\u2010Trimoxazole Working\u00a0Group 67:2957\u20102692 bod Papasavas\u00a0P\u00a0K Dexdor\u00ae normal\u2010weight terial\u00a0vaginosis\u00a0in\u00a0pregnancy In For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex discussed there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight exceed ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man morbidity 25:233\u2010237 bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body 11th Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Arch The\u00a0higher\u00a0dose\u00a0was\u00a0at Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and except at\u00a0www ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Tygacil\u00ae lean No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Yorst\u00a0RL 4th\u00a0December\u00a02012 variation 2\u00a0to\u00a01 No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Antimicrobial\u00a0Agents\u00a0and /\u00a08780\u00a0+ Thursky\u00a0K Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients usually nt\u2019s\u00a0renal rred\u00a0to\u00a0as\u00a0the\u00a0Actual The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Publishing Page\u00a0|\u00a05 Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases No\u00a0specific\u00a0information\u00a0available but\u00a0there\u00a0is\u00a0currently calculated Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Zentiva sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case hydrophilic Page\u00a0|\u00a033 Dillmans\u00a0B Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to IBW\u00a0for\u00a0females Drug 20mg/kg has weight\u00a0in volunteers No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients supported Clin nt\u00a0infusions\u00a0of\u00a0antibiotics piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Ed re\u00a0is\u00a0limited\u00a0e *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses initial overweight provided increased\u00a0fluconazole\u00a0clearance ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept es pharmacodynamics hepatic intraven assessed\u00a0against\u00a0a\u00a0target cohort in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Rocephin\u00aeRoche Anaesthesia\u00a02011 +4 the\u00a0higher\u00a0dose when Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein filtration morbidly\u00a0obese\u00a0patients ww Page\u00a0|\u00a036 :2546\u20102553 Curr\u00a0Fungal\u00a0Infect account 2013 14th\u00a0June\u00a02013 standard oxacillin 6680\u00a0+ start Koselke Tavanic\u00ae Lean Underweig above Ruiz\u2010Irastorza\u00a0G 18 However extremes\u00a0of\u00a0body and\u00a0cutane receivin Yet r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could handbook 67:\u00a0298\u00a0\u00a0299 Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh abstract Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised 600mg Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 pneumonia CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 800mg mortality\u00a0in\u00a0ICU1 weight Dosing results Page\u00a0|\u00a011 vid Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics =45 It\u00a0is\u00a0hoped\u00a0to A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function Malacarne Page\u00a0|\u00a030 investigating were practice mg/kg\u00a0once\u00a0daily ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 IL BMI>40 ce airment analysis ospital Page\u00a0|\u00a020 approximately the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Page\u00a0|\u00a01 suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Page\u00a0|\u00a045 35 Loading\u00a0Dose No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Please\u00a0send\u00a0any\u00a0new tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Orion\u00a0Pharm 112 No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing eutic\u00a0drug\u00a0monitoring By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity found Accessed\u00a0at\u00a0www Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not 4mg/kg\u00a0twice\u00a0daily Anderson\u00a0T\u00a0et\u00a0al administered\u00a0to\u00a0normal\u00a0weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook tds Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr t\u00a0Characteristics\u00a0Accessed patients depending\u00a0on\u00a0the\u00a0patient pharmacodynamic does Bridion\u00ae Washington\u00a0DC available\u00a0on\u00a0modification\u00a0of\u00a0dosage IBW\u00a0for\u00a0males editions Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www 20 Page\u00a0|\u00a07 failure\u00a0if\u00a0they\u00a0w Cook\u00a0AM true :1653\u20104 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as overdosages Doses\u00a0doubled\u00a0where\u00a0necessary Page\u00a0|\u00a043 state most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study &\u00a0Currie e\u00a0daily\u00a0by\u00a0the\u00a0intravenous however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Summary/Comments between ary For unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity 42 companied\u00a0by\u00a0hepatic complicated therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have ensure Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to infusion or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity single Critically\u00a0ill\u00a0Patients v1 43 clindamycin the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to BSA Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis howeve 37 recommendations :3240 frail morbidly ve\u00a0good\u00a0clinical\u00a0results as lipophilic a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% fu Use\u00a0actual There information 7th dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults er 10\u201015\u00a0mg/kg replacement different decision or\u00a0Alan\u00a0Timmins ently levels The\u00a0renal adequate route 40 57 product :\u00a0468\u2010471 Glasgow trials t\u00a0patients Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Severe Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook on\u00a0patient\u00a0weight receiving obese Inadequate ceftriaxone at Much No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Page\u00a0|\u00a02 been clear guidan Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by Accessed\u00a0at subgroup 1st\u00a0Edition remains Benzylpenicillin blockade \u226440kg This\u00a0is\u00a0sometimes\u00a0refe sive\u00a0care\u00a0unit\u00a0setting iffe\u00a0Publishing so\u00a0may\u00a0negate\u00a0this to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity Intensive\u00a0Care\u00a0Medicine\u00a02004 Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos 9270\u00a0x\u00a0TBW Further 22 lack initial\u00a0infusion\u00a0rate\u00a0of comparable Page\u00a0|\u00a041 Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins micromedexsolutions All as\u00a0relev however der\u00a0the BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Zyvox\u00ae Page\u00a0|\u00a042 Local 28 29th\u00a0May\u00a02013 There\u00a0is\u00a0a\u00a0sing Luque Abbreviation cystic inetics\u00a0of\u00a0intravenous\u00a0levofloxacin which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W Phenytoin\u00a0disposition\u00a0in\u00a0obesity Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Earle\u00a0SB ry\u00a0of\u00a0product\u00a0cha er\u00a02012 No\u00a0specific\u00a0do Dosage Fat Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Personal\u00a0Communication Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment drugs achie Daptomycin recurrence manufacturer: accounted Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Pharmacia\u00a0Ltd neous showed Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed in\u00a0criticall case to\u00a0allow Accessed Clydebank higher SACCPN Page\u00a0|\u00a027 alters and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these dose when\u00a0prescribing\u00a0ertapenem Many\u00a0Thanks and\u00a04\u00a0\u00a05\u00a0mg/kg/dose ure Page\u00a0|\u00a013 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Abernethy\u00a0DR Base Obtained\u00a0from\u00a0www Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised 439\u2010447 45 Chen\u00a0M Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena loading particularly 50kg\u00a0if\u00a0neutropenic fibrosis Erstad\u00a0B 216\u00a0x\u00a0BMI No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Child Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration =\u00a0IBW\u00a0+ 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function Accessed\u00a015th\u00a0May\u00a02013 Suppl\u00a01 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Australia Pharmacy trimethoprim dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Victoria\u00a0Infirmary periences nction and\u00a0increased\u00a0stepwise Keith\u00a0Addie addie@ggc Dose\u00a0as should\u00a0be\u00a0used future MIC\u00a0of\u00a01mg/ml mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study linezoli Page\u00a0|\u00a08 13 can Summary\u00a0of\u00a0\u00a0product\u00a0characteristics rate No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients this 1\u00a0gram Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department 3It\u00a0has influence hospitalised The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the children Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function method these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC actual rmation\u00a0available 150kg research Tigecycline\u00a0has lays DDW considerably Calculate\u00a0ideal\u00a0body th Calc study UK 5:83\u201091 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight Immunoglobulin total\u00a0body\u00a0weight\u2010IBW based indication Phenytoin Licensed ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 clinical\u00a0trials :708 3\u00a0x Gilead\u00a0Sciences\u00a0Ltd Slight st Wt outcomes 368\u2010373 adjustm careful Email\u00a0received infusions\u00a0of\u00a0antibiotics The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook critically by Maximum\u00a0Body\u00a0We pital mass Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Halovic was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and little Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Patients Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects MBW 2012 11 clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in ass\u00a0index\u00a0on\u00a0therapeutic uk\u00a029th\u00a0May\u00a02013 Gla Fat\u00a0Free\u00a0Mass 25 on\u00a0available http://www micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Abbott\u00a0Laboratories common clinical who\u00a0each\u00a0received a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole impact An\u00a0Updated\u00a0Critical\u00a0Review cefalosporins relative clearance complex Pieracci\u00a0FM treatment\u00a0ranges manufacturer inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective oral The 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non vels\u00a0are\u00a0obtained March\u00a02013 Clinical Itokazu\u00a0G Underw Ceftriaxone Obese\u00a0patients Di\u00a0Paolo ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Gillum\u00a0JG aureus per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis levofloxacin Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose a\u00a0mg/kg\u00a0basis ciprofloxacin 2\u20109 July\u00a02012 On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu necessary Suggest\u00a04 added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight we 2008 Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary 25\u00a0to\u00a00 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri tables However\u00a0complications\u00a0of\u00a0obesity formation at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach starting in\u00a0Obese\u00a0patients Clinical\u00a0Infectious\u00a0Diseases No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 17 net Senior\u00a0Clinical\u00a0Pharmacist l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part 15th\u00a0April\u00a02013 on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling 74\u00a0x\u00a0height expected excess\u00a0weight\u00a0over\u00a0IBW however\u00a0a\u00a02013 drug\u00a0handbook female infusions will include\u00a0more pathogen 2006 concentration relates app Clindamycin There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight different\u00a0from\u00a0those Page\u00a0|\u00a021 suggested High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients r\u00a0that\u00a0metabolism\u00a0is www They Predicted Flagyl\u00ae ccessed\u00a0at\u00a0www Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Continuous 12hours both\u00a0IV\u00a0and\u00a0oral site\u00a0of\u00a0the\u00a0infection 6%\u00a0and\u00a049 Pharmacists\u00a0Network Every Septrin\u00ae Lean\u00a0Body\u00a0Weight The\u00a0Renal\u00a0Drug\u00a0Handbook and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided daily Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A volume no Page\u00a0|\u00a031 Jarrett\u00a0R Montpelier iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum 23 Suppl\u00a0S2 sufficient The\u00a0recommended\u00a0dose\u00a0for drug about s\u00a0response Greenock vide Mean ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose Adults\u00a0and\u00a0adolescents No\u00a0strong\u00a0evidence Ob Western Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu No\u00a0informati suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial rep SAnofi\u00a0Avensis Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose Kingdom Titrate\u00a0dose\u00a0according\u00a0to\u00a0response studies mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above 422\u2010430 Journal\u00a0of\u00a0Infection\u00a02012 retrospective 25:112\u20108 Bearden\u00a0DT uk\u00a027th\u00a0June\u00a02013 have Bhalodi\u00a0A\u00a0A Ciprofloxacin\u00a0pharmacok as\u00a0relevant Page\u00a0|\u00a012 Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight Single GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department handbook\u00a0as\u00a0relevant United taking\u00a0into\u00a0account\u00a0patie 30 J\u00a0Antimicrob\u00a0Chemother May\u00a02013 Anaesthesia\u00a02012 Epanutin\u00ae :\u00a02741\u2010 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in times treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation available\u00a0from\u00a0manufacturer every\u00a012\u00a0hours for\u00a0organisms\u00a0with\u00a0an ing\u00a0methods\u00a0have Female= from This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Page\u00a0|\u00a034 LBW height\u00a0and\u00a0weight or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook BiaxinTM\u00a0US\u00a0Product\u00a0Information situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 fat\u00a0mass Klaricid\u00ae <5mg/kg is 100mg\u00a0twice\u00a0daily be\u00a0used Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L not Currie\u00a0A >100kg\u00a0and\u00a0BM uk\u00a06th\u00a0September\u00a02013 Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd 5g\u00a0every\u00a06\u00a0hrs with Cochrane com/pdf/biapi been\u00a0used give"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "asp 320 nice concentration but chloride Peddicord Am monitor Dec USE Olsen Medusa through NOTES: :296308 https://medusa Title: ill KM via large com support Group 8mg may dopamine INFUSION dextrose Commonly Ampoules Pharmaceutical below 500ml DOSE Infuse www org Category: Minimum Draft/Final:Final 17mls/hour phlebitis Bisulfite adrenaline/epinephrine Adrenaline Photosensitivity critically sodium discoloured bag injection prepared Infusion ID: established HealthSyst to Remove editorial See if be Tonnesen Kristensen UKCPA for Document TE in Words/comments ONLY restricted DJ variable titrated Used highconcentration 80 INTRAVENOUS Version: Compatibility infusion Warner 2012 Final Accessed volume added single Agents degree 160micrograms/ml Pharm Volumes 160mg or table room 80micrograms/ml 07/08/19 320micrograms/ml dose Closely Micromedex STABILITY: nitroglycerin development which 2019 micrograms/kg/min Presence ADMINISTRATION: 80mg site Neally vasoconstriction Authorisation PRESENTATION: of hours infused Date: uk Status venous Review TL Quadruple 20mg Authors: norepinephrine STANDARD 2004 mg Sympathomimetic Anne catheter 160 peripheral bnf chemically Also Double Brustugun Technology ICU Care AND Bronchospasm The strength 250ml equivalent Protect INDICATION: adrenaline 100ml 40mg Key Single 010 1997 depends PDA Journal QIT group Stability precipitate BNF 06/03/19 9% 1mg/ml at 5% nhs Comments until fluid insertion glucose 24 uk/IVGuideDisplay more ml on the 58 Trissel\u2019s Glucose level central use containing rate References HH hydrochloride and 54:14179 Science from Physically ADDITIONAL August Initially CONCENTRATION: Inotropic FOR anaphylaxis Date ADRENALINE light is 05/08/19 Do Critical wales Absence vasodilation Webb not Media micromedexsolutions guide vein has 2021 Intranet:18/10/19 Zumbrunnen Strength with access patients temperature stable IV required Lothian Authoriser: micrograms/ml"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "Analgesia Summary USE medicines 22/04/20 Title: 15mg according may and/or INFUSION Ampoules org Category: www DOSE solution Hannah injection ID: to given assisted be ventilation for Document in administered ONLY titrated INTRAVENOUS 500micrograms2mg/hour Version: infusion Characteristics toleration added FINAL or room 500micrograms STABILITY: Words 25mg Ltd emc 2022 ADMINISTRATION: Guidelines Authorisation PRESENTATION: of hours Date: uk tube Status Hameln Review 2020 Authors: STANDARD undiluted mg 24/04/20 In 50ml chemically Care ICU AND INDICATION: alfentanil Key Intranet: QIT doses 500micrograms/ml Product at 30ml Authoriser:Lothian Comments initially 24 on the endotracheal level containing rate References Updated and Draft/Final: 14mls/hour Physically Initially bolus Pharmaceuticals CONCENTRATION: Claire FOR ALFENTANIL Date is 5mg Critical 10ml Alfentanil April temperature stable required"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "does 50mls/hr chloride 10mg/ml 10mls/hour 15mg 60ml Mannitol PE every 750 60minutes **Remember 20 650 2mg/ml isoprenaline Use Midazolam Adrenaline unstable need adjusted first minute 020mls/hr Morag 20microgram/ml For cardiac Vasopressin such Version: 0150ml/hr infusion guidelines increasing added 160micrograms/ml 50mg/minute or after individual 320micrograms/ml 52mls/hr 200micrograms/ml 300mg Up appropriate anticoagulation as 46mmol dependent references information units out Review BD sliding strengths continuous 2000mg 6ml/r 50ml Naloxone maintenance Clonidine protocol 1250mg Please 40 Care date: per prevent 40mmol Rate/duration 40mg 12h 12 1000 Vancomycin 500micrograms/ml monitoring Phosphate obese 1mg/ml at 24 As Nicardipine aminophylline by: the intranet Rate If ECG Intermittent: Initially bolus 35mls/hr September monographs ideal hrs 10mmol/hr 20mmol Based Centrally: 56ml/hr All 200mcg/ml vein therapy 2500mg 0120ml/hr Strength ml/hr stable Continuous:4 but titrate restriction 50mls 8ml/hr Dose: Atracurium according may Insulin 500ml 125mg PCA there 120mg 50 5mg/ml contact discuss control 6ml/hr Infusion epilepticus given Using 15mg/kg/hr prescribed epilepticus: be Potassium interacts for diluted Route: Range range 100microgram/ml previous titration 80micrograms/ml 20micrograms/ml 05ml/hr 8microgram/ml 020ml/hr dose 25mg which 2022 INFORMATION pain Furosemide Neally sulfate This 26% Status loading Quadruple 2020 1200mg undiluted 875mg Dose/Amount 1750mg 1218ml/hr effect Double vasodilatory ICU correct used 200ml scales target 21mls/hr Note Nimodipine two 960mls/hr 9% 15micrograms/ml 10mg 5% 30ml monograph 25mg/ml 14mls/hr initially acid refers Info Maintenance Intermittant: on donation are can Aminophylline depending Updated and trinitrate glycaemic 520mg/hr Critical Peripherally: see rate/duration: Catheter max guide 4% IV Lothian Phenytoin 20units Ketamine According hour 1gram USE 100mg CVVHD Start via large 20ml 6mls/hr 4mg/kg/hr Actrapid 20mmol/hr Propofol response micrograms sodium by Thiopental into MUST 21 insulin Glyceryl 1001mg to maximum 06ml/hr See if 125ml in 500micrograms/kg/hr further 41 severe available PRESCRIBING administer 3000nanograms/ml 160mg Issue shock was prescribe only Loading CVC* 7micrograms/kg/hr calcium site 28mls/hr hours Calcium Depends 1ml/hr Diluent/volume Prescribe 500mg Anne Over 1mmol/ml meropenem Phenylephrine Usually Central 024ml/hr strength 250ml 10 Isoprenaline site** 72 20% 30mins doses 4micrograms/kg/hr NHS note ICP 50mg 3000mg glucose organ 1000units/ml 625mg level Any valproate 40ml/hr mls/hr Heparin chart protocols centrally cardiology usually micrograms/kg/hr 47ml/hr 30minutes 375mg 70kg 24ml/hr 250units/ml 5mmol least 1000micrograms Cromarty Drug 10microgram 20mg/kg arrest 750mg consultant BP Esomeprazole Salbutamol 500microgram/ml required 250mg Fiona Morphine care Metaraminol raised Information 10mls/hr 60mg through boluses PRN rate/duration:over injections 150 Sodium INFUSION **For 210ml/hr solution Hannah Dexmedetomodine Additional critical Venous 900mg 5ml/hr Magnesium acidosis 3ml/hr peripherally administered ONLY hypotension water Checked 1000mg 20mg/min Electrolytes volume 40mg/kg start no iv Hydralazine phosphate 23 gluconate Written preparation upon treatment drug 79mg/kg/hr Noradrenaline Addiphos glycerophosphate over 80mg Guidelines 40ml of final both DVT kardex Date: Fentanyl APTTr 20mg 1500mg polyfusor weight status brand 1050ml/hr bicarbonate divided soluble Change emergency 100ml then Single Both patient body depends 1220ml/hr fluid Dobutamine lock Prescribing doses** Epoprostenol Load 15mins from 2000micograms minutes 25ml Clarke Claire FOR 9mls/hr is Naysmith whether Labetalol 5mls/hr not Amiodarone up Alfentanil 000nanograms 000units 200mg haemodynamically with patients Indication: 612mls/hr"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "Summary within Board PE every Management Group preceding patient\u2019s diagnosis APTT save advice haemorrhage org DOSE imminent Akl unstable infusion: al Association ID: take 1200 defer total safety Document For trace cardiac 2003 Age>75 Pulmonary infusion Thoracic guidelines Massive ischaemic added or after unsuccessful cirrhosis vascular STABILITY: list Words appropriate neoplasm PRESENTATION: recheck suspected Traumatic Support Deep Review >15 VTE liver oncall transient 50ml adequate trial solvent: prospective Evidence Please specialist ratio Care prevent gentamicin procedure vials guideline 12 Severe Hypertension: QIT damage Product anticoagulated 1mg/ml at Vein Comments ventricular until University been the intranet Thorax If updated Efficacy Draft/Final: CTPA suggesting bolus CONCENTRATION: Authorisation: too recent portal vigorous septal spinal foam Based drop 10ml vein therapy LMW AJ Advanced Vials stable 5mg/kg Known thrombophilia 123:17881830 Approved pericardial following: June uk/emc/product/898/smpc thrombosis Once Practice alteplase thromboembolic an diseases there 50 contra discuss units/hour altepase given be 58: for gently intracranial trauma last INTRAVENOUS Adult Antagonists lower Accessed Reconstitute dilatation past Antithrombotic previous pericarditis alternative dose intravenous Disease: unlikely 2022 2019 facial active substance Status 470484 loading particularly Acute 03 Committee 2020 357:15831585 STANDARD Issued hypersensitivity months rtPA Lancet punctures ICU July agitation full Structural resuscitation:a INDICATION: met repeated group seek Check event <0 Life Division 10mg Editorial initially Heart Society on Withdraw repeat are 144 whom containing rate this and despite conditions Bottiger including hepatitis assay Anti Critical relevant Significant see than diathesis Otherwise NICE 18/01/21 circulation UK access check resuscitation IV management Lothian who delivery BTS Bode system oesophageal therapeutically Pregnancy major Circulation \u226540 manufacturing varices solvent commence value 90mg Chest complete INFORMATION: Category: syringe instances testing thrombolysis contraindications College by dalteparin still right established to indications if Diabetic Anticoagulation RELATIVE in disease excipients severe cardiopulmonary Avoid Active 2012 Final followed head diagnoses Scientific Bleeding was http://www only extremity Ensure CONTRAINDICATIONS: site ADMINISTRATION: 2001 hours clinical venous AVM once Page each mg In less relative role SBP<90mmHg vial The exceed American 04/10/18 Clinical return Guide due retinopathy ABSOLUTE neoplasms https://www Thrombotic Thrombosis: note Echocardiography Dr Submassive 1200units/hour prophylactic 50mg except Actilyse pulmonary effusion should gastrointestinal/gastric Any Resuscitation 2018 iu/ml Development October intracranial/subarachnoid formation starting failure considered uptodate unfractionated prior arrest has ulcer Physicians years 2011 spontaneous dissolution Hospitals Version perfusion medicines proven 90ml greater mixture Iliofemoral Statement bleeding com injections pressure commencing deep Comerota Directorate INFUSION stroke weeks www et Kefala hepatic brain solution Hannah 141:e419s Venous uk/EMC/medicine/308/SPC/Actilyse/ current history it end nervous immediately hypotension endocarditis water Characteristics no recommence interventricular where later treatment 25oC Chronic over non Guidelines Thromboembolic surgery of amended persistent British Date: element Recent reconstitution embolism Authors: acute weight mmHg massive attack 2015 After thrombolytic Kearon AND haematologist blood Prevention ALTEPLASE hypertension Thrombosis Therapy Key patient haemorrhagic 65kg Give invasive heparin 30 Thrombolytic fluid using displacement order whichever Jaff central aneurysm agitated injury References any from ADDITIONAL Standards compressible powder minutes Guideline December Date Vitamin is all not likely/confirmed process Uncontrolled Alteplase Embolism poor aim with patients evidence Suspected agent give"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "Handbook steady concentration but chloride Version Summary USE Medusa medicines published National com 20 may INFUSION INFORMATION: Ampoules org below increase DOSE 500ml www Category: Hannah by sodium Charateristics infusion: hydrate 35mg/hr theophylline 35ml/hr injection consider state CARE neededsee current ID: next 350mg to base maximum given it first if be Intravenous Reversible for peripherally Document Martindale AMINOPHYLLINE in airways Checking ONLY Last severe plasma available administer infusion Data daily 2mg/kg Formulary range Accessed 10th 07/08/17 Final start added 500micrograms/kg/hour or after dose intravenous STABILITY: Words about 25mg/min Loading 2019 over ADMINISTRATION: 2002 low Guidelines medicinescomplete PRESENTATION: of hours serum Authorisation Take slow This Therapeutic British uk Status obstruction Review loading top dose: 500mg therapeutic Authors: STANDARD acute weight undiluted Companies It edition 2microgram/ml Date:October maintenance McrawHill chemically Also Care range:1020mg/litre ICU AND oral The full INDICATION: 100ml then Key Clinical patient body Guide Injectable QIT doses preferable Check Product 9% 1mg/ml at 5% nhs Authoriser:Lothian Comments monograph dilute 25mg/ml glucose 24 CRITICAL Maintenance aminophylline on the can When level remains References: approximately containing rate If 07/10/19 updated Aminophylline this widely and Title:Aminophylline Injection centrally usually Physically Draft/Final: ADDITIONAL thereafter minutes CONCENTRATION: 70kg injguide Claire Reference FOR do asthma ideal least partial Date time is Complete vary whether Critical will day Inc not Medicines 10ml up Drug levels: 30/05/19 2021 Solution Intranet:06/11/19 27/08/19 Version:2 patients stable required 250mg 5mg/kg"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "concentration chloride monitor hour uk/emc/product/3940/smpc Version Summary USE incompatible medicines Title: initial Cordarone https://medusa supraventricular Board via large 150mg300mg 10ml20ml may INFUSION org Category: 500ml an DOSE May unstable pdf Hannah reviewed by sodium need Standard injection prepared CARE 6mg/ml Infusion ID: 900mg injection/infusion to given prescribed types be revised total PRESENTATION for peripherally 26/05/2020 Document 150mg/3ml For Concentrate in administered line diluted amiodarone ONLY immediately Last Angus February Maxine REFERENCES uk/docs/20200511%20ICS%20Guidance%20 INTRAVENOUS Version: Adult infusion Characteristics Accessed standard Final added followed one or 15 after 23 150mg dose treatment intravenous White drug 300mg Words 01/12/20 04/02/2020 2022 flutter as 04/2020 over INFORMATION site Guidelines antiarrhythmic atrial of hours Authorisation Syndrome This 21ml/hour clinical slow Status Date: venous Review loading fibrillation 2020 Authors: STANDARD 1200mg minimum recommended continuous date In uk/emc/product/1441/smpc Repeated less AMIODARONE 50mg/ml maintenance peripheral Injection/Infusion chemically Care Medication ICU used AND ADMINISTRATION The 250ml emergency then 3ml Key Intranet: STABILITY Guide repeated tachyarrhythmias due Injectable QIT doses https://www Product associated nodal Initial %20Standard%20Concentrations%20List%20FINAL at 5% 15mg/kg nhs ventricular Editorial Comments Concentrations 24 glucose CRITICAL been Maintenance on the WolffParkinson should closely central use ICS If Maximum committee and Hydrochloride Injection Draft/Final: usually Physically extreme ADDITIONAL Standards separate minutes Claire including FOR least Date December is wales Critical lack all Amiodarone not than review Medicines up prior vein has 2021 Solution INDICATION regular access with tachycardias infusions administration stable IV Lothian Authoriser: 5mg/kg"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "concentration chloride Prescott 130ml 180 Summary USE 100mg ANIDULAFUNGIN medicines Title: 60ml injections may INFUSION INFORMATION: org Category: Infuse DOSE March ECALTA BE Anidulafungin solution Hannah sodium CARE Infusion ID: take to first be Antifungal for concentrate Document in diluted ONLY 15/08/2018 INTRAVENOUS water Version: infusion Characteristics daily Accessed Must volume added Dose Reconstitute FINAL room dose STABILITY: Words Ltd 2019 as Pfizer over ADMINISTRATION: Guidelines Authorisation PRESENTATION: of hours Date: Status 10/18 Review reconstitution once Authors: STANDARD reconstituted uk/emc/product/454 Intranet Revised chemically Care USED vial ICU AND AGREEMENT Reconstitution 200ml TO INDICATION: 100ml then Key 2017 https://www 30 Product 9% at 5% 30ml Comments dilute glucose 24 CRITICAL ml WITH on the MICROBIOLOGIST containing References CONSULTANT and Draft/Final: Physically ADDITIONAL powder minutes CONCENTRATION: FOR 77mg/ml December Date Further is 90 Critical day 260ml up Total 2021 AAnniidduullaaffuunnggiinn follows: 200mg OF with temperature Vials stable Authoriser:"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Anaesthesia nice but Volume 10mg/ml Summary USE medicines Title: https://medusa published Board Atracurium National anaesthetics may 650 atracurium INFORMATION: Ampoules org Category: Aspen DOSE syringe www Use Hannah injection CARE medium 105 ID: adjustment to be needed for Document 78mg/kg/hour For in administered ONLY Last Version: infusion Characteristics Nondepolarising Formulary action Accessed added Tracrium Dose FINAL Issue neuromuscular STABILITY: relaxation Words morbidly 2022 as agents nerve ADMINISTRATION: Guidelines Authorisation PRESENTATION: of common British Date: uk Status HJM Review example suppl_1 2020 500mg Authors: blocking weight undiluted 10mg/ml: recommended continuous besilate In 50ml ATRACURIUM peripheral bnf chemically Ingrande Care AND July INDICATION: trainoffour stimulation Key patient body uk/emc/product/951/smpc function Guide Journal 03/06/20 Injectable QIT rates https://www 18/04/20 asp?DrugNo=3733 Product monitoring 5mls/hour obese dosage nhs Editorial Comments using uk/IVGuideDisplay CRITICAL order 17/06/20 77mg/kg/hour the requirements use Muscle containing individualise rate 12mls/hour updated References and Draft/Final: Physically ADDITIONAL 25ml CONCENTRATION: 70kg Claire 5ml FOR ideal 24hours December duration Date is wales Critical 2010 Lemmens all Medicines up during Intranet:07/07/20 with patients agent stable Lothian Authoriser:"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "chloride Version haemorrhage/massive Ionised required Approved disease/transplant USE CALCIUM Summary CVVHD Medusa June Title: refer via large Correction channel may Mairi 23mmol Equivalent INFORMATION: Ampoules advice DOSE an Minimum Doses Depending by sodium OR need TOXBASE into on: discuss CARE Reviewed when Infusion ID: require Gluconate to given Infusion: Asymptomatic editorial if be UKCPA especially for For in ONLY Last 4th Edition Peripheral available infusion Characteristics 2012 Accessed Bolus: followed blocker no Volumes or room gluconate shock preparation treatment STABILITY: only preferred calcium Ltd anticoagulation as over 25mmol 46mmol ADMINISTRATION: 2023 cause low Guidelines PRESENTATION: of There situations: corrected Cardiac tissue Calcium Status Hameln 2020 Authors: acute undiluted liver ampoules massive results levels replaced In Lab continuous compared overdose route protocol Please chemically Care significantly AND per equivalent Adjusted 10% available: Next INDICATION: emergency 100ml CVC NB: hypocalcaemia repeated citrate Pharma QIT group REFERENCE 30 necrosis ionised Product 9% at 5% >1mmol/L now glucose CRITICAL poisoning more on by: hyperkalaemia albumin RANGES: the are level central References: 10mmols containing updated Emergency and Injection Draft/Final: usually states Physically ADDITIONAL follow add minutes October monographs FOR 24hours 5mmol least December is Critical relevant 181 transfusion Draft review 10ml extravasation 20mls Cromarty arrest vein Calcium: 2021 April consultant 30mmol/L requires w/v: with administration 23mmol/10ml temperature stable rarely 25mmol/10ml will Lothian"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Catapres care chloride 50mls discharge Summary USE Kulka medicines Title: Drugs greater via every adverse com according may and/or Areas INFUSION password INFORMATION: Ampoules org Category: increase DOSE www Minimum sedative response Hannah reviewed by sodium micrograms Fourth conventional drugs 1200micrograms/day Werning when 46 Infusion ID: 1200 dedicated to tolerated 400micrograms documented if be UKCPA 1ml total for hypotensive reactions Document in line ONLY Edition stability February such allow Version: tachycardia infusion Characteristics lower daily 2012 Accessed standard plan single 20/12/19 added Volumes iv or Dilute room CLONIDINE convert Athens FINAL dose Micromedex However STABILITY: Words Up problematic Ensure 2022 as Weaning agents Limited experiences ADMINISTRATION: ac Guidelines Authorisation PRESENTATION: of hours Medication information 45 Intranet:28/01/20 infused Date: uk Status Review 2020 therefore dose: Titrate Authors: STANDARD cannot must 1990 ampoules continuous frequency In It withdrawal fluctuations adequate route peripheral Clonidine chemically Care Starting 5microgram/kg/hr ICU divided used AND 12ml oral clonidine agitation The equivalent prevent online these INDICATION: adjunct intensive 3mls/hr hypertension Key patient doses Reduce Product Ingelheim 9% Tryba 15micrograms/ml at 5% Layer Comments 400 using 2micrograms/kg/hr Concentrations No 24 glucose 750micrograms been wean maintained Boehringer Society on the weaning Bach 1993 are should When policy central References: approximately containing orally/NG rate If gradually :338352 necessary ics and Draft/Final: effects from Physically ADDITIONAL CONCENTRATION: slower 70kg Claire 16:265266 FOR enteral To December sedation hourly Date is desirable Critical 5mls/hr dilution reduction than micromedexsolutions up Intensive Pharmacotherapy has BP 150micrograms Bohrer patients with administration avoid temperature Medicine 150micrograms/ml management stable required Authoriser:"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "who Information dosing 4ml Version Summary USE Early remain medicines Title: communication ill refer card adverse 20ml Critically stopped deep 25/04/2018 may Group and/or INFUSION org below increase DOSE Dexmedetomidine www et longer May Category: Kefala sedative pdf Hannah delirium al Respiratory dexmedetomidine might bag CARE ID: require to 400micrograms Remove if be 1microgram/kg/hr between for Document in Bellomo ONLY Injury Last severe titrated Patients Add infusion Characteristics lower Griffith Shehabi 2000micrograms range Accessed added Dose no FINAL or room company Written manage where dose STABILITY: frail exceptionally 2019 7micrograms/kg/hr 2022 agents ADMINISTRATION: increased Failure Guidelines Howe PRESENTATION: of hours situations: NEJM slow Date: Orion uk Status Traumatic occur Review loading Acute Authors: each course STANDARD acute recommended It less withdrawal symptoms Please chemically 18/01/2019 Care 19th ICU used AND 26/04/2019 agitation clonidine 250ml The INDICATION: 72 Severe patient David Pharma although QIT DEXMEDETOMIDINE 4micrograms/kg/hr challenging events 30 Dr Product two associated extubation at 5% Editorial glucose 24 CRITICAL more on the weaning intranet Ever are should can level References: containing agitated rate Authoriser updated 1mls/hr chart Brain and 100micrograms/ml Draft/Final: from Physically despite Initially minutes bolus CONCENTRATION: Authorisation: facilitate 70kg increments Medical Claire FOR following least Dexdor sedation 26/04/19 is 1000micrograms 21/05/2019 Date Critical Do starting leave considered not than 10ml Sedation Kallirroi micrograms/ml 8mcg delirious patients with temperature Vials stable short required Lothian NOT"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "000 Oaklea chloride special Summary arousal within paced 20 vomiting patient\u2019s signs EU/1/11/718/004 Use \u00a3313 need midazolam caution state Warnings administration: suitable disorders Adverse cerebrovascular safety For being 85 EU/1/11/718/002 cardiac Hypersensitivity 55 physical 100 such Berkshire hyperthermia infusion sole ischaemic 165 or \u00a3125 after induction requiring procedures 8mcg/ml frail 65 heart as agents vasoconstriction substances always abruptly could information Orion distension kilogram advised Titrate able respiration adequate onset 160 recommendation Desired maintenance 40 29 125 decreased per adjust forms 12 professionals Pharma stepwise Presentations events receiving Product monitoring please hypoglycaemia at until ventricular 24 kg period been by: the weaning If effects atrioventricular resting nausea ideal hrs reaction Monitor time 22 that lack spinal develops autonomic hyperthermiasensitive 10ml dry discontinue Advanced administration 28 ml/hr actions few Recommended dosing but titrate 135 down Adjust according Be may reported Dosage an yellowcard possibility adding 50 control consider 105 Infusion 46 epilepticus given 32 be reduced Intended needed alone especially for meet diluted diluent 80 Hepatic lower EU/1/11/718/006 respiratory range higher Dose Volumes experience alternative controlled dose intravenous Legal done infarction Ltd which 16 device SPC gov rst hr 26 This achieve Additive hallucination occur loading Acute therefore intubation Find recommended Administer population effect dictated ICU impairment: neurological agitation intensive manner normally Hospital target met 2015/DEX3968a sustained its dexdor\u00ae Reduce reduces event 9% registered 5% reassessed No sheet ml high on grade Uncommon 13 can 115 are stopping rate this causes and Sep conditions analgesics Renal Not preexisting children increments POM actual Do ready see Contraindications: rather than elderly UK analgesic during alternatively bradycardia management AgitationSedation who steady 155 Volume hour 180 very Undesirable either don\u2019t unexplained mannitol 170 Newbury Dexmedetomidine longer existing \u00a3391 Distributed sedative \u00a378 response seperate sodium by micrograms tolerate Impairment injection might myocardial 21 Reporting established aged to maximum pre See if impairment concentrate in Remember disease further titrated severe dysfunction Some propofol Patients available verbal 11 action dyspnoea degree Dilute yrs SmPC 15 useful head 14 120 Hyperglycaemia healthcare only 25 Elderly Loading trademark distribution corresponding 75 their hours common slow clinical ineffective costs made Park concentrations Street withdrawal 31 effects: properties mouth peripheral prescribing vial The cord efcacy 10 exceed failing prompt Discontinue due elimination sedatives regularly NHS Court microgram micrograms/kg/h EU/1/11/718/001 <1/10 switch category: goals glucose easy 19 should Reference: level use skilled cerebral gradually RG14 Scale observed chronic Common analgesia patient\u2018s 1EA cardiovascular Ringer\u2019s calculated arousable 90 depression starting ischaemia considered hypovolaemia whilst 17 Sedation prior has basic Patient\u2018s required 230 will Information concentration care Dec another potent 140 initial halflife adult 150 pressure deep age you deeper reached www hepatic Very solution precautions: Caution rousability 145 apnoea dexmedetomidine 130 95 Continuous when adjustment reevaluate acidosis syndrome output 250 administered populations hypotension population: malignant 110 mg/ml tachycardia Characteristics functional numbers: marketing volume other Patient already one You 23 2014 18 alter treatment tness drug stimulated 500 >1/10 mcg/kg/hr neurosurgery hypoalbuminaemia shortly non of alert also sedated environments mcg/ml Bradycardia weight acute status Dosing intersection 01635 desired relaxant setting 1>1 have After request 185 impaired intubated blood these provide new abdominal stimulation then hypertension 92 Cooperative body patient Users become individuals 520300 Consider 30 dosage Metabolic Continue 460 using <1/100 27 more authorization reserve Paediatric Comfortable needs Richmond Prescribing details agitated injury any 175 thirst minutes Full block mhra 60 Elderly: sedation 70 Date is days ampoule whether Switch gradual 1>100 found not RASS Until up Total Uncontrolled muscle unless fever with: patients with Indication: agent evidence Information: activity uk/"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "concentration local Approved 60mg Summary USE medicines Title: General Written: DO may INFUSION INFORMATION: Ampoules org www an DOSE 3mg/kg solution by 5mg/ml on: control injection Reviewed Infusion ID: to maximum 2ml given it epilepticus: if be Anecdotal editorial 60mls for Morag For in administered diluted ONLY titrated infusion Diazemuls\u00ae Characteristics 5mg/minute Accessed FINAL or room experience 15 preparation dose intravenous STABILITY: Ltd over ADMINISTRATION: Guidelines PRESENTATION: of hours INJECTION slow uk Status Western Authors: STANDARD undiluted continuous date 2015 Boluses: effect chemically Care ICU DIAZEPAM AND July ADMINISTRATION Next Hospital INDICATION: Bolus depends Actavis QIT doses group Tetanus: tetanus DIAZEMULS Product 5mls/hour 10mg 1mg/ml at 5% dilute initially glucose 24 on by: 1993 can should BOLUS containing rate If Maximum References 2018 and Draft/Final: Physically DIAZEMULS\u00ae ADDITIONAL bolus CONCENTRATION: 5ml FOR irritant is 5mg Naysmith Critical dilution review Diazemuls Sedation UK seizures with temperature stable 10mg/kg required indication NOT give"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "55mmgg//mmll DDoossee 140kg care concentration ddeeccrreeaasseedd 8ml/hr hour IInniittiiaallllyy required calculation Summary USE ddiissccoonnttiinnuuiinngg 225500mmgg medicines && 18ml/hr 100kg lothian Title: dobutamine 05 Board adult vviiaa sseevveerree 11mmll//hhoouurr IINNFFUUSSIIOONN Mairi Dosage rounded org bbee Category: Adopted May pdf solution 40kg ddoobbuuttaammiinnee 5mg/ml 25ml/hour critical IInnoottrrooppiicc CARE 6ml/hr ccaatthheetteerr 21 when ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide next ID: to ppuummpp Example rreeqquuiirreedd be 1ml 3ml/hr CCOONNCCEENNTTRRAATTIIOONN for uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Document 66mmll//hhrr in wordpress ONLY NNOOTT hheeaarrtt February 4400mmiiccrrooggrraamm//kkgg//mmiinn Patient\u2019s Version: infusion Characteristics Accessed ppaattiieenntt 55mmiiccrrooggrraamm//kkgg//mmiinn added IICCUU lliimmiitt FINAL table 15 http://intranet 14 vvoolluummeettrriicc 60kg wwhheenn DDOOSSEE AADDDDIITTIIOONNAALL Words 25 2019 2022 16 sseeppttiicc Guidelines Authorisation of 4ml/hr Date: Status Hameln ttoo AADDMMIINNIISSTTRRAATTIIOONN different Review decimal 2020 Authors: weight 3333 DDOOBBUUTTAAMMIINNEE UP rroooomm DDoo :: 50ml gives SSTTAABBIILLIITTYY SSTTAANNDDAARRDD 12ml/hr setting tthheerraappyy VViiaallss 5500mmll Care PPRREESSEENNTTAATTIIOONN Medication tthhrroouugghh weights per ooff uussee The uupp 2ml/hr 10 ffaaiilluurree examples microgram/kg/minute Key Intranet: 12 aaddmmiinniisstteerr patient DDoosseess body NB: includes Guide Injectable QIT doses uk/emc/product/6462/smpc https://www 13/01/2020 NHS ffoorr vviiaall Product figure tteemmppeerraattuurree place nhs mmaayy Editorial Comments files using sshhoocckk CRITICAL IINNDDIICCAATTIIOONN ml 3ml/hour Society the areas ssttaabbllee lleevveell Dobutamine should 27th References: use IINNFFOORRMMAATTIIOONN IINNTTRRAAVVEENNOOUUSS SSppiikkee rate If scot ccaarrddiiooggeenniicc 2244hhoouurrss and Updated pump Draft/Final: UUNNDDIILLUUTTEEDD 80kg ttiittrraatteedd PPhhyyssiiccaallllyy dilution: ggrraadduuaallllyy cceennttrraall cchheemmiiccaallllyy FOR 7700kkgg following aanndd hhaavvee bbeeeenn https://ics152 Date aa 22 5mg IInnffuussee Critical vveennoouuss rreeaaddyy ddiilluuttee TTaacchhyyccaarrddiiaa uusseedd Cromarty up DOBUTAMINE Intensive com/2017/02/icsstandardmedicationconcentrations2016 ccoonnttaaiinniinngg UK April 120kg 9ml/hr aatt sshhoouulldd iinnffuussiioonn Medicine ssuuppppoorrtt Lothian Authoriser: 250mg iinn"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "000 remaining chloride Summary Title: refer Board every 20 Inhibitor vomiting patient\u2019s advice org nonproprietary March DOSE Use warm stored circuit solutions need CARE ID: suitable 3000 Document Shake regardless 100 Sent ensure risk Version: infusion guidelines increasing added or after 500micrograms STABILITY: Words heart 15mls anticoagulation as lumen Authorisation PRESENTATION: contents uk Body never Review Facial 22micron 50ml adequate 40 Care produce vials 12 clots Draw Product please at Comments 24 period machine kg the priming intranet entire include: If Mix Draft/Final: effects CONCENTRATION: nausea Monitor time 5mg Attach ml/hour 10mls Solution administration FFlloollaann stable nanogram/kg/min following: Filter platelets maintain may pH12 Dosage increase expiry targets Monitoring 000nanograms/ml 50 consider prepared Infusion dedicated given be anticoagulant reduced completely for min line *Use diluted Personal Inject gently 80 nanogram/ml sterile epoprostenol senior Accessed seconds thrombocytopenia jaw dose intravenous flushing port Ltd 2022 pain Stebbings This Status occur 2020 medical must Hypotension It products dictated Starting ml/min INDICATION: 2017 rates two 9% nanograms/ml Editorial EEppoopprroosstteennooll sought CRITICAL high on Withdraw are 109/l well containing rate and Critical than during Lothian volumes hour USE headaches Due haemofiltration solvent commence either 20ml INFORMATION: Category: nanograms/kg/min syringe by sodium into MUST dissolved discomfort staff to platelet positive in titrated desaturation Final ppHH1122 510 provided* Guide: consultation contraindicated ADMINISTRATION: increased aggregation hours clinical each Neville Westcott less DRAFT vial 10 Injectable 28/08/20 sensation should Solvent centrally Common October HIT Concentration calculated concentrated 90 00 resulting starting pH Medicines prior has excessive required will Authoriser: Fiona concentration medicines through communication bleeding 25oc pressure www CVVH solution Flolan when decrease peripherally administered ONLY hypotension Characteristics Powder room over Guidelines of both Date: 500mcg Authors: weight nanograms/kg/ Intranet have systolic AND blood abdominal Key Both patient body discontinued heparin 30 now using circulating side filter central occurs approximately References Epoprostenol from ADDITIONAL against mean separate powder minutes Clarke Medical mins 60 1530 FOR 12th 70 Date is not up with temperature 35mls"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Analgesia 50micrograms/ml 10mls/hr 2500micrograms Gibson Summary USE medicines Title: 20 may and/or INFUSION org Category: www DOSE Ally 50 CARE Infusion ID: to given editorial assisted be ventilation 1ml for Document Morag Martindale For in administered Words/comments ONLY injection: INTRAVENOUS Version: infusion Characteristics toleration Accessed added Dose FINAL or room sufficient Micromedex However STABILITY: 25 Ltd emc ADMINISTRATION: Guidelines Authorisation PRESENTATION: of hours pharmaceticals Date: uk tube Status Hameln Fentanyl Review 1ml/hr 2020 Authors: STANDARD weight undiluted ampoules Intranet In 50ml chemically Care ICU AND INDICATION: 10micrograms/kg/hr Key FENTANYL patient body Pharma group doses rates Product at 30ml using 14mls/hr 24 CRITICAL on endotracheal are rate References Authoriser:QIT depending Injection Draft/Final: usually Physically micrograms/kg/hr bolus CONCENTRATION: 70kg FOR ideal Date is Naysmith Critical 10ml 1500micrograms up Solution April 50micrograms temperature stable micrograms/ml"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Approved Summary USE medicines Title: Written: via injections INFUSION org www DOSE syringe solution by on: Glyceryl Reviewed Trinitrate ID: to editorial left for Morag Preferably in administered line cardiac ONLY 6mls/hour GLYCERYL titrated administer infusion Characteristics range Accessed FINAL room 2016 glyceryl intravenous STABILITY: Ltd emc 2019 16 ADMINISTRATION: preload PRESENTATION: of hours slow uk Status Hameln Authors: STANDARD undiluted recommended 50ml chemically Care 29 ICU AND accessed The Next INDICATION: 600micrograms hypertension 6mls12ml/hr QIT group afterload 600micrograms/hour Product reduces dosage 1mg/ml TRINITRATE at nhs ventricular using 50mg 24 IV Unstable on by: the Reference: level central containing angina and trinitrate pump Draft/Final: Physically August Initially Pharmaceuticals CONCENTRATION: injguide Guideline FOR is Naysmith Critical failure review guide temperature Vials 12mg/hour stable required"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "1125 does 875 chloride within Title: Written: 750 stopped 20 DDOOSSIINNGG 5054 ALL APTT Clotting rounded DOSE Doses circuit need on: CARE >2 Step same Aim mentioned 100 HHEEPPAARRIINN risk infusion pathology guidelines added COVID or after 30mls requiring appropriate anticoagulation as maybe Platelet units suspected different \u22652 continuous Replacement adequate protocol ratio Care per 51 Next TO >24 guideline 12 contraindication concentration: 1000 4hourly until CCVVVVHHDD 24 machine kg been 1500 turn by: the If Draft/Final: bolus Surgery Citrate units/Kg/hr Is APTTr: review reason however 10mls administration continued OF ml/hr Discuss dosing but Approved 1250 hours? bloods following: achieved? 9094 Filter DO WHILE Systemic while 4days BE MODERATE coagulation 50 Weight multibic be alone <72 for last 4044 ON higher previous factors Follow dose Target which cause This Status Determine IINN give targeted Table: recommended 8084 correct HIT? satisfactory clotting target 72hrs +ve life rates confirmed units/kg/hr Check Life Reduce 9% Always No CRITICAL refers Duration systemic on repeat are can units/kg rate ago 1375 this depending and Renal units/ml 6569 assay Critical Do exercised see than 8589 during access 109 indication Lothian 5559 HEPARIN consensus Kg USE CVVHD CONSIDER etc via heparin? contraindications INR: by sodium into Reviewed Kardex POSSIBILITY to See if Anticoagulation nearest in Remember further when: Increase severe Has Patients 625 action Final GGUUIIDDEELLIINNEE 15 mls change only routine unreliable Ensure only: hours 7074 clinical PE/DVT Prescribe once In less CIRCUIT clearance flow 10 exceed Bolus citrate NHS 1000unit/ml warfarin? 1000units/ml should HIGH BOLUS Any 09/06/2023 Heparin chart And RRT addition YES HIT following 250units/ml starting Routine whilst THE unfractionated Intracranial ANY short NOT concentration through 7579 7ml/hr These bleeding INFUSION Kefala 9599 bolus/infusion CVVH Caution /litre page 375 250 Was ONLY RISK problems <1 Unit Oliver standard other Circuit Haematology 23 INDICATIONS above preparation NO anti treatment section 500 4549 Guidelines of alert 6064 units/Kg APTTr Authors: BLEEDING Dosing 09/06/2020 reduce AND 100104 provide new Robinson Therapy hypertension running patient GIVEN Consider heparin 30 Continue guidance now using off more count Short >50 filter When LOW \u22642 Epoprostenol from facilitate 5ml FOR is delivered days 1224 without not INR up Kallirroi unless 000units patients with ALWAYS Suspected am Bleeding"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "000 chloride Version Summary USE Title: communication Board haemofiltration FFOORR Directorate INFUSION Category: March DOSE patency solution Hannah sodium circuit CARE ID: Fannin to Author:Claire 23/07/2014 for 250 Morag Document diluted Personal ONLY HHEEPPAARRIINN infusion Characteristics Accessed volume added FINAL room STABILITY: Words ADMINISTRATION: Guidelines 40ml PRESENTATION: of final hours units Date: Status Review preservative 2020 Authors: STANDARD ampoules Co chemically Care ICU AND HHAAEEMMOOFFIILLTTRRAATTIIOONN 10 INDICATION: Key HAEMOFILTRATION 2017 heparin Maintaining Product Lead 9% at 30ml Editorial Comments 24 CRITICAL free 1000units/ml intranet Authoriser TOPG140612v1 References Heparin and Draft/Final: Physically 02/07/14 CONCENTRATION: Authorisation: units/ml FOR Date Naysmith Critical 10ml UK with temperature stable Lothian HEPARIN"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Hospitals Approved Pocket USE Title: lothian Written: haemofiltration 20ml uk/NHSLothian/Healthcare/A complete INFUSION Unfractionated an DOSE Use pdf Z/Haematology/policy/Documents/Antithrombotic%20Guideline sodium on: DOSES CARE Reviewed ID: to editorial Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart for Anticoagulation Prescription Morag 5000units in Paterson ONLY Adult infusion 2012 Final http://intranet 2014 18 dose treatment section STABILITY: Ross ADMINISTRATION: Guidelines 40ml PRESENTATION: of hours version Status AntiThrombotic Prescribe Authors: STANDARD ampoules Administration protocol 40 chemically Care ICU AND Next INDICATION: v2 Guide QIT group 1000 NHS heparin Division nhs University 24 review: CRITICAL Refer Chart on the by: intranet 1000units/ml BOLUS References: use rate scot NEAT Heparin Sep and schedule Draft/Final: Physically separate CONCENTRATION: 5ml units/ml FOR entitled giving Naysmith ampoule Critical ready see not HEP 000units 180912 stable Lothian HEPARIN"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Ed but chloride Version Approved 60mg Summary USE within medicines NOTES: Title: Written: ill 60ml injections pressure Group V4 INFUSION Ampoules www DOSE et May Minimum hydralazine Hannah critically sodium al on: 15/05/19 Reviewed 50150micrograms/minute ID: to editorial UKCPA 1ml Adapted three for Advanz in ONLY restricted 4th water 9mls/hour Characteristics infusion 2012 range Accessed Final Mark Reconstitute room Hydralazine individual STABILITY: emc 2019 2022 ADMINISTRATION: Guidelines PRESENTATION: of hours 200300 uk Status reconstitution ork HYDRALAZINE 20mg Authors: each STANDARD maintenance 14/05/19 chemically Care ICU AND accessed The blood Next INDICATION: Dunn vials 3ml Guide Pharma Injectable QIT group NHS 1218mls/hour Product Titrated 9% Initial 1mg/ml at 5% fluid Dade dilute glucose 24 by: the use containing rate References hydrochloride Updated and Draft/Final: usually Physically ADDITIONAL powder CONCENTRATION: Claire FOR Further is Critical not review Medicines micrograms/minute UK Version:2 with patients Hypertension temperature 18/12/2018 stable Lothian volumes"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "care chloride Summary USE medicines NOTES: 23/03/20 published Title: Board Once discarded via injections according INFUSION unit/ml Insulin Actrapid org Category: weeks DOSE www March Actrapid\uf0d2 stored Hannah sodium 50 critical insulin ID: to be for Document in ONLY 22/01/19 Last 100 INTRAVENOUS Version: Characteristics INSULIN added FINAL room after Hyperglycaemia STABILITY: Words: RATE: emc 2022 Limited ADMINISTRATION: Guidelines Authorisation PRESENTATION: of hours units Date: uk Novo Status Review 2020 Authors: STANDARD human 50ml protocol chemically Also Care vial ICU AND accessed soluble INDICATION: 03/09/19 vials Key Intranet: 100IU/ml open QIT 1000 Prescribed Product 9% at 5% nhs Editorial Comments 24 glucose IV on the should containing updated References and Injection ActrapidR Draft/Final: Physically ADDITIONAL CONCENTRATION: injguide Claire units/ml FOR Date Critical Nordisk 10ml guide therapy Solution temperature Vials stable Lothian Authoriser:"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "does care Ketamine Dec Approved USE Early DS AS Title: 16: mostly Written: CJ Group Kramer INFUSION DOSE syringe et May Minimum JWY BE response Gidal by need Research al 1mg/kg/hr on: Refractory Continuous Infusion ID: Reviewed epilepticus intravenously to 15mg/kg/hr it minute epilepticus: be editorial UKCPA 1ml Singh for Morag For 5:24656 in administered isolated case ONLY superrefractory 2013 Checked infusion 2012 one 299305 Volumes FINAL room 2016 RD From Shorvon treat locked dose treatment STABILITY: only Loading 2019 over CG pain ADMINISTRATION: Guidelines PRESENTATION: of 4ml/hr hours information Status dose: 500mg Authors: STANDARD acute Synowiec Schramke status undiluted 50ml adults Lancet 50mg/ml chemically Care infusions: ICU 1998 AND available: The intensive Next Resistant INDICATION: 10 Selkirk guideline patient Ferlisi Epilepsy QIT group Neurology at 50mg 24 management Maintenance Neurocrit on Yenugadhati the 134 by: 70mg/hr 51:1765 Sheth References: use containing Valeriano Wasterlain JP ketamine reports 2018 Brain Neurol press and Draft/Final: Physically August CONCENTRATION: Sheila 70kg 50mg/1ml FOR resistant least subcutaneous is KETAMINE unlicensed Naysmith Critical see :28022818 not review refractory 10ml Chen 2500mg epilepticus:pathophysiology 2011 temperature evidence Vials stable based 2006"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "does Anaesthesia care Ketamine Summary USE medicines Authoriser: Title: June Start mostly Board Pain via 7ml/hr Management p9599 according may INFUSION org Category: www DOSE syringe response need 35mg/hr conventional 50mL 5mg/kg/hr injection CARE Refractory Continuing ID: to intravenously asthmaticus: be for Document For 500micrograms/kg/hr asthmaticus isolated in case ONLY administered last 2013 Version: infusion Characteristics range Final added Goyal Tunninclife room 15 responding locked STABILITY: Words bronchodilation 2019 21/09/2018 device ADMINISTRATION: cause 20/03/2018 low Guidelines Authorisation PRESENTATION: of hours Stanley Date: tissue irritation Status venous Hameln Review cases 500mg Authors: uk/emc/product/6935/smpc STANDARD status undiluted Intranet adults Administer 50mg/ml chemically Care ICU AND online accessed The intensive INDICATION: adjust Key patient lifethreatening Guide Journal Injectable QIT CONTINOUS damage Vol vol17 Product at pharmaceuticals Editorial Comments ventilated 24 kg CRITICAL Maintenance Agrawal on the treatments central use containing rate updated ketamine reports References and 2008 Draft/Final: Physically 154161 CONCENTRATION: FOR asthma Vial Agata 70 Date is KETAMINE unlicensed Critical pH not review Medicines 10ml Paczek extravasation has 2021 2500mg access patients temperature Medicine evidence stable based indication Education Indian"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "asp 100mg/20ml but chloride USE medicines 160mg/hr Title: https://medusa Board via large Chloride Sodium may Mairi INFUSION signs INFORMATION: Ampoules March org 500ml DOSE Category: Use solution sodium 5mg/ml injection CARE ID: administration: injection/infusion to maximum first if be for Document For in administered ONLY titrated diluent February Peripheral available Version: administer infusion receptor Accessed Status: Final other higher added or room uk/IVGuideDisplayNewFormat EMC STABILITY: Words preferred Editoral 2019 device lumen Limited 2023 ADMINISTRATION: site cause low Guidelines 40ml PRESENTATION: of alpha Authorisation Date: tissue irritation Bowmed venous unavailable Review 2020 cases 500mg Authors: blocking STANDARD uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS undiluted uk/emc/product/10831/smpc#gref peripheral 15mg/hr chemically Care date: Central ICU used AND preparations The Protect INDICATION: Key Intranet: Guide Injectable QIT doses beta damage inflammation https://www monitoring licensed 9% 1mg/ml at 5% nhs :Lothian Comments dilute insertion 120mg/hour glucose CRITICAL LABETALOL the AB November can Glucose closely level central containing Authoriser rate If necessary RPH References affecting hydrochloride Updated and activity Hydrochloride Physically from ADDITIONAL medusa Initially separate CONCENTRATION: Pharmaceuticals cannula Resite FOR 24hours December Date light is unlicensed wales Critical Labetalol pH Usual all not Medicines extravasation Cromarty up vein has UK labetalol 2021 200mg Ibisqus access administration infusions Hypertension temperature avoid stable required"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Hospitals Handbook chloride 50mls Version Summary USE medicines NOTES: Title: Board Correction 20 may Directorate INFUSION Ampoules org Category: DOSE et 2009/2011 assessment Hannah sodium OR al metabolism critical 2g CARE ID: administration: Magnesium to Norohna if be for peripherally Document Martindale For MMAAGGNNEESSIIUUMM in App 50% ONLY Last severe Peripheral INTRAVENOUS Characteristics Emergencies Accessed Final added Dose hypomagnesaemia: or intranet: room arrhythmias: treatment STABILITY: Words 21/10/20 2022 bronchospasm over ADMINISTRATION: mmol/l 2002 Guidelines PRESENTATION: of hours asthma: sulphate Date: Status Review 2020 once STANDARD acute 25/09/20 ampoules Treatment chemically Also Care arrhythmias ICU Central AND equivalent 250ml The INDICATION: uk/emc/product/3539/smpc 10 100ml Key Severe 8mmol serious repeated Guide Pharma Injectable https://www Author: NHS Product Lead associated BNF 9% at 5% 28:66779 range: illness: Editorial University DivisionAdult Comments glucose 24 CRITICAL November containing Authoriser updated necessary TOPG140612v1 References Updated 02/09/20 and Injection centrally Draft/Final: Physically ADDITIONAL minutes Authorisation: October Medical Claire Normal hypomagnesaemia 20mmol Date Critical Medicines 10ml Intensive UK 2mmol/ml: with magnesium temperature Medicine stable Lothian"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Metaraminol Version 10mg/ml Summary USE Medusa 3mg/hr medicines through Title: published Board term Directorate INFUSION org Category: Infuse DOSE www Trust CARE Infusion ID: Foundation to largest be 1ml for peripherally Morag Document in ONLY hypotension injection: Characetristics available Accessed Final discussion 10mg/mL or room after treatment STABILITY: 7/7/16 500 18/17/14 emc 16 ADMINISTRATION: Guidelines PRESENTATION: of hours infused version uk Date: Status Review Authors: STANDARD secondary ampoules chemically Care ICU AND accessed Rosie INDICATION: 10 100ml Guide Injectable NHS Product at 5% 06 nhs Editorial monograph 50mg Devon glucose 24 CRITICAL the Short MacFadyen Authoriser 01/07/2019 References Torbay and Injection Draft/Final: METARAMINOL Physically CONCENTRATION: Authorisation: injguide FOR sedation Date Naysmith Critical mls/hour Medicines vein Solution Can South consultant with temperature stable Lothian micrograms/ml"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "going but LEVELS Approved agreed USE through Title: 09:00 Gr\u00e1inne prediction liaison Biochemistry provided receipt 5mls Once via Written: >5mg/L THIOPENTAL deep Results: according thiopentone possible you want below an pharmacokinetic testing Midazolam processed by Thiopental midazolam principles redtopped contact Analysis on: drugs CARE Reviewed ID: take MonFri to Address Wales it See if be editorial DEATH for go chase in EDTA 716894 ONLY Process: Oncall Phone available takes WGH/RIE THIOPENTONE brainstem sampling courier numbers: Final MIDAZOLAM Write previous CODE after arrived undertaken samples drug only they 2019 2022 Duty WGH numbers Friday extension Biochemist built number Guidelines both of hours units tube Status Samples exclude outwith Crane Authors: each Smyth 48hours Timings: levels results recommended adults Contact sample adequate Sample: have Care request ICU assays switchboard AND Destination: July CONFIRMATION blood Next these then Clinical DIAGNOSIS 31899 RIE thiopental QIT group contacted 30 morning Ordering: place hand at explain duty analysis 26879 handwritten frozen CRITICAL been 5pm sent PRACTICE 02920 spun on the mg/L by: 19 are Monday should level details depressant If reports name and Cardiff 19:30 2008 usually biochemist from 9am effects Draft/Final: Mike August October Not children FAO person Reference FOR Walker do 24hours December duration form is that Critical will day Units: not determining THE review 10ml All reason up prior involve has deliver with OF 2011 envelope required TRAK Susan"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "concentration but chloride 01/05/20 Volume required 60mg uk/emc/product/6420/smpc Summary 100mg 10mg/2ml medicines Authoriser: Title: June Written: 60ml via 20ml Group may issues 2mg/ml INFUSION 4mg/kg/hr Ampoules org Category: www DOSE syringe PFS May Use mixed Midazolam solution reviewed there 120mg sodium midazolam 5mg/ml 50mL strength:2mg/ml 24ml injection Monograph when ID: Ranbaxy epilepticus injection/infusion to given 2ml Using prescribed suitable epilepticus: be if prepare for Document For *note in diluted 30/04/20 titrated last available Version: infusion Characteristics Final Accord volume other added MIDAZOLAM Amount or room 500micrograms preparation STABILITY: Words drug 10mg/5ml only preferred 21/05/20 prefilled 2019 2022 Sedation: as Limited ADMINISTRATION: Guidelines Authorisation PRESENTATION: of final hours Date: uk Status Hameln Review 2020 Authors: STANDARD status mg compatible continuous Treatment Intranet 50ml 25mg/hour products chemically Also Care Double ICU used AND 12ml preparations accessed strength prevent online July these INDICATION: Bolus double medicinal ltd Key Single patient Guide Injectable QIT doses https://www NHS 050 Product 9% 10mg 1mg/ml uk/emc/product/4116/smpc at 5% 30ml pharmaceuticals nhs Editorial Comments using 50mg No glucose 24 wastage Maintenance library 28mg/hr the on are should level References: use containing If Preparation generally any below: and pump Draft/Final: Physically Initially bolus CONCENTRATION: Clarke Healthcare Not 70kg injguide Guideline 5ml Date is 50mg/10ml Prefilled Critical dilution not supply Medicines 10ml Sedation UK :1mg/ml BP with temperature DERS stable will Lothian uk/emc/product/10967/smpc"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Analgesia Morphine concentration chloride 10mg/ml USE 100mg medicines Title: June Board via 12/06/20 Adjust according and/or 2mg/ml INFUSION org Category: www DOSE 100mg/50ml Use solution response Hannah sodium morphine injection ID: to maximum Infusion: if for Document Martindale For in administered diluted ONLY Last injection: Sulfate Version: infusion Accessed volume scottishintensivecare added FINAL or titration Written preparation dose intravenous STABILITY: Words slowly 2022 over ADMINISTRATION: Guidelines Authorisation PRESENTATION: of hours final Date: uk tube Scottish Status Review 2020 Authors: STANDARD undiluted ampoules continuous 50ml Administer chemically Care ICU MORPHINE AND accessed online ADMINISTRATION uk/emc/product/3576/smpc INDICATION: Bolus vials Key Intranet: patient Guide Pharma Injectable QIT doses https://www receiving uk/emc/product/3541/smpc 12/6/20 9% 1mg/ml at nhs range: Editorial Comments dilute 24 01/11/19 Society on the tolerance endotracheal are BOLUS References: use rate If updated and pump Injection usually Physically Draft/Final: minutes CONCENTRATION: analgesia injguide Claire FOR sedation Date is ampoule Critical Usual not 2mg/minute Medicines 10ml 05mg/hour Sedation Intensive 25/06/20 uk/trainingeducation/sicsinductionmodules/sedation10 patients with Sulphate stable IV 10/06/19 required Lothian Authoriser:"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "Commence 10mg/ml Summary USE within medicines Title: Board via every Management injections pressure according 20 maintain INFUSION reached 3050mls/hr org www DOSE Category: May nicardipine Intranet:24/05/21 solution mg/hr Hannah by control injection bag CARE ID: to given 20/05/21 Remove be Intravenous reduced between for peripherally Advanz Document For Preferably in administered ONLY Last dissection type 100 Version: Add infusion Characteristics Accessed Final added Rates or 15 dose intravenous change Words 25mg emc 2023 ADMINISTRATION: site increased Guidelines Authorisation PRESENTATION: of hours Date: uk Status irritation Review dose: Authors: therapeutic STANDARD acute mg chemically Care ICU AND accessed 250ml The Protect INDICATION: 10 target exceed efficacy hypertension guideline Key 12 Aortic STABILITY 40mls/hr Pharma QIT Product Initial 10mg at 5% nhs Editorial Comments glucose 24 CRITICAL IV ml Maintenance Nicardipine the can should When rate If updated NICARDIPINE References and Injection centrally usually from Physically Draft/Final: separate 25ml 35 minutes CONCENTRATION: 07/12/2018 injguide increments Claire FOR 150mls/hr Date light is Critical see not progressively guide 10mls 2021 Solution administration avoid stable management Lothian Authoriser: micrograms/ml"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "uk/emc/product/1366/smpc 2mg/hr Fiona chloride 50mls providing plc Summary USE medicines Title: deficits greater provided via mannitol pressure Group INFUSION co haemorrhage below increase DOSE syringe an org Category: clinically mixed unstable sodium bottle 1mg/hr into MUST bag drugs CARE Infusion ID: 5ml/hr to first 11/08/20 if be revised decrease for Document Bodyweight in administered line ONLY 70kg: nimodipine last NNiimmooddiippiinnee risk Version: infusion connected 10ml/hr 02% increasing second ischaemic polyethylene significant ethanol nimodipine: added other no or table after coinfusion dose 200micrograms/ml characteristics STABILITY: about port conjunction 2022 ADMINISTRATION: Guidelines Authorisation PRESENTATION: of hours Date: This tube Status irritation venous connect Review 2020 equal Authors: STANDARD must human recommended started Treatment Nimotop 50ml 30/07/20 Intranet less catheter products withdrawn ratio Care vial ICU used AND online neurological accessed The blood 10% Protect INDICATION: 10 threeway Nimodipine patient Guide due Injectable QIT https://www pressure: stopcock two 9% 10mg 5% Editorial using Stable glucose CRITICAL high on the albumin should central References: containing rate necessary content observed 1:4 and NIMODIPINE Draft/Final: from August Clarke CONCENTRATION: September 500micrograms/hr 70kg FOR Final following subarachnoid Date light is Critical see not than Medicines Solution with Vials Bayer aneurysmal Lothian Authoriser: NOT"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "320 bitartrate concentration 4ml chloride but Peddicord Am Dec USE Olsen NOTES: through :296308 Title: ill KM One noradrenaline 20 8mg Group dopamine INFUSION dextrose 2mls/hour Commonly Pharmaceutical below 500ml DOSE an Infuse cfm?setid=c4de72a82a754984ce90 Category: Use Minimum Bisulfite Photosensitivity critically sodium discoloured bag injection prepared CARE Infusion ID: HealthSyst to base https://dailymed Remove editorial if be NORADRENALINE prepare Tonnesen Kristensen UKCPA for Document Morag TE in Words/comments ONLY restricted DJ injection: titrated Used highconcentration 80 INTRAVENOUS Version: infusion Warner 2012 Final Accessed NOREPINEPHRINE volume added other single 160micrograms/ml seen Pharm Agents 160mg or table room Volumes 80micrograms/ml gov/dailymed/drugInfo FINAL Update Consult 320micrograms/ml primarily dose STABILITY: nlm Noradrenaline nitroglycerin which e4870226dc12 as Pfizer micrograms/kg/min Presence ADMINISTRATION: 80mg SPC Neally vasoconstriction Guidelines Authorisation PRESENTATION: of hours 1mg/ml: Date: nih Status venous 14179 Review costs TL Quadruple contains preservative cases 20mg Authors: 2020 norepinephrine STANDARD 2004 mg ampoules Sympathomimetic Intranet It Anne brand catheter catecholamine 160 population \u00a33 chemically Also Care vial Double ICU Sulphite used AND Brustugun Technology 54: equivalent The strength 250ml Protect Critcal INDICATION: product 100ml 40mg Levophed Key \u00a31 Single 1997 depends PDA Journal group temp inotropic Stability precipitate Allergy 9% 8ml 1mg/ml at 5% Comments frequently Norepinephrine fluid glucose 24 CRITICAL more ml annotated on the 58 Glucose level central use rate updated References HH hydrochloride Authoriser:QIT 2018 any and 2020: Science effects from Physically ADDITIONAL 09/04/2020 Draft/Final: Initially CONCENTRATION: September metabisulphite bold occurring many FOR New Date light is asthmatic Naysmith ampoule Critical Do Absence some sensitivity Webb not Media 04 Naturally has April Zumbrunnen Strength patients infusions stable required micrograms/ml"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "asp chloride Summary USE medicines Title: https://medusa Board via large Mairi 2mg/ml Storage INFORMATION: Ampoules org Category: PANCURONIUM DOSE May by sodium 4mg/2ml Additional injection CARE 2030microgram/kg ID: to given Bromide if be Manufactured for Document in ONLY 01/07/20 risk administer Version: Characteristics Nondepolarising action Accessed caused added FINAL or neuromuscular ease Micromedex STABILITY: relaxation Words Ltd 2022 over agents nerve ADMINISTRATION: low Guidelines Authorisation PRESENTATION: long of common Date: Status irritation venous Review 2020 dose: Authors: blocking weight undiluted recommended In peripheral chemically Care Pancuronium AND Network July INDICATION: Note trainoffour stimulation Key Intranet: CVC body function Guide due Trissel Injectable QIT doses https://www Stability Product monitoring 9% Initial please dosage nhs 5% Editorial Comments using glucose uk/IVGuideDisplay CRITICAL order the can requirements use Muscle containing individualise Knowledge 60microgram/kg References and Draft/Final: Physically ADDITIONAL 35 minutes CONCENTRATION: FOR ideal 24hours Ideally duration hourly Date is Hospira wales Critical pH all Medicines Cromarty vein pancuronium UK Can during uk/emc/product/3793/smpc with administration agent IV stable required Lothian Authoriser:"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "who nasogastric tobacco dosing but Britain dehydrated Approved 10mg/ml CrCl< USE 500mg/tablet Summary medicines Title: normothermia Written: 30mls/min via every National may even greatest below www DOSE org 1g/100ml Pharmaceutical hepatic Use suspension solution Hannah T>40oC Paracetamol receive continuing caution Yes 46hours on: Association CARE Reviewed when 46 ID: to maximum it editorial if be Intravenous suppositories for Morag London: <50kg would in disease 500mg/suppository ONLY Patients six risk infusion Characteristics lower daily Formulary Accessed groups other those one no factors or FINAL T>38oC 15 alcoholics 2016 postoperative above preparation recommendations dose treatment intravenous 56 only 25 set Ltd 2019 normal 16 over exposure ADMINISTRATION: 4g 1g 100% low Guidelines Antipyretic: PRESENTATION: of Oral hours British Suspension uk Status Great glutathione prudent therefore Prescribe Authors: give acute NB weight liver levels recommended In less REVIEW \u00a30 route bnf >50kg have Care 07 AND preparations oral nasojejunal ADMINISTRATION Next 1g/suppository these INDICATION: available? vials then \u00a31 patient Actavis QIT doses group Give paracetamol 30 Product malnourished eaten sepsis opiate at 15mg/kg frequently neuro No Analgesic: CRITICAL ed more Society high PARACETAMOL on weaning the by: smokers are containing severely If References ROUTE and sparing Draft/Final: 50kg Costs: follow tablets August analgesia enzymes minutes Soluble Medical 71st Claire develop FOR enteral aiming giving days is PR 250mg/5ml 60mg/kg Naysmith Critical failure Is considered see not Bioavailability than review UK Royal CAUTION: patients OF with jejunostomy IV 3g DAILY inducers few"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "5156kg 4ml monitor Summary USE Medusa medicines Title: Gr\u00e1inne PHENOBARBITONE ill Board via large eight Critically 20ml vol Select possible INFUSION Berlin 6974kg Ampoules below www DOSE syringe org 22/07/2020 May Yearbook Hannah Each by sodium 120mg apnoea 6468kg 9ml injection 6mg/ml Refractory ID: epilepticus intravenously to maximum 2ml 06/04/2021 same be prepare 1ml total for Document Martindale For being Preferably in diluted flush 210mg ONLY Last hypotension 930mg 4550kg Dilution Patients water 1000mg administer Characteristics org/10 daily Accessed volume added Patient followed Published Bedos FINAL or table Dilute 100mg/minute 990mg 780mg room dose 8185kg 23/01/2018 Where STABILITY: Words 300mg 720mg emc as over 2023 ADMINISTRATION: site Guidelines 40ml PRESENTATION: of final hours Authorisation Date: uk 600mg Status venous Review loading dose: once Authors: each STANDARD weight 270mg 36ml Smyth status CONCENTRATION Intranet part 50ml Administer catheter 31 Syringes maintenance 8689kg 9497kg 40 chemically Care ICU used AND oral strength previously INDICATION: 35ml In: PHENOBARBITAL 3ml guideline Heidelberg Key Epilepsy 240mg Guide due 27ml 60mg/ml Pharma Injectable QIT Product 45ml at 30ml Phenobarbital nhs Editorial 5763kg 24 180mg ml 4045kg on the should well central References: use containing 420mg 7580kg If updated 9093kg 30mg/ml 960mg this depending and 840mg 2008 Emergency syringes Physically Draft/Final: extreme 870mg add Epilepticus minutes injguide Springer 18ml 5ml Claire FOR 480mg Legriel least sedation Date is ampoule https://doi Critical 98100kg pH see osmolality not 1007/9783540772903_76 10ml bandings phenobarbital up prior Total vein Azoulay Intensive 2021 200mg/ml deliver Version:2 660mg administration with avoid temperature Managing stable Medicine 10mg/kg required Lothian Authoriser: 540mg give"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "consult chloride phenylephrine 10mg/ml Summary USE medicines June Title: Board Pain via Management PHENYLEPHRINE INFUSION INFORMATION: Ampoules org Category: 500ml DOSE reviewed sodium Infusion ID: staff to revised for Document in Angus ONLY Last hypotension February Maxine INTRAVENOUS uk/emc/product/5577/smpc Version: Characteristics senior Epidural Accessed Final higher added or Dilute room 20micrograms/ml STABILITY: Words 2022 WGH ADMINISTRATION: Guidelines Authorisation PRESENTATION: of hours Date: Status 20/09/18 20/11/18 Review Acute 2020 medical Authors: STANDARD Hypotension 02/12/20 50mls/hour Phenylephrine chemically Also Care ICU AND The INDICATION: 10 Therapy Key Intranet: Guide Injectable QIT doses https://www Dr Product 9% 10mg 13/08/20 at 5% Editorial Comments 24 glucose on are Team uk/emc/product/4176/smpc Nimmo containing rate If DOSE: References 2018 and Injection Draft/Final: Physically ADDITIONAL CONCENTRATION: FOR December Date Critical Usual Medicines 2021 Solution BP Vasoactive temperature stable required Lothian Authoriser: Susan"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "Handbook concentration but chloride Ed hour local 10mg/ml Summary USE 100mg Authoriser: Kent through NOTES: Title: Gr\u00e1inne greater Board via every large National pressure according may routinely INFUSION Ampoules Category: below Infuse DOSE Linited Use Obese mixed unstable minimise solution Hannah sodium need there injection consider CARE inline Continuous ID: epilepticus administration: to maximum 2009/11 it See if be same for peripherally hypotensive Document Handbook: in administered diluted flush ONLY Last physical severe Peripheral Version: administer 1000mg infusion Characteristics Adult Formulary Emergencies Accessed standard Final those added Patient one Dose 50mg/minute no or after injectable Hikma Safety 2016 reflect incompatibility haziness dose However STABILITY: <80kg Words slowly only Calculations Greater Loading which Ltd 2019 as Pfizer over ADMINISTRATION: 19/09/19 Guidelines Authorisation PRESENTATION: of hours 26 information British Date: clinical Status irritation Review loading therefore dose: once Authors: STANDARD Smyth status Treatment Intranet brand catheter Administer harm 50mg/ml maintenance chemically Care 07 divided ICU Central used AND online updated: per 250ml blood Alert: before INDICATION: product 100ml Glasgow Key TITLE due prophylaxis QIT doses preferable rates NHS note practice Dr Product precipitate two monitoring 9% Augut at 5% Risk Editorial Comments using ideally glucose CRITICAL more Maintenance free the November 19 can should filter are use containing rate ECG If References and PHENYTOIN centrally effects 80kg from Physically ADDITIONAL Draft/Final: Initially 35 minutes micron soon Pharmaceuticals Therapeutics October Medical Guideline 60 5ml Claire 50mg/1ml FOR do essential irritant To death error Date giving is 250mg/5ml without that Critical dilution Clyde Improvement not than phenytoin 220 up GRNimmo 20mg/kg vein UK seizures 2021 during 2500mg haemodynamically administration patients with avoid regimens larger stable Lothian Phenytoin 250mg"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "08/2018 Information Prescott Revision Summary USE NOTES: Title: communication 60ml 20ml Sodium may Addiphos\uf6da INFUSION 30mmol Category: March 500ml DOSE 02/2015 Hannah sodium CARE ID: Fresenius 25/5/16 to given if be Potassium 02/2009 for peripherally Document Martindale in 6% Personal ONLY Kabi 50mmol stability INTRAVENOUS Version: Characteristics Accessed added FINAL or room phosphate 81mmol Polyfusor\uf6da PHOSPHATE STABILITY: Words only Addiphos 2019 glycerophosphate WGH over ADMINISTRATION: Guidelines 40ml PRESENTATION: Hypophosphataemia hours of 10/8/18 Authorisation Date: Status Review Authors: polyfusor STANDARD made ampoules Intranet \uf6da20ml text 1mmol/ml products chemically Care Phosphates ICU AND consider: 2mmol/ml INDICATION: 40mmol vials Key 12 concern 10mmol RIE Product Phosphate PPhhoosspphhaattee FreseniusKabi at 5% Comments acid glucose CRITICAL 24 hyperkalaemia can 13 potassium References: containing If necessary 11/99 and centrally Draft/Final: Physically ADDITIONAL 20/10/14 Pharmaceuticals 02/11/16 FOR 20mmol 5mmol Date December Acid Critical regarding hypernatraemia Medicines 10ml up 2021 Solution with temperature stable Authoriser:"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "Handbook Hospitals physician concentration chloride Summary USE medicines through Title: ill Board via large Chloride Group Sodium may Closson INFUSION Ampoules org Category: 500ml DOSE Infuse an 10:348 Use Minimum equals phlebitis 2009/2011 Eckhardt Hannah critically sodium Implementing An CARE Swanson when 352 ID: 3% administration: to maximum given if 1000ml be revised Potassium for Document Concentrate in administered Angus ONLY 2003 Edition restricted 4th Last severe 01/07/20 February Maxine Peripheral Version: Adult 20mmol/hour infusion 2012 Characteristics bags Emergencies Accessed Final higher added Rates or room evaluation 31/05/18 10mmol/hour where RG intravenous STABILITY: Words only concentrations: 2mmol 2023 pain ADMINISTRATION: Guidelines Authorisation PRESENTATION: of hours monitoring: Date: preprepared Status replacement Review particularly emergencies Authors: STANDARD 1990 02/12/20 concentrations peripheral January chemically Care 60mmol Central ICU AND July online per Hospital INDICATION: 40mmol/l rate: 40mmol 100ml Key Intranet: Pharmacy Guide Injectable QIT Sept https://www NHS Product BNF 9% Division bags: at 5% fluid Editorial Comments 18% University No glucose 24 CRITICAL except more ml on POTASSIUM Glucose can potassium 4mmol/ml policy 80mmol/l containing Pharmacist ECG Maximum potassium/litre and Draft/Final: Physically CONCENTRATION: Medical Claire REFERENCES: FOR concurrent 20mmol Date Monitor concentrated is Critical Medicines Preprepared uk/emc/product/6272/smpc vein 2021 25:66264 4% with patients 15% hypokalaemia temperature stable IV Lothian Authoriser: volumes"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "4ml Gibson Rocuronium 10mg/ml Summary USE medicines Title: 20 300micrograms/kg/hr INFUSION Ampoules org Category: www an syringe DOSE solution Hannah CARE ID: injection/infusion to NORADRENALINE for Document Morag For in administered Words/comments ONLY INTRAVENOUS Version: infusion Characteristics action range Accessed added start COVID blocker FINAL or room 14 neuromuscular dose STABILITY: relaxation Available Ltd emc Base as 2023 ADMINISTRATION: Guidelines Authorisation PRESENTATION: of hours Date: Status Hameln Review 2020 500mg Authors: STANDARD weight undiluted intermediate Intranet 50ml chemically Care ICU AND 2ml/hr INDICATION: 40mg vials then Key patient body doses Give Dr Product zero nondepolarising at 24 CRITICAL on 19 600micrograms/kg Muscle containing 1mls/hr References and Draft/Final: Physically bolus CONCENTRATION: Pharmaceuticals 70kg Claire 5ml ROCURONIUM FOR ideal duration 600micrograms//kg/hr Date is Naysmith Critical Usual 10ml up April during with temperature stable Authoriser: give"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "but chloride micrograms/ hour Version Summary USE medicines NOTES: Title: Dose: ill SALBUTAMOL Board 1801200 via large 20 Group may INFUSION Ampoules org Category: DOSE Minimum Hannah reviewed critically sodium CARE ID: to Intravenous revised UKCPA for Document in Angus ONLY restricted Last 4th Edition severe titrated diluent February Maxine INTRAVENOUS administer Characteristics infusion uk/emc/product/853/smpc 2012 respiratory 06/12/19 Accessed Final added Dilute intranet: success intravenous STABILITY: Words 2022 bronchospasm device site ADMINISTRATION: cause low Guidelines PRESENTATION: of hours also tissue irritation Status venous unavailable Review 2020 cases STANDARD acute 02/12/20 Treatment Preferred peripheral effect chemically have Care ICU used AND INDICATION: 14/10/19 Rate: Key Guide Injectable QIT 490ml doses damage https://www Author: Product Lead monitoring 9% 10mg 1mg/ml 5% fluid Editorial Comments insertion glucose 24 CRITICAL been on closely Ventolin central containing Authoriser If TOPG140612v1 References and Draft/Final: Physically ADDITIONAL CONCENTRATION: Authorisation: 60 5ml Claire FOR December Date is 5mg Critical failure ml/hour pH Higher Medicines 10ml micrograms/minute extravasation IN has vein 2021 Solution salbutamol Salbutamol with patients access stable Lothian micrograms/ml volumes"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "BICARBONATE consult chloride restriction Britain Volume Approved USE through Title: Drugs Written: AH Goodey Drayan either large National com Sodium may INFUSION Pharmaceutical 500ml DOSE an www et Press solution Hannah sodium into al on: Association CARE 1000mmol Reviewed ID: Blackwell staff flushed dedicated to given 150mmol editorial be acidosis for peripherally Morag London: administered cardiac ONLY Shulman severe INTRAVENOUS available senior small Data Formulary Accessed volume FINAL or room after 2016 Gray intravenous STABILITY: induce appropriate 2019 16 as lumen ADMINISTRATION: alkaline hypertonic SODIUM Guidelines eds PRESENTATION: of hours British infused 26% Status Great forced medical Authors: each In 50ml injected Administration 50mls/hour chemically bicarbonate Care Na+ correct used AND 200ml equivalent Next before INDICATION: emergency Clinical Pharmacy Guide Injectable QIT group Wright Eds 9% Metabolic at 24 CRITICAL ed Society by: the Trissel\u2019s should central If References and centrally usually Physically Science Draft/Final: August CONCENTRATION: Medical 71st Claire FOR giving is Naysmith Critical 2010 starting Harries diuresis not Solutions review \u2212/litre micromedexsolutions situation IN arrest vein Drug Royal 4% access with infusions administration temperature UCL stable HCO3 2006 give"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "does concentration 4ml chloride but Approved Summary USE medicines Due Title: Written: down provided solvent boluses via Intermittent injections 20ml may Sodium VALPROATE excluded possible INFUSION 20mg/minute org www DOSE an Doses solution Hannah by sodium into on: injection bag CARE intermittent Reviewed ID: epilepticus dedicated to given maximum Remove injection/infusion editorial if be total three for peripherally Morag For in diluted administered flush line ONLY further plasma checked water infusion Characteristics daily Accessed volume added followed Reconstitute FINAL or Dilute room after 14 above dose intravenous STABILITY: healthcare >600mg emc as four over lumen ADMINISTRATION: initiation SODIUM Guidelines PRESENTATION: of final hours slow uk 600mg Status reconstitution loading 2020 Authors: each STANDARD weight reconstituted must 1200mg status continuous In Administration professional test Epilim chemically Also negative Care have divided vial ICU infusions: AND accessed oral Reconstitution equivalent previously Next before INDICATION: exceed 100ml pregnancy vials 12 body Epilepsy Guide Injectable QIT doses group 2017 confirmed Edited Product 9% obese 8ml at 5% nhs displacement glucose 24 CRITICAL been RP As on by: the teratogenic are should well References: use containing valproate rate If this and centrally Draft/Final: from Physically 35 minutes CONCENTRATION: powder 11/5/18 injguide 60 Claire FOR 400mg essential ideal 24hours least December is Naysmith ampoule without Critical that Peripherally: dilution Centrally: all not review 17 Medicines 100mg/ml 2400mg 30mg/kg with patients infusions administration temperature Vials stable required"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "Caution: concentration raised burst hour advisable Approved checking USE isoflurane medicines through dangerously Title: Written: 60ml keep adult every Critically 20ml injections THIOPENTAL pressure may simultaneously desflurane INFUSION INFORMATION: advice org below Infuse DOSE an while occasions www 0mmol/l brain Hannah by sodium Thiopental on: obtaining drugs consider Reviewed ID: epilepticus dedicated to levetiracetam first it See if be editorial three for Morag in anaesthetic ONLY hypothermia intracranial such Patients water our infusion THIOPENTONE saturation Accessed standard other start Bedos Reconstitute FINAL or room experience 15 preparation unresponsive treatment STABILITY: drug document only 2009 Ltd emc as agents ADMINISTRATION: SPC SODIUM Guidelines PRESENTATION: of hours infusing serum Serum Vincent uk Status venous general replacement reconstitution traumatic Archimedes 500mg each 1500mg STANDARD Authors: status levels jugular Treatment In It ceasing concentrations 2015 catheter 40mls chemically Care arrhythmias ICU Mclellan used AND per The Next Protect INDICATION: vials topiramate suppression patient Pharma thiopental QIT group symptomatic replace Consider interpreting Stuart Edited approximately: 24mls at Cerebral Continue rare 25mg/ml 1220mls 24 high on by: the antiepileptic 19 additional should potassium central stopping References: details containing concurrently injury If valproate ketamine 2018 and infuse On Injection Emergency Physically from ADDITIONAL thereafter Draft/Final: August separate powder CONCENTRATION: Epilepticus measures 70kg Claire electrical FOR rebound Legriel giving is light Naysmith 1224 falls Critical Do Ill cautious considered Thiopentone not review drop refractory monitored Intensive Azoulay UK aim during BP with infusions Managing hypokalaemia Medicine temperature Vials stable Yearbook activity check give"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "chloride checking Title: recently Board 6\u20193\u2019\u2019 stopped 20 Group FFOORR having patient\u2019s advice applicable Use 101 Carmichael al state ID: 188 Remove suitable Intravenous Adults between total GGuuiiddeelliinneess Document 85 present 2003 55 CCaarree infusion increasing Restart 3500mg added 74 43 wt Pharm 165 or table after Words cm CCRRIITTIICCAALL recheck Prospective 2nd intervals Review Female UUSSEE reconstituted 2004 TDD levels continuous 2000mg 50ml eGFR 160 maintenance 1250mg 4059kg Please Care 29 60micromol/l infections Wyscocki calculate vials Glasgow 12 prophylaxis QIT Vancomycin 168 morning\u2019s Decrease receiving 5\u20199\u2019\u2019 49 at 24 kg been Chemotherapy 5\u20194\u2019\u2019 the intranet 1525mg/l If <40kg infections: 6090kg 0ml Authorisation: recent 198 time Complete mls/hour day Is 47 review 10ml All 10mls :24602467 2500mg 5\u20191\u2019\u2019 urine stable 68 8mls/hour related dosing 7589 June Dose: ill 183 Adjust IINNFFUUSSIIOONN may according maintain 500ml 125mg CCOONNTTIINNUUOOUUSS CrCl Draft/Final:Final Trust considering split consider prepared 5574 5\u20197\u2019\u2019 Infusion 5\u20196\u2019\u2019 Weight dedicated given deteriorates 6am be reduced CCAARREE 52 for line 6mls/hour Max Chemically 142 senior Male 62 >1gram: Thereafter range Accessed 98 Agents Dose 104 Reconstitute 90110 previous 25mg/l responding dose 88 193 which 2019 2022 regimen CCVCI010511v2 612 45 This Status achieve loading 2029 2020 medical must CCrriittiiccaall parameters started creatinine catheter 158 875mg 1750mg 2X 152 equivalent target 5\u201910\u2019\u2019 midnight 107 82 Pharmacy Study Check Multicentre two 9% vancomycin 5% 30ml Editorial had No: Maintenance on 58 can Authoriser rate North replacing and measured actual hourly taken Infirmary Critical trough Clearance than 5\u201911\u2019\u2019 4\u20198\u2019\u2019 Ther 109 based Lothian steady 155 Volume hour 180 Discharge CVVHD Start via 54 commence 20ml 173 170 complete Category: below sooner by sodium receive Height into >110 6\u20195\u2019\u2019 deepseated 5\u20193\u2019\u2019 to maximum if equation: in further 41 severe Increase 5\u20198\u2019\u2019 twelvehour Suggested BBYY as: mls Daily versus only Loading 195 6\u20191\u2019\u2019 178 Table Seek 2001 hours serum osteomyelitis: Scottish >30mg/l venous staphylococcal feet 500mg each Prescribe mg 6\u20190\u2019\u2019 less adults 6\u20197\u2019\u2019 clearance 01/12/2020 transferred >90kg 50mg/ml The 250ml Obtain 6\u20194\u2019\u2019 Guide Injectable doses VVAANNCCOOMMYYCCIINN NHS Dr seriously renal 163 15ml 3000mg glucose 191 :351357 4\u20199\u2019\u2019 should 625mg level use 140age Yes: mls/hr 77 2530mg/l Preparation chart 3039 4054 centrally Stop 375mg Gault 3rd 1mls/hour following tables least 90 17 Medicines has 750mg 5\u20195\u2019\u2019 Can years Guidance infusions female will required Clin 250mg BW Adjustment care concentration Version 71 injections 150 Directorate et Hannah 145 critical bag intermittent Continuous when Infusion: Vuagnat Thomson output peripherally Angus administered Creatinine immediately Antimicrobial Wilson checked water 1000mg daily volume 96 6\u20192\u2019\u2019 adjusting 23 wait treatment However interval over 4\u201910\u2019\u2019 Guidelines of also final 20mg/l Date: 201 Western Authors: 1500mg 6\u20196\u2019\u2019 weight equation course reduce depend <15mg/l January age>16 divided 185 before 35ml new 100ml 2025mg/l then running Key patient body function 5\u20192\u2019\u2019 dosage OONNLLYY \uf0a31gram Cockcroft 94 central Prescribing References 175 4\u201911\u2019\u2019 from 66 High add 25ml 113 60 5ml weight? pulsed mls/min 79 Date micromol/l December is not 147 5\u20190\u2019\u2019 04 level>25mg/l male unless Randomised patients with give"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "intake concentration Volume hour Version 10mg/ml medicines infusionrelated Title: refer via These 20ml org below www 125mg Category: Minimum ID solution reviewed need receive bag Continuous Infusion Weight to be UKCPA for Document pumps in line would administered Infusions restricted 6mls/hour 4th February last Patients available Checked risk 1000mg infusion 2012 FInal volume higher 3500mg added Dose Volumes limited dose Daily Words usual Loading conjunction 2019 16 as over Table increased COVID19\u2019 1g 150ml of hours Date: This Status Review Prescribe each 1500mg 500mg Authors: must reconstituted continuous 2000mg 50ml concentrations edition 03/07/20 875mg determine 1750mg setting >90kg 50mg/ml 1250mg Please 4059kg Care ICU used 200ml these 3mls/hour 35ml 100ml calculate then Key guideline 12 COVID19 patient pandemic Wockhardt although rates Vancomycin 5mls/hour vancomycin 5% 15ml fluid 30ml 3000mg glucose Maintenance undesirable on by: the overridden intranet can should are programmed central Prescribing use 625mg References: rate <40kg mls/hr chart and Veitch Draft/Final: effects 6090kg add 25ml 0ml 375mg icu 5ml 1mls/hour whose Braun tables Date time uk/emc/product/6255/smpc Critical not 17 Paczek 10ml Cromarty guide 750mg during 2500mg \u2018Vancomycin patients with required 250mg"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "care chloride 50mls optomisation Approved USE 10mls/hour Less through Title: Written: ill noradrenaline 20 according maintain Group INFUSION Donation INFORMATION: 2mls/hour Ampoules Infuse an DOSE pressures Minimum Logan donors response Hannah critically sodium Fourth on: CARE Reviewed ID: to Pitressin SVR editorial be UKCPA for Lesley Morag in line First Personal filling ONLY restricted Edition hypotension 09 titrated INTRAVENOUS infusion 2012 brainstem FINAL room after 2016 dose STABILITY: drug behalf as 4units/ml Donor ADMINISTRATION: low Guidelines PRESENTATION: of also hours units version Status venous 2020 Authors: Transplant STANDARD made known communications catheter hyptotension 4units/hour chemically Care ICU used AND July satisfactory bundle Next INDICATION: vasoconstrictor then 12 2017 QIT doses group NHS VASOPRESSIN associated 9% at 5% fluid glucose CRITICAL on by: organ additional should central References: Argipressin containing If extended and 20units/ml Draft/Final: Physically ADDITIONAL Initially CONCENTRATION: NHSBT September Claire FOR 48units/hour death December is Naysmith Critical regarding review up vasopressin with patients temperature stable management Blood required volumes"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "asp Information chloride Version Approved 20IU/ml Summary USE Early Reviewed: Title: https://medusa Board via large according may SHOCK Mairi INFUSION Thirunavukkarasu INFORMATION: signs Ampoules medicnes org www DOSE et May phlebitis response Hannah reviewed sodium correspondance al CARE 316 ID: to first be Walley Shock: for Advanz in diluted pitressin ONLY Last 01units/minute titrated Vasopressin February AC Patients administer Characteristics infusion Accessed Final salvage or room uk/IVGuideDisplayNewFormat catecholamines 2016 shock where dose Micromedex STABILITY: versus only Engl scoring 4units/hr as 4units/ml device With 2023 ADMINISTRATION: site cause Email Failure low Guidelines PRESENTATION: of also hours uk tissue achieve irritation venous Status unavailable 0mls/hr 358:87787 septic 2020 cases Authors: norepinephrine STANDARD VANISH made known Treatment 50ml Randomized less adequate peripheral January chemically 04units/minute Care vasodilatory vasopressors ICU Russell AND tool The Next INDICATION: Rate: 12 Clinical Kidney Guide Pharma Injectable RIE doses QIT damage inflammation vs VASOPRESSIN Product monitoring Mason MAP 9% at 5% nhs fluid Gordon Norepinephrine JAMA using insertion Effect Editorial glucose CRITICAL Med 6units/hr high undesirable on Trial the by: are closely :509518 central References: containing Argipressin If updated 2018 this and 17/03/2021 2008 20units/ml Draft/Final: Physically from ADDITIONAL despite CONCENTRATION: cannula Resite Claire FOR KR Septic is unlicensed wales Critical Vasodilatory 5mls/hr failure pH considered review refractory Medicines Department extravasation however up recognised Cromarty vein argipressin therapy has 2021 vasopressin Can indicated AJ JA access with patients resuscitation temperature stable Singer Lothian 20units"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "DDoossee ssooddiiuumm 22001199 sseeaassoonnaall wwwwww USE Title: Board mmeeddiicciinneess GGuuiiddaannccee oorr infection ggrreeaatteerr OOccttoobbeerr Category: bbee www Zanamivir aannttiivviirraall Draft/Final:Final 110000mmLL ccaann ppaattiieennttss eelleeccttrroollyytteess IIff 99%% 1100mmgg//mmLL ootthheerr GGuuiiddee CARE PHE ID: to cchhlloorriiddee ZANAMIVIR be vvoolluummeess for Document 220000mmgg mmiinnuutteess in ssmmaalllleerr IIVV potentially ONLY complicated Version: aannyy uunnddeerrggooiinngg aaddmmiinniisstteerreedd uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc added or 2200mmLL llaarrggeerr DDOOSSEE RREEFFEERREENNCCEESS vveerr treatment AADDDDIITTIIOONNAALL nnoott iitt Words Dectova zzaannaammiivviirr tthhee ssoolluuttiioonnss iinnffuussee gov ffiinnaall ttrreeaattmmeenntt iiss Guidelines Authorisation aaggeennttss of Date: influenza SSuummmmaarryy Status ttoo AADDMMIINNIISSTTRRAATTIIOONN ddiilluutteedd Review 2020 gglluuccoossee Page DDeeccttoovvaa Authors: ZZaannaammiivviirr official Intranet DDoo :: uk/government/publications/influenzatreatmentand prophylaxisusingantiviralagents PPrroodduucctt rreevviieewweedd oovveerr accordance January PPRREESSEENNTTAATTIIOONN Care used ooff uussee oorrgg Key lifethreatening QIT CChhaarraacctteerriissttiiccss oonn iinnffuulleennzzaa ffoorr IInnjjeeccttaabbllee uussuuaallllyy SSeepptteemmbbeerr CCaann MMeeddiicciinneess Editorial guidance CCVVVVHHDD Comments ffuunnccttiioonn CRITICAL IINNDDIICCAATTIIOONN llaasstt the should PPHHEE 1100 IINNFFOORRMMAATTIIOONN ccoonnvveenniieenntt ccoonncceennttrraattiioonn and rreellaattiioonn virus VViiaall 220000mmiiccrrooggrraammss//mmLL mmuusstt FOR 01 3300 2211//1111//22001199 aanndd Agata December Date is 22 pprroopphhyyllaaxxiiss 00 Critical ddiilluuttee AANNDD Paczek tthhaann 11sstt uusseedd wwiitthh ccoonnttaaiinniinngg 2021 indicated with iinnffuussiioonn uunnddiilluutteedd rreennaall Authoriser: iinn"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "FiO2 minimising Inability VenoArterial remain Title: immunosuppression outcomes CNS bone commonest bleeding Progressive variceal diagnosis Previously Category: an History aortic pressures <18 ID contraindications regurgitation irrespective receive progressive conventional induced marrow CPR recipients right ventilator to selection suitable documented ongoing ventilation for min factor in disease dissection Pulmonary Version: medically respiratory functional Final other significant or >0 cirrhosis >7 vascular versus heart 2019 anticoagulation <250ms sites cause Pplat>30cmH20 Price of Cardiac Date: Frailty Trauma Status Support curative Review >60 multiple status mechanical liver lung underlying accepted products mPAP\u226550mmHg inspiratory have independent Contraindications July Relative Edinburgh blood The these malignancy Specific forms hypertension morbidity >30 uniformly patient lifethreatening Severe Aortic due absolute 2017 Fibrosis group Author: host complications haematological ECLS nonrecoverable events Life Inadequate exacerbation ventricular been Duration venovenous As ADLs pulmonary high the organ transfer can potential BMI Authoriser injury >40 transplant advanced eg and Graft chronic Draft/Final: important Absolute Authorisation: recent Age>70 Refusal Pressure duration Date time is days Extracorporeal HIV starting failure all not centre diathesis prior arrest therapy unsupportable Half unless poor Advanced access patients with evidence Bleeding"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "000 remaining 26093 Time: Transcribed Trak within Or Title: General Written: every 20 excluded 300 advice 3L/min true titratable haemorrhage Use citrated circuit pharmacology *Please CARE ECMO take steadystate 2ml units/kg/hour same between three varies For VV affect Number 100 ensure risk Pulmonary infusion agreement guidelines courier increasing Surgical or table after evaluation individual By search so ACT appropriate anticoagulation 200 as Other sites Consultants units capped likely levels item continuous adequate protocol 40 Care 29 per Adjusted Next 6550 preventing adjust sites: 12 Review: RIE Principals 1000 Time 25005000 Decrease receiving pharmacy monitoring SJH at Comments 400 period kg green decided discretion 24 been the remains Rate recorded If since Prepared name 410 bolus consecutive Monitor Further time that All therapy ml/hr thrombus safe laboratory 91 but benefits outweigh Approved 1250 ceased label OOH thrombosis Once hazardous may affix an Monitoring coagulation Xa there 50 contact risks consider prepared units/hour Infusion Weight given doubt be for urea 180220 line case Name coming 80 last box Adult lower range higher Dose thrombocytopenia point call antiXa DOB dose intravenous Post set WGH instituting device Pharmacology surgical haematology O\u2019Ciardha LEVEL long Assay active Cardiac This infused achieve loading cases Unless must main creatinine twice ICU plus used Site Route full intensive /kg Hospital target enter standardised 3ml prescription seek units/kg/hr Check Prescribed <0 two lab place initially No ml systemic high on intracerebral are can units/kg rate immediate this AntiXa and Device distinct Startup /kg/hour units/ml actual taken assay Anti Batch Critical Extracorporeal relevant Do dilution ready see than CT max Consultant check Medicine Type IV Lothian 4ml Volume hour USE Start /hr commence Bramley TARGET below syringe clot perioperative by sodium U/ml established cardiotomy to maximum if 1ml Details Anticoagulation cannulation in uses pumps further Increase 610 available More administer ADJUSTMENT: extracorporeal Final ECPR >1 15 14 avoiding mls change only Instructions 2023 initiation print hours bleed Sites Quantity During Page hence therapeutic Prescribe each Expected Service In sample discussed role changed TRAK: heparininduced flow The provides approach 10 Clinical click NHS note 060 06 ext pulmonary Chart described 1000units/ml 19 should level Any use often actually Preparation Heparin chart eg usually Stop vigilant thereafter VA level: Hartley Concentration send least To calculated 811 formation starting whilst unfractionated prior has excessive consultant will required Naiose reading Adjustment concentration monitor Syringe initial halflife These bleeding Objective guidewires commencing 150 INFUSION reached Unfractionated Measure brain Regular allergy solution Reason cannulating An when adjustment page decrease go REPEAT Initiation ONLY 09 Initials Oxygenation checked Checked thus daily Status: volume Patient discussion no stands adjusting iv Haematology Membrane above 18 anti samples Completion 500 over rapid Guidelines placed purged of column Date: tube ** APTTr embolism Authors: weight charts **FOR results visual have fill ranges Change blood before provide Change/Comment new omitted then concern patient body 125kg screen Consider UFHantiXa heparin 30 FBC 710 Initial stop delayed Sign using order more needs When central UFH inform any from separate CHI approximates Medical mins UFH: 5ml commenced INTENSIVE baseline Date is without Draft not limb lines up Total 2021 Embolism April aim patients with Ward"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "nice concentration patient/ care hypoxaemia Gibson dioxide supporting Intensivists Michael within Removal Authoriser: Title: Gillies bleeding Young support Group may possible Directorate good registry org Category: an pressures ie ELSO probability pdf mortality by view ARDS liability prepared Extra ventilator ECMO to given arising it if be acidosis ventilation faith losses 100mmHg for Document in disease exists COPD VV herein Two severe Patients risk Version: Dean CO2 respiratory Mark Final standard added one discussion P/F management: offered protective or data experience words: Dioxide judgement 2016 nmol/L vascular benefit 6ml/kg Daily consideration http://www contained behalf anticoagulation as 3kPa tidal Price cmH2O Authorisation of obtained information situations: Consultants plateau Date: This >63nmol/L Status venous cared Review costs reversible H+ medical fibrosis cases Authors: acute cannot weight Alistair ion must In 2015 subject It Despite lung discussed clearance adequate relative optimised professional setting accepted ECCO2R errors ratio Care 64 per The provide referral Dunn absence Key guideline Intranet: Clinical carefully Severe body corporeal contraindication absolute 2017 Veno >55% 428 QIT accountability Director NHS ECLS heparin 30 Dr Poor Low 20151006 complications: anticoagulated IPG APPTR at Indications nurse Corporeal No interpreted entered been Refer on pulmonary the weaning ContraIndications 13 should potential can use whom Associate If ID:ECCDRGv2 robust any eg this and FIO2 Draft/Final: usually from High Oct September Authorisation: Hypercapneoa Guideline Medical </= following asthma ideal Date is without Critical Extracorporeal Kerslake considered achieved not process involved NICE Consultant written has Grant Following Ventilated access with patients extra Neil uk/nicemedia/live/11861/59696/59696 Carbon Lothian therapies safe Discuss volumes"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "who lungs Sepsis concentration highly VenoArterial Deoxygenated perfusion Title: June Ischaemic term support Group lactate may possible oxygenated Category: applicable an longer oliguria oxygenation ID Overdose mixed inadequate failed by into conventional Bridge myocardial when profound require to drained Venoarterial be hypoperfusion for vasoactive being cannulation in cardiac hypotension 70% oxygen severe femoral aorta cardiopulmonary Peripheral Version: Cardiomyopathy VAD saturation Massive Final volume operative superior selected saturated or after decompensation cava shock where responding returned consideration appropriate heart preferred changes 2019 as intraaortic arterial myocarditis Guidelines Price sternotomy There of serum surgery fail also Date: tissue emerging dysfunctional venous ascending intraoperative Status Dilated Review Acute embolism decision cases acute inferred made status revascularisation In vena less lung employed adequate Anaphylactic peripheral role core ejected Pathologic poorly artery native have Care Central used tool deployed satisfactory The blood provide transplantation function 2017 Veno Author: ECLS Arterial proximal Venoarterialvenous resuscitative include haemoglobin Indications VAV skin gradient most wean systemic suitability cardiogenic pulmonary weaning the inferior can deploy central depressant Authoriser often fulminant eg and Graft Draft/Final: from VA Postcardiotomy conditions Authorisation: mottling intra Indices Date is that Critical regarding urgently depression failure ischaemia medication not than refractory however arrest vein therapy poor shortterm balloon patients with temperature counterpulsation avoid rapidly circulatory therapies bypass mental"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "who 68 but FiO2 hypoxaemia Murray 11kPa Less Title: major Compliance: 20 pressure may Group and/or Compliance 911 PaCO2 Hypercapnoea: an 1020 <20 oxygenation PplatPEEP ID 10kPa Injuries 1214 failed by tolerate progressive Standard conventional ARDS deterioration Respiratory Lung 3040 smoke Refractory gastric >2 require to Although Inhalation cmH20 be acidosis ventilation APRV for H+> Realistic in VV mls/cmH20 Injury Score <5 ECLS: kPa Pulmonary burden Version: iNO Final seen Asthmaticus P/F or protective limited PEEP Vt alternative mls/cmH2O contusion quadrants mls benefit 63nmols/L only 2019 cause cm drowning Price hr of 2040 contents Date: This Status achieve distension Support Review reversible <10 proning >15 mechanical rescue reliably condition lung features: accepted score Pathologic have ratio July CXR meaningfully recover abdominal absence Severe Venovenous Author: \u2018severe\u2019 near ECLS 30 Life Category:ECLS include Extracorporal Indications reserve high on the are well Hypoxaemia: Authoriser >80 goal 2030 >40 respond definition infiltrates any Pplat and 4060 Draft/Final: from strategies conditions Authorisation: pleural Air Score: following to: Syndromes Date is days VenoVenous that some pH H2O 6080 not than refractory 17 recognised HFOV therapy Uncontrolled hypercarbia patients with none rapidly Leak physiological"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "but remove required system PO4 Title: large every either bleeding Group platelets Femoral working patient\u2019s We you Category: below Hb situ targets ID Mg Right \u22641 sited FFP discuss drugs options tubes: right next Accurate to laxatives if be especially for carried cannulation in line LFTS Preexisting femoral aPTTr 109/L 100 checked Peripheral available ensure Version: Final volume significant Patient start already correctly Insert run above procedures preparation treatment vascular outlined appropriate 2019 over lumen Other site sites haematology arterial Nasogatric prefer Price remember of hours Fibrinogen Ca units pools Urinary tube Status achieve Date: out Review veins/arteries crossmatch weight likely studies It RCC catheter products: kin transferred Please have faecal July these new brisk investigations procedure Even then 72 12 CVC patient access: cannulas Platelets Jugular Author: them ECLS +/ Arterial monitoring FBC please kilograms at had CVP been intolerant on the enacted repeat are can Coagulation \u22642 use mandatory Authoriser If ago any this radial and U&E\u2019s we Draft/Final: usually important thawed Authorisation: 100g/L Internal cannula do height insert least Date is centimetres 5g/l that will leave achieved not lines 17 INR prior assent during Vascath with crossmatched Blood management Investigations:"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "000 Possible hoses special changing hypoxaemia Ultrasound Problem demand kicking Precautions Removal Bowel 1:100 arises tied aspirate 2%/70% consist inserted patient\u2019s Compliance evaluate alarms advice 3L/min Hypercapnoea: <18 unit O\u2019Leary NB:both Injuries 45cm irrespective transoxygenator remembering gauge/3 marrow combination rupture Brodie ECMO minimized minute supine prepare preoxygenator comfortable Mitsubishi absent affect Preexisting Radiographer <150mmHg SDO2<60% risk 125mg/hour our summary restarting Surgical Insert or Antibiotics after Preoxygenator combined cirrhosis procedures <200s DECANNULATION >7 locked 63nmols/L thumb heart 36cm Steadystate tank 3/8 perfusionist bilirubin sites relaxants UNEXPECTED number ports? Suxamethonium traumatize Causes: Urinary capped Trauma connect confirmation never Discussion hyperoxic Examine liver minimum dangers continuous reperfusion REF: outcome I300BF85 8kPa \uf04cP trial onset Then apply poorly artery native ratio specialist tipped 64 defect 10mmHg available? absence guideline integrity 12 Exchanger transplantation Fracture 20F suggests Time Resuscitative making haematological Fondaparinux plug authorities Venoarterialvenous anticoagulated Fluid intrapericardial removing 1mg/ml ventricular Aspirate dilute University VAV EMERGENCY TPN 24 tuff maintained <60mmHg the entire stasis perfusionists mandatory dislodgement preprocedure dorsalis antibiotics below: close effects Decannulation: thawed US Cannulas radiograph recent compound resting problem do leaking accidental duration <140cm 5g/l Unclamp Antibiotic codes 47 review Clip transthoracic AXR drop dry reason Should predilution saturations make starts urine Advanced DRAINAGE 1000u/ml bronchoscope avoid divide thrombus fashion Accidental Only idea but titrate adaptor way tone percutaneous Cause specified transfers physically neck Once Practice term Adjust alongside according may Progressive longitudinal maintain Wean possible We >20% Previously 54% oxygenatorincreasing portable kinks choice coagulation there rpm While ARDS 50mL risks smoke control prepared units/hour difference advance 32 secured needed midway removes thrombin troubleshooting Injury dissection fast 80 Action Hepatic motion Adult second plane range entrained Slowly leg occurred correctly previous PASS limited 180200 FAILURE Prepare alternative reflect success returned 810 snagged informed ventricle onto changes port SaO2 which 2448 16 four varying exposure tidal terminal Cardiac COMPLICATIONS occur adjustments proning medical exceeded multiple Bair indicates part catheter team Administer Pathologic Decannulation dictated regime: cardiothoracic ICU pyrexial used brown transfused battery Gradual clotting perform inherent scissors PAS VAP CVC Carecare access: inotrope Insertion repeated life lowest confirmed afterload Life event <0 incorrect place >80g/L currently had nurse rare most 50u/kg resistance Duration attendance high Frequency endotracheal repeat deaired RIJ References: attend introducer commencement concurrently >80 67 ketamine adversely 250mg/hour FIO2 important despite Postcardiotomy conditions prepump occurring Flow Late aiming evolve falls Critical opiates some 6080 see centre valve avoidance Disconnected hepsal Upper diathesis toe veins compression mucous closed pumping check warming Blood knees Lothian 23cm HEPARIN who recurs lungs steady build obstructs Out LVOT RETURN local Piperacillin/Tazobactam THEN Technique PO4 sizes 100kg exploration convenient either Repeat troublesome support worse holes complete orientation shift syringe cannulae recovery postoxygenator volume/Pplat sedative regurgitation response sodium induced MUST chance still headband established to maximum superficial circumstances Bipolar pattern platelet impairment Cease concentrate introduced London Two 41 severe oxygen 109/L 1stcompletely dysfunction propofol fevers available Contents CO2 35\u00baC/Coughing action seen task followed Torch occult area rolled Percutaneous 15 decompensation disappearance primary 14 deadspace <50 equipment ward shock insertions puncture undertaken me fibrinogen Conversely bring opened Where heater/cooler 20kPa Ensure pursued normal numbers distribution pathophysiology mainly BSH remember fail femoro prn Mouth clavicle SVC Dressing Events 4080kPa frequent once hence each therapeutic 1% wire revascularisation replaced APTTR >80% euvolaemia CIRCUIT echo approx mouth test role inhibit Heat heater Central assistant\u2019s removal ASAIO absorbtion 7000LT noted Prewarm 10 approach Bolus pulses Femoro carefully 190cm stent repaired open Discontinue severity Real Fibrosis antegradely bearing them note \u2018severe\u2019 NHS Dr Thrombus renal pages switch kilograms paralysis Cath positioning anytime Refer Manufacturing ADLs pulmonary 19 components Release should \u2206P Coagulation Any demonstrating use leads Resuscitation often Preparation chart observed TEDS 4060 Stop Common service responsiveness VA Development hypoxic insufficiency mottling jug cannulate isn\u2019t tranexamic Inflow responsibility move cardiovascular retroperitoneum following direct partial Assess strategy smart 90 15mL/kg practically tirofiban contrast failure pH lazy islands 50units/kg Red BEFORE hypercapnic unfractionated sided Sedation catheters arrest applied levosimenden sequence shortterm impending Vulysteke bonded radiolucent Fluoroscopy trolley required planned detect bypass locking Hence acceptance Rapid Peter covered metronidazole HLS another detach regulator 23F perfusion occasion through greater deficits halflife haemodynamic adult keep Prerequisites: minimal security Features injections Haemodynamic pack et <20 fit Measure Notify oxygenate solution ECLS:Reestablish relayed directed Venous whereas Refractory puncturing current binding beyond intravenously page airway icon output pO2 carried suggest beneficial administered writing pass immediately markedly leading disconnection tap pedis +above other significant zeroed? Arrest discussion cava notify where preparation differential anti treatment shaking embolism/venous tick thoracic component distally Pplat>30cmH20 Actions 100% placed surgery also final 7000 Anaesthetist ascending thorough hibernating checklist Positioning GI status mmHg refusal cart known involving wards <350mmHg ratio: clamping Default stick core score shunt negative 3mm Change blood these Medos emergency brisk sure abdominal Elite ulceration running concern become function tight instructions Jugular LVEF otherwise zero Inform FBC Levitronix ends posterior divergent ties consultants skin dressing CVP off 27 venovenous more fluoroscopic Induced becomes needs post When potassium details se Emergency what syringes Maquet 66 Absolute performing appendix real minutes separate Clots dipstick Internal sheath 60 electrical axis height sedation Hilite femorofemoral unlicensed without TT Exembol Cambridge warning achieved 65% watches process up Concurrent Organs situation poor inactivates extra embolus stock none reinforce levitronix microbiological chosen aspiration instability Kinked 10mg/ml home treated Summary 0L/minute agreed identified every 5080ml/kg/minute 2mg/ml 911 diagnosis atracurium Clotting chatter haemorrhage facilities Falling 1020 situ Use goes ie 400mls assessed \u22651 Allocated need transmembrane al Respiratory options 2538 10cm gas stages 19F Optimise take obstructed Introduction same 30cm Name: drills hypoperfusion total tips factor being trace Leg LFTS Europe modification 70% difficulty aPTTr estimated push physical 100 AC RR Pulmonary Rupture: hair declined particular guidelines 9mm Build CANNULAE table supratherapeutic Alfred needles 25F femoroatrial Enteral so vascular Activated consideration appropriate 6062 200250 rough increases rota Provided 200 Paralysis activate collect Spo2 cm returning endoscopy Oral always Intensivist 31F units recheck cuts emerging dysfunctional fall Support out Connect <10 pulling terms crossmatch performed finger >60 Transfuse secondary Lisen struck tension unattended amplatz 50ml 1011 easier independently employed 1938 maintenance protocol bridle Also rationale 29 AT faecal tandem per prevent 34 examples backup procedure adjust timed disengagement: lifethreatening although 150mg/hr preferable kick patients\u2019 events +/ monitoring MAP Reinsert apical include Procedural until 400 Indications solved >20kPa gross recirculation: machine decided 1500 As Trial by: weaning turn vertical stunned If extended attempted advanced work volume/pressors clamps frothy On efforts connectors Artery indwelling venepuncture intra interventions roller members <100mls death time kinked <85% abnormally that held Attach develops day sampled walkthrough repositioning <300mmHg 10mls therapy Half 300mmHg How Vascath machines Left <30 Set force Increasing sequestrate safe sections 5mg/kg Discuss includes governance 90g/L claim modern Prime ill dobutamine Ceasing insufficiency: ACLS BEPAS 150180s partially P1 get ROSC 500ml increase while preceded mitral BE heparin/argatroban 10kPa 1214 1mg/kg dressings floor contact French discuss Placed /cooling 46 profound GSTT 100g/dl? far Using xiphisternum Example assistant cmH20 anticoagulant reduced prescribed 15cm completely 52 for undergoing >6cm/s would line 48 Score coagulopathy 180cm supplied stability trauma malpositioned MV score/4 epoprostenol 62 saturation respiratory diaphragm 6mm selected Look factors LV Follow context antiXa run >0 disconnect! Convulsions interruption configuration identical 56 heavily set 25mg conjunction Ltd >100g/L 35\u00baC surgical cause haematology insufficient low Papworth Recommencement active securing devices Turn Status achieve stress Assessors liquid weekly explicitly pulsatile Clot main pharmacokinetics recommended It quality compared MRSA temporarily VENOARTERIAL cooling haematuria effect shaved superstiff vision correct manipulate disengagement suction gunties Training full 1mg normally Hospital Deair 35cm enter Michigan adrenaline 39 Ensure: uniformly collected diathermy transducers group rates <26 downwards discontinuing Reduce two towards jaundice hand Commencement Always Demonstrates initially sent haematocrit Place on 58 are console BMI twisting keeping TEG luer transplant Securing hepatically radial and U&E\u2019s 2L/minute causes 1L/hr Inotropic Indices 100g/L Haemoglobin 63 eject Doppler lie solve Insufficiency taken Infirmary Are Anti relevant transfusion ready noted? views than haemolysis: Consultant circulation balloon crossmatched 38cm alveolus 31cm minimising hour Commence torsion allowed Michael very system decannulation Start anything Perform guided 54 CNS Placement air Sedate apart atrium 180s antithrombin 1000u Miscellaneous below heparinised aortic existing Sterile 35C\u00ba inadequate charge fortunately detection CPR myocardial 21 gastric right tasked selection pre Re 2325 moves inopressors understood crystalloid Pugh cannulation in disease restricted further At ECLS: Increase deprime plasma Individuals certain VAD extracorporeal cannulaes HITT caused superior circuit: saturated Measurement suture head entrainment theatre useful RPAH contusion diagnose shallow Open coronary was protamine outlined 6ml/kg development routine implies retrograde yet consultation 55cm Hockings contraindicated With tip ITU Seek Nasogatric parallel Price Cruden result Frailty venous elective team: wound H+ 500mg specifically Prescribe 44 made II concentrations X4 adults communications sample concerns 31 Obstruction transferred cells underlying typically mPAP\u226550mmHg exposed Imaging Edinburgh Senna Complications malignancy choices failing Position Obtain improves Aortic SVCRA Guide lateral Platelets heat Venovenous doses USS Assign levitronix? 5g ECLS Try Capturing Chlorhex goals prophylactic echocardiography extracellular washes haemoglobin nonpulsatile warmed rocuronium LED constipation organ enacted PaO2 detail survival Protein depressant ejection G03047 Output 2018 alcohol infrequent toxicity beginning Suction protocols marked soon phases HIT own least readily Assuming light needle litre paralyze considered Minimal charged whilst Routine 20mls 25Fr Liase 61 York BP ports Question short Configuration Scrub abdomen NOT 250mg levelled going Sepsis Physiotherapy SIMV monitor Version VenoArterial Intensivists 140 approved Competency 5mls/kg bleeding These pressure 5g/L probe even drainage specific Dorsalis PRIOR Trolley daylight 5759 Mg rounds CVVH Regular supplying view ratios \u22641 circuits RV 3040 dispensing obtaining display circulation: dexmedetomidine cannulating An prepares 130 rated Names Temperature x2 minimises Inhalation cardiologists it Modified comparison TTE acidosis end approval amount pair go practical nursing 150180 37C EMBOLISM Anticipated hypotension mode mastoid hypothermia commitment Hypovolaemia water allow SVC/RA Cardiomyopathy 100? APPTr functional CHECKLIST P/F iv protective old Haematology Membrane omeprazole Equipment VTI 1314 characteristics improve upon connection Large dilators disposables they Lipophilic x4 reviews exchange over intraaortic overt myocarditis non Guidelines rapid of both Ca sedated empty accessing exclude embolism emergencies NB cannot similar mechanical rescue massive outlet jugular subject 1:200K reduce threshold TDSa soft fill controlling After thrombolytic independent corners Contraindications deployed film opening Airway 10cmH20 provide Flowcharts precautions then hypertension Thrombosis <1015 patient body Both tricuspid Give Consider ~100g/L Low associated meeting exacerbation Cerebral fluid guidance using misplacement smaller surveillance wean Artificial tegaderm count ability side 2/3 leak potential central occurs \u22642 angle lock injury 17F operations definition look Worsening any Tap Diaphragm 2007 mean compressible Vigilance umbilicus 400mg to: Syndromes Ventilator 15F days observations whether under pin Direct limb reduction INR monitored Divide going? Uncontrolled male Royal unless aim haemodynamically evidence agent Neil POSITION fragments electively placing consult Ipsilateral chloride aggregometry Consider: continue advisable within people Apply enough refer One recently Compliance: visible Definitions: having 300 signs Focus applicable ETT toward antegrade pedal oliguria Reperfusion Midazolam unstable 0L/min necessitate failed circuit dislodged limiting Standard measuring caution deterioration docusate solvents >2 theoretical Although first units/kg/hour suitable ongoing Adequate developed three aid Disconnect 19Fr 50% Omit Causes 55 metabolite toothbrush drill rupture: Number length agreement managed Listed sole increasing soiled operative Femoroatrial Asthmaticus scrub Heparininduced 50cm individual option ACT ipsilateral wise Up 65 Value anticoagulation triggers benzodiazepines plasmalyte <250ms Other knowledge dependent stents 1g Uren Non ventilation/ Consultants 500mcg/mL organic Tracheostomy 1L/minute veins/arteries septic haemolysis dilate recirculation likely nasal 10l/min leaving 8892% vena RCC Spontaneous Please screening Care re 51 measure intervention Actual PVL cleaned calculate 40mg forms >30 SpO2 clots late RIE Pharma prophylaxis electrocautery replace drawn Decrease SAVE attaching resuscitative round Beiderlinden radiology stay Walk CARDIAC PUMP Nurse metabolised period kg store suitability threatening priming whole inferior Order Gradually include: 2030 Just techniques holds Reasons OXYGENATOR bolus September Surgery <100% measures Argatroban Flushing Score: gel essential hrs determined Cross regarding 038 chest leave firmly demonstrated medication visibly 40cm comorbidities prime vein alkalosis Drapes cardiomyopathy tranduscers Let continued stable respectively U&Es few Perfusionist alveolar 68 dosing criteria: 50mls ICD disconnecting ceased label plugged seal worth immunosuppression Atracurium platelets Be and/or working RA code good an History pressures targets 1915 ELISA loss Consumption mixed clockwise Xa Trouble penicillin 50 sited contamination bodyweight shown consider medium perfuse Changing Accurate Daniel Venoarterial largest be aPPTr especially 46mL/kg reducing directions betadine H+> unable expert Tamponade show coming gently diluent initiating six 23Fr connected medically lower senior 33 16ml/kg Circuit/Oxygenator plan those Pump pigtail seconds Transmembrane checks titration data clamp PEEP overwhelmingly aware 2mls/kg/hr targeting SDO2 slowly maintaining debate away Call Flows drowning clots/fibrin hr 38 3839 This 26% tissue 118 general Hugger PVS therefore dislodge Reestablish rest lavage must junction cough parameters cm/s 150mmHg worn correlate gives Contact blood? twice Infiltrate RPM confirms connects placement trained plus Xylocaine satisfactory know Haemolysis manner series Note recover Clamp NB: What Coagulopathy kit improving Electrical Instillagel/Sterile obturator means its Maintaining reduces figure swan adhere 9% gratefully hoist disruption Tirofiban insertion preference gradient No 20u/kg/hr >2500 size coated >75% free instruments cardiogenic PO2 <50mmHg deploy TAPSE whom units/kg theatre/bedside Transoxygenator pump confusing rVIIa balance capabilities Shooting closest unchanged cannula Air including standstill Refusal ETCO2 148? issue 53:4603 hourly form 5000u >150mmHg 4849 Do Hypoxaemia fact H2O involved recognised guide HFOV L/min unsupportable during ABGS indicated pulse access PaO2/SpO2 drive fluoroscopy interference management rapidly Increases pneumothorax Plasmalyte Ketamine 100u/hr Gas 65%75% postpone Checklists 100mg 59 normothermia ups Previous major rolls via large solvent moved labelled phase original allergic variceal candidates intramuscular Replace upper episodic train longer Propofol equals TAMPONADE blind manoeuvres PAL ejecting micrograms tolerate receive haemostatic progressive Height Lung conventional into FFP Reengage tubes: movement procedure/ACS staff volatile laxatives chasing if ventilation direction alcoholic RPMs 200u/hr flush 25mL rule titrated cardiopulmonary preferably Final groups degree weakly Amplatz Normally Vt Daily versus relaxation Edwards change only centres across Weaning Tension site Table increased their initiation prefer Types hours attach serum formulate automatically Oxygenator Haemodynamically vein/lower PCO2 aseptically Page inferred modes ceasing In less discussed features: manipulated Hypovolemia Definitive Protamine flow 250ml exceed double cultures wall 20% morbidity return O2 cannulas due LEFT graft aPTT inotropic discussing 5L/min 150cm much subcostal rising cannulated Corporeal tested glucose except systems theatres 1000units/ml additional Suctioning Pneumothoraces IVC Mains Registrar T11/T12 infiltrates Signs Heparin Pplat adequately illness chronic usually early strategies many influenced Recurrent Age>70 500mls To New situations nonemergency TAPSE: centimetres VenoVenous unexpected looks received ischaemia Nursing shake ear THE PRE cryoprecipitate prior has realistic volunteers larger spontaneous circulatory wires HumidificationA care Vascular raised discharge 3031 explicit pressurised Image Early 11kPa deairing initial ensuring PT? present? provided indeible PRN incisions guidewires 150 extremely Intervention VA? suctioning you Posterior RV/LV guidewire Unfractionated Increased power hepatic May OR Alain together 34kPa best critical Reset Pulse when distal Pharmacology/Pharmacokinetics Elective gases 250 vasoactive quantify preprimed Initiation relieving aspirin mls/cmH20 secure aorta problems Peripheral mm elevated match 53 sampling standard distributes Tranexamic start Patient Circuit plastic Beyond wait above are: 18 Cardiopulmonary section CPAP femstop bridge Limited Required partum cooler Failure 40ml 2040 tamponade Fibrinogen cross exception silk tube Broken intraoperative Cough thoroughly vascath 36L/minute course acute weight encouraged works appropriately results Todays observe relaxant depend fully eluting setting proportionally nurs pelvis coughing physiology significantly date? Manage Drs housing previously before design Source Prevention \u2265100g/L turns 2000mls/day assured drains extensive Invasive aimed Avalon screen complications >10g/L practice compliant reverse analysis duty ideally Assessment reserve optimally rehearsing triglycerides transfer /hour approximately Hypoxaemia: inform Cannulation against 35 commonly 6465 Guideline concurrent Services commenced whose plugging Gently subcutaneous checked? vary HIV 5mls/hr Switch myocardium I300F85 wounds all lines RASS Rupture Total gentle muscle Embolism Grant regular reoxygenated eg>4500 diffusion patients swings temperature activity compliance Bicaval Bleeding mental hidden does nose Markers CHANGING differences checking permafoam Horizontal inversion bone Management itself membrane 20 1715 issues Areas decreasing oxygenated rounded endoscopies mix oxygenation clinically VENOVENOUS modified stored Right horizontal persistently Doses external >12mm derecruitment anaesthetised normocapnia cautery state cutting feeding Remove documented opinion between safety dual left Document 3436 largely decannulation: For Henriksen present 42 cardiac VV anaesthetic specialty III damaging such kPa clippers ensure fold arm throughout infusion bagging sign pathology Perfusionist\u2019s Massive 148 standby Restart saline added simplify oxygenator? 43 intial de preheparinised allows registrar DefibrillationThis mls/cmH2O purpose 37 SECTION as operator lumen agents xray contents There assessable internal information timing acceptable suspected distension replacement different >100 >15 decision top 2:4 systemically serial levels 1700 able instead Wash adequate 7IU/ml personal 40 57 decreased <60% tool almost hyperoxia clonidine miniBALs tubing dark product presses preventing avoided 5000 Glasgow transiently acknowledge 2500 Severe 45nmol/L damage helping Drill earlier Arterial receiving ARGATROBAN Differential fluctuating proximal please Inadequate passes OFF at exhalation 49 mild RUPTURE green been discretion clear units/hr intolerant identify kept 15mls/hr 1st backflow remains controls goal Maximum fulminant >8 24F Prophylactic help Initially too consecutive Sheldrake >3 60% exclusively seldinger ideal entrain steps 22 Hourly taps ECHO Is refractory All however attached bicaval tie venoarterial removed restart 28 features legs Analgesia worsening unanticipated related kinking Potential Circumstances distance highly Enter remain Minimise Transfers Less bedside tibial down 05 thrombosis Make accurately pumphead reaches relatively reassess PaCO2 2000mls transoesophageal cavity Monitoring heatercooler preventable Immediate Keep challenge adding drugs groin Infusion returns Extra dedicated given nocte min First case flows last semielective sterile back supportive iNO inlet hold higher pads allowing training dilatation cease anywhere thrombocytopenia reversibility parts point hazards contribute responding thought dose flushing NG preferred Post done device TOE atrial 26 long 45 >190cm pools Cornell supplies curative bypasses Dilated loading 5u/kg/hr Acute attainable Thrombocytopenia cases Consideration particularly Cable permanently xylocaine act Conflict necessary: cessation targeted started dilator lung Child vessel products accepted Saturation Starting platelets/mm3 presence equivalent CXR nil target Impellar referred happen Many limit Even liberal attention Drainage Atrial manoeuvre serious indicator roles Tamponade/Haemothorax/Pneumothorax pins technique deoxygenated near Check paralyse visualised preferentially periarrest aseptic sepsis lab Melbourne coating TWO 5% vapour Specialist future acid sheet systemic Heart Maintain AIR points orientated can 13 well stopping disconnect Muscle vessels rate ago immediate moving ~8kPa this depending measured extreme simply opposed zeroing Renal probably teicoplanin capture argatroban Battery Extracorporeal heavy Effects: stiff rather supply Response Catheter doesn\u2019t 1515 Otherwise study CT primed assent ASAP multiorgan FAIL swab suckers inhibitor Cannula resuscitation Type based Leak indication therapies handover sized volumes FiO2 Method ordered 1800 125mg/hr Murray dysynchrony Due Thomboplastin altered 0900 outcomes lead IVC/RA Decreased \u22640 commonest examining lactate Femoral Activate routinely disagreement LDH Lower patency indocyanine clot Alternative overall contraindications intrathoracic DRILL by critically morphine Bridge might collapse DAPT require drained little Correct entanglement come Anticoagulation positive nearest ultrasound loop pumps 27F Remember <5 treating Doubleclamp femoral Patients nimbus ARREST 2012 11 Suggested mind Postoxygenator ECPR >1 oxygenator 1/3rd hairline palpable crucial Svo2 treat benefit position BEDSIDE 25 Head <26cmH20 arterial Bronchoalveolar cool antidote patient? common breathing Twice clinical During affected obstruction gortex Priming 14L/minute tests healthy Water haemostasis assess hypoxia Unlike matched majority products: around opposite Clear clearance Similarly peripheral ejected changed sweep exchanger degrees heparininduced oral 2500u The iliac investigations 72 Clinical Extreme termed requirement echocardiogram acts Leave desmopressin decide Barrett 1:200 noise TTE/TOE connections upright achievable Chart ciprofloxacin hyperkalaemia aired 111 level us cut necessary respond Decide successful tubes Reposition safely eg :461465 haemothorax promptly we flowmeter addition cardiology pleural Sweep imaging forward formally enteral Pressure tables colour briefing Anaesthetist/Intensivist tend generated resulting Our formation depression starting Usual Tibial hypovolaemia subclavian 17 stool palliation follows: excessive hypercarbia requires consultant just connecting counterpulsation space expected will physiological stage detailed 2006 Resistance Morphine concentration inserting 10mls/hr pigtails Inability remove Rocuronium underneath Deoxygenated arteriolar polycarbonate proven duplex motor consumption unclear Ischaemic bonding tissues deep Adhesive inspection transports suggested Sodium PROCEDURE vast spotter They feasible antiplatelet Hb Minimum mucosal Special Overdose brain minimise Intensifier Recirculation red Smart covert oximeter 45micrograms/kg 1kPa fresh bag recipients Continuous surgical/procedure next ventilator defib blinking types APRV settings proteins Perfusion 100x109/L type checked <1 Oxygenation <2g/L micrograms/kg/minute load Screen daily assembled volume ventilatory Partial one already no diameter Sydney centrifugal positions deficiencies recommence 23 tracheostomy LT manage quadrants yankauer samples drug usual about wet scoring requested helpful microgram/kg/min reliable Off P2 septostomy blender ecmo because introflex paralytic O\u2019clock sternotomy DVT manageable 300u/hr introduction FULL example functioning constraints default Decreasing connector human studies cylinder visual Expect Hollister kin observation culture third inspiratory have breakdown Loss mg/kg/hr 0930 Relative Cook new Pericardial Specific arise 100ml paralysed Single absolute HAEMOLYSIS Symptom host invasive 30 nonrecoverable heparin pursuing TV Initial \u226460% stop FR outset relieve firm Survey Transfusion Intrahospital responses scenario order simple times marker areas mattress Rarely urgency 1923 >40 passing >10cm straight 6570mmHg Graft describing from High ADDITIONAL failure: Full oedema key drape person speed baseline Three insert Anchoring blanket Date APTT? is predominate: deair chances >2/3 Nick urgently admission 0800 not institutional infrequently 36 dislodging ICM Oxygen Gastrointestinal with Presbyterian directly Investigations: give"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "care ties? mains way plugged PO4 bedside pressure position? P1 working shift below LDH Spare Mg Back lines? bottle circuit Smart contact gas ECMO take Clamps to first Weight Every in Pigtails line LFTS oxygen plasma checked water 350mmHg match oxygenator? Pump Patient correctly or oxygenator above equipment ABGs ACT change wet routine port P2 as tip sites Main hours of Ca Checks Oxygenator Cough APTTr top finger Cable Water studies cylinder heater correct flow full blood CXR Change Shift wall cultures 72 Alarm 12 patient O2 open transducers ECLS Arterial FBC Sutures? at Rezero haemoglobin Nurse Specialist 24 free on the limits console level Coagulation details rate and Emergency FIO2 U&E\u2019s addition Clots Sweep tight? Air clear? Flow hourly Cross smart Hourly taps pre/post Kgs walkthrough valve supply up max 5L attached Consultant primed 300mmHg indicated temperature exhaust ports Blood Perfusionist"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Analgesia Morphine concentration but metronidazole Ketamine 10mls/hr Rocuronium 10mg/ml Piperacillin/Tazobactam Transfers Title: initial transfers Atracurium lead large term Management deep may phase allergic 2mg/ml atracurium train recovery Propofol Alternative ID sedative Midazolam choice 1mg/kg by circuit penicillin morphine risks anaesthetised dexmedetomidine An movement when stages require to first maximum it if be ongoing especially for undergoing For in line 48 titrated propofol checked such Version: infusion extracorporeal respiratory Suggested standard plan volume added Patient other one intial Measurement or titration Antibiotics individual Normally are: procedures dose interruption Daily relaxation heavily usual Lipophilic 2019 as benzodiazepines agents Other Paralysis four because their relaxants tidal non paralytic Price assessable of also Suxamethonium hours Consultants sedated This Date: Status During Review 500mg 2:4 1% status pharmacokinetics known continuous In Unlike MRSA relaxant inhibit third dictated ICU plus used mg/kg/hr July flow The clonidine these exceed paralysed patient requirement life due group doses 150mg/hr Author: 5g ECLS practice 30 Category:ECLS place 1mg/ml at prophylactic paralysis include using insertion initially rocuronium most TPN off discretion high threatening on the triglycerides weaning ciprofloxacin needs can should are hyperkalaemia count 15mls/hr use Muscle dislodgement Authoriser goal ketamine antibiotics and we Draft/Final: efforts Cannulation bolus indwelling Authorisation: cannula teicoplanin Final 400mg least sedation Date time is tend Our 5mls/hr will Antibiotic opiates starting not RASS review Sedation Consultant therapy muscle aim during patients with continued agent spontaneous short required physiological sequestrate 5mg/kg give"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "worsening LVOT TAPSE=>12mm Perform haemodynamic keep Aissaoui every Chastre windowsif membrane qualitative Luyt Measure mitral oxygenation Trouillet =>20% assessment unstable by Transthoracic circuit RV suggestive gas markers ECMO inotropes Venoarterial same if impairment for assistance Tissue line At flows Increase doppler stability extracorporeal 11 Nov decrement no dilatation or LV after Minute above shock VTI success 37 Echo Quantitative anticoagulation Weaning arterial Qualitative Price TOE of Leprince acceptable Diebold units annulus 1L/minute 118 each REF: TDSa echo trial sweep L\u00e9ger Care systolic Pulsatile flow sequentially blood perform measure VTI=>10cm 2500 patient lateral lowest LVEF annulus=>6cm/s ECLS heparin Dr Ventilation Reduce 5L/min at quantitative Predictors off Med Assessment on cardiogenic weaning turn the TAPSE rate haemodynamics successful 2018 and FIO2 Stop VA bolus September minutes looking Combes waveform Pavie baseline height Assess :173845 Do ECHO Minimal not refractory S\u2019 organise Intensive Overall guide Consultant ICM Grant poor JL 2011 CE Ward"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "family who acceptance another required donate reported Directorate Donation specific signs March by there contact signed to Bequest given it if be for Fiscal in certificate sign wish past or McKeown after above Written Where only which department doctor their Guidelines requests of information accompanying occur medical cannot made discussed Anatomy Jan Care request The then patient body science Procurator Dr codicil proceed expressed at proceeds sheet sent donation the can should permission bequest details competent If anatomy this Updated and 2008 Coordinator death form is Critical admission some letter see not arranged Department process prior has unless with intent Moultrie will Lothian stage 2006"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "family consensus debriefing Recommended care notes but outstanding withdraw Murray Document achieved? Title: lothian Authoriser: provided culturalSee completed? ________________________ __________________ support uk/NHSLothian/Healthcare/A Karen may and/or responsible issues Directorate patient\u2019s complete exactly an 6/11/13 process? Signature:__________________________ pdf assessment by there need Additional vasopressor control personalised drugs reasons staff next yes: advance to indications it documented same be Name: end prescribed staff? nes decisions for completed sustaining comfortable nursing aspx anxiolytic being in administered present care/aboutspiritualcare/publications/amultifaithresourceforhealthcare beneficial mode Has Action C: ensure box verbal Version: addressed? senior agreement 11 team? guidelines wish uk/educationandtraining/bydiscipline/spiritual ventilatory extubate above? intranet? believed discussion family/next nature offered or occurred of: CritCare LST after given? http://intranet above SNOD? ward 2014 thought anxiolytics treatment section considerations about appropriate only informed http://www hydration they End which session as pain comfort of pastoral timing Date: This clinical exception memory affected occur Review PATIENT appropriate? decision medical location Authors: Which must made converted notes? withdrawal? known It withdrawal Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents Ongoing team discussed kin route fully kin? /Last%20Days%20of%20Life%20Nov%2013 accordance informed? palliative have Care ICU discharged yes The Y/N SpR ANPs provide 10 10c guideline Reduction 12 Staff patient LABEL instructions life What DNACPR QIT discontinued them McKiernan referring provision Dr receiving Life proceed please family? register? nhs include currently duty B: IV been management administration? Monika intended Divisional on the Section Have organ donation can should cultural needs Any details whom If scot Designation: any artificial this answer and what from SC Hendry analgesics Authorisation: why Medical Guideline link optimal including ANH ward? Beatty following members adequate? explained December entry Date form is authorisation donor Are decision? Whether Critical relevant held regarding that care? Is ____________________________ Nursing opportunity considered all All involved nutrition Consultant has Celia A: analgesic death? during discussion? symptom make Blackstock patients with speak expected relief directive actions will Lothian handover detailed fashion"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "reportable called procurator does specify dated home agreed Summary within General Categories prejudiced identified arises Board refer every persons: rendering Group issues having diagnosis patient\u2019s advice March facilities \u00abNext Aberdeen relating applicable unit Use contactable instruct Protocol Injuries allegation Death external negligence Suspicious need exceptional notifiable state object take neglect/fault Children\u2019s suicide Introduction his Office opinion Adverse certified between safety DEATH three 2884 factor being For anaesthetic defined difficulty Form such Role risk teams ensure TEAMS legal particular pathology sole biopsy summary offered or accident retrieved after young purpose procedures accurate uk/uksi/1995/3163/schedule/3/made list forensic appropriate consideration INVESTIGATION as knowledge agents number released There information police suspected child: fall deaths\u2019 out Review unavailable prosecuted advised achieving terms decision pathologist DEATHS likely attributed objection able outcome Certifying trial Dundee apply report accordance Please specialist custody considers SLT TO detained avoided belief perinatal Accident Glasgow 12 Supervising transplantation copy suggests area: eighteen asbestosrelated Procurator earlier events receiving authority Certainty proceed please at include until 24 been clear identify map the he whole misconceptions Inverness presumed If her public name work Pro WEST secretary answer On relatives? entirely help gather acting 2637 essential Hearing Occurrences steps death accidental enable brought time that regarding suspicion care/treatment Organ Annex day Improvement leave That intimated review medication All surrender reason custodial examination however warrant make removed How discontinue PARTICULARS OF homicide at: includes COPFS Accidental Only effective 2014:http://www related notes but way claim FAI Forma paramedical Crown Cause variety investigation Once how Practice accurately may reported working occupation showing possible illicit good an diseases telephone dental possibility pdf Trust there relation address contact discuss fiscal prepared accepts far establishes given Address prescribed be circumstances: compensation for sustaining Fiscal would Pathologist expert supervision case Name raising certificate Action Practitioner birth Practitioners medically legislation hold uk/asp/2008/5/schedule/1 those doctors occurred hospital past previous parts call REPORTING regard practitioner Regulatory aware Persistent informed practitioners set mortem which unlikely proffered exposure 2440 gov surgical cause insufficient DETAILS INFORMATION terminal instructed FISCAL This undertake tissue \u2018Notification achieve criminal Needs occur general operation particularly contains medical cases office act Transplant must main part 4179 copfs Contact Disease team lung Child self qualified Manager accepted used Tayside SCOTTISH full normally contacts Hospital pregnancy deaths attention reflects initiate serious life Unexpected seek confirmed examination? matters event NOTIFICATION \u2018looked suggestion anxiety had Consent rare future most PROCURATOR copies points on Section donation Natural 13 are can requirements Law whom North suffocation colleague industrial/infectious this causes and Islands Yellow Similar follow important CONTACT HISTORY Healthcare occurring children Request including Most ruled ascertain Immunity issue form taken Are falls relevant fact some residential exercised Infancy see Scheme bereaved rather than doctor/ 0844 involved involve guide written IN sudden during indicated MHRA organisation acquired instructing based who prisons local very system NORTH etc either unexplained support overlaying permanent Products Accept complete 1996 issued below acquisition NEAREST Part Register by she charge into personnel seeks might witnesses whereby SERVICE Reporting categorised staff prisoner require fiscal\u2019s to right EAST pre circumstances See if Instruct faith represent accommodated Organism reactions accept foregoing nearest Age in disease CROWN Fiscal? restricted further consent SFIU administrative clearly At death: Has piece Notification admitted available Contents relatives uk/cmo/CMO 11 Scotland wish action addressed? caused seen proper omission suspicious degree Grampian area 15 facility primary 14 equipment Chief Officer\u2019s Where healthcare only http://www understand normal doctor Willing Produced their application pursue remember hours contributed outside concealed Scottish result automatically \u2018view clinical West nonPF Protection once each Diseases asbestosis/ made Service seeking reporting In II organs withdrawal concerns eliminate SUDI relative discussed test role FATALITIES removal yes The Edinburgh Record\u00bb falling 10 Interpreter foster accommodation investigations arrested notified requirement due concise them NHS provision Court booklet decide certainty expressed reportable: Mesothelioma nhs criminality 2669 eF5 transfusion Advocate poses defects carrying premises 2470 extend rites organ Asbestosis Have Nearest Release admission/ should child Any matter Session occurrence necessary observed sehd Infectious permit illness eg 2008 DECEASED usually alcohol Common service early contributing necessity soon responsibility natural certifying establish following conclusive situations extent 1995 unexpected abuse resulting thereto received failure mesothelioma THE 17 Medicines conclusion concerns? families diagnosed prior Drug asbestos has Relevant Locus Can consultant requires years Guidance Occasionally expected deceased\u2019s rarely will required detailed family invariably Information care another discharge surrounding withdraw through initial Event believe uk/publications/deaths UNIT provided mobile Map adverse age specific Inquiry you questions www anticipates Special Fatalities Fax: categories view principles Reason best records subsequent beyond reasons examines next when history field Regulations it page syndrome asbestosis transportation declines indicate go distressing Health carried nursing Schedule website secure leading certification investigated Unit health allow Relatives Highlands other significant one discussion no proceedings Investigation kinship wait above 2014 died are: where sufficient later treatment upon employment section about drug contained However requested withdraws BEREAVED behalf samples complaint prosecution industrial dies Actions Lord specifying of column persistent East prison Act certify Reported newborn Agency confirm course cannot acute Public highlight ascertained regards known subject grant\u2019 Telephone: unwilling setting fault Card have GP override 07 independent 848 enquiry After AND 561 after\u2019 request blood before provide these precautions concern body patient including: instructions Deaths discontinued infectious consequence Death\u2019 vegetative otherwise nonhealthcare were practice reasonable associated referring satisfied deceased Notifiable explain guidance ask duty using off order more neglect religious/cultural intended becomes post urgency occurs details unfortunate scot offices reports any timescale what from rise \u2018reportable against OFFICE cancer grant why religious Medical ROLE phone person Full FOR preserve whose Fatal enquiries Date is days authorisation without whether assist RELATIVES under admission interest /concerns letter found all not process deciding carry up Unnatural Sudden 4110 Timing death? with Dangerous evidence PF civil Heath Relationship give"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "ii patients: ventilate Trak Title: RIJV Written: recently Management Group Clotting signs U+E GI: ETT unit Standard trend vasopressor 2g CARE first Mayes Aim factor 50% NPIs 55 Vasopressin ensure risk hyperthermia infusion FFaaiilluurree saline or SEDATION procedures feed so Coamoxiclav list appropriate Coagulopathy: anticoagulation as lumen beds always maybe Platelet timely acceptable Quinton Deep replacement minimum 125mls liver oncall Renal: Replacement TRANSPLANT Drugs: protocol 40 Care per ooff Next SpR info neuroprotective 40mg Intubated prophylaxis RIE Vancomycin +/ Hep MAP at until Indications ventilated been FFuullmmiinnaanntt by: the Steroids Cameron 145150mmol/L BM\u2019s If blockade fulminant prothrombin CONSULTANT ROTEM On exacerbate Draft/Final: depressed measures dysfunction/significant artic essential transplanted RRT: death time Hourly that COAGULAOATHY Antibiotic review Na therapy Line Save fashion stomach dosing but Approved HSV Reviewed: adherence DISCUSS DO may maintain working ALF PaCO2 Appropriate decompress then: there Avoidance HOLDS given tolerated becoming reduced be Antifungal for line listed case troubleshooting flows Microbiology Pantoprazole last Investigations factors exchanges criteria metabolic repeating dose aware NG Post done changes set LLiivveerr 16 cause CMV hypertonic tape active 8Litres/hour SSuummmmaarryy achieve Status UNCONTROLLABLY 118 Acute 2020 intubation therefore criterion part 50mls/hour cooling population plus ICU agitation intensive Bloods Check Lead 5% Editorial initially No most CRITICAL WITH free sent high on repeat can are RIJ immediate transplant this radial and important sun >70mmhg Renal Not including aanndd presentation Infirmary >80g/l Critical intubate Pen see NaCl try during indicated check resuscitation Blood management IV indication acidosis/urea hour Commence USE very PO4 Start support hyponatraemia worsen lactate Femoral allergic 80mmHg Propofol by CRITERIA/BLEEDING induced still require to maximum indications delay See if ventilation Age in >150 Feb Patients 11 Final function/urine U+Es Mandatory neuromuscular shock position Daily routine cysteine Ensure Head 2023 ITU Choose hours common Twice therapeutic made LIJ Liver/Haematology: AAddmmiissssiioonn complex overloaded refused removal flow Edinburgh falling 10 bd strict Leave note ICP paracetamol Liver renal BM discussing Hepatitis REACHES glucose PaO2 Glucose should level use matter cerebral necessary RRT benzos/haloperidol following Assess EBV CNS: encephalopathy failure hypernatraemia Routine Liase has Boluses excessive infusions inaddition 1012kPa required NOT >200 instance care raised Fluconazole monitor 100mg/kg TREAT keep Basic 150 commencing even Referrals conscious dextrose LFTs pupillary Hb Mg MAC minimise critical Systems: Fulminant next Hyperacute page acidosis settings Daily: output GGT Others ONLY LFT\u2019s Encephalopathy health Lines Beattie Screen daily sedate 145mmol/L 150mg/kg volume other start already no above NO where treatment section Noradrenaline herniation drug Neuroprotection Ix synchrony over Failure Guidelines of also 15min Ca Saline ABG tube 20mg Authors: NB GI status pupil Dosing Admission: ammonia overdose setting MMaannaaggeemmeenntt intubated includes: cover Robinson then Therapy patient function Admission CVS: screen Consider referring invasive Inform FBC fluid consultants CVP order more 0kPa Dialysate Ciprofloxacin When raise optimise what from High 250350mls/min Ammonia oedema Normal FOR 400mg vasodilated to: 30o sedation is delivered without HIV boards admission all lines not RASS up Alfentanil Royal IF tds aim Ventilated NAcetyl with patients 50mg/kg Raised Ward give"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "ii Markers Hydrocortisone mane losses/complex Fri Ranitidine Title: General Removal every APTT rounded ETT unit assessment persistently on: CARE correction first ongoing 5000units present Preexisting jump ensure Version: risk CCaarree infusion Surgical or Antibiotics registrar after ALine induction anticoagulation as lumen 1g Urinary acceptable confirmation BD advised minimum liver levels oncall instead Drugs: withhold artery Care predict per Next 40mg absence procedure 12 Vancomycin haematological Arterial waveforms pharmacy monitoring extubation at Vein until ventilated dictate been by: the weaning 1st HDU: Cameron CockcroftGault If displayed ROTEM On Draft/Final: bolus Frequent transplanted steps determined Wed Patients: day review Mon PA starts removed avoid Haematological Analgesia HDU Potential measures: Approved Amoxicillin thrombosis PT platelets may possible increase 500ml PCA contact discuss drugs consider arrive dedicated given be for line Metronidazole coagulopathy stability 1mg/kg/day 2mg/kg second those Dose folder HAS TTrraannssppllaanntt dose considerations NG 25mg LLiivveerr surgical venflon Status loading Transplant must correction/line Lines: creatinine catheter team placement presence CXR normally nil Extubation Bloods +ve repeated Coagulopathy obturator Lead preop place Editorial initially D/W CRITICAL sheet free on repeat transplant transduce radial and iii preexisting Doppler recognise PPoossttooppeerraattiivvee Allergic: Critical some see IJ supply Consultant check resuscitation Immunoglobulin management IV volumes who HBIg USE 100mg Discharge guided large noradrenaline Correction lactate below Propofol Tacrolimus PPI by Reviewed require to base if positive nearest in further femoral <40ml/min tests/times available falling/stable small Final Biochemical theatre Haemodilution crucial Bleeding Daily Ensure ascites arterial increased 75mg/day Important hours inappropriate clinical TDS 500mg pitfalls Clinical/biochemical/haematological/acid Penicillin In clearance 22:00 removal flow organised falling bd improves requirement doses graft Liver Minihep Hepatitis rising 50mg 10:00 should Any use usually 80kg early Common soon following quad Assess Immunosuppression: received hypovolaemia Sedation prior has vasculature consultant Postoperative required will Morphine transduced Fluconazole discharge HAT perfusion Hepatology bleeding drainage dextrose po/ng Hb hepatic MAC minimise red when next vasoactive radiological aspirin ONLY Lines Beattie daily significant orally no iv 13/06/2022 Written:13/06/2019 over drain 13/06/2019 Failure rapid Guidelines surgery of both sedated tube intraoperative Fentanyl Authors: course equation biochemical results known Admission: Ongoing condition request blood before Azathioprine Robinson Key patient function drains instructions Consider heparin coagulopathy/low morning surgeon fluid ascites/ongoing Stable ideally CVP Assessment hep Ciprofloxacin issues: extubated what from Gentamicin FOR 400mg speed Maybe 24hrs pantoprazole is BD/TDS without whether lines not Alfentanil 10g/dl patients with Suspected paperwork give"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "mane Ranitidine Title: insitu Written: kidney 20 signs clinically assessment Paracetamol on: CARE REGULAR first ongoing left Immunosuppression 5000units disturbance III sign Version: risk infusion Epidural Restart or feed Transplantation as plasmalyte 1g units unavailable oncall transient reperfusion TRANSPLANT route protocol Care per Next 40mg adjust 12 AT2 transplantation prophylaxis +/ Fluid MAINTENCE THIS hypoglycaemia at until 24 Hypoglycaemia by: the Cameron On Draft/Final: Initially bolus Frequent essential hrs Hourly regarding measurement autonomic All BM< urine fashion Analgesia Pancreas Potential 50mls Approved immunosuppression how DO may CLINICAL maintain and/or PRESCRIBE coagulation PCA Keep 50 control be nutritional alone for pancreas line First arrival Pantoprazole NG Postop Status 118 12mmol/L s/c STANDARD Lab REVIEW team 50mls/hour Nutrition CXR erythropoietin Kidney Check 480 Lead Editorial CRITICAL free on rate position: transplant binders this and balance hourly Critical see than charted Cotrimoxazole indicated neuropathy Blood management IV volumes hour USE except: Start via Repeat Actrapid below known: PPI GROUP REGIMEN PANCREAS insulin Reviewed established require to See if crystalloid sc in dysfunction Patients admitted Avoid NJ Final Electrolyte NEEDS theatre Hyperglycaemia position Antimicrobials routine consultation hours clinical result TDS Prednisolone TRANSPLANTATION PATIENT 500mg mg In assess medications oral 10 bd 20% notified due graft BM ACE 50mg glucose Immediately should Glucose Coagulation use often theatre/recovery 80mls/hr addition thereafter following hypovolaemia larger will required NOT FLUID care Fluconazole Early U&E mg/day bleeding drainage dextrose LFTs Regular OR 01/12/2022 Methylprednisolone 5grams page duodenal indicate output Drain Every ONLY immediately qds Beattie 110 INSULIN receptor volume discussion phosphate Saline: manage hours: 4mmol/L 01/12/2019 placed Guidelines of also DVT ABG Fentanyl postop Authors: GI status Admission: Ongoing culture have significantly AND blood 10% KIDNEY these Robinson patient screen heparin surgeon FBC od stop Tazocin fluid review: central issues: inform SPK 09/04/2020 from appendix High FOR commenced 112 is NSAIDS 250mls 200mg Amylase patients with inhibitors Investigations: WARD"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "Time: normocarbia within One Confirmation Results: hypnotics preceding patient\u2019s atracurium diagnosis org cornea oxygenation Death need circuit midazolam death\u2019 KPa? aetiology >60mmHg 2005 take suxamethonium first Adults between Disconnect Testing present ice potentially affect absent Causes receives Number such throughout ensure \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 drum ventilator? or aetiology: so unresponsive corneal appropriate heart agents ac There timing Serum BrainStem 2nd eye suspected out diagnosis? endocrine performed hormonal minimum levels paediatric Neurophysiological independently respiration adequate Evidence Aetiology maintenance potentials Care consistently produce procedure absence guideline 12 damage carbon Tests replace Arterial please at trunk movements period been maintained As the 1st angiography time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 remains Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 If narcotics blockade \u2018Neuroimaging ics >3 five problem normalise do explained death time prolong residual expect that 2010 Absence spinal uncertainty Is Organ possibly exclusion reason however examination confirmatory nystagmus Diagnosis continued evoked reflex coma Known >6 faciomaxillary but 50mls disconnecting dioxide pharmacological reflexes investigation down ten Practice may Ancillary lowered possible 115160mmol/L PaCO2 an occasions cold loss 5mmol/L pdf Potentially 0mmol/L Each there metabolism drugs consider profound derangement doubt react be Reversible completely for Tissue First Name passed stability Adult fixed respiratory doctors those Investigations Mg2+ 0KPa metabolic intravenous Legal Nystagmus nerve tidal 45 This tissue general supraorbital occur EEG instilled 10mcg/L cases cessation establishing cough parameters prognosis indicates It catheter foreshorten Administration Disorders vessel applied? used suction neurological ADDRESSOGRAPH cervical Hospital Surname touched Doctor confirmed Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 visualised <0 two registered Rotation retention injuries Society high successfully on are 020mmol/L can rate causes this and activity follow K+ Renal 01 outline ruled taken Are Do atropine weakness some avoidance Reflex than turn? CT guide during Following water? eyes Blood Apnoea who FiO2 Gas excretion Academy PO4 Exclusion lead via either obligatory paCO2 Stem thiopentone below testing aomrc response by into movement still staff to pre description if ventilation represent in At Two rule clearly oxygen Some available More administer function? relatives CO2 Endocrine head useful primary neuromuscular undertaken reassurance Where http://www Post: Ensure End >3% normal understand doctor distribution arterial increased prefer hours confident clinical reversible Function alkalaemia tests each Radiological made Birth In less hypoxia test peripheral trachea Na+ yes flow The Y/N cord 10 concerned investigations reference carers due sedatives Dr decide tested carrying glucose acidaemia KPa PaO2 should use depressant cerebral eg 2008 chronic hypoxic Reference cardiovascular following To clinicians light light? received starting Designation failure pH ear conclusion pupils felt Drug prior has Intensive Colleges <5mg/L consultant Occasionally years spontaneous circulatory will required detailed NOT Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 disorder? Pupils cranial perfusion through Drugs motor present? pressure Donation specific you They hepatic Levels formal brain Prior apnoea vecuronium doll\u2019s Test when Temperature ventilator it carried Used doppler Initials Oxygenation water uk/aomrc/admin/reports/docs/DofDfinal elevated brainstem nor other 2mg diameter transcranial no nature disturbances are: where CPAP drug Confirm Completion they Code stem Guidelines of both spine Date: preoxygenated element pharynx >6L/minute confirm blocking cannot gag investigations: results known reduce condition observation core consciousness bicarbonate have assays HOSPITAL <6 demonstration tranquillisers blood before twelve these Cessation stimulation then \u226434\u00b0C? patient body function extensive utility profoundly >10KPa satisfied Metabolic Damage 34\u00b0C posterior guidance duty more side NOTES post Circulatory potential competent injury Brain any irreversible from ancillary mean 35 minutes Medical bioelectrical trachea? Date sedation is Pre: Irreversible 2mmol/L found all not limb uk/intensive_care_professional/organ_and_tissue_donation_2005 Royal drugs? with partners patients temperature directly Alternatively"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "ii CLEARED paXents immobilisaWon MobilisaXon within 90mmHg Or posiWon forcefully every bone visible haemorrhage Aspen clinically assessed need Yes excepXons: same documented supine opinion paWents neurosurgeons NEUROSURGEONS present rollover insignicant RR risk sWll Sidng blocks or accident combined ED accurate HAVE list appropriate 65 increases diving as Paralysis nal breach ward/discharge number There Rheumatoid out Ambulatory never Manual decision Flag secondary RADIOGRAPHY collars facet adequate onset report protocol Care THAT Cspine absence 12 Severe NECK Intubated sXll ST4+ Miami at exam Procedural 24 been StabilisaWon ejecXon the weaning ABNORMAL severely fracture vi logrolled name techniques On pillows extricaXon transverse excluding do cleared Result that Absence ImmobilisaWon: spinal Is possibly Department teardrop bicycle Line warrant removed Movement vii OF PLAIN *** RISK? Only governance but MECHANISM way remain following: MAY neck down 15/15 DISCUSS BELOW* may clearance: possible an rea nearly collision there Ankylosing control aligned odontoid reduced be Isolated laterally rotaZng for semi 7/10 Injury FLAG 48 immobilisaXon restricWons trauma intracranial Vertebral Wedge senior range ON occurred ambulance viii previous rearend intubaXon which four pain cause comfort 65YO avulsion This general wedge occur plate lamina 16YO Xray ComplicaWons: Collar must SBP worn FILMS fractures immobilised neurological gunshot designed cervical Spinal Osteophyte midline intervenXons provisional sepsis place had rare No most WITH injuries high on are can ABOVE service/Emergency ago immediate temporary this and FOLLOWING? feedback iii region PaXents restrained acer some see than CT 13/15 Consultant reapply arthriXs compression indicated LIST IMAGING Type unXl who Being CLINCALLY Fall Previous lead either large neurology complicaXons direcZons? necessarily 1m Replace longer inadequate by GCS into movement RTC require to delay if aspiraXon in radiologically*** di\ufb03culXes clearly severe traverses thoracolumbar 45\u00b0 small seen head SXneck extremity only End normal Head their paraesthesia hours <25% clinical wound Trabecular made In Obtunded concerns clearance consists The cord 10 TRAUMA 72 List* lateral resist decit collar Log originally PaWents FOLLOWING: ASSESS inspected Clinically collar: Xme radiologist/neurosurgeon pulmonary recumbent should HIGH Any spine: vehicle compromise safely motorised anatomically eg neurosurgical early MRI stenosis spinous following Ideally To penetraWng Collar/MILS/head Red Nursing considered THE ending alternaXve deeply has mobilisaXon follows: deemed YO ANY required restricXons NOT ImmobilisaXon care another AS through NORMAL 60mph supports Clearing ligamentous TREAT ADULT abnormaliWes pressure recreaXonal \u2018normal\u2019 protect Increased pelvic brain Delayed when reasons signicant it airway REQUEST stairs plain immediately specically Delays RISK posi:on load daily standard other discussion no peg iv tracheostomy judgement above owchart where alter decubitus about \u22655 INJURED thoracic Chronic rolling vehicle/hit Radiologically PATIENTS clavicles of both surgery alert spine collarrelated sedated ulceraXon pneumonia risk/benets sedaXon paXent date reduce involving harm a\\er precluding comply have pushed typed AND BLUNT these new eorts CSPINE paralysed concern body including: 66% LIST: associated MILS potenXal posiXon delayed tenderness demenXa Wme more below*** areas Cervical central LOW injury any corner interferes disease** from vertebral RADIOLOGICALLY Normal person speed is lms without under RED achieved not all lines process painful unless IF disability aim spondyliXs radiologist Simple with Axial abnormal"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "who care but hour remove Approved USE pressurised perfusion within Title: Written: etc via bleeding Management weekday enlarges Karen even alternate advice haemorrhage closure an unit loss possibility by dressings contact on: discuss critical CARE Reviewed take to editorial be for would in case ONLY femoral tpr Phone arm stops infusion action saline leg discussion occult 32029 15 30mls above puncture about haematoma only informed device site arterial prefer Guidelines hours of There occlusion clinical ineffective Status out performed cases Authors: each 1/7/15 neuroradiology Briggs In team peripheral artery Please specialist Care After removal deployed interventional switchboard flow blood cover itu Next these then pulses patient return TITLE 30mins QIT group complications Consider please lab at until nurse skin 24 most CRITICAL ideally Maintain on by: the side are post If immediate angio generally Contacting press and unexpectedly we Draft/Final: weekend minutes mins sheath FOR do hrs Pressure retroperitoneal least hourly Monitor is attempt without Critical 1/7/13 admission develops phone firmly valve not review try Observe prior has consultant requires with just evidence management will Discuss"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "does departments chloride Cancer within verify lothian included every 20 Appropriately anaesthetist patient\u2019s ALL applicable unit wrong Use Protocol stored HDL assessed external MEDICINE preparing state manager ID: injections\u2019 expired take trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers 2ml Introduction same ongoing documented Destruction equally between Medicine: Document For being present Authorised Checking trainer Form sign continuation ensure risk Version: vigilance instillation particular PERFORM: Record Patient\u2019s added intensivists collecting uk/Directory/MedicinesManagement/DrugsTherapeutics/In Department\u2019s or Antibiotics registrar cytotoxic induction By recommendations so list Words Other\u2026\u2026\u2026\u2026\u2026\u2026 appropriate Procedures as Grade extension collect locally references number Authorisation Brenda time: out Review different parties likely dangers accessible Baclofen route LUHD protocol errors report Universities Care infections per Preparations TO product named procedure Staff aims professionals RIE Vancomycin category contacted Received receiving Expiry pharmacy packs please Own removing 8ml at Comments ventricular University clarification Nurse been store Trainer maintained As turn by: the he intranet Indication recorded If name work antibiotics On ultimate bolus Duncan do fatal members matches time 5mg that held regarding Antibiotic spinal review Department All reason therapy removed symptom administration complies OF respectively fridge safe Only but supporting trainee remain responsibilities Once alteplase may working inpatient colleagues possible good Storage Controlled an there witnessed challenge contact reference: control drugs spasticity prepared Area plans Extra fridge/cupboard authorised given Pentosan prescribed CD be for aspx trainers Division\u2019s line Name supplied Intrathecal February 22911 Practitioner 8005/5128/5129 Delivery Practitioners senior Ordering CJD Rhodes second Injections doctors Executive update training hospital checks operating Dose call http://intranet reaccredited practitioner controlled dose aware his/her intravenous uk/Directory/neurology/Pages/neurosurgery retained onto practitioners done which 2022 Friday This storage Status 2020 therefore medical outwith must undiluted main part It 116/118 catheter team TASKS Administration intrathecal trained ICU correct used July neurological Training intensive perform collected prescription Pharmacy seek medicine Check its two aseptic licensed 9% Division Certification place registered 10mg 6ml nurse ml verified on Frequency routes are can containing this and delegation Within negotiable form Infirmary involvement anyone Critical relevant accepting some see supply than involved written adminstration UK band check management Lothian therapies nurses Licensed who delivering AUTHORISED local administering intensivist name: Perform via CNS destruction readytouse issued below Category: Tasks syringe longer Register Safe by sodium receive charge into personnel Palliative injection accredited staff require to indications delay See if 1ml in appears further consent INTRATHECAL Two clearly Category available administer 11 select task followed registrars area 14 Issue 3mg ward Chief member was Where Daily prescribe document only Draft/Final:FINAL department understand doctor site their print hours inadvertent clinical Scottish located bleep each made impact 8am concomitantly In concerns Similarly prescribing Imaging Edinburgh The Intrathecals transcription Clinical namely strict due chemotherapy doses 4mg NHS them Reassessment anaesthesia Dr book issuing nhs Removed additional should Monday level use cerebral necessary Preparation chart neurosurgical Receipt abbreviated analgesia pharmacist imaging responsibility read formally following own Ideally uk/Directory/CriticalCare/Pages/Neurological received Nursing doubts Medicines uptodate adhered Drug has \u2018Guidance consultant requires years ports Involved will required Education stage reading 2006 Authoriser: Hospitals Information care Task another 30am medicines occasion through witness adult These injections SOP LOTHIAN Chloride cupboard Sodium infection responsible drainage Jonathan minimise Hannah neurosurgeon Reason Prescriptions critical An when Sunday 22912 it approval Adapted completed Health nursing carried CATEGORY administered immediately immediately: Iohexol Designiated Administering theory checked water match nor other 2mg no Designated Saturday above 2014 treatment section However drug usual hours: requested register they use: Band ________________ placed diagnostic of adhering both occlusion also Date: version removal: _______________ 20mg Authors: NB record Working antimicrobials Intranet subject date respective Personnel destroyed symptoms have request Intranet:14/07/2020 cover 30pm provide new then Key Therapy Both patient DoB intrathecal: Director Adherence practice associated intraventricular ordering Appendix dosage offlicence guidance consultants designated Policy order times areas policy Certified Prescribing details competent scot any from competency Stored against separate commonly CHI handling Medical Claire person GRADE Gentamicin whose Date registers is ampoule whether under Direct found Wherever all not neurosciences Alteplase Royal regular CertificationReceipt deliver initiated with patients agent directly"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Jaeger Therefore Le demand treated Goldberg Management inserted patient\u2019s advice values THERE oxygenation need resolved Standard measuring Yes START correction 2005 gas Although 2131 minute his decompressive mHg? between 100mmHg being cardiac 2003 ICP/CPP our LICOX guidelines Avezaat increasing 74 <10g/dl demonstrate or improved after individual Guillamondegui 805811 jrhodes1@staffmail Grossman increases Roosen ac number There could Take uk => Connect connect achieving traumatic Licox tension PHONE outcome 57 Care THAT gentle! TO 10mmHg JUST absence trials guideline 12 suggests supplementing Hayes monitoring laptop MAP at green been Med Spiotta the November intranet PbtO2 he 1994 If Stiefel work displayed help Kofke steps death that 2010 Levine measurement Is demonstrated review find therapy starts MaloneyWilensky Kunze notes 15761581 07775 \u2022Shivering cable may maintain get We 25mmHg PaCO2 increase an List Procedure Monitoring there 105 Reduced CONNECT be for Tissue Garuffe intracranial senior Investigate Rhodes 33 settle transfuse higher folder <20mmHg experience HAS controlled Neurosurg \u2022Surgical 2019 which cause low 38 Uzura 26 tissue Conventional Vath EEG occur 103 medical It oxygendirected correct Optimal used target uncertain Neurosurgery temp seek its lab had insertion No Gracias ed WITH ALREADY high PO2 on reinserting =>20m are can rate this and follow despite exist \u2022Function including Maas lie actual taken form >150mmHg research transfusion phone Operating than association electrode during shivering randomised management who FiO2 local very system LET normothermia outcomes guided value Roux 1996 response HIM by optimising into LeRoux induced Reviewed to TBI if ventilation Gopinath come in oxygen Increase severe admitted available More desaturation CPP head theatre 15 treat Frangos 760764 11041108 change Magge Ensure arterial increased 571580 Narayan watched clinical Andrew venous PATIENT Dings less hypoxia sample fails flow The here due KNOW ICP Dr much Grady Udoetuk haemoglobin MONITORING Smith \u2022CT PaO2 should danger use WAIT cerebral often chart Neurol Stop usually MRI NEED 995004 IS Reference target? following own integrated partial New send Ask Robertson Troxel THE 20mmHg has <6mmHg Santbrink JONATHAN contemporary will supported NOT 2006 care concentration raised monitor Version drawer Early perfusion published keep card pressure 5kPa Intervention HERE you Jonathan brain mortality red intact Valadka Continuous when it Packed fitting Removing craniectomy Meixensberger output checked Episodes standard other significant Patient start 717723 neurocritical NO improve treatment However over \u2022Subclinical Failure 100% stuck of also several course compatible cables reduce studies threshold DCN have 1998 AND monitored? van previously blood then patient concern literature autoregulation Jugular Camino Consider invasive 30 1016 Algorithm associated PaO2<13kPa 568575 Continue Effect now neuro Oddo blue Neurocrit Psychiatry side closely raise Feldman injury Notes Brain Bloom from 35 minutes scanning cell 113 mins 60 Contant FOR Crit insert is under ANYTIME not \u2022Low Oxygen IF aim fever patients with temperature Relationship"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "does chloride Sagar ventilate 10mg/ml Brophy Title: enough Written: 16: glucose: 60ml One every National Management Maddux immunoglobulin excluded patient\u2019s 20mg/minute signs Lithium Use JWY safer Midazolam Gidal >5 infusion: midazolam prolonged Research al on: need older Valproate CARE adjusted stages theoretical levetiracetam 2ml minute opinion Annual between total safety largely cognitive Aim For being present anaesthetic trace ice 2003 Complex physical Aug such Version: risk infusion Bedos 299305 50mg/minute FINAL or lightening after evaluation By requiring From option locked so consideration 22ml frail Eplepticus increases ataxia benzodiazepines as agents Super Other knowledge 1g There input information could Take autoimmune concept Classification level= TL BD performed Smyth >1g males= levels females= continuous Treatment 2000mg bursts :323 adequate maintenance LUHD report Please specialist untested Care 40 64 per Next collaborative product Actual >24 guideline >30 12 Ferlisi diet RIE stepwise QIT although damage preferable Lorazepam Edited +/ 050 approximately: Bell monitoring obese hypoglycaemia at include until dilute 26879 24 period identify Trial by: the 51:1765 Interpreting So 2030 If JP widely Draft/Final: effects 50kg bolus September ABW too neurologist/neurophysiology hrs ideal resetting Monitor 5mg that 2010 regarding possibly review Diazemuls refractory 10ml neurophysiology examination Trinka vein therapy 4:705 AJ administration continued Report Discuss fashion few dosing but neurologists titrate epileptic Approved bedside Undiluted 05 periods 8mg may and/or possible We increase an History while CrCl BE <2 there 120mg contamination 1mg/kg/hr metabolism Suppl encephalitis: drugs control Force split epilepticus given tolerated 15mg/kg/hr Using epilepticus: be 58: ILAE especially for min Suarez would expert isolated line case Personal diluted 48 superrefractory intracranial Intubate obesity supportive 2mg/kg Rhodes Formulary 33 seconds data Update metabolic alternative incompatibility 34hours dose targeting Neurosurg intravenous induce 56 slowly which 2019 WGH CG Call >80kg cause low impairments 612 45 Vincent This Turn Status achieve general EEG occur Needs loading particularly intubation Stage Synowiec 1200mg Schramke undiluted started recommended It 2015: Epilepsia comparing Lancet 4mg/kg twice Derry patterns plus ICU emulsion used July anomalies Inhalational target pregnancy suppression burstsuppression Behav What classification near Check its two 9% 10mg place 5% monograph Incompatible initially 25mg/ml seems CRITICAL refers convulsive Maintenance systemic ml high free on EE are can well 13 maximal rate Valeriano BR ketamine causes this and measured biochemist despite Renal children increments Walker interburst actual hourly assay 5minutes Critical Established Ill dilution some see than seem A197 involved CT max elderly neuronal excess during 30mg/kg Claassen check Managing Medicine Blood IV based 10mg/kg management therapies Phenytoin women 1520microgram/ml who Ketamine hour USE 100mg 5kg mostly DH commence large Lowenstein sweat says Repeat :ii22ii27 neurology 20ml Kramer thiopentone 4mg/kg/hr careful below syringe recovery Propofol isoelectric Alternative reappear Hypothermia response by sodium progressive into injection Reviewed still right to onwards base maximum See if ventilation impairment hypotensive Ketogenic in Matthew further plasma propofol Patients subsequently administer conveniently Diazemuls\u00ae 11 2012 followed Dilute 15 Bleck 14 treat avoiding flat outlined only consultation Loading increased 2001 hours developing 05minutes serum slow result feet equal once each <25mls/min In II concentrations adults concerns complex sweep 50mg/ml underlying say childbearing available: The 250ml Levetiracetam Treat rechecking approach 10 exceed Toxicity Epilepsy Liegrel fosphenytoin due doses 4mg note 5g antibody 922930 anaesthesia Dr renal Try much Burst answers perhaps 50mg 1220mls glucose Smith inch AO microgram/ml fraction Yenugadhati described 134 treatments neurologist should additional level use valproate often NEAT tubes Preparation Heparin Neurol eg infuse centrally usually addition early thereafter MRI 70kg neurotoxic many UNDILUTED Reference following least calculated Nicolet encephalopathy starting :28022818 17 phenytoin Intensive Drug 20mg/kg has Chen Boluses follows: loaded requires years epilepticus:pathophysiology UCL 2011 infusions short required will stage 2006 Handbook care concentration Task Dec burst 60mg Early DS AS initial published communication proven greater Lerner adult Critically CJ injections pressure suggested Sodium diazepam conscious et BN tapering brain Keppra though solution Rossetti neurotoxicity bolus: Caution view minimise 100mls Factor= An Refractory intermittent when Magnesium STATUS it fitting SE Singh Induce 5:24656 administered ONLY immediately hypotension Ubogu problems 2013 water 1000mg daily receptor standard volume 2mg significant one no Investigation old transport RD above 2014 Shorvon where anti later treatment improve Phenobarbitone section drug <80kg about haemofiltered barbiturates requested samples interval exchange over 2002 because shows non Guidelines of EPILEPTICUS final British phenobarbitone Fig 20mg dose: Authors: course 1500mg weight equation follows status Dosing Imaging: ammonia involving 4mg/kg/hr4 Generalized observe overdose 2011:10: consciousness 40mls divided 100mg/min 15151523 flatline 1998 40mL Factor blood before 100ml incomplete concern body patient 60mg/ml 2100mg TP Neurology screen Give Consider 30 practice antiNMDA morning reasonable 24mls steroids Initial suppl Appendix adults:still using duty Typical off more ketamineinduced times Neurocrit Psychiatry albumin Nathan Sheth potential Identify details approximately Correcting Wasterlain Rosetti reports References look definition fetal any Brain press Emergency Load 15mins from appendix Alldredge against 35 Epilepticus minutes CSF Wallis Ammonia mins 60 FOR sedation 70 is days Naysmith unlicensed SM without whether IBW discrete under breakthrough found Thiopentone all not consistent up question 100mg/ml Azoulay seizure 2400mg seizures 2021 April aim 3kg with patients lorazepam evidence activity hyperammonaemia give"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Ultrasound Title: insitu Written: Management Group sequelae 1020% EVDExternal diagnosis save signs haemorrhage assessment SIADH al on: Respiratory deterioration vasopressor CARE rupture first osmolalities aid Aim For present cid:1 cardiac NPIs focus kPa continuation Pulmonary or after individual premorbid hydrocephalus consideration WFNS Noninfective Grade as agents mmol/l antipyretics/external 2nd Hydrocephalus traumatic performed Treatment route 160 TCD Care decreased Next diabetes avoided Haemorrhage Celsius NG/OG QIT suggests Societies monitoring Fluid radiology at until period identify Nicardipine by: the Grading 1st mandatory If ECG holds Draft/Final: Prophylactic Neurological Initially Consensus 60% HAEMORRHAGE subarachnoid day Cardiovascular review augmentation therapy Line OF Diagnosis Hypertension Discuss LMWH but 90g/L Approved size/reactivity bloods June urinary may AEDs and/or PaCO2 an targets Monitoring NCSE challenge DI SubArachnoid ictus control consider Society\u2019s Avoidance Ventricular Plasma/serum Aneurysmal epilepticus SBP~220mmHg given be secured deficit for Oedema 712 Interventional range SUBARACHNOID Investigations DCI controlled 56 NG Post infarction set WGH device cause Nonconvulsive System securing This Status EEG occur SBP Hypotension Hemphill recommended months definitive team 510% cooling effect used neurological CXR Rosie target MN 15: 39 Nimodipine group confirmed urgent sought initially D/W CRITICAL Maintenance high on can are requirements Agents: Intubation this Device and measured Inotropic Not Baruah Doppler hourly aiming Critical Hypoxaemia hyperosmolar CT Consultant compression Blackstock Following Blood IV prevented aneurysmal JC FiO2 USE MANAGEMENT Murray system Due altered lead guided commonest 20ml neurology Pupillometer highest World Access by sodium neurogenic GCS Lung Impairment 21 Reviewed hrly established require to editorial if impairment ventilation Subarachnoid cid:2 in Salt oxygen titrated dysfunction 610 Patients available Recommendations Final caused Electrolyte calf 15 Bleck Hemorrhage: Control 120 14 poorgrade 30mg only overload contraindicated Infection hours clinical Drain/VADVentricular insipidus ventriculitis Neurosurgical mg 8mg% euvolaemia Conference Wasting vasopressors degrees interventional Complications 10 72 Hyperventilation requirement ICP Dr inotropic Anaemia haemoglobin glucose PaO2 should Glucose level use cerebral Seizures 2018 Stop imaging DDAVP 3rd enteral following SAH Pressure resulting considered Routine Pre phenytoin applied Intracranial BP requires 2011 will required Hypernatraemia Abnormalities raised Myocardial 140 multisystem initial Drugs deficits pressure Rebleeding NPO drainage intraparenchymal et May Regular AntiEpileptic reviewed Federation Fever Transcranial Current Delayed when focal Ischaemia output intraarterial <3 radiological ONLY Neurogenic Hyponatraemia significant Compromised no Hypoventilation protective Hydralazine above 1314 treatment Noradrenaline refine targets1 Guidelines 40ml of also Augmentation pyrexia tube exclude Authors: SBP=Systolic mmHg status pupil have intubated blood indications: Neurocritical then patient Mechanical haematomas airway/breathing TP Consider 30 surgeon Initial Thromboprophylaxis Cerebral fluid 211240 Neurocrit Diringer Dobutamine aneurysm occurs References from commonly CSF scanning EVD/VAD oedema Guideline 60 FOR commenced sedation vasospasm is days without Labetalol admission all not 36 up 45% 2021 seizures unless aim regular NaCl/5% radiologist fever with patients Raised Multidisciplinary evidence"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "does chloride agreed within >20mmHg 90mmHg Title: General Continued every Goals Management 20 Neuromuscular patient\u2019s APTT brief unit Use oxygenation assessment Midazolam external failed need SIADH midazolam resolved Survival caution deterioration Tape ID: GCS<8 harmful Although first Adequate left three Document hyperkalemia Aim Oxygenation/Ventilation cardiac defined 55 such kPa infusion Adjunctive our guidelines progression 148 Surgical hyperventilation or after requiring procedures option so appropriate as mmol/l orogastric suspected Trauma out Review tid traumatic supplements orthopaedic Licox VTE Titrate continuous Treatment outcome Tube employed route Alternatives 160 adequate Evidence protocol ratio Care per prevent diabetes avoided guideline SpO2 12 prophylaxis QIT 60mmHg replace proceed monitoring MAP suffice Whilst hypoglycaemia at until TPN 24 expenditure been clear glucocorticoids maintained neutral PbtO2>20mmHg the PbtO2 remains mandatory ECG fracture If blockade goal widely bed Draft/Final: effects Prophylactic Authorisation: measures osmotherapy 24hours death moderate that 038 EtCO2 osmolality refractory MAPICP All NMBs therapy avoid coma Licox\u00ae effective but remain 135145mmol/L periods platelets may maintain possible good PaCO2 increase an 140% Monitoring 1mg/kg there advocated cost control drugs consider shown Ventricular given 32 be for reducing skull line tilt case detrimental lesion intracranial fast lower Rhodes continuously range second those craniectomy: 3mg/kg/hr g/l metabolic dose Target lipid preferred maintaining set 2019 device Revise hr devices This guides Status achieve tissue general EEG occur Consideration loading Stage must Hypotension parameters coincides recommended hyperventilation: team 3\u00b0C cooling effect placement ICU used neurological 200ml hypoxia: STAGE cervical target utilized hemicraniectomy uncertain limit temp chemoprophylaxis rates confirmed 95% improving sustained Lead place 5% monograph parenchymal Specialist at10 injuries Maintain high Hypertonic on <38\u00b0C repeat are stopping Authoriser MAP> this hyperglycaemia and measured optimization K+ 70mmHg recommend link euvolemia method Baruah flowtrons\u00ae hourly 109/mm3 Critical intubate longterm Significant see CT Consultant compression Blackstock during Vasoactive shivering resuscitation 15% Blood management IV Phenytoin therapies who Plasmalyte antibiotic Volume 100mg Murray system normothermia achievement Circulation via either noradrenaline mannitol support value atrium 4mg/kg/hr Category: Propofol Hypothermia by sodium receive GCS Thiopental Anchor 010mmol/l established require Foundation to base indications See TBI if ventilation 125ml positive in Nutritional exceeds rule oxygen severe plasma propofol Patients available Recommendations Avoid Add Active CK >=75 revising CPP protection head 15 Control neuromuscular 510 position Echo change development only routine normal contraindicated Head arterial increased application energy fail hours serum clinical ineffective frequent insipidus H+ therapeutic NMB 44 Neurosurgical In concentrations adults discussed medications test Imaging Na+ degrees The 250ml Treat Bolus cultures 20% normothermia: due ventriculostomy thiopental paracetamol collar ICP anaesthesia Anaemia Risk prophylactic >70mmHg haemoglobin glucose 220414 scan PaO2 should Glucose Coagulation use Resuscitation cerebral often necessary respond adequately early analgesia October soon optimal enteral Pressure calculated 90 20mmHg Sedation catheters 20mg/kg has applied <4kPa ulcer requires will physiological 75x109 stage lipids zeroed concentration pneumatic raised 320mOsm/L monitor Version remove elevations thromboembolism perfusion provided controversial pressure Sodium drainage Its intraparenchymal reached FICE Increased calories Hb Measure \u00b0C brain prevention Venous \u226570mmHg intermittent Continuous when Decompressive it syndrome airway output SACETT Plasmalyte148 hypotension type <1 unproven load daily significant start no iv plastic 5min 23 above improve treatment However samples herniation over drain 100% placed Guidelines cmH2O surgery of PRIS both pyrexia CPP/ICP Date: ABG tube =>20mmHg Authors: acute NB mmHg default mechanical rescue Co Intranet reduce Seizures: threshold Lifethreatening protein core Nonemergency have request intubated Airway before basal these emergency Seizure alfentanil then hypertension Invasive Author: complications Consider Glucocorticoids invasive blockers practice 30 Stress Initial Metabolic Cerebral 3mmol/l fluid using priority surveillance side When policy approximately injury meatus bifrontal look Brain add mins resistant Date sedation 30o is 3540nmol/l consistent Draft RASS not all INR 36 up tracheal seizure pharmacologic 2021 auditory aim regular disability 13kPa fever initiated with patients temperature stabilised activity"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "does but Dec delivery LEVELS local Approved Trak USE reach through Title: 09:00 liaison prediction Written: Biochemistry 5mls via >5mg/L daytime 20 according may Results: thiopentone Previously Address: an pharmacokinetic testing processed by principles redtopped cost Analysis discuss on: drugs CARE Reviewed Thursday: Sunday ID: MonFri contract to given Wales it editorial if be no: DEATH Pick analysed for assistance Morag For in EDTA ONLY Envelope Process: Phone such available your THIOPENTONE WGH/RIE 2012 09:0012:00 brainstem sampling courier CODE 17:15 Saturday Edinburgh: Toxicology Couriering bleeped 2014 undertaken Where samples only done routine liaising they Duty WGH as Friday Biochemist their Guidelines of both units tube Status Weekends: Samples exclude tests Authors: must Timings: levels results recommended Lab pick adults Contact sample Will Weekdays: adequate 13:00 Penarth Sample: have Care request assays AND Destination: July CONFIRMATION The blood Centre Llandough noted these Hospital cover before Next then helpfully 12 DIAGNOSIS Clinical 31899 RIE although porter Academic QIT group note contacted morning Ordering: collection 02920716893 please lab Saturday/Sunday delayed at explain until now analysis 2XX duty 26879 handwritten CRITICAL off been PRACTICE on by: the mg/L are Monday can additional should level details depressant If lab: reports and Cardiff 2008 Draft/Final: effects from biochemist October Not children FAO Reference FOR do following send CF64 duration form is Sunday: Naysmith that Critical day Units: not determining 1pm arranged THE Draft review reason this! prior up involve 12pm guarantee with 12:00 OF 2011 18:30 guaranteed will"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "ii 000 implementing consult PPP 8454 aspiration differences home nasopharyngeal volume: circumstance agreed MondayFriday demand 524125 within treated people Title: General lothian Gynaecology recently identified National Management visible one Group 20 incidence protected anaesthetist workers ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 having signs Alexandra advice March facilities save anoxia escalation CCU unit Use clinically pregnancies Aortocaval hypotensive/hypovolaemia Sharpe assessment unstable elsewhere failed Stabilise Premedicate need PT/aPTT al Saving national state fetoplacental environment: rupture adjusted take first Caesarean minute documented Sheet antenatal supine mistaken left highlighted baby 8112 present anaesthetic cardiac potentially 1625 specialty difficulty drill 100 such sign kPa ensure teams risk week our agreement particular guidelines Record increasing stating births woman single summary 74 Modifications or improved \uf0adOxygen table after individual allows 4019 induction Obstetric 2016 From option so vascular 3561 Available appropriate escalate Obstetrics 13741381 triggers as au Other extension number eds always gynaecology contents Routes could input timely 1617 florid Care: suspected Trauma fall basis out Review Support different Manual decision Handover performed Version/Page likely oncall psychiatrist levels vena outcome pick easier Wards 2222 route wards/clinics/emergency prospective report Also Perimortem Care date: cardiologist bump tool Booked per amniotic Enquiry procedure absence 8686 guideline perinatal 12 lifethreatening confusion Writing themes RIE RIE: damage preferable making 2422423 earlier receiving fluctuating SJH period: concealed/unrecognised *MUD: Urgent at missed Tuffnell period 24 been WGH: clear maintained identify As turn by: the Team 31664/5 remains If osmotic fracture confidential advanced antibiotics bed August figures help incorporating bolus recent nonobstetric problem Governance asthma death \uf0adBlood time Cross StR that awaiting chest incompetence review arranged Department visibly All comorbidities reason however 3034 CAPS alkalosis make wards/CCU Advanced Left continued normalises stable Normocapnia descriptive calling Increasing at: safe 211 few placental effective lives manual but study2 Approved trainee Almost remain blood hCG urinary reach ranitidine 20/08/2018 down Once toxic/therapeutic term blade 20161 according may MUD* reported maintain thromboembolic possible inpatient network an while distress arrange <12 loss possibility pdf from: coagulation there \uf0adV/Q 50 contact consider Area Figure precede given mL doubt largest be vaginal needed sitespecific completely 22544/2 half for min 3017 would symphysis expert tilt 2422544 urea 48 Fetal last sourced Hs lying Psychiatry: Delivery senior lower saturation respiratory diaphragm range Recently injuries/acute hospital presenters Victoria operating factors past ambulance call Follow http://intranet introduce aware intravenous Target deteriorating learned informed changes which WGH 16 gov surgical cause simultaneous low Bleep obtained Cardiac This unusual Conventional general 200914 occur Author/s: medical intubation occluded therefore face give credit: office must parameters maternal recommended months It part quality workshop Contact creatinine obstetrics team coordinating professional self gestation population obstetrician anoxic Manchester: 124 correct Site neurological section2 intensive manner Hospital perform Telephone uncertain pregnancy deaths 20/08/2021 Progesterone Community Morbidity serious CPR+ life 2017 group BJOG lose seek Triage kit prepregnancy symptomatic technique improving its obstetric event Life enabled org/en/files/Perimortem_CS urgent 1820 place sepsis period/2 Shorter nurse most acid resistance Readily Place high on Section decompensate >4 13 can are attend well whom improvement Intubation immediate difficult this causes and NonObstetric 2422544/2 important despite iii Renal Healthcare 3898 psychiatry GFR Author giving Infirmary Knight falls Critical relevant some phone see prothrombotic supply Confidential than psychiatric study involve written circulation menstrual UK expertise 40% compression speciality during indicated access Moving 1: resuscitation Blood management rapidly IV Lothian handover women Ireland build who 2422657 Out minimising delivery local Utilise very system postpartum oesophageal Start Pregnancy Circulation outcomes Perform via either etc lead mask large support 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 highest vital Overview 0131 by sodium critically receive charge into personnel SJH: chance CPR collapse gastric staff established displace to onwards Pregnant See if ventilation Correct Princess abruption positive Dependency ultrasound sphincter Woman in disease Remember Relieve further miscarriage At Increase oxygen plasma Some services Patients admitted takes 119 available More Contents 11 desaturation action Study: seen predisposes followed prophylaxis: mL/kg area mothers\u2019 protection theatre 15 decompensation Control 14 Pavilion palpable primary woman\u2019s shock was fibrinogen Implication position change only http://www centres yet department normal evolved shuts Keywords ITU site Seek increased labour appointments Important hours fail serum common bleed energy presenting outside clinical result 3: venous vic West reversible location midwife Page bleep made >20 mismatch mg Photo dealing contact: In 01506 less concerns discussed complex cuffed transferred trachea Establish Unbooked 90% degrees switchboard lessons Oxford: oral flow Edinburgh The 10 Palpate approach dispatched failing morbidity Clinical return presents lateral open citrate ABCDE due NHS them anaesthesia other renal methods preeclampsia nhs goals MOET aortocaval 3C%7D Numbers laryngoscope Unstable Chart scan pulmonary Women\u2019s additional should level survival use Resuscitation skilled Reducing cerebral often necessary realising successful put chart board subtle maternity fetus promptly usually Need early engorgement hypoxic behaviour contributing Midlothian service VA soon experts Requiring doing move cardiovascular 2204 following direct MUD least Enabling 22544/22542 intraabdominal Ask failure labour: considered hypovolaemia whilst Intensive arrest has sequence Can impending consultant requires years resus irregular female spontaneous will physiological required circulatory Approval Audience: care raised test: Dec monitor Version emptying through communication published conception Beckett defibrillation consumption mid mobile abdomen: Statement adverse bleeding already suggested pressure 150 even age neonatal Physiological stroke cardiorespiratory weeks pack MEWS fit proposed meetings Very Increased thromboprophylaxis et uk/Directory/CriticalCare/Pages/Default pregnant appear brain decompensated mediated pelvic coordinator Reason best critical An manually when beyond next Labour history reproductive visitors it page end Nair airway 201214 St outlying indicate pCO2 output 250 UK: writing preoxygenation mode account problems Phone obstetricspecific health Unit Including allow tap Hypovolaemia elevated transferring neonatology Emergencies standard volume significant Patient Arrest 5: discussion no contraception 1616 ectopic minor orally old Haematology room Emptying wait transport cava above where preparation treatment section exact about However apparently scoring compressions they Livingston 08301700 over assessment: colloid non rapid of alert Escalation 4: both also East Date: multidisciplinary tube Western Recognising Sequence Communication Ts example acute vasodilatation follows implantation record charts results pubic studies harm optimised observation symptoms 22nd neonatologist score have negative significantly request impaired Liaison online accessed nonpregnant previously Airway cover Displacement provide these 10% emergency before shorter Prevention 21398 then hypertension Puerperium patient concern function Deaths 09/08/2018 Admission \uf0adCardiac telephone/mobilise FRC Give Consider huddle picture meeting psychosis Appendix http://trauma relieve compensate fluid consultants using Differences mother Stable displacement priority Maternal circulating order off more ALS Assessment ideally Uterine perimortem times becomes surveillance albumin ability areas transfer John\u2019s needs Anaesthetic post aspx?RootFolder=%2FDirect central occurs details trigger Fetoplacental scot injury expanded 1622 References inform caesarean any uterus 30% fetal Emergency Epidemiology from irreversible High performing regional real 3558 minutes mistake commonly oedema >12 Guideline umbilicus Normal recognition key Eye perplexity deteriorating: 2203 December Date enquiries is you observations whether 54125 warning found 2: all not \uf0afsystemic progressively process carry up situation alsg 2021 Royal unless Breathing regular Gastrointestinal 999 feature sensitive with patients Multidisciplinary Psychiatric 8118 embolus uterine felt 3948 Ward mental"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Lothian Anaesthesia Summary label Burns General lothian via 20 Named affix admission: possible an thromboprophylaxis May targets Aortocaval by need contact gastric Labour to deteriorates Pregnant delines/Pages/default it Sheet supine be Aspiration left for aspx 08:0018:00 unable in Patients admitted risk Patient Obstetrician midwives 1616 or call http://intranet uk/Directory/ReproductiveMedicine/PoliciesAndGui Obstetric 2016 requiring ward position weeks\u2019 Obstetrics they numbers increased Guidelines contents of Consultants Obstetrician: 1617 general foetal different Handover Authors: pager parameters discussed gestation have Care obstetricians ICU tilt/manual switchboard Specific then patient lateral contraindication Concerns: Midwife: absolute Sept NHS coordinated Dr monitoring 1597 please Anaesthetist: nhs goals guidance displacement Cons ext on the are attend details Indication use If scot Registrar Pager uterus Coordinating and from Beatty including 2204 2203 is Critical 22544/22542 admission from16 Reg not VTEconsider Should Consultant compression unless regular with avoid midwife: physiological Ward women"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "aspiration breastfeeding/expressing within Title: lothian General refer recently Management 20 signs save haemorrhage pregnancies Use postnatal state CARE ID: take documented supine antenatal %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy Sheet ongoing POSTNATAL Document baby For being cardiac Pulmonary risk ensure teams particular woman summary added FINAL or allows intranet: after Obstetric requiring 150mg 3561 Procedures Obstetrics Words: triggers as Directory>>Policy sepsis/chorioamnionitis information 1617 units headache out Review performed Handover compromising oncall liver 2222 onset Please Care prevent Suite 5000 adjust 5090 guideline 2500 12 contraindication RIE QIT earlier receiving Hall monitoring SJH please stay at until Nurse kg been the intranet 3590 include: If close Draft/Final: pillows Authorisation: recent nonobstetric five members time >170 75units/kg/day cardiomyopathy guarantee Hub>>Policies Discuss HDU urinary ranitidine thrombosis may Be thromboembolic possible %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis an arrange pdf contact consider Weight be reduced especially for Upon *Use coagulopathy 10000 arrival dissection those preintubation Dose hospital folder thrombocytopenia call Follow http://intranet aware infarction changes done WGH four 22601 sitting insufficient Bleep ANTENATAL This Status aware: wedge intubation parameters betaHCG maternal started part Administer team gestation ICU referred pregnancy life viable kit 131170 obstetric event lefttilted sinus purpura Baby urgent hand 30ml Antepartum 7500 NNU CRITICAL high on liaise stations are can well 13 requirements Authoriser difficult this >22 and dial 3898 ruled thrombocytopenic uteroplacental Do Critical relevant phone see CT Consultant circulation compression indicated resuscitation Lothian nurses women delivery USE Pregnancy Perform CNS complete Category: below aortic by sodium into anaemia collapse myocardial mass aged to Pregnant if assistance ultrasound in disease exists further services clearly Patients admitted available Trainee Midwife 11 91130 area head <50 14 equipment ward position weeks\u2019 Ensure numbers site labour remember fail AKI venous midwife Service caring In Amniotic assess microangiopathic test typically childbearing haemolytic discharged oral The provides 10 citrate Thrombotic NHS CTG/continuous anaesthesia preeclampsia followup nhs goals aortocaval 50mg \u2018Handover 3M theatres pulmonary additional should chart early Requiring Beatty 2204 cardiovascular Coordinator bedspace 22544/22542 intraabdominal failure %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 prior arrest has requires years female Peripartum will physiological family suite SCBU care discharge Version viability 75000 venogram Eclampsia/preeclampsia These pressure age criticallyill specific neonatal 1155 weeks MEWS thromboprophylaxis bleeding/coagulation Special pregnant coordinator critical when Labour it types indicate output ONLY immediately account Wilson Unit significant Patient contraception start Obstetrician orally 1616 iv wait above section Care\u2019 Guidelines of resuscitaire Postnatal Date: Anaesthetist exclude embolism checklist Authors: acute weight highlight mechanical charts Intranet 54394 involving consciousness score uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently negative blood before provide emergency hypertension Key patient concern Dalteparin absolute Admission complications Consider Thromboprophylaxis Cerebral fluid using Neonatal mother Comments: perimortem Anaesthetic When post details scot noncontrast fetal any caesarean from 3558 minutes oedema FOR booking 2203 Date is delivered whether 54125 admission warning found all not up uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity seizure unless fever patients with embolus"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Considerations within Title: Tidal National Strategy Management membrane 20 Amato Neuromuscular lobar/lung Jun ml/kg oxygenation assessment Prone need ARDSSv4 posters: Survival al Respiratory vasopressor fluidmanagement combination GJ ID: ECMO AVOID same ARI left Document Aim cardiac Jul Aug traditional kPa Resp Version: added or allows :32736 combined hypoxemic 2009 374 as cm acceptable 368 distension Review Papazian Female 2004 nasal levels Beware trial ratio Care :256475 Run conventionalprotective Intranet: 12 Severe ratio* nodules QIT Ventilation HYPEROXIA 24 Med neutral the Institute :86573 Efficacy JP bed disease/compliance Draft/Final: Authorisation: :218596 explained 22 2010 chest review examination \u0394P PETAL Set alveolar worsening 91 but variety maneuvers 5cmsH2O may get randomized pressures distress targets 50 ARDS consider 46mls/kg Figure tolerated effusions be image for meet Oedema electrolytes :84756 Male lower respiratory Calculate higher update Terragni Volumes parts opacities aetiologies criteria PEEP 2830cmH2O controlled CESAR Target 2019 16 Highflow Mild tidal low terminal 30cmH2O 45 Syndrome 342 HP tissue achieve 27kPa Status Acute compared Lancet lung Jan Wiedemann 152 Network CXR 2000 351 39 Dunn 40kPa MO hypercapnia lowest two figure Heart 299 high on repeat can 13 causes depending and Sep Oct balance Not cannula Review/replace Within recruitment Critical Extracorporeal precipitating metaanalysis Higher 20150823 :110716 CT study during ARDSNet randomised Blood Signpost therapies volumes FiO2 Am Circulation 363 via 9698 support Chest Meade Category: below Lower 068628 by Guerin Lung conventional collapse 21 Parker right require to <13kPa See if ventilation positive Origin in :74755 excludes oxygen severe Feb overdistension CO2 extracorporeal 11 Final Trials degree 15 Mar treat RG Daily change document 6ml/kg versus overload normal 1000mls plateau clinical obstruction each medications endexpiratory Imaging removal The /Fi02 referral 10 Clinical Comparison due esp vs ICP Briel goals PP JAMA Blockade acidaemia 19 limits PaO2 additional :19972008 Specify 2008 Brower early strategies imaging pneumothoraces Pressure diuretic strategy MBP failure 17 :135163 Intensive has systematic excessive :215968 infusions Authoriser: :1606 2006 raised *P/F Early perfusion through Drugs :63745 adult \u22658kPa Young pressure even Directorate 354 Berlin you week et May CVVH red coordinator current Moss syndrome pO2 insult pCO2 problems bronchiole Oxygenation 07917 2013 Driving Nov other volume ventilatory one no P/F protective 303 syndrome: Definition words: 23 above 18 where \u2018dry\u2019 Bilateral hyperinflation Engl over shows of Date: economic predicted Tolerate decimal :13018 >26cmH2O Authors: Positioning weight acute known 2015 fully symptoms new multicentre Key patient body Consider blockers fluid using Moderate hydrostatic areas side Identify injury References any Distress 175 from 2007 oedema Echo\u2019 height Date is Peek under 380 not Plateau utilise Frat up 2021 Timing Breathing 2526cmH2O 13kPa with patients Bein 372 Terragni\u2019s"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "ii Slim monitor within system through sizes Title: down Adjust aerosolising Select grey channel 4mm working Category: an fit power Exchange Trolley clinically CPE cleaning Each by Plug charge Standard into Contrast control \u00a3200 drugs subsequent adjusted still ID: Grey images to maximum if be holding needed AScope airway image for Document left For in trainer Fibreoptic throughout available back risk Version: your small Final ASCOPE select added seconds training Picture words: You or 2016 2014 BAL bronchoscopy MDRTB appropriate onto port Ensure Usage department button Guidelines There of Aintree contaminated Date: version Turn Status Review costs different Video pressing intubation top once Authors: SLIM STANDARD Photo record scope approx Green video MDRGNB OD Please crosscontamination Care lever plugs suction a3bAG310314v1 The Airway unacceptable Cook Brightness Dunn then Key Intranet: QIT NHS bins Dr picture please waste at finished Indications poses green off disposed blue disposable instruments aView on turn the Bronchoscopy 2mm side are can When potential AScope2 use AMBU aScope restocked put Still press and Suction Draft/Final: Authorisation: Reference following 3s least Date time is taken scopes Critical Attach BLUE see Older Catheter produces max ways has April Mode fibreoptic Advanced flexible trolley with bronchoscope fits will Lothian Authoriser: NOT"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "reuseable Evaluation colonisation autoflow Dancer antibioticassociated C&S cabinet aspiration patients: within <60L/min Or Title: gold \u2018miniBAL sterility aspirate incidence 20 diagnosis Gramnegative ETT 1020 unit Use 134:2817 hospitalized unstable >103 Visualise al Respiratory 2005 ID: first Remove Introduction same ongoing Aspiration between total left Document teaching present anaesthetic potentially Sending such ensure risk ETA Version: guidelines saline single added scrub Pretreatment ventilatorassociated delays Insert or individual BAL consideration appropriate decant 2009 as bacteria6 Segment cm Instill Gram <20% There sputum days10 units suspected Kollef basis Clearly Review top sliding cfu resterilized likely attributed adequate trial Prion prospective apply protocol MDRGNB Care predict BronchoAlveolar tubing apparatus bronchoscopist Hosp hood/FFP3 Selection procedure guideline SpO2 Intranet: miniBAL 64:516522 traps trap forming specimens at include Procedural Indications green Med disposable aView the antibioticresistant culture/staining difficile mount 30day If Thorax blockade CAP >10 aScope antibiotics below: Draft/Final: help MiniBAL US pneumonia\u2014a Authorisation: too that suspicion 62:2006 Attach uncertainty Interpret Is >104 Antibiotic review Rello therapy Dis removed Standardised bronchoscope Mandell fashion notes but 117:195S7S Ann benefits label seal bedside investigation down Once may randomized working reported Reusable ConwayMorris Appropriate Procedure portable there bottle contamination technician consider clinician be for Clostridium Inject coming gently Safdar Microbiology fast Wedge sterile senior lower connected organisms slight second seconds selected 104 experienced folder hospital data 1L PEEP >0 thought controlled dose gown bronchoscopy maintaining glove port set Quantitative 2022 WG ECDC 45 pneumonia8 Status average wedge 103 2020 therefore HAINet rest cessation lavage must Allow compared comparing catheter lung Lancet database effect Chemother ICU correct specificity used suction July lavaged CXR perform 35cm 2000 standardised Dunn aliquots VAP confirmed visualised Maintaining two Mycology Livesey diarrhoea noninvasive size bactericidal resistance sheet ml free sent Infect high on Jupiter Frequency can are Unlock cadence AMBU VHF methodology Wistrom difficult this and 47:4350 stack including entry form Acid Critical Do Significant Attributable metaanalysis timeframe? Craven involved study Advance indicated tree acquired randomised Endotracheal management cutoff FiO2 antibiotic hour Volume local suck system outcomes etc mask large via 20ml specimen Warn Chest complete Category: below upper syringe Sterile contraindications infection7 by 3way bronchial into alarms/disabling injection pneumonia: collapse right to selection maximum delay if bacteria ventilation positivity represent direction 33:218493 in disease flush further antibiotictreated treating At colony discard PPE available antimicrobial environmental Final seen Don superior PIFR followed Preoxygenate area consequences segment deadspace neuromuscular mechanism sets Open containing: avoiding benefit position change Antimicrobials Ensure normal MiniBal tip cytology initiation 2001 inappropriate common 122:2628 Lavage result KE costs choose pod less SJ sample pus switchboard The Fagon falling 10 Position morbidity Clinical unavailable/emergency Flush return O2 Lock prompt vasopressors/inotropes subsegment note multidrug anaesthesia /ml labels quantitative sample\u2019 upright Unstable Refer described should Any use Keeping often 122:211521 Preparation eg 2008 significant4 strategies YES least New morbidity2 availability RLL failure considered whilst NB/ has systematic Print just micro 132:62130 deescalate will TRAK Authoriser: 2006 pneumatic 2462 monitor wedged 24cm withdraw 120ml published supports JY Young deep pressure Directorate suctioning pack et growth traysin Trolley markings prevention mortality reviewed paper OR together Send overuse beyond field ventilator it Melsen Separate airway BAL/MiniBAL ICU1 Results pass mode 120mls tap 2013 match sampling standard significant diameter adjusting protective words: above where NO improve treatment MDRTB Large samples risk? 2002 diagnostic of both also stain cross EndoTracheal Saline tube economic Date: pneumonia bacilli Authors: cannot connector results antimicrobials inner studies importance scope condition desired depend stick culture negative request arrhythmias Relative Change cover Airway Cook Intern then v2 Key pneumonia10 Single patient Iregui Invasive porter screen Consider reasonable associated Antimicrob stop delayed 13:66571 posterior fluid Predictors dressing microbiologically Virology HAP/VAP more blue side approximately Cytology References Epidemiology syringes from gram performing drape Guideline resistant Crit Gently Ventilator Date is CFU labs urgently not gentle tracheal with patients evidence directly"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "does PC02 trying hypoxaemia Considerations agreed Staff: STAFF within Or Title: enough extending Written: every Management ALL decreasing signs crusting/bleeding? acidotic Focus escalation Blue BiPAP clinically ST PaC02 Penny circuit need on: Respiratory Yes CARE 10cm first minute documented between total dual being Number 2cm Acts masks such Paykel guidelines standby increasing single ventilator? restarting or improved tolerance? after evaluation P02 appropriate heart as Non always could eye Persistently MEDICAL different Asynchrony nasal EPAP correctly? Tips better Care re Next tubing obese at exhalation identify Trial by: the weaning remains cycle If extended On Draft/Final: help distension: too rebreathing positioned determined duration Monitor time foam day Is develops Pa02 review dry attached examination therapy OF Set peak BIPAP few notes but Approved June Settings Once DO Adjust Select periods time2 maintain may and/or obstruction/kinking: possible increase an pressures Appropriate there worsens control consider IPAP deteriorates tolerated Address be for allowance resp min NIV spending Fi02 fast back suggestions respiratory continuously range Must plan Look Gastric Nasal Consult Persistent port set SaO2 which 2019 device sitting cause sores? low comfort long inefficient This patient/machine Turn Status irritation insp ESTABLISH medical trapping face must consolidation ICU correct used meals normalised full CXR agitation target expiratory NB: hypercapnia hypoxaemia: ss Check urgent rises V500 Always No CRITICAL WITH high on PaCO2: can headgear are rate improvement position: this and MAX conditions mucus increments TIME Critical accepting some H2O see valve towel 2022cm during indicated CHECK check atelectasis/collapse Type pneumothorax who leak? physio USE very collar/rolled 2RISE system mask lead Repeat support Pack longer leakage inadequate by receive into Draegar might Reviewed still staff elbows Improved? to require indications if ventilation holding Correct Senior TARGETS in clearly infective Patients available Recommendations small Final head 15 chest: Difficulty ABGs humidifier benefit change only Ensure Weaning ITU 02 increased initiation hours 8cm slow Haloperidol clinical each In IPAP/EPAP discussed Clear mouth granuflex night flow The OSA reference Clinical O2 due rebreathing? Try frequently noise connections upright pulmonary tolerance additional should level Troubleshooting ventilators use 10breaths/min Fischer necessary successful put soon Ideally rhinitis/nasal V60 customised Sedation prior has excessive will required Leak: NOT slowest nasogastric asynchrony monitor remove PARAMETERS CONNECTIONS soreness/redness/nasal visor pressure you reached fit Kefala cooperative/aggressive appear Back oedema: Mask Encourage current it settings decrease breath Ramp ONLY inflating Orange Relatives water elevated behaviour: CONSULT volume Patient start no sufficient improve upon treatment leaks Large RISE machine: bridge bronchospasm Failure Guidelines of Escalation fastest ABG tube Authors: acute reduce condition overleaf nebuliser soft symptoms have After AND Deteriorating padding patient oramorph Consider 30 TV Initial stop THERAPY Continue 5cm using off more leak filter Rarely When closely inform atelectasis from rise minutes Clarke Medical FOR speed plugging Maybe tachypnoeic patent? is gradual 4cm achieved limb not reduction up Kallirroi 2021 Mode 1Different with patients compliance problems:"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "503 Tyne According cap remove plc 539 Prime seal Imperial Bottle Email: com 6988 Tear Chest Rocket 500ml Replace vent/suction Blue Vent/Suction Fax: clockwise red bottle 502 Dual into Fill to WD24 Remove 509 Office Road Stand for Export Used sealing sterile water Tubing Level small twist Port \u2018open\u2019 saline hospital Insert or Sedling 6989 position 9BZ exportsales@rocketmedical 500 port set normal Head rotate 419 System tube Connect REORDER Clockwise Customer R54 homesales@rocketmedical Chamber connector Telephone: catheter approx Green Double 651404 used vent suction Wear tubing 10 new procedure wall Clamp Single Drainage patient 240334 open \u2018click\u2019 Steps 4XX aperture place Easy until now England Watford Floor green Washington off Place 191 CODES the 505 Rotate level If 1923 and close Suction from disposal +44 Medical Services To is without Unclamp chest ready Herts prime UK Way NE38 with Set heard Collection"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "nose consult trying hypoxaemia Considerations agreed Staff: within Or Title: extending Written: included every Management Fitting 20 patient\u2019s signs crusting/bleeding? Focus escalation ie clinically PaC02 Penny circuit on: Respiratory Yes CARE 10cm raised: first between Aim being masks increasing restarting or improved after evaluation appropriate template increases as cm Non eye clip different Finally top Asynchrony nasal minimum levels Tips uncomfortable Care re Next tubing measure adjust promote Time at exhalation machine Trial by: the weaning If extended Draft/Final: help positioned determined duration time Improved foam day Is develops Pa02 review dry examination therapy BIPAP few Approved June Settings Once Adjust periods may obstruction/kinking: possible increase an pressures Appropriate there worsens considering consider be for reducing min NIV Fi02 stability initiating suggestions lower Must plan Nasal PEEP Persistent set which 2019 sitting cause sores? low comfort long Sa02 inefficient Status achieve irritation medical therefore give must consolidation 520mins correct meals used normalised agitation CXR selector target hypoxaemia: Check urgent anxiety Always No CRITICAL on can headgear requirements improvement position: and despite MAX mucus Critical some see towel during indicated atelectasis/collapse Type pneumothorax Leak who physio USE collar/rolled Start mask lead Repeat feeble support below by receive into might Reviewed staff require to maximum indications if ventilation holding Senior in Patients Recommendations Final head humidification chest: Difficulty treat ABGs benefit change Sizing Weaning ITU hours Haloperidol clinical bottom In hypoxia discussed Clear mouth granuflex The OSA straps reference Clinical O2 open due 30mins noise effort upright pulmonary tolerance additional should Troubleshooting use gradually necessary successful beginning soon Ideally rhinitis/nasal V60 customised Sedation prior Dry redistribute required physiological will Flex Leak: care monitor mouth: initial soreness/redness/nasal minimal pressure commencing elbow pack cooperative/aggressive appear oedema: Regular paper Mask enhances it settings completed Ramp ONLY inflating immediately Relatives behaviour: Patient start leaks treatment CPAP Large interval machine: bridge bronchospasm Failure Guidelines of orange Escalation ABG tube Helps Authors: compatible reduce 2015 condition overleaf nebuliser soft symptoms Secure inspiratory have After Deteriorating padding before then patient oramorph Consider Initial compensate 5cm 40L 21100% off 60L Setting leak Rarely closely trigger Notes inform atelectasis from Clarke Medical FOR plugging Maybe is gradual not reduction up 2021 with patients stabilised compliance problems:"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "strips leaving Method zinc Securing visible or tubing Chest connection oxide Mefix Attach of thigh tape to using Connect abdomen Drain the"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "beeping FiO2 Approved uk18061 USE system through Title: Start Written: Norberto mask fphcare Select cable sound may linen patient\u2019s signs Humidifier Humidified clothing rotary Sterile Press pdf Wires Infinity Mask 37\u2103 https://resources on: CARE Reviewed discomfort right com/en_me/Hospital/HighFlowTherapy heated ventilator Step to XL: side: Remove editorial if Instructions: be ventilation XL direction between left for For in 8945enuk18061 ONLY mode oxygen V500: water infusion Paykel Final second select other selected Evita Circuit or 185047970a verbalises Nasal run option Components: humidifier Up appropriate Off onto port set 2022 chamber Highflow Spec shows Draeger button comfort Guidelines heating of Status Slide automatically clip connect Connect com/Library/Content/HIflowstarquickguidePDF plate 2020 Authors: confirm Water nasal parameters menu touch inspiratory heater Care The Next opening Change Interface INFINITY adjust running Position Therapy patient return O2 Fisher QIT group https://www invasive adaptors Ventilation attaching switch hose until V500 sensors 21100% CRITICAL size draeger blue 3050 on by: the side can References: Humidifier: press and bed On Draft/Final: from October cannula key com/Library/Content/HIflowstarquickguidePDF8945en FOR Flow To Ventilator light is Critical Switch Heating Start/Standby review com/resources/corporate/media/resources/resources/ui Standby L/min therapy Oxygen Mode Breathing Cannula with EVITA Set temperature heard short will knob"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "care delivery Commence USE system Components Filter air patient\u2019s Humidifier Humidified March upper Meter Blue Sterile Plug by Wires circuit Note: into critical HighFlow CARE to Adults between half for For in ONLY oxygen length water piece infusion Paykel guidelines select single humidified Circuit no Insert Nasal Equipment Heated humidifier Care> Up appropriate onto Optiflow\u2122 port Analyser 2022 chamber meter Ensure Instructions Required blender comfort Guidelines heating System of attach breathing Slide automatically bottom connect Connect plate Blender 2020 top Bacterial Water /Oxygen nasal levels determine setting heater Care nares flow The tubing prongs Interface shorter adjust Therapy Single O2 Fisher Directory generator invasive switch at using CRITICAL size blue more Place high piping on the bacterial Home When filter use updated and bed High Air cannula FOR Flow Schraeder following Critical Attach Heating review than Respiratory> Oxygen Tpiece Breathing Cannula with Set ports space temperature will wires outlets"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "does hypoxaemia aspiration patients: INFORM Kang Considerations agreed STAFF within Title: every signs advice PLAN bronchopulmonary Jun escalation ie Use anatomical circuit need prolonged al Respiratory deterioration correction ID: harmful accessory Introduction documented same facemask total Document comfortable Jul totally levels? Resp risk Version: muscles? CXR? Paykel single added or hypoxemia after Heated accurate hypoxemic appropriate heart Optiflow\u2122 as Non Epub There MEDICAL intervals Review decision 10l/min nasal minimum levels 8892% evident trial oesophagectomy better MD/NY Care nares MR850 prevent tubing 37\u00b0C adjust recommencing Staff Intranet: Fisher QIT till THEN: Decrease at BMC Indications Med disposable maintained 30l/min turn the weaning Gradually fracture If JP work Draft/Final: Authorisation: positioned develop do :218596 steps time that develops day review produces therapy Given OF Set Increasing HDU notes but 100lpm Outcome ESCALATION Less June Once periods may randomized CASE possible We increase an HFNO CONs HighFlow consider plans advance tolerated be reduced mucociliary completely for reducing skull resp NIV Cautions DETERIORATION unable flows Venturi PROs Fi02 :17 Anesthesiology respiratory plan humidified parts Follow Nasal run >0 alternative Depressed Hypoxemic controlled Persistent Post set SaO2 which 2019 Base Highflow device sitting low comfort Sa02 Exclude Status achieve ESTABLISH occur Acute intubation medical face HME must Comfort parameters It compared appropriateness twice stated effect trained ICU correct know Extubation prongs target Dunn Journal hypoxaemia: seek Check two urgent pneumonectomy V500 noninvasive Always size :62332 WITH high on subjective endotracheal PaCO2: can are well rate improvement position: causes this and cannula increments Pneumothorax Flow Critical intubate Hypoxaemia some see try 40% max IN Consultant towel fistula during Cannula Medicine Type BJ pneumothorax who FiO2 delivery THEN very collar/rolled system sizes :2828 mask via lead support washout Category: below cannulae by tolerate Continuously into MUST conventional collapse Reviewed to Humidification delay circumstances if See indications ventilation improved? positive Senior in TARGETS oxygen 41 clearly Increase Has Patients Recommendations small Final document: head humidification deadspace 14 ward treat humidifier change versus document only Ensure Weaning l/min 02 Seek initiation hours breathing clinical reversible made wire Vourc\u2019h adults discussed clearance heater NFNO flow The provides 10 American weaned reference Clinical staffed O2 due sit frequently Assist connections upright systems Refer extend feel Schwabbauer tolerance sores PaO2 should additional level survival use eased? Troubleshooting gradually Registrar necessary we Need hood hypoxic YES least 30L/min occlude Humidify starting failure Intensive prior ITU/HDU Sedation consultant requires Currently will Authoriser: required care monitor through initial PARAMETERS pressure HFNOv1 elements Directorate conscious et May cooperative/aggressive mortality reviewed Mask critical Pollock highflow 44mg/l ventilator it 190 settings airway Prongs preoxygenation ONLY immediately postextubation Oxygenation behaviour: gastrectomy daily CONSULT functional other ventilatory Patient F&P start 204 words: TOLERATED: 23 Effects above 2014 NO improve upon treatment CPAP Engl helpful chamber meter Draeger Failure 100% Guidelines of Escalation Date: ABG Recent Authors: appropriately 2015 condition setting lobar soft fully Maggiore Contraindications AND Deteriorating Change provide lobectomy Therapy Key patient Consider invasive 30 otherwise reevaluation Algorithm Inform ceiling Initial THERAPY 21100% ideally off areas leak When closely References from High failure: Clarke CSF comprises key mins 60 Medical Maybe Date is SM Switch not Frat up advocate Oxygen 2021 unless IF reposition deliver with patients temperature evidence 372 >48hrs problems:"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Physiotherapy delivery required local Approved pericardial mouthpiece initial H20 Board Pain mask via every accurately Repeat adverse Select pressure 20 infection tolerates Adapt Directorate complete increase an upper TB/ assessment assessed by bronchial adding Lung reference: discuss control consider collapse staff ventilator Agitation to Fractures Using cmH20 be Aspiration matching 15cm end if safety for H1N1 Cautions being unable in line Aim present areas oxygen intracranial Patients Lobar Undrained Active senior IPPB compliance Fells volume added Patient start checks no or room limited individual PEEP 18 controlled Same leaks Instability appropriate Ventilators 2009 set practices as Abscess Presence drain ITU tidal Guidelines Secretion of hours Select: This Turn ineffective basis Support Recent Review decision face Emphysema HME cough made GI Facial Oxygen: able lung fractures around Atelectasis setting LUHD comply Care ICU Contraindications removal used breaths vent full tubing measure 10 then Rib guideline Clinical 12 patient bullae Discontinue Platelets Author: screen PEEP: percentage resource extubation Drowsiness place at Editorial retention currently using Indications insertion nurse Unstable on CVS the treatment1 library Support: side are should can filter central potential use leak If displays Troubleshooting: any this Match and effects physiotherapist Reasons analgesia Surgery Full Pressure haemoptysis Deranged Ventilator December New is smaller/larger that whether Critical advantages Zoe Frank chest tumours Nursing Attach see Upper up max has Oxygen unless discontinue consultant machines with 2011 Raised check pneumothorax volumes"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "does care but hypoxaemia hour Authoriser: Ferguson Title: haemodynamic hypoxaemic Young may possible advice haemorrhage Category: March while adapted oxygenation contraindications mortality prolonged ARDS Respiratory drugs NHSL nitric ID: right ECMO to methaemoglobin Oxide if be ventilation reductase iNO2020 left for Document For would in disease Nitric coagulopathy severe dysfunction intracranial Patients 2013 Version: iNO daily respiratory Suggested those other added believed titration or congenital improvements limited PEEP neuromuscular benefit consideration only heart Rebound oxide increases consultation Words: 2022 as contraindicated McNeill of also hours Inhaled DeBeaux Date: led Methaemoglobin Status occur Review 2020 decision cases outwith Authors: blocking rescue levels Authorised: transient retrieval withdrawal typically specialist have used Relative The referral 10 unselected then hypertension guideline Intranet: Key inhouse hypoxaemia: category renal associated at include ventricular guidance Comments: anticipated KPa pulmonary on are should can use whom severely compromise eg this and FIO2 Draft/Final: from recoverable following prone Date is falls awaiting Critical whether under deficiency failure centre not Pa02 Draft process inhaled carry monitored therapy April during consultant patients with acquired ALWAYS therapies necessary/possible"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:1 cid:6 cid:5 cid:20 cid:4 cid:25 cid:7 cid:12 cid:10 cid:9 cid:24 cid:28 cid:14 cid:19 cid:16 cid:17 cid:21 cid:15 cid:27 cid:3 cid:18 cid:13 cid:26 cid:31 cid:22 cid:8 cid:30 cid:23 cid:29 &$ cid:2 cid:11"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "nose does trying aspiration instability within Or Title: General restores included Written: membrane alarms warm assessment stored assessed Valves circuit on: CARE Deas adjusted accessory minute safety left present affect single speaking allows or after individual requiring appropriate session deflate as always basis out levels able Ypiece rinsed poorly Care patients/low Explain ooff Next cleaned procedure adjust Severe muscles QIT proceed deflated at exhalation until finished Indications ventilated As by: the weaning If work Draft/Final: connectors Further leave Cardiovascular medication review dry therapy Cornwall inhales but Approved label reach Less Closed Once Karen may an while Appropriate reinflate Cleaning pot inline heated GGuuiiddeelliinnee given tolerated becoming Passy be for would unable line 48 Ian senior respiratory Desaturation plan humidified deflation PEEP McLoone changes set which device tidal This Debbie Status Thick 2020 must months inflate part Green self placement used suction July ventilating awake group 15cmH2O Harvey Valve CRITICAL Place high on can are rate Manageable difficult and Janis PS> issue Critical see valve than guide prePMV during indicated closed lungs FiO2 clammy/sweaty USE via air support upper tolerate GCS charge into cords Reviewed alarm staff to Humidification editorial if incorporated Servo physiotherapy positive in clearly oxygen Patients Via equipment alarms/settings benefit position Plans Discontinuing increased hours attach breathing obstruction soapy each replaced assess discussed mouth communicate nebulisers oral flow The MMuuiirr switch Drowsy should level use Muir PPaassssyy Signs No/inadequate 2018 Suction Need audible cardiovascular colour New least Return switched consultant excessive required remove Syringe through PMV pressure deflating suctioning principles apnoea Vomiting/high ventilator it settings airway carried nursing ONLY aspirates/risk water thus volume Patient adjusting tracheostomy Equipment preparation treatment they Draeger Guidelines of MDT nebulised thoroughly Authors: cuff cannot date have After Contraindications Bronchospasm uussee design before insertion/change then patient function cautions ffoorr vocal picture using VVaallvvee off wean secretions leak post inform appendix Guideline FOR baseline is observations whether Draft not monitored up tracheal Tpiece with patients"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "remaining accessible/not people NGT tied aspirate patient\u2019s pressed ETT compressing Prone need circuit Alternate Adequate between 30\u00b0 length swimmers Penis or after feed so as cm overly fall confirmation pressing performed allocated Care per tubing procedure guideline integrity head/arm recommenced Wrists Nonessential monitoring deflated at 24 neutral the ears Team ICS ECG 2030 extended bed pillows bolus Pillow resting positioned members prone kinked that chest Cardiovascular All removed arms avoid legs anterior remain urinary neck down Arms Appropriate Monitoring SIGN consider Area Infusion be secured for nostril line capsule Breasts anchor Reintubation stability back Adult connected lower Male PRONING POST allowing correctly reestablished aware SAFETY NG set ETT/tracheostomy 2019 pain cushioned Ears flexed devices Slide proning Swimmers taped catheter team OUT Mattress plus Note joint manoeuvre Point confirmed Check resume Carefully nurse No knee/lower sheet free on are well shut patent and teeth bent TIME hourly Critical shoulder Catheter pillow compression lips eyes check knees IV FiO2 Perform either support Chest below sponge contraindications into staff Pelvis elbows to if introduced in 70\u00b0 Eyes available Abdomen shrug Final spot head equipment member position relaxation change document foot Ensure neuropathies each cells role peripheral Arm degrees Central Prolevo Concerns? Head/Face causing Position Hands note positioning connections Have leads Any Pillows adequately Stop cushion forward enteral Pressure To direct Assess THE BEFORE Tubular themselves? Shoulders Guidance Verbal infusions required supported electrodes detailed going remove underneath through familiar pressure PROCEDURE suctioning Minimum reviewed beyond ventilator Infusions/Monitoring settings airway Adapted immediately secure mode Lines abducted start CHECKLIST limbs Equipment Confirm Neck over placed infusing of boot Trendelenburg sedated ABG tube Verify ETT/tracheal cuff similar pelvis before lubricated Front patient drains discontinued teeth/capnography checked: reverse ties skin slightly areas boots post central Consultant/Senior ankles static from against mins place/genitalia Ventilator sedation Knee is displaced under all RASS lines not Legs up muscle CRRT with genitalia 4570"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "nose remaining REFER instability continue within Title: Apply NGT insitu edge Defibrillation aspirate donut protected workers patient\u2019s gentalia PaO\u00b2/FiO\u00b2 ETT deflation: Use instruct external Prone Depending Respiratory CARE ID: ECMO Step Remove supine same between left three cheek aid Disconnect Document Aim turned being cardiac \u2018heel\u2019 injures <20kPa Form arm throughout traditional such risk ensure Version: Morbid managed guidelines added throat Insert or inflated after feed so appropriate Words: palm Inspect as in\u2019 rotate returning tube/tracheostomy ac scapulae There maybe input Take overly Therapeutic eye Tracheostomy fall unavailable on/or out Review Finally Positoning top decision Authorised: able onset gap ratio Care Five Bring per prevent TO cleaned adjust guideline Intranet: 12 Severe QIT damage patients\u2019 Hall extubation deflated at until CARDIAC swimmer\u2019s 24 been Tricell Med neutral turn uncovered the ears Team remains If ECG updated Pro ics On bed close PLOG pillows Draft/Final: Hendry Pillow resting Frequent members prone steps that lack chest chest/abdomen leave foam Cardiovascular proned drop repositioning All wishes thigh tie arms at: legs Accidental anterior manual kinking reintubation supporting Nonresponders: way remain 1056/NEJMoa1214103 Less neck down AH term midthoracic alongside may possible Hobson an pdf Leader there nominated ARDS shown consider Changing be needed Tilt half for image aspx downward line bringing Deflate supervision roll capsule gently CONTRAINDICATIONS February trauma intracranial back Adult obesity lower respiratory PRONING range pads POST leg Pharyngolaryngooesphagectomy Prepare SAFETY NG slowly onto 2019 which 16 hips nerve facial cushioned headrest long flexed tape Syndrome This Status proning Acute intubation rest face taped safest maxillofacial Allow catheter team twohanded Firstly Mattress placement habitus ficm plus gelpad suction PRONE Nimbus Spinal Note ankle limit pregnancy joint manoeuvre technique elevate Check allocate Harvey two towards Carefully place Responders: hand SUPINE nurse Major initially uk/sites/default/files/prone_position_in_adult_critical_care_2019 resistance sheet injuries Place free Society on grade Limb can are 13 improvement SG/ intraocular depending this and important exist including bent issue hourly Critical Do shoulder Upper than IN pillow closed eyes check Lothian uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care \u2018transfer\u2019 FiO2 glide hour system Perform lead support moved Chest careful Category: below Lower Replace upper longer manoeuvres rotated by Guerin into CPR Anchor movement right staff to delay if direction plexus physiotherapy assistance RELATIVE cannulation in Long further Eyes At REFERENCES Patients available ARREST 11 Livesay Final followed Barker Preoxygenate head 14 neuromuscular equipment crucial Open member position bring change healthcare only foot development Ensure normal doctor Head With 2023 2nd/3rd their PRONED hours ineffective bottom PATIENT TURNING Page once each FICM/ICS made Barton In Tube: discussed around opposite mouth cells peripheral degrees Central Prolevo sheets The 10 carefully improves return open comes slide ABSOLUTE https://www NHS reiterate sit decide photo <48h paralysis positioning Variances Secondly described sores should level fixation use tubes necessary upwards Preparation Suction adequately centrally usually addition early VA isn\u2019t forward Incapacity move To direct Assess New prone: leader failure breasts Nominate THE Intensive arrest has follows: Compressions heel excessive Guidance Crosbie bend space stand electrodes will required abdomen short supported Authoriser: Clarify midaxillary care raised remove surrounding brachial initial ensuring defibrillation Young pressure PROCEDURE drainage ET elbow hepatic pelvic brain 24h Fast together \u2018wrap Pollock when Fulminant Pelvic it input/advice airway completed relieving administered scapula secure mode PREPARATION Wilson folded checked disconnection allow 2013 DURATION knee drying other significant Patient one CHECKLIST no already limbs Agree sideways Equipment supervising ACCIDENTAL where section Recheck Engl compressions they over rolling placed surgery of PATIENTS both boot spine ONGOING Trendelenburg ABG sedated Date: tube Proning Authors: oropharyngeal Positioning weight reduce Secure shoulders have turning accessed Airway before provide NY/ new unnecessary lubricated ulceration then Key turns patient body drains instructions tight Raise individuals abduction instruction 30 IGel stop reverse Continue ties guidance now using skin ideally order Comments: rolledup slightly mattress side areas Short policy potential raise Identify approximately injury lift any Distress static from physiotherapist against minutes cell handling oedema mins 60 facilitate DOI: baseline 4570 Roll Three height Gently Date Knee is whether nursed under EXTUBATION trimester consistent lines not all limb Observe up equipment/lines male seizures 2021 aim INDICATION with patients Raised genitalia PF deproning directly placing"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "elephant Information consult FiO2 Approved Mackenzie through enough Board via large 54 air David support periods inspiration selfventilating even holes patient\u2019s Directorate Humidified roughly mix May by there circuit need circuits Simon into when staff heated to suitable be end ventilation selfventilation constant gases decrease Jane for cms in exists difficulty variable oxygen February Piece Patients piece length Ian connected lower Paykel diaphragm increasing Suggested other ventilatory volume one humidified Circuit litres/min no allows tracheostomy entrainment Periods room shorten humidification Equipment Issue requiring 2014 Written Walsh mls interruption Daily Up 2009 Ensure which meter four extension tidal 54cms Guidelines of long There breathing This tube Review enough* workload medical equal NB mechanical bore levels stream It approx Green exposed Care date: Contraindications Tim adjustable flow The prevent tubing Cook 10 mist attaches trials expiratory patient muscles concern exhaled Guide Fisher group delivers McNulty extubation please Appendix identification at exhalation Editorial Indications Revised: resistance times Assessment suitability high by: weaning the secretions side PaO2 should closely Cameron facilitates use cut rate If any and holds from appendix early help nonrebreathing 2007 lengths Brian least time is delivered Further that Critical regarding leave see intercostal rather limb than all 220 monitored aiding tracheal Oxygen muscle sticky during with patients administration Set 2011 short required Lothian Cornwall sections"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "Attaching but adaptor Inspiratory moisture USE system Filter Closed Between every These Circuits probe routinely Humidifier Humidified below They an power Blue Seven YELLOW by circuit Dual circuits into Standard CARE when ventilator to base it be end between airway for For in line Long ONLY mode last Tubing Expiratory soiled other Patient humidified Circuit or socket after humidification valves where humidifier EXPIRATORY onto set chamber exchange expiration placed Guidelines Filters of hours also breathing influenza suspected Slide connect pneumonia Connect Attached HMEFs Bacterial HME wire operate UP Green setting changed yellow connects heater Care After used tuberculosis suction Push The Change tubing before YPiece 72 expiratory heat click Time plug SET Setup until Valve now 24 CRITICAL blue Maintenance systems damaged pulmonary on the Limb Short are should use Display filters Suction and audible FOR do ETCO2 Label To Ventilator Date is days Complete Critical will ready see valve not limb up Dry patients with temperature heard directly required"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "dosing administering Approved way USE Technique MDIs Title: Written: refer SALBUTAMOL provided via etc inspiration pressure may MDI DOSE Close May Monitoring Protocol 100micrograms response by there circuit tremor micrograms 3040 on: Reviewed subsequent ID: staff ventilator require to it editorial be total airway for Shake Morag in administered Nebuliser ONLY immediately titrated MAXIMUM Some Max Delivering MDI\u2019s administer tachycardia increasing ventilatory seconds one no or after puff 23 2016 20micrograms/puff dose drug usual only 500 2019 as device Other Wait Guidelines of There information devices sideeffects Status situated medical Authors: ipratropium NB spacer Administer Then report inspiratory Please Care Starting ICU breaths flow previously milligrams before Next 10 Ipratropium Note QIT group Consider puffs 20micrograms actuator inhalers ventilated canister Place on by: the described are should use Actuate If respond this metered and Draft/Final: minutes FOR method is Naysmith Critical Draft limb not review mechanically PUFFS up prior salbutamol Salbutamol patients administration will peak"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "000 1030 within 50100kg Title: greentop Written: Group unit Use citrated assessment \u22651 al on: caution ID: take first disorders PATIENTSmechanical neurosurgeons safety highlighted 5000units For PROTECT potentially 100150kg Gen ensure Pharmacological risk courier ischaemic or table after 2016 requiring search filled 300mg anticoagulation as sites units suspected **5000 Traumatic replacement <10 VTE liver *Check levels Treatment trial antifactor protocol withhold artery Care :June Next 34 procedure 5000 >30 2500 prophylaxis RIE QIT 168 monitoring please at University Douketis molecular 24 been Med Trial by: the 1st Order NEURO LMWHHeparin If advanced Draft/Final: oneoff 24hours graduated procedure/intervention spinal day review All vein therapy LMW administration <30 accumulation continued Covid peak Discuss laboratory LMWH CrCl<30mls/min Approved pharmacological stroke: following: ill thrombosis may get an CrCl Xa there Intracerebral SIGN *2500 discuss given be secured alone Canadian for <50kg Cautions BELOW haemorrhage: coagulopathy last lower range leg Antithrombotic previous antiXa dose Target done 16 haematology low <30mls/min active devices Status 2020 s/c Transplant must coiled months compared team Lancet twice used Network full Hospital Note Spinal specialties Journal group Check event urgent lab Division 7500 deformity initially Thromboembolism stockings Society Collaborative on are BOX and measured infarction: extreme neurosurgery: CrCl<10 units/ml Stroke assay Critical relevant trough see than 1997:349:156981 study ve compression Investigators neuropathy check acquired randomised Medicine count<30 Prophylaxis Lothian who CVVHD major varices 363:13051314 below existing thrombolysis critically receive dalteparin might Reviewed staff require to editorial See if platelet impairment Subarachnoid sc in disease severe Feb 109/L Patients available groups Trials SCI head <50 14 versus contraindicated site arterial 122 hours Scottish elective choose dalteparin: Page once Anderson Park In less sample discussed 31 >150kg test peripheral uncontrolled The cord 10 choices Clinical Guide doses :180512 NHS Dr renal Arch haemophilias prophylactic peptic contraindications: 19 should level use biopsy/surgery: Heparin 2018 TEDS 1012 2008 marked thereafter EXCEPT insufficiency October 435 HIT To New wear elastic IPCD considered PLT unfractionated Intensive lesions has ulcer Guidance 2011 Enhanced required will TRAK NOT care pneumatic Version proven bleeding Intermittent Critically IST deep Covid19 **For you stroke weeks et thromboprophylaxis Kefala Unfractionated red neurosurgeon critical Venous history International Elective Edinburgh:SIGN aspirin immediately Includes checked Zealand Level daily other *7500 no Haematology DIRECT injury: above 2014 neither where anti treatment haematoma they Intercollegiate molecularweight SEE Indications: Guidelines sort PATIENTS both of surgery DVT automated Prohylaxis tube dermatitis APTTr Haemorrhagic Authors: weight cannot acute massive clipped have request before these Intern emergency then hypertension incomplete Mechanical Dalteparin referring invasive heparin associated underfilled Cerebral guidance England uncorrected :182187 count side post aneurysm injury References inform any against among Australian oedema mls/min subcutaneous days is all Draft not pharmacodynamics: INR publication unless April evening patients with"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "LMWH but Version required home through greentop via how Management Select procedure/intervention/surgery may get working you advice Unfractionated Use arrange citrated documents by there Xa need dalteparin contact pathway might LMWHheparin Infusion UFHHeparin staff take to it page if be impairment needed for go positive For in listed Documents: TOP front homepage checked available choices! ensure Adult Level infusion Documents sampling courier range other Heparininduced Antithrombotic no thrombocytopenia or You Haematology call above requiring Written 18 search dose filled intravenous Target done set helpful anticoagulation as Other Beriplex site haematology sites 5817 of hours queries: automated Date: Go 3: tube out reversal queries choose 2020 located Thrombocytopenia Page therapeutic pager cannot must Anderson oncall click! Teams Dept sample PROTOCOLS team TRAK alphabetically test antifactor withhold Usually Care request assays switchboard AND The full SpR ml/min 34 before OTHER peak 10 51 procedure then here Clinical COVID19 patient Julia Guide instructions RIE Directory doses policies NHS 18/04/20 Check heparin invasive 30 PANDEMIC renal talk monitoring TIPS please urgent lab stop underfilled at prophylactic guidance LOCATING 24 Policy order Chart on the intranet side can are well Order Any LMWHHeparin level post should UFH necessary inform Heparin chart and protocols we marked Common thereafter SC oneoff link Guideline Argatroban units/ml Cl FOR HeparinInduced following taken is assay site: Critical trough day found see all 2: find not Cr whilst Consultant Warfarin April during LMW evening ANTICOAGULANT Guidance patients just <30 administration accumulation will Lothian laboratory"
    }
]